<SEC-DOCUMENT>0001808805-26-000034.txt : 20260728
<SEC-HEADER>0001808805-26-000034.hdr.sgml : 20260728
<ACCEPTANCE-DATETIME>20260728160639
ACCESSION NUMBER:		0001808805-26-000034
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		64
CONFORMED PERIOD OF REPORT:	20260630
FILED AS OF DATE:		20260728
DATE AS OF CHANGE:		20260728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nautilus Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001808805
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				981541723
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39434
		FILM NUMBER:		261211870

	BUSINESS ADDRESS:	
		STREET 1:		2701 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206-333-2001

	MAIL ADDRESS:	
		STREET 1:		2701 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARYA Sciences Acquisition Corp III
		DATE OF NAME CHANGE:	20200408
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>naut-20260630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e9007-3d81-7923-8b9d-11e8abe8f7df,g:a24f2a1f-f751-4ff8-9f53-5ed913cc112d,d:be513a7507ca44a6b324aa5f298cbb8b-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2026" xmlns:naut="http://www.nautilus.bio/20260630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>naut-20260630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001808805</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-26">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-27">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2026</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q2</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" scale="0" id="f-750">1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="naut-20260630.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>naut:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="institution"><xbrli:measure>naut:institution</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-09</xbrli:startDate><xbrli:endDate>2021-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:PrepaidExpenseAndOtherAssetsCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:PrototypeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:PrototypeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CostOfRevenue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis"><us-gaap:QName.domain>us-gaap:CostOfRevenue</us-gaap:QName.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_1"></div><div style="min-height:9pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.792%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.434%"><tr><td style="width:1.0%"/><td style="width:2.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">x</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">June&#160;30, 2026</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.434%"><tr><td style="width:1.0%"/><td style="width:2.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.252%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________ to _________ </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39434</ix:nonNumeric></span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">NAUTILUS BIOTECHNOLOGY, INC.</ix:nonNumeric></span></div><div style="margin-bottom:5pt;padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.550%"><tr><td style="width:1.0%"/><td style="width:32.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.325%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">98-1541723</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">2701 Eastlake Avenue East</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Seattle</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Washington</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">98102</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">206</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">333-2001</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant's telephone number, including area code)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"/><td style="width:35.035%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.416%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">NAUT</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>  &#9746;    No  &#9744;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>  &#9746;    No  &#9744;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:58.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.218%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.952%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">o</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">x</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">As of July&#160;24, 2026, the registrant had <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">127,255,223</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">NAUTILUS BIOTECHNOLOGY, INC.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_13">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_13">iii</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_16">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_16">Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_16">iii</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_22">Condensed Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_22">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_22">, 2026 and December 31, 2025 (unaudited)</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_22">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_28">Condensed Consolidated Statements of Operations for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_28">a</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_28">nd Six </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_28">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_28">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_28">, 2026 and 2025 (unaudited)</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_28">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_31">Condensed Consolidated Statements of Comprehensive Loss for the Three</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_31"> and Six</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_31"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_31">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_31">, 2026 and 2025 (unaudited)</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_31">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_34">Condensed Consolidated Statements of Stockholders&#8217; Equity for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_34">and </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_34">Six </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_34">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_34">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_34">, 2026 and 2025 (unaudited)</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_34">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_40">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_40">Six </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_40">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_40">June 30</a><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_40">, 2026 and 2025 (unaudited)</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_40">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_43">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_43">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_88">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_88">20</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_121">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_121">32</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_124">33</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_127">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_130">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_130">34</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_133">Risk Factors</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_133">34</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_136">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_136">79</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_139">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_139">79</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_142">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_142">79</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_145">Other Information</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_145">79</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_148">Exhibits</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_148">80</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_151">SIGNATURES</a></span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibe513a7507ca44a6b324aa5f298cbb8b_151">81</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in the sections entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; Forward-looking statements include, but are not limited to, statements concerning the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on the success of our proteomics platform (the &#8220;Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">platform&#8221;), which remains in the development stage and subject to scientific and technical validation;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the timing and progress of the development of the Nautilus Voyager platform (including our broadscale assay) and any commercialization timelines;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the functionality of the Nautilus Voyager platform, including our plans to expand our proteoform portfolio and develop our broadscale assay;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the availability of private and public research funding for proteomics research and development activities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates of our addressable market, market growth, future revenue, key performance indicators, expenses, capital requirements and needs for additional financing;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the rate and degree of market acceptance of the Nautilus Voyager platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the Nautilus Voyager platform on the field of proteomics and the size and growth of the addressable proteomics market;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage and grow our business and commercialize our Nautilus Voyager platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement our phased commercial launch plan for different applications of our Nautilus Voyager platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model and strategic plans for the Nautilus Voyager platform in both targeted proteoform and broadscale proteomics analysis;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain intellectual property protection for our products or avoid or defend claims of infringement;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the performance of third-party partners, manufacturers and suppliers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in applicable laws or regulations;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise financing in the future;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the length of time that our existing cash resources will fund our operations;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our success in retaining or recruiting, or changes required in, our officers, key employees or directors or other key personnel;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the volatility of the trading price of our common stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop, manufacture, support, and commercialize new products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to be in compliance with the Nasdaq Listing Rules, and maintain the listing of our public securities on The Nasdaq Stock Market LLC;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations about market trends; and</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of local, regional, national and international economic conditions and events, volatility in the global financial markets and general economic downturns, on the foregoing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements include statements that are not historical facts and can be identified by terms such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or similar expressions and the negatives of those terms.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item 1A, &#8220;Risk Factors,&#8221; elsewhere in this Quarterly Report on Form 10-Q. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q also contains estimates, projections and other information concerning our industry, our business, and market opportunity, including data regarding the estimated size of the market. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report on Form 10-Q may appear without the &#174; or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_13"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_16"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">As of June&#160;30, 2026 and December&#160;31, 2025 (Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.927%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2025</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">13,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">12,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-32">70,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-33">91,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">3,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-35">2,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">87,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">105,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-38">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-39">3,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-40">25,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-41">27,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-42">45,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">52,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-45">1,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-46">163,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-47">191,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-48">1,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="f-49">943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">3,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">3,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">3,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">8,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">7,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">23,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">26,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-58">32,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-59">34,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 8)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-60"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-61"></ix:nonFraction></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-62"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-63">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-64"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-65">200,000,000</ix:nonFraction></ix:nonFraction> authorized as of June&#160;30, 2026 and December&#160;31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-66"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-67"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="f-68"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="f-69">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June&#160;30, 2026 and December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-72"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-73">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-74"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-75">1,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of June&#160;30, 2026 and December&#160;31, 2025; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-76"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-77">127,224,640</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-78"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-79">126,469,610</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June&#160;30, 2026 and December&#160;31, 2025, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-80">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-81">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-82">492,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-83">488,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-84">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-85">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-86">361,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-87">332,020</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-88">131,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-89">156,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-90">163,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-91">191,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">Three and Six Months Ended June&#160;30, 2026 and 2025 (Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.807%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-92">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-94">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-96">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-98">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-100">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-102">190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="f-104">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="3" id="f-105">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="f-106">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="3" id="f-107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="f-108">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="3" id="f-109">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="f-110">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="3" id="f-111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-112">9,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-113">10,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-114">19,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-115">21,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-116">6,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-117">6,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-118">12,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-119">14,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-120">15,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-121">17,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-122">32,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-123">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-124">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-125">2,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-126">2,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-127">4,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-128">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-129">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-130">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-131">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-132">1,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-133">2,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-134">2,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-135">4,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-136">14,469</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-137">15,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-138">29,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-139">31,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-140"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-141">0.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-142"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-143">0.12</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-144"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-145">0.23</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-146"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-147">0.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-148"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-149">127,135,738</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-150"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-151">126,204,632</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-152"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-153">126,886,646</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-154"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-155">126,174,603</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Three and Six Months Ended June&#160;30, 2026 and 2025 (Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-156">14,469</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-157">15,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-158">29,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-159">31,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on securities available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-160">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-161">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-162">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-163">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-164">240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-165">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-166">574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-167">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-168">14,709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-169">15,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-170">29,740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-171">31,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_34"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Three and Six Months Ended June&#160;30, 2026 and 2025 (Unaudited)</span></div></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.051%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Total Stockholders&#8217; Equity</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-172">127,070,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-173">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-174">491,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-175">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-176">346,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-177">144,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-178">69,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-179">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-180">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-181">84,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-182">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-183">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-184">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-185">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-186">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-187">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-188">14,469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-189">14,469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-190">127,224,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-191">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-192">492,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-193">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-194">361,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-195">131,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.166%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Total Stockholders&#8217; Equity</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-196">126,148,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-197">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-198">483,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-199">189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-200">289,632</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-201">194,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-202">18,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-203">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-204">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-205">138,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-206">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-207">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-208">1,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-209">1,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-210">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-211">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-212">15,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-213">15,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at June&#160;30, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-214">126,305,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-215">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-216">485,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-217">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-218">304,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-219">181,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_37"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Three and Six Months Ended June&#160;30, 2026 and 2025 (Unaudited)</span></div></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.043%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.051%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Total Stockholders&#8217; Equity</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-220">126,469,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-221">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-222">488,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-223">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-224">332,020</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-225">156,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-47" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-226">670,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-227">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-228">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-47" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-229">84,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-230">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-231">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-232">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-233">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-234">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-235">574</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-236">29,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">29,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-238">127,224,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-239">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-240">492,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-241">331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-242">361,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-243">131,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.262%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.166%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended June 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Total Stockholders&#8217; Equity</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-244">126,106,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-245">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-246">481,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-247">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-248">273,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-249">208,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-250">60,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-251">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-252">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-253">138,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-254">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-255">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-256">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-257">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-258">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="f-259">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-260">31,646</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-261">31,646</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Balances at June&#160;30, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-262">126,305,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-263">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-264">485,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-265">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">304,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-267">181,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2026 and 2025 (Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-268">29,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-269">31,646</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-270">2,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-271">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-272">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-273">2,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-274">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-275">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Amortization (accretion) of premiums (discounts) on securities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="f-276">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="f-277">980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-278">953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-279">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-280">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-281">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="f-282">376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="f-283">390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-284">2,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-285">2,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-286">26,826</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-287">27,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of securities</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-288">55,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-289">45,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of securities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-290">28,496</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="f-291">11,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-292">964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-293">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-294">26,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-295">33,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-296">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-297">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="f-298">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="f-299">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-300">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-301">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="f-302">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-303">6,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-304">13,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-305">28,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-306">14,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-307">35,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Supplementary cash flow information on non-cash activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions of property and equipment included in accounts payable</span></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="f-308">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="f-309">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_46"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="f-310" continuedAt="f-310-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Description of Business and Basis of Presentation</span></ix:nonNumeric></div><ix:continuation id="f-310-1" continuedAt="f-310-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) is a biotechnology company incorporated in 2016 with corporate headquarters in Seattle, Washington and research and development headquarters in San Carlos, California. Since the Company&#8217;s incorporation in 2016, the Company has devoted substantially all of its resources to research and development activities, including with respect to its proteomics platform, business planning, establishing and maintaining its intellectual property portfolio, hiring personnel, raising capital and providing selling, general and administrative support for these operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, Nautilus Biotechnology, Inc. a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp. III, a Cayman Islands exempted company and the Company&#8217;s predecessor company (&#8220;ARYA&#8221;)), consummated the  business combination (the &#8220;Business Combination&#8221;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#8220;BCA&#8221;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#8220;Mako Merger Sub&#8221;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#8220;Legacy Nautilus&#8221;). As a result of the Business Combination, ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; and Mako Merger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as the surviving company and becoming a wholly-owned subsidiary of ARYA (the &#8220;Merger&#8221; and, collectively with the other transactions described in the BCA, the &#8220;Reverse Recapitalization&#8221;).  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in conjunction with the completion of the Business Combination, certain investors (&#8220;PIPE Investors&#8221;) subscribed for the purchase of an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-60" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-311">20,000,000</ix:nonFraction> shares of common stock of the Company (&#8220;New Nautilus Common Stock&#8221;) at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-61" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-312">10.00</ix:nonFraction> per share for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-313">200.0</ix:nonFraction>&#160;million (&#8220;PIPE Financing&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-315" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-314" escape="true">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#8217;s financial position, results of operations, and cash flows for the interim periods. The interim financial results are not necessarily indicative of the results for a full year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025 on file with the SEC. The Company&#8217;s reporting currency is the U.S. dollar.</ix:nonNumeric></ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its technology, raising capital, and recruiting personnel. The Company&#8217;s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company&#8217;s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of June&#160;30, 2026, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-316">361.2</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-310-2">The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock and common stock. In June 2021, the Company received gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" scale="6" id="f-317">345.5</ix:nonFraction> million from PIPE Investors and the Business Combination offset by approximately $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="naut:PaymentsOfReverseRecapitalizationTransactionCosts" scale="6" id="f-318">18.2</ix:nonFraction> million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. The Company had cash, cash equivalents, and short-term investments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="f-319">84.0</ix:nonFraction> million as of June&#160;30, 2026. As of the date on which these condensed consolidated financial statements were issued, the Company believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its operations for at least the next twelve months following the issuance of the condensed consolidated financial statements. The Company&#8217;s actual results and its near and long-term future capital requirements will depend on many factors, including its growth rate and the timing and extent of spending to support its research and development efforts. Future liquidity and cash requirements will depend on numerous factors. The Company will be required to seek additional equity or debt financing to fund future operations, and the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.</ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_49"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-320" continuedAt="f-320-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Significant Accounting Policies</span></ix:nonNumeric></div><ix:continuation id="f-320-1" continuedAt="f-320-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-321" escape="true">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Other Risks and Uncertainties</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-322" continuedAt="f-322-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed to perform as contracted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in marketable debt securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of negative global and national events and the need to obtain adequate additional financing to fund the development of its products. There can be no </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-320-2" continuedAt="f-320-3"><ix:continuation id="f-322-1"><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-323" continuedAt="f-323-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">aker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM re</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-323-1">views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-324">one</ix:nonFraction> operating and <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-325">one</ix:nonFraction> reportable segment. The Company&#8217;s long-lived assets are entirely based in the United States.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-326" continuedAt="f-326-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service revenue is derived from the generation and analysis of proteomic data for our Iterative Mapping Early Access Program (&#8220;Early Access Program&#8221;) customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the promised services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of the service to the customer, meaning the customer has the ability to use and obtain the benefit of the service.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service revenue consists of service fees for the generation and analysis of proteomic data for our Early Access Program customers. The Company generally has one performance obligation for the generation and delivery of proteomic data to the customer. Revenue from services is recognized once the results are delivered to the customer, which is when the customer obtains benefit of the service. Customers are invoiced generally upon delivery of services, and payment is typically due within 30 days.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Revenue</span></div><ix:continuation id="f-326-1"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities related to the grant awarded from The Michael J. Fox Foundation (&#8220;MJFF&#8221;) commenced in the second quarter of 2026. The Company recognizes grant revenue as qualifying costs are incurred and the donor-imposed conditions are substantially met under Accounting Standards Codification 958-605. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amounts received in advance of satisfying the underlying conditions are recorded as grant liabilities within other current liabilities, or within other long-term liabilities if settlement is expected beyond 12 months. Cash receipts from grants are classified as operating activities in the condensed consolidated statements of cash flows. Expenses incurred in connection with this grant arrangement are recognized as research and development expense in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Grant revenue, and the related research and development costs incurred, were $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-327"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-328">0.2</ix:nonFraction></ix:nonFraction> million for the three and six months ended June 30, 2026. The Company received the first payment of $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="naut:GrantLiabilityCurrent" scale="6" id="f-329">0.4</ix:nonFraction> million from MJFF in the second quarter of 2026, which was recorded as a grant liability in accrued expenses and other liabilities in the condensed consolidated balance sheets. Of the $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-5" name="naut:GrantLiabilityCurrent" scale="6" id="f-330">0.4</ix:nonFraction> million received, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Revenues" scale="6" id="f-331">0.2</ix:nonFraction> million was recognized as grant revenue as qualifying costs were incurred during the six months ended June 30, 2026, and $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="naut:GrantLiabilityCurrent" scale="6" id="f-332">0.2</ix:nonFraction> million remained recorded as a grant liability as of  June&#160;30, 2026.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-320-3" continuedAt="f-320-4"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-333" escape="true">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Expected Credit Losses</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-334" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Following the commencement of sales under the Early Access Program in the second quarter of 2026, the Company began recording accounts receivable, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consists of amounts due from customers for the sales of services, net of any allowance for expected credit losses. As of June&#160;30, 2026, the Company had accounts receivable balances of less than $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-335">0.1</ix:nonFraction> million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for expected credit losses on receivables is estimated based on an evaluation of historical experience (once available), current aging of receivables, the financial condition of customers, and forward-looking economic conditions. Accounts receivable balances are written off against the allowance when they are deemed uncollectible, at which point collection efforts are discontinued. Management evaluated the Company's outstanding accounts receivable as of June&#160;30, 2026, and concluded that <ix:nonFraction unitRef="usd" contextRef="c-3" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:fixed-zero" scale="0" id="f-336">no</ix:nonFraction> allowance for expected credit losses was required, as the balances were deemed fully collectible. There were <ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:fixed-zero" scale="0" id="f-337"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" format="ixt:fixed-zero" scale="0" id="f-338">no</ix:nonFraction></ix:nonFraction> write-offs of uncollectible accounts during the three and six months ended June 30, 2026.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-339" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers investments with an original maturity greater than three months and remaining maturities less than 12 months to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its marketable debt securities as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a marketable debt security is below its amortized cost basis, the Company evaluates whether it is more likely than not that the Company will be required to sell the security before its anticipated recovery in market value and whether credit losses exist for the related securities. Credit-related losses are recognized as an allowance for credit losses on the balance sheet with a corresponding adjustment to earnings. Unrealized gains and losses that are unrelated to credit deterioration are reported in accumulated other comprehensive income (loss).</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-340" continuedAt="f-340-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-320-4" continuedAt="f-320-5"><ix:continuation id="f-340-1"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory, net</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-341" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2026, in connection with the launch of our Early Access Program and other commercialization activities, we began capitalizing inventory costs. Inventory is stated at the lower of cost or net realizable value with cost determined using a standard cost system, which approximates actual costs determined on the first-in first-out basis. Standard costs are reviewed and updated periodically to ensure they remain representative of current production costs. Materials that may be utilized for either commercial or, alternatively, for research and development purposes, are classified as inventory, specifically as raw materials and supplies. Amounts in inventory used for research and development purposes are charged to research and development expense when the item enters the research and development process and can no longer be used for commercial purposes. During the six months ended June 30, 2026, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="naut:InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" scale="6" id="f-342">0.5</ix:nonFraction> million was charged to research and development expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for slow-moving, excess or obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values. For the quarter ended June&#160;30, 2026, the Company did not have any inventory reserves. As of June&#160;30, 2026, the Company had inventory of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-343">0.6</ix:nonFraction> million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-344" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within interest expense and amortization in the Company&#8217;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-320-5"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-345" escape="true">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#8217; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2026 and 2025, net unrealized gains and losses on marketable debt securities were included as a component of comprehensive income (loss).</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-346" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The ASU is effective for the Company for the fiscal year ending December 31, 2027 and for interim periods beginning after December 31, 2027. The Company does not anticipate adoption to have a material impact on its consolidated financial statements and related disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="ibe513a7507ca44a6b324aa5f298cbb8b_55"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">3. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-347" continuedAt="f-347-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-348" escape="true"><ix:continuation id="f-347-1" continuedAt="f-347-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2026 and December&#160;31, 2025:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cash equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="f-349">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="f-352">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="f-353">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-356">87,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-357">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-358">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-359">87,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-361">52,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-362">35,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-363">88,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-364">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-365">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-366">87,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="f-367">697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-368">52,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-369">35,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-370">13,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-371">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-372">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-373">13,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-374">11,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-375">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-377">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-379">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-380">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-382">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-383">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-384">25,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-386">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-387">25,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-389">15,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-390">9,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-391">40,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-392">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-393">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-394">40,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-395">11,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-396">18,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-397">9,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-398">129,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-399">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-400">341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-401">128,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-402">12,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-403">70,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-404">45,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:22.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.141%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cash equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-405">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="f-406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-407">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-408">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-409">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-412">90,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-413">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-415">90,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-417">49,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-418">40,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-419">91,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-420">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-422">91,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-423">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-424">49,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-425">40,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-426">15,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-427">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-428">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-429">15,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-430">10,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-431">4,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-433">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-434">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-436">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-438">1,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-440">46,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-441">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-442">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-443">46,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-445">34,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-446">11,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-447">63,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-448">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-449">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-450">63,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-451">10,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-452">41,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-453">11,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="f-454">155,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-455">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-456">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-457">155,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-458">11,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-459">91,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-460">52,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-347-2" continuedAt="f-347-3"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments have a contractual maturity date that is one year or less from the respective balance sheet date. Long-term investments have a contractual maturity date that is more than one year, but less than two years from the respective balance sheet date.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-461" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses and fair values of available-for-sale securities that have been in an unrealized loss position for a period of less than and greater than 12 months as of June&#160;30, 2026 are as follows: </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#12644;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Securities in Unrealized Loss Position Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Securities in Unrealized Loss Position Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-462">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-463">69,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-466">253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-467">69,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-468">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-469">13,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-472">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-473">13,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-474">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-475">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-478">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-479">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-480">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-481">21,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="f-482">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="f-483">1,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-484">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-485">23,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="f-486">340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="f-487">107,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="f-488">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="f-489">1,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="f-490">341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="f-491">108,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><ix:continuation id="f-347-3"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed its investment portfolio based on the underlying risk profile of the securities and have  no loss expectation for these investments. The Company reviewed the securities in an unrealized loss position and evaluated the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. The Company recognized <ix:nonFraction unitRef="usd" contextRef="c-14" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="0" id="f-492"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="0" id="f-493"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="0" id="f-494"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:fixed-zero" scale="0" id="f-495">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> credit losses during the three and six months ended June 30, 2026 and 2025, and had <ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-496"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-497">no</ix:nonFraction></ix:nonFraction> allowance for credit losses as of June&#160;30, 2026 and December&#160;31, 2025.</span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_58"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-498" continuedAt="f-498-1" escape="true">Composition of Certain Condensed Consolidated Financial Statement Line Items</ix:nonNumeric></span></div><ix:continuation id="f-498-1" continuedAt="f-498-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-499" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-500">6,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-501">6,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-502">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-503">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-504">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-505">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-506">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-507">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prototype equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-508">2,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-509">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-510">2,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-511">1,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-512">12,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-513">11,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-514">8,714</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-515">8,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-516">3,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-517">3,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded depreciation expense of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-518">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-519">0.6</ix:nonFraction> million for the three and six months ended June 30, 2026, and $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-520">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-521">0.9</ix:nonFraction> million for the three and six months ended June 30, 2025, respectively, which was primarily allocated to research and development expense. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-498-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-523" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="f-522" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-524">1,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-525">2,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="naut:AccruedResearchAndDevelopmentCurrent" scale="3" id="f-526">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="naut:AccruedResearchAndDevelopmentCurrent" scale="3" id="f-527">221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-528">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-529">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="naut:GrantLiabilitiesCurrent" scale="3" id="f-530">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="naut:GrantLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="f-531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="f-532">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="f-533">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-534">3,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-535">3,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="f-537" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-536" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-538">13,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-539">12,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long-term assets (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-540">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-541">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-542">14,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-543">13,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consisted of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-544"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="f-545">1.0</ix:nonFraction></ix:nonFraction>&#160;million of restricted cash and $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:DepositsAssetsNoncurrent" scale="6" id="f-546"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DepositsAssetsNoncurrent" scale="6" id="f-547">0.2</ix:nonFraction></ix:nonFraction>&#160;million of deposits as of June&#160;30, 2026 and December&#160;31, 2025.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-548" continuedAt="f-548-1" escape="true">Common Stock</ix:nonNumeric></span></div><ix:continuation id="f-548-1"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-549"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-550">127,224,640</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June&#160;30, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Reserved for Future Issuance</span></div><ix:nonNumeric contextRef="c-1" name="naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" id="f-551" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-143" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-552">32,974,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-144" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-553">29,341,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-554">19,291,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-555">17,270,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Employee Stock Purchase Plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-145" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-556">6,697,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-146" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-557">5,518,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-558">58,963,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-559">52,130,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_67"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-560" continuedAt="f-560-1" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="f-560-1"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. For the three and six months ended June 30, 2026 and 2025, <ix:nonFraction unitRef="usd" contextRef="c-14" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-561"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-562"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-563"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-564">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> income tax expense or benefit was recognized, due to a full valuation allowance recorded against its deferred tax assets. For three and six months ended June 30, 2026 and 2025, the effective tax rate was <ix:nonFraction unitRef="number" contextRef="c-13" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-565"><ix:nonFraction unitRef="number" contextRef="c-14" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-566"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-567"><ix:nonFraction unitRef="number" contextRef="c-15" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-568">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>%, primarily due to a valuation allowance recorded against the net deferred tax asset balance.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-569" continuedAt="f-569-1" escape="true">Equity Incentive Plans and Stock-based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-569-1" continuedAt="f-569-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;) and the 2021 Employee Stock Purchase Plan (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;2021 ESPP&#8221;). As of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2026, <ix:nonFraction unitRef="shares" contextRef="c-143" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-570">32,974,336</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-145" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-571">6,697,982</ix:nonFraction> shares were available for grant under the 2021 Plan and 2021 ESPP, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 ESPP, participants are permitted to purchase shares of Common Stock, up to the IRS allowable limit, through contributions (in the form of payroll deductions or otherwise to the extent permitted by the administrator of the 2021 ESPP) of up to <ix:nonFraction unitRef="number" contextRef="c-147" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="f-572">15</ix:nonFraction>% of their eligible compensation.  Participants are permitted to purchase shares of the Company&#8217;s Common Stock at <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-573">85</ix:nonFraction>% of the lower of the fair market value of the Company&#8217;s Common Stock on the first trading day of an offering period or on the last trading date in each purchase period. The Company offers a <ix:nonNumeric contextRef="c-149" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" format="ixt-sec:durwordsen" id="f-574">six month</ix:nonNumeric> purchase period. Participants may end their participation at any time during an offering and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The number of shares of common stock available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year in an amount equal to the least of (i) <ix:nonFraction unitRef="shares" contextRef="c-149" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-575">3,734,500</ix:nonFraction> shares of common stock, (ii) a number of s</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">hares of common stock equal to one percent (<ix:nonFraction unitRef="number" contextRef="c-149" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="f-576">1</ix:nonFraction>%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year. On January 1, 2026, the number of shares available under the 2021 ESPP increased by <ix:nonFraction unitRef="shares" contextRef="c-150" decimals="0" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-577">1,264,696</ix:nonFraction> shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 Plan, the Company can grant incentive stock options, nonstatutory stock options, stock appreciation rig</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">hts, restricted stock, restricted stock units and performance awards to employees, non-employee directors and consultants. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Options generally expire <ix:nonNumeric contextRef="c-151" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-578">ten years</ix:nonNumeric> after the date of grant. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares available for issuance under the 2021 Plan will be increased on the first day of each fiscal year in an amount equal to the least of (i) <ix:nonFraction unitRef="shares" contextRef="c-151" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-579">18,672,200</ix:nonFraction> shares, (ii) a number of shares equal to five percent (<ix:nonFraction unitRef="number" contextRef="c-151" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="f-580">5</ix:nonFraction>%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. On January 1, 2026, the number of shares available under the 2021 Plan increased by <ix:nonFraction unitRef="shares" contextRef="c-152" decimals="0" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-581">6,323,480</ix:nonFraction> shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2017 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At the time of adoption of the 2021 Plan and the 2021 ESPP, no further awards will be granted under the 2017 Equity Incentive Plan (&#8220;2017 Plan&#8221;). Stock-based awards forfeited or cancelled from the 2017 Plan are returned to the pool of shares of Common Stock available for issuance under the 2021 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Date Fair Value of Stock Options</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In determining the compensation cost of the option awards, the fair value for each option award has been estimated using the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Black Scholes model</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-582" continuedAt="f-582-1" escape="true">The significant assumptions used in these calculations are summarized as follows:</ix:nonNumeric></span></div><ix:continuation id="f-582-1"><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.047%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.049%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-153" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-583">5.3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-154" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-584">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-155" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-585">5.3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-156" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-586">6.0</ix:nonNumeric>  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-157" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-587">5.3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-158" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-588">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-159" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-589">5.3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-160" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-590">6.0</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-161" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-591">75.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-161" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-592">80.7</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-593">97.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-594">103.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-163" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-595">75.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-163" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-596">82.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-164" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-597">97.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-164" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-598">103.0</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-161" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-599">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-162" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-600">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-163" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-601">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-164" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-602">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-161" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-603">3.91</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-161" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-604">4.29</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-162" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-605">3.90</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-162" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-606">4.04</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-163" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-607">3.69</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-163" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-608">4.29</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-164" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-609">3.90</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-164" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-610">4.04</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-569-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Expected term: The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding. The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility: We became a public company in 2021 following the Business Combination, and as such, the Company lacked company&#8209;specific historical and implied volatility information to solely utilize its own data for purposes of establishing the volatility assumption for use in the Black-Scholes model. Therefore, we estimate our expected volatility of the Company&#8217;s common stock based on a mix of company-specific historical volatility and an average of historical volatilities of selected industry peers deemed to be comparable to the Company&#8217;s business corresponding to the expected term of the awards. The Company will continue to apply this process until an adequate amount of historical information regarding the volatility of its own stock price becomes available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield: The expected dividend rate is <ix:nonFraction unitRef="number" contextRef="c-163" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="0" id="f-611">zero</ix:nonFraction> as the Company has no history or expectation of declaring dividends on its common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" id="f-612" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option award activity during the six months ended June 30, 2026:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-613">17,270,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-614">3.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-615">3,614,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-616">2.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-617">670,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-618">1.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-619">923,289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-620">2.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-621">19,291,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-622">3.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-623">7.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-624">4,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-625">19,291,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-626">3.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable at June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-627">12,308,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-628">3.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-629">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-630">2,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2026, there was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-631">10.1</ix:nonFraction> million of total unrecognized compensation expense expected to be recognized over a weighted average-period of <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-632">2.8</ix:nonNumeric> years. Aggregate intrinsic value represents the difference between the fair market value of the common stock and the exercise price of outstanding, in-the-money options. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-633" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the total stock-based compensation expense included in the Company&#8217;s condensed consolidated statement of operations:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-634">459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-635">686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-636">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-637">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-638">699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-639">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-640">1,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-641">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-642">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-643">1,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-644">2,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-645">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense included within cost of service revenue was <ix:nonFraction unitRef="usd" contextRef="c-173" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-646"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-647">not</ix:nonFraction></ix:nonFraction> material for the three and six months ended June 30, 2026.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_73"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">8. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-648" continuedAt="f-648-1" escape="true">Commitments and Contingencies </ix:nonNumeric></span></div><ix:continuation id="f-648-1" continuedAt="f-648-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2026 as the Company had not yet received the related goods or services. As of June&#160;30, 2026, the Company had open purchase commitments for goods and services of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LongTermPurchaseCommitmentAmount" scale="6" id="f-649">3.2</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" scale="6" id="f-650">3.0</ix:nonFraction> million are expected to be received through the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#8217;s results of operations, financial condition or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, San Carlos, California, and San Diego, California. The Company's operating lease in San Diego expired during the six months ended June 30, 2026, and was replaced by a new lease that qualifies for the short-term lease exemption under ASC 842, and therefore is not recorded on the  condensed consolidated balance sheet as of June&#160;30, 2026. The letter of credit associated with the prior San Diego lease was released in the third quarter of 2026.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-651" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2026:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Lease Obligations</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Six months ending December&#160;31, 2026</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-652">2,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-653">6,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-654">6,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-655">6,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-656">6,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2031 and thereafter</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="naut:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-657">5,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-658">34,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-659">6,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-660">27,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2026 and 2025, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-661">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-662">3.6</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="f-663">1.0</ix:nonFraction> million in cash-collateralized letters of credit with <ix:nonFraction unitRef="institution" contextRef="c-3" decimals="INF" name="naut:NumberOfFinancialInstitution" format="ixt-sec:numwordsen" scale="0" id="f-664">one</ix:nonFraction> financial institution in lieu of security deposits in connection with the San Carlos and San Diego lease agreements. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Agreements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="f-648-2" continuedAt="f-648-3"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. </span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-648-3">The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.</ix:continuation> </span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-665" continuedAt="f-665-1" escape="true">Basic and Diluted Net Loss per Share</ix:nonNumeric></span></div><ix:continuation id="f-665-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-666" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2026 and 2025:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-667"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-668">14,469</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-669"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-670">15,033</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-671"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-672">29,166</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-673"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-674">31,646</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-675"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-676">127,135,738</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-677"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-678">126,204,632</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-679"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-680">126,886,646</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-681"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-682">126,174,603</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-683"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-684">0.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-685"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-686">0.12</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-687"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-688">0.23</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-689"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-690">0.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-691" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three and Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-175" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-692"><ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-693">19,291,337</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-177" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-694"><ix:nonFraction unitRef="shares" contextRef="c-178" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-695">18,996,250</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-179" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-696"><ix:nonFraction unitRef="shares" contextRef="c-180" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-697">87,375</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-181" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-698"><ix:nonFraction unitRef="shares" contextRef="c-182" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-699">122,653</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total potentially dilutive common share equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-700"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-701">19,378,712</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-702"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-703">19,118,903</ix:nonFraction></ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-704" continuedAt="f-704-1" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="f-704-1"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM uses consolidated net loss in assessing operating decisions, allocating resources and evaluating financial performance. Consolidated net loss is used to monitor budget versus actual results. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-705" continuedAt="f-705-1" escape="true">The Company included a summary of the segment net loss, including significant segment expenses for its single reportable segment: </ix:nonNumeric></span></div><ix:continuation id="f-705-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"/><td style="width:41.039%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.448%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.448%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.448%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.841%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-706">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-707">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:Revenues" scale="3" id="f-708">190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="f-709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="f-710">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="3" id="f-711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="f-712">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="3" id="f-713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-714">7,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-715">7,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-716">15,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:LaborAndRelatedExpense" format="ixt:num-dot-decimal" scale="3" id="f-717">16,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional services and laboratory expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="naut:ProfessionalServicesAndLaboratoryExpenses" format="ixt:num-dot-decimal" scale="3" id="f-718">3,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="naut:ProfessionalServicesAndLaboratoryExpenses" format="ixt:num-dot-decimal" scale="3" id="f-719">3,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="naut:ProfessionalServicesAndLaboratoryExpenses" format="ixt:num-dot-decimal" scale="3" id="f-720">6,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="naut:ProfessionalServicesAndLaboratoryExpenses" format="ixt:num-dot-decimal" scale="3" id="f-721">6,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Facilities expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="naut:FacilityExpenses" format="ixt:num-dot-decimal" scale="3" id="f-722">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="naut:FacilityExpenses" format="ixt:num-dot-decimal" scale="3" id="f-723">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="naut:FacilityExpenses" format="ixt:num-dot-decimal" scale="3" id="f-724">5,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="naut:FacilityExpenses" format="ixt:num-dot-decimal" scale="3" id="f-725">5,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-726">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-727">1,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-728">2,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-729">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-730">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-731">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-732">2,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-733">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-734">15,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-735">17,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-736">32,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-737">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation to net loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-738">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-739">2,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-740">2,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-741">4,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-742">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-743">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-744">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-745">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-746">14,469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-747">15,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-748">29,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-749">31,646</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.810%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Footnotes:</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Other segment items for the Company&#8217;s single reportable segment include travel and entertainment, insurance, tax, expensed computer hardware and software, depreciation, and other miscellaneous expenses.</span></div></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis provides information that our management believes is relevant to an assessment and understanding of Nautilus Biotechnology, Inc.&#8217;s (&#8220;Nautilus&#8221; or the &#8220;Company&#8221;) condensed consolidated results of operations and financial condition. The discussion should be read together with the condensed consolidated financial statements and the accompanying notes to those statements that are included elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements for the year ended December&#160;31, 2025 and the related notes included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 26, 2026. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Nautilus&#8217; actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in the section titled &#8220;Risk Factors&#8221; in Part II, Item 1A as set forth in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated or the context otherwise requires, references in this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; section to &#8220;Nautilus,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to the business and operations of Nautilus and its consolidated subsidiary.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_91"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a development stage life sciences company focused on creating a platform technology to quantify and unlock the complexity of the proteome. We were founded to address longstanding challenges in proteomics through the development of a new analysis method, Iterative Mapping, for the quantification of single, intact protein molecules at scale. Our mission is to transform the field of proteomics by broadening access to high-quality proteomic data and enabling fundamental advancements across human health and medicine. Iterative Mapping is designed to enable broad and deep characterization of the proteome while delivering high reproducibility through direct single-molecule counting. By repeatedly interrogating individual protein molecules and aggregating results across billions of measurements, Iterative Mapping generates digital protein counts that are intended to support consistent comparison across samples, experiments, and time. The Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform is designed to implement the Iterative Mapping method. The Nautilus Voyager platform integrates nanofabricated protein arrays, affinity reagent probing, advanced optics and fluidics, and machine learning&#8211;based analysis into an end-to-end workflow inclusive of instrumentation, consumables, and software. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since our incorporation in 2016, we have devoted substantially all of our resources to research and development activities, including with respect to our proteomics platform, or Nautilus Voyager platform, business planning, establishing and maintaining our intellectual property portfolio, hiring personnel, raising capital and providing selling, general and administrative support for these operations. We have not generated any material revenue from our Nautilus Voyager platform or other sources since inception. Our ability to generate revenue sufficient to achieve profitability, if we ever do, would be expected to take a number of years, and will depend on the successful development and eventual commercialization of our Nautilus Voyager platform, if it ever occurs. Our Nautilus Voyager platform, which includes our end-to-end solution comprised of analysis services, instruments, consumables, and software analysis, is currently under development and will require significant additional research and development efforts, including extensive testing prior to commercialization. These efforts require significant amounts of additional capital and adequate personnel infrastructure. There can be no assurance that our research and development activities will be successfully completed, or that our Nautilus Voyager platform will be commercially viable. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order to commercialize our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform in volume, we will need to establish internal manufacturing capacity or to contract with one or more manufacturing partners, or both. Our technology is complex, and the manufacturing process for our products will be similarly complex, involving a large number of unique precision parts in addition to the production of various reagents and antibodies. We may encounter unexpected difficulties in manufacturing our Nautilus Voyager platform, instruments, and related consumables. Among other factors, we will need to develop reliable supply chains for the various components in our Nautilus Voyager platform, instruments, and consumables to support large-scale commercial production. In connection with our Nautilus Voyager platform, upon completion of development we intend to utilize hundreds of unique multi-affinity reagents and various standard antibodies in order to generate deep proteomic information at the speed and scale which we expect our Nautilus Voyager platform to perform. Such reagents and antibodies are expected to be more difficult to manufacture and more expensive to procure. There is no assurance that we will be able to build manufacturing or consumable production capacity internally or find one or more suitable manufacturing or production partners, or both, to meet the volume and quality requirements necessary to be successful in the proteomics market.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are in the early stages of establishing our commercial organization and distribution capabilities. During the six months ended June 30, 2026, we made our first sales hires as an initial step toward building an internal sales infrastructure, and we intend to continue expanding these capabilities to support the sales of our products. We are commercializing our Nautilus Voyager platform in phases that began with research collaborations with leading biopharmaceutical companies, academic institutions, and research organizations exploring utility of pre-commercial versions of the platform. The next phases of our strategy involve a land-and-expand strategy in which we provide customers with access to the Iterative Mapping method on the Nautilus Voyager platform for an initial application, with the expectation of, over time, adding additional applications in expanded targeted proteoform analysis and, in the future, broadscale proteomics, which customers would access depending upon their specific proteomics needs. While our development efforts continue for our broadscale assay, those efforts have not advanced sufficiently to support general availability of that assay in 2027 to our target specifications. We have identified key improvement areas, which we expect to advance broadscale performance. Due to the need for further improvements to the broadscale assay and the demand we are seeing for proteoforms from the market, we plan to reallocate resources from the broadscale effort to accelerate our proteoform application development.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Initial customer access to the Nautilus Voyager platform is being enabled through our Iterative Mapping Early Access Program (&#8220;Early Access Program&#8221;) in which we perform analysis and profiling of samples in our facility and such data and analysis is shared via a cloud platform. We announced the launch of our Early Access Program starting with target specific service offerings in January 2026 for the analysis of the microtubule-associated protein tau (&#8220;Tau&#8221;), which has been broadly associated with the onset and progression of Alzheimer&#8217;s disease in human patients. Our early access framework is expected to expand further to support additional targeted proteoforms assays in neuroscience and new disease areas like oncology, starting with RAC-alpha serine/threonine-protein kinase (or &#8220;AKT1&#8221;), which acts as a control hub for growth and survival signals and is a pathway active in many cancers. We do not anticipate that these early access activities will result in any material revenue. With data gained from our Early Access Program customers, we plan to leverage publications to drive awareness and customer demand to later sell instruments and reagents to select customers performing targeted proteoform research. We expect to initiate our commercial launch in early 2027 by opening the Nautilus Voyager platform for pre-orders, with instrument shipments beginning in mid 2027. At the time of these first commercial shipments, we expect general availability to include the Voyager instrument, our Tau Proteoforms assay, an AKT1 Proteoforms assay and an additional oncology proteoforms assay. As we continue expanding the platform&#8217;s assay portfolio, we concurrently expect to enable a broader diversity of sample types, including blood, which is the most prevalent sample type behind cells and tissues already enabled today. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Go-to-market plan</span></div><div style="margin-bottom:9pt;text-align:center"><img src="naut-20260630_g1.jpg" alt="Go-to-market plan 7.27.26.jpg" style="height:334px;margin-bottom:5pt;vertical-align:text-bottom;width:600px" id="i-1"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We intend to commercialize our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform through a direct sales channel in the United States, and through both direct and distributor sales channels in regions outside the United States. Given our stage of development, we currently have limited marketing, sales, commercial product distribution or service and support capabilities. We intend to build the necessary infrastructure for these activities in the United States, European Union, the United Kingdom, and potentially other countries and regions, including Asia-Pacific, as we execute on our phased commercial launch strategy for our Nautilus Voyager platform. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, Nautilus Biotechnology, Inc., a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp. III, a Cayman Islands exempted company and the Company&#8217;s predecessor company (&#8220;ARYA&#8221;)), consummated the business combination (the &#8220;Business Combination&#8221;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#8220;BCA&#8221;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#8220;Mako Merger Sub&#8221;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#8220;Legacy Nautilus&#8221;). As a result of the Business Combination, ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; and Mako Merger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as the surviving company and becoming a wholly-owned subsidiary of ARYA (the &#8220;Merger&#8221; and, collectively with the other transactions described in the BCA, the &#8220;Reverse Recapitalization&#8221;).  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in conjunction with the completion of the Business Combination, certain investors (&#8220;PIPE Investors&#8221;) subscribed for the purchase of an aggregate of 20,000,000 shares of common stock of the Company (&#8220;New Nautilus Common Stock&#8221;) at a price of $10.00 per share for aggregate gross proceeds of $200.0&#160;million (&#8220;PIPE Financing&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, we financed our operations primarily through private placements of convertible preferred stock and had raised aggregate net proceeds of $108.4 million from these private placements. In connection with the consummation of the Business Combination and PIPE Financing, we received additional gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination, offset by approximately $18.2 million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. As of June&#160;30, 2026, we had cash, cash equivalents and short-term investments of $84.0 million. As of the filing of this Quarterly Report on Form 10-Q, we believe that our existing cash, cash equivalents, and short-term </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">investments will enable us to fund our planned operating expenses and capital expenditures through at least the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant losses since the commencement of our operations. Our net loss was $29.2 million during the six months ended June 30, 2026, and we expect to continue to incur significant losses for the foreseeable future as we continue our research and development activities and planned commercialization of our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform. As of June&#160;30, 2026, we had an accumulated deficit of $361.2&#160;million. These losses have resulted primarily from costs incurred in connection with research and development activities and to a lesser extent from selling, general and administrative costs associated with our operations. We expect to incur significant and increasing expenses and operating losses for the foreseeable future. Our net losses may fluctuate significantly from period to period, depending on the timing of and expenditures on our planned commercialization and research and development activities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect our expenses and capital requirements will increase substantially in connection with our ongoing activities as we:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue our research and development activities, including with respect to our Nautilus Voyager platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct activities to develop and deliver service offerings and to establish and operate service laboratory operations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">undertake activities to establish and expand sales, marketing and distribution capabilities for our Nautilus Voyager platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur increased costs related to production tooling and required testing;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain, protect and expand our intellectual property portfolio, including patents, trade secrets and know how;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement operational, financial and management information systems;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract, hire and retain additional management, scientific and administrative personnel; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to operate as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we will require substantial additional funding to develop our products and support our continuing operations. Until such time that we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, which could include income from collaborations, strategic partnerships or marketing, distribution or licensing arrangements with third parties or from grants. We may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the disruptions to, and volatility in, the credit and financial markets in the United States and worldwide, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">recent and any potential future financial institution failures,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> geopolitical conflicts, such as the conflicts in Eastern Europe and the Middle East, and otherwise. Our failure to obtain sufficient funds on acceptable terms, or at all, when needed could have a material adverse effect on our business, results of operations or financial condition, and could force us to delay, reduce or eliminate our product development or future commercialization efforts. We may also be required to grant rights to develop and market products that we would otherwise prefer to develop and market ourselves. The amount and timing of our future funding requirements will depend on many factors, including the pace and results of our development efforts. We cannot assure you that we will ever be profitable or generate positive cash flow from operating activities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Impact of Negative Global or National Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Businesses have been and will continue to be impacted by a number of challenging global and national events and circumstances that continue to evolve, including extreme weather conditions, economic uncertainty, increased tariffs, inflation, changing interest rates,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> any potential future financial institution failures,</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and geopolitical conflicts, such as the conflicts in Eastern Europe and the Middle East. The extent of the impact of these events and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">circumstances on our business, operations and development timelines and plans remains uncertain, and will depend on certain developments, including the duration and scope of the events and their impact on our development activities, third-party manufacturers, and other third parties with whom we do business, as well as its impact on regulatory authorities and our key scientific and management personnel. We have been and continue to actively monitor the potential impacts that these various events and circumstances may have on our business and we take steps, where warranted, to minimize any potential negative impacts on our business resulting from these events and circumstances.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have been and continue to actively monitor our supply chain in light of these challenging global and national events and circumstances, including our third-party materials suppliers. We have, in the past, experienced some supply disruptions, including closures at certain chip manufacturers, which led to extended lead times for certain chips and lower availability of certain reagents. While certain of these disruptions have been resolved, we are continuing to monitor our supply chain and contingency planning is ongoing with our partners to reduce the possibility of an interruption to our development activities or the availability of necessary materials. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of these global and national events and circumstances, either individually or in aggregate, is highly uncertain and subject to change. We will continue to actively monitor any developments related to these global and national events, and may take actions to mitigate potential negative impacts to our business, and that may alter our operations, including those that may be required by federal, state or local authorities, or that we determine are in the best interests of our employees and other third parties with whom we do business. At this point, the extent to which these global or national events and circumstances may affect our future business, operations and development timelines and plans, including the resulting impact on our expenditures and capital needs, remains uncertain.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_94"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Grant revenue consists of a research-related grant from The Michael J. Fox Foundation and reflects the commencement of grant-related activities during the second quarter of 2026. Our service revenue is derived from the generation and analysis of proteomic data for our Early Access Program customers, which commenced in the second quarter of 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service revenue consists of costs incurred in performing the service, including costs of consumables. Costs also include salaries, related benefits and stock-based compensation expense for Nautilus Proteomics Analysis Services personnel, depreciation and amortization, allocated expenses for technology and facilities, and charges related to inventory reserves. Cost of service revenue is recognized in the same period as the related performance obligation is rendered.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span id="ia53852aa67814aee9b10c5489186190f_5354"></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses account for a significant portion of our operating expenses and consist primarily of salaries, related benefits and stock-based compensation expense of product development personnel, laboratory supplies and equipment, depreciation and amortization, external costs of vendors engaged to conduct research and development activities, and allocated expenses for technology and facilities. We expense research and development expenses in the periods in which they are incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We plan to continue to invest in our research and development efforts and to increase our investment in research and development efforts related to our product development and grant-funded research initiatives. While we experienced certain cost savings associated with our workforce reductions implemented in the first quarter of 2025, in the future, we continue to expect research and development expenses to increase in absolute dollars as we continue to advance our product development, expand our grant-related research activities, hire additional personnel </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and retain existing personnel, purchase supplies and materials and allocate expense to our research and development facilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses consist of salaries, related benefits, and stock-based compensation expense for personnel in executive, operations, legal, human resources, finance, marketing, commercial, IT personnel and administrative functions, professional fees for legal, patent, consulting, accounting and audit services, directors and officers insurance, allocated expenses for technology and facilities, and marketing expenses. We expense selling, general and administrative expenses in the periods in which they are incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">While we experienced certain cost savings associated with our workforce reductions implemented in the first quarter of 2025, in the future, we expect that our selling, general and administrative expenses will increase substantially over the next several years as we hire additional personnel to support the growth in research and development activities and our planned commercial growth, including sales, marketing, service, support, and distribution infrastructure. We also anticipate that we will incur higher expenses related to accounting, audit, legal, regulatory, insurance, compliance with the rules and regulations of the SEC, Sarbanes-Oxley Act and those of any national securities exchange on which our securities are traded, investor and public relations, and other administrative and professional services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other income consists of interest income on our cash, cash equivalents and investments (including accretion and amortization of discounts and premiums on marketable debt securities). Other miscellaneous non-recurring expenses such as gains or losses on disposal of property and equipment are also included.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_97"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended June 30, 2026 to the Three Months Ended June 30, 2025 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our condensed consolidated statements of operations for the periods indicated:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.361%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.364%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change <br/>(%)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,613&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,394&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(781)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,325&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,703&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(378)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(773)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(770)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,469)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(15,033)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">*Percentage is not meaningful</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was $0.2 million for the three months ended June 30, 2026, driven by grant revenue of $0.2 million from the commencement of our activities related to the grant awarded from The Michael J. Fox Foundation in the second quarter of 2026, and service revenue of less than $0.1 million for the sales of services under the Early Access Program during the three months ended June 30, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Service Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service revenue consists of costs related to the generation and analysis of proteomic data on behalf of our Early Access Program customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $9.6 million for the three months ended June 30, 2026, compared to $10.4 million for the three months ended June 30, 2025, a decrease of $0.8 million, or 8%. The decrease was due to  a $0.2 million decrease in stock-based compensation expense and a $0.2 million decrease in laboratory and professional services. Also contributing to the decrease was a $0.2 million decrease in facilities expense driven by the expiration of the San Diego lease, decreases in maintenance costs for our leases, and a $0.2 million decrease in depreciation expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses were $6.3 million for the three months ended June 30, 2026, compared to $6.7 million for the three months ended June 30, 2025, a decrease of $0.4 million, or&#160;6%. The decrease was due to a $0.3 million decrease in salaries and related benefits, attributable to reduced incentive compensation costs during the period, and a $0.3 million decrease in stock-based compensation expense. These decreases were partially offset by a $0.2 million increase in professional services attributable to legal and recruiting fees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) was $1.3 million for the three months ended June 30, 2026, compared to $2.1 million for the three months ended June 30, 2025, a decrease of $0.8 million, or 37%. The net decrease was primarily due to a $0.8 million decrease in interest income driven by a lower cash, cash equivalents, and investments balance as well as decreased yield rates on investments during the period.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Six Months Ended June 30, 2026 to the Six Months Ended June 30, 2025 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our condensed consolidated statements of operations for the periods indicated:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"/><td style="width:42.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.492%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.494%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Change <br/>(%)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,320&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,930&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2,610)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,742&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,011&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,269)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(3,879)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,749&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,562)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total other income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1,574)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(29,166)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(31,646)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">*Percentage is not meaningful</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was $0.2 million for the six months ended June 30, 2026, driven by grant revenue of $0.2 million from the commencement of our activities related to the grant awarded from The Michael J. Fox Foundation in the second quarter of 2026, and service revenue of less than $0.1 million for the sales of services under the Early Access Program during the six months ended June 30, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Service Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service revenue consists of costs related to the generation and analysis of proteomic data on behalf of our Early Access Program customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $19.3 million for the six months ended June 30, 2026, compared to $21.9 million for the six months ended June 30, 2025, a decrease of $2.6 million, or 12%. The decrease was primarily due to a $1.1 million decrease in salaries and related benefits, which was primarily driven by savings from the reduction in force implemented in the first quarter of 2025 and reduced incentive compensation costs during the period, as well as a $0.5 million decrease in stock-based compensation expense. The decrease in stock-based compensation expense is primarily driven by stock options granted at the time of the Merger becoming fully expensed in 2025. Also contributing to the decrease was a $0.4 million decrease in facilities expense driven by decreases in maintenance costs for our leases and the expiration of the San Diego lease, a $0.4 million decrease in laboratory and professional services, and a $0.3 million decrease in depreciation expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses were $12.7 million for the six months ended June 30, 2026, compared to $14.0 million for the six months ended June 30, 2025, a decrease of $1.3 million, or&#160;9%. The decrease </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">was primarily due to a $0.9 million decrease in stock-based compensation expense, which was primarily driven by stock options granted at the time of the Merger becoming fully expensed in 2025. Also contributing to the decrease was a $0.7 million decrease in salaries and related benefits driven by savings from the reduction in force implemented in the first quarter of 2025 and reduced incentive compensation costs during the period, and a $0.2 million decrease in facilities expense. These decreases were partially offset by a $0.4 million increase in professional services attributable to legal and recruiting fees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) was $2.7 million for the six months ended June 30, 2026, compared to $4.3 million for the six months ended June 30, 2025, a decrease of $1.6 million, or 37%. The net decrease was primarily due to a $1.6 million decrease in interest income driven by a lower cash, cash equivalents, and investments balance as well as decreased yield rates on investments during the period.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_103"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have not generated any material revenue from product sales and have incurred significant operating losses and negative cash flows from our operations. Our net loss was $29.2 million for the six months ended June 30, 2026. As of June&#160;30, 2026, we had an accumulated deficit of $361.2&#160;million. Prior to the Business Combination, we funded our operations primarily with proceeds from the sale of convertible preferred stock. Prior to the Business Combination, we had raised net proceeds of $108.4&#160;million from these private placements of our convertible preferred stock. In June 2021, in conjunction with the consummation of the Business Combination with ARYA, we received additional gross proceeds of approximately $345.5&#160;million from PIPE Investors and the Business Combination, offset by approximately $18.2&#160;million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. As of June&#160;30, 2026, we had cash, cash equivalents and investments of $129.2&#160;million.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our primary uses of cash to date have been to fund our research and development activities, business planning, establishing and maintaining our intellectual property portfolio, hiring personnel, raising capital, and providing selling, general and administrative support for these operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In February 2024, we entered into a sales agreement (the &#8220;Sales Agreement&#8221;) with Cowen and Company, LLC  (&#8220;TD Cowen&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">under which we may offer and sell up to $125.0 million of shares of our common stock from time to time through an &#8220;at the market&#8221; offering program under which TD Cowen will act as sales agent. Under the Sales Agreement, we set the parameters for the sale of shares, including the number or dollar amount of shares to be issued, the time period during which sales are requested to be made, limitations on the number or dollar amount of shares that may be sold in any one trading day and any minimum price below which sales may not be made. The Sales Agreement provides that TD Cowen will be entitled to compensation for its services in an amount equal to up to 3.0% of the gross proceeds of all shares of common stock sold through TD Cowen under the Sales Agreement. We have no obligation to sell any shares under the Sales Agreement and may at any time suspend solicitation and offers under the Sales Agreement. During the six months ended June 30, 2026, we did not sell any shares of common stock pursuant to the Sales Agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The shares of our common stock to be offered and sold under the Sales Agreement will be issued and sold pursuant to our shelf registration statement on Form S-3 (File No. 333-277437) (the &#8220;Shelf Registration Statement&#8221;), which was filed with the SEC on February 28, 2024 and which became effective March 6, 2024. No securities have yet been sold under the Shelf Registration Statement. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Shelf Registration Statement will remain in effect for up to three years and allows us to sell from time to time up to $300.0 million of common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, purchase contracts or units comprised of any combination of these securities, for our own account in one or more offerings and is intended to provide us flexibility to conduct registered sales of our securities, subject to market conditions and our future capital needs. The terms of any offering thereunder will be established at </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the time of such offering and will be described in a prospectus supplement filed with the SEC prior to the completion of any such offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any material revenue and we may not generate any material revenue from the sale of products or from other sources in the near future. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We implemented a workforce reduction in the first quarter of 2025. The cost-saving initiatives resulted in reductions to personnel-related expenses during fiscal year 2025. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">However, we expect our expenses and capital requirements will continue to increase substantially in connection with our ongoing activities as we:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue our research and development activities, including with respect to our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct activities to develop and deliver service offerings and to establish and operate service laboratory operations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">undertake activities to establish sales, marketing and distribution capabilities for our Nautilus Voyager platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur setup costs related to production tooling and required testing;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain, protect and expand our intellectual property portfolio, including patents, trade secrets and know how;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement operational, financial and management information systems;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract, hire and retain additional management, scientific and administrative personnel; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to operate as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of the filing of this Quarterly Report on Form 10-Q, we expect our current cash, cash equivalents, and short-term investments will be sufficient to fund our operating expenses and capital expenditures for at least the next 12 months. We continue to face challenges and uncertainties and, as a result, our available capital resources may be consumed more rapidly than currently expected due to: delays in execution of our development plans; the scope and timing of our investment in our sales, marketing, and distribution capabilities; changes we may make to the business that affect ongoing operating expenses; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; changes we may make in our business or commercialization strategy; changes we may make in our research and development spending plans; our need to implement additional infrastructure and internal systems; the impact of global and national conflicts or other disruptions; and other items affecting our forecasted level of expenditures and use of cash resources including potential acquisitions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Until such time as we can generate significant revenue from commercialization of our products, if ever, we will continue to require substantial additional capital to develop our Nautilus Voyager platform and fund operations for the foreseeable future. We intend to obtain such capital through public or private equity offerings or debt financings (including potential sales under the Sales Agreement), credit or loan facilities or a combination of one or more of these funding sources. We may also seek additional financing opportunistically. We may be unable to raise additional funds on favorable terms or at all. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and disruptions to, and volatility in, the credit and financial markets in the United States and worldwide, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">any potential future financial institution failures, geopolitical conflicts, such as </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">the conflicts in Eastern Europe and the Middle East, and otherwise. Our failure to raise additional capital, if needed, would have a negative impact on our financial condition and our ability to execute our business plan.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our expected future capital requirements depend on many factors including expansion of our product portfolio and the timing and extent of spending on sales and marketing and the development of our technology. If we raise additional funds by issuing equity securities, including any issuances pursuant to our &#8220;at the market&#8221; equity offering program under our Sales Agreement with TD Cowen or our Shelf Registration Statement, our stockholders will experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Historical Cash Flows</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For the Six Months Ended June 30, 2026 and 2025 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the six months ended June 30, 2026 and 2025:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in&#160;thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(26,826)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(27,287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">26,255&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">33,985&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,811&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2026, net cash used in operating activities was $26.8&#160;million, resulting from our net loss of $29.2&#160;million and decrease in net changes in assets and liabilities aggregating $2.9&#160;million. Net cash used in operating activities includes non-cash charges aggregating $5.2&#160;million, which is driven by $2.5&#160;million of stock-based compensation expense, $2.2&#160;million of amortization of operating lease right-of-use assets, and $0.6&#160;million of depreciation. These non-cash charges were partially offset by $0.1&#160;million of net accretion of discounts on securities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2025, net cash used in operatin</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">g activities was $27.3 million, resulting from our net loss of $31.6 million and decrease in net changes in assets and liabilities aggregating $1.8 million. Net cash used in operating activities includes non-cash charges aggregating $6.2 million, which is driven by $3.9 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> of stock-based compensation expense, $2.3 million amortization of operating lease right-of-use assets, and </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.9 million of depreciation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. These non-cash charges were partially offset by </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$1.0 million of net accretion of discounts on securities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2026, net cash provided by investing activities was $26.3&#160;million,  resulting from&#160;$55.7&#160;million in proceeds from the maturities of securities, partially offset by $28.5 million in purchases of securities and $1.0&#160;million in purchases of property and equipment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2025, net cash provided by investing activities was $34.0 million, resulting from $45.9 million in proceeds from maturities of securities, partially offset by </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$11.3 million in purchases of securities and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> $0.6 million in purchases of property and equipment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2026, cash provided by financing activities was comprised of $1.3 million of proceeds from the exercise of stock options and issuance of common stock under the employee stock purchase plan.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2025, cash provided by financing activities was comprised of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">$0.1 million of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">proceeds from the exercise of stock options </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and issuance of common stock under the employee stock purchase plan.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_106"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our contractual obligations and commitments, refer to Part I, Item 1, Note 8, &#8220;Commitments and Contingencies,&#8221; in our notes to condensed consolidated financial statements in this Quarterly Report on Form 10-Q.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_112"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses. We evaluate our estimates and assumptions on an ongoing basis, and base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for the judgments we make about the carrying value of assets and liabilities that are not readily apparent from other sources. Because these estimates can vary depending on the situation, actual results may differ from these estimates. Making estimates and judgments about future events is inherently unpredictable and is subject to significant uncertainties, some of which are beyond our control. Should any of these estimates and assumptions change or prove to have been incorrect, it could have a material impact on our results of operations, financial position and statement of cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies and estimates as compared to those disclosed in our audited financial statements as of and for the years ended December&#160;31, 2025 and 2024.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_115"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our condensed consolidated financial statements, see Part I, Item 1, Note 2 &#8220;Significant Accounting Policies&#8221; in our notes to condensed consolidated financial statements in this Quarterly Report on Form 10-Q. </span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_118"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Smaller Reporting Company Status</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are currently a &#8220;smaller reporting company,&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements, as well as reduced disclosure obligations regarding executive compensation in periodic reports and proxy statements. We will remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of our common stock held by non-affiliates exceeds $250 million as of the last business day of our second fiscal quarter, or (ii) our annual revenue exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the last business day of our second fiscal quarter. We cannot predict if investors will find our common shares less attractive because we may rely on these exemptions. If some investors find our common shares less attractive as a result, there may be a less active trading market for our common shares and our share price may be more volatile.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Qualitative and Quantitative Disclosures About Market Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our market risk exposure is primarily a result of fluctuations in interest rates and inflation. We do not hold or issue financial instruments for trading purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We had cash, cash equivalents and investments of $129.2 million as of June&#160;30, 2026. The primary goals of our investment policy are liquidity and capital preservation. We do not enter into investments for trading or speculative purposes. The carrying amount of our cash equivalents reasonably approximates fair value, due to the short maturities of these instruments. Our investments are exposed to market risk due to a fluctuation in interest rates, which may affect the fair market value of our investments in marketable debt securities. As of June&#160;30, 2026, the effect of a hypothetical 1.00% (100 basis point) change in interest rates would have changed the fair value of our marketable debt securities by $0.9 million. Such change would only be realized if we sold the marketable debt securities prior to maturity. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Inflation generally affects us by increasing our cost of labor and goods and services. We believe that inflation has had some effect on our financial results during the periods presented. If we experience continued or future inflationary pressure, it may impact the costs of our operations as well as the costs to manufacture, sell and distribute our products and provide our services in the future. We may not be able to fully offset those increased costs through reduced spending or price increases to our products and services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a&#8209;15(e) and 15d&#8209;15(e) under the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June&#160;30, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting during the quarter ended June&#160;30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations on the Effectiveness of Controls</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_127"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PART II: OTHER INFORMATION</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_130"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in various claims and legal proceedings. Regardless of outcome, litigation and other legal and administrative proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_133"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should consider carefully the following information about the risks described below, together with the other information contained in this Quarterly Report on Form 10-Q and in our other public filings, in evaluating our business. If any of the following risks actually occurs, our business, financial condition, results of operations, and future growth prospects would likely be materially and adversely affected. In these circumstances, the market price of our common stock would likely decline.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties that you should consider before investing in our company, as more fully described below. The principal factors and uncertainties that make investing in our company risky include, among others:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are a development stage company that has incurred net losses in every period to date, is in the early stages of commercializing our products and/or services, and expects to continue to incur significant losses as we develop our business. We may never achieve profitability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is entirely dependent on the successful development and commercialization of our proteomics platform (the &#8220;Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">platform&#8221;), which remains in the development stage and has been, and could in the future be, subject to delays, technical challenges and market acceptance challenges. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not compete successfully with our initial or future products in the highly competitive life sciences technology market.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent upon third parties for certain aspects of the development and commercialization of the Nautilus Voyager platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business depends significantly on research and development spending by pharmaceutical companies as well as by academic institutions and other research institutions and any reduction in spending could limit demand for our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to launch our Nautilus Voyager platform successfully and even if it is successful, we may experience material delays in our commercialization program relative to current expectations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results may fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or our guidance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect that we will need to raise additional capital to fund our development and commercialization plans, which may not be available to us on favorable terms or at all.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to obtain and maintain sufficient intellectual property protection for our products and technology, or if the scope of our intellectual property protection obtained is not sufficiently broad, competitors could develop and commercialize products similar or identical to ours.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to protect our intellectual property and proprietary rights throughout the world. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may become involved in litigation to enforce or defend our intellectual property rights, or to defend ourselves from claims that we infringe the intellectual property rights of others.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may face liability and/or negative publicity for any unknown defects or errors in our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory and Legal Compliance Matters</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products may, in the future, be subject to regulation by the FDA or other regulatory authorities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are currently subject to, and may in the future become subject to additional, U.S. federal and state laws and regulations, as well as the laws and regulations of other countries, relating to how we collect, store and process personal information, and how we transmit analytical data to our customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future expansion of our development and commercialization activities outside of the United States, may subject us to an increased risk of inadvertently conducting activities in a manner that violates the U.S. Foreign Corrupt Practices Act and similar laws. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Environmental and health safety laws, including any failure to comply with such laws, may result in liabilities, expenses and restrictions on our operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our employees, independent contractors, consultants, commercial partners, distributors and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Operations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience a significant disruption in our information technology systems or breaches of data security.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are highly dependent on our key personnel, and if we are unable to recruit and retain key executives and scientists, we may not be able to achieve our goals.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operations and financial results could be adversely impacted by global and national events, such as global geopolitical conflicts, including war, trade embargoes, tariff policies and boycotts, changing interest rates, volatility in the global financial markets and general economic downturns.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Global supply chain interruptions may negatively impact the development and commercialization of our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of and market for our Common Stock may be volatile, which could result in substantial losses for investors and/or an inability to readily trade in our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will have broad discretion over the use of the proceeds to us from our &#8220;at the market&#8221; equity offering program and may apply the proceeds to uses that do not improve our operating results or the value of your securities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will continue to incur significant costs and management resources as a result of operating as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to timely and accurately report our financial results and projections as a public company may be impacted by the effectiveness of our internal controls, and our estimates and judgments relating to critical accounting policies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our risk factors are not guarantees that no such conditions exist as of the date of this report and should not be interpreted as an affirmative statement that such risks or conditions have not materialized, in whole or in part.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a development stage company that has incurred net losses in every period to date, is in the early stages of commercializing our products and/or services, and expects to continue to incur significant losses as we develop our business. We may never achieve profitability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a development stage company that has incurred net losses in each quarterly and annual period since inception and that has not yet generated any material revenue. We expect to incur increasing costs as we continue to devote substantially all of our resources towards the development and commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform, which includes our end-to-end solution comprised of analysis services, instruments, consumables, and software analysis. We cannot be certain if we will ever generate material revenue or if or when we will produce sufficient revenue from operations to support our costs. Even if profitability is achieved, we may not be able to sustain profitability. We incurred net losses of $14.5 million and $29.2 million during the three and six months ended June 30, 2026, respectively and $15.0 million and $31.6 million during the three and six months ended June 30, 2025, respectively. As of June&#160;30, 2026, we had an accumulated deficit of $361.2 million. These losses and accumulated deficit were primarily due to the substantial investments we made in the scientific and technological development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">platform. We expect to incur substantial losses and negative cash flows for the foreseeable future. In addition, as a public company, we will continue to incur significant legal, accounting, and other expenses. These expenses will make it harder for us to achieve and sustain future profitability. We may incur significant losses in the future for a number of reasons, many of which are beyond our control, including the other risks described in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is entirely dependent on the success of our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform, which remains in the development stage and subject to scientific and technical validation. If we are unable to develop and commercialize our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform successfully and in a manner that provides currently anticipated functionality and levels of performance, we may never be able to recognize any material revenue, and our business, operating results, and financial condition will suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our future success is entirely dependent on our ability to successfully develop and commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">platform, which is based on innovative yet complex and unproven technologies and which is anticipated to be used in demanding scientific research that requires substantial levels of accuracy and precision. We are investing substantially all of our management efforts and financial resources in the development and commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager platform, which remains in the development stage and subject to scientific and technical validation.  Development challenges have, and may in the future continue to cause delays in or inhibit our ability to commercialize our platform assays in one or more application areas. Additionally, in developing our platform technology, we currently rely on co-development partners to assist us in the development of certain component technologies in our platform. We have experienced difficulties with some of these partners successfully delivering these component technologies on time and to our specifications, and these partners may not be successful in delivering these component technologies on time, to our specifications, or at all, in the future, which could have an adverse impact on our ability to meet our development timelines, and/or our products&#8217; level of currently anticipated functionality and performance. While our goal is to leverage our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform to comprehensively measure the human proteome, the human proteome is dynamic and far more complex and diverse in structure, composition and number of variants than either the genome or transcriptome. If we cannot successfully complete platform development, if we are unable to achieve our goals for mapping the proteome, if our products and services fail to deliver currently anticipated functionality and levels of performance in commercially valuable applications, if our products and/or services are found by a court of law to infringe the intellectual property of another party, or if we are unable to obtain broad scientific and market acceptance of our products, services and technologies, we may never recognize material revenue and may be unable to continue our operations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not yet commercially launched our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform. We may not be able to launch our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform successfully and even if it is successful, we may experience material delays in our commercialization program relative to current expectations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are commercializing our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform in phases that began with research collaborations with leading biopharmaceutical companies, academic institutions, and research organizations exploring utility of pre-commercial versions of the platform. The next phases of our strategy involve a land-and-expand strategy in which we provide customers with access to the Iterative Mapping method on the Nautilus Voyager platform for an initial application, with the expectation of, over time, adding additional applications in expanded targeted proteoform analysis and, in the future, broadscale proteomics, which customers would access depending upon their specific proteomics needs. While our development efforts continue for our broadscale assay, those efforts have not advanced sufficiently to support general availability of that assay in 2027 to our target specifications. We have identified key improvement areas, which we expect to advance broadscale performance. Due to the need for further improvements to the broadscale assay and the demand we are seeing for proteoforms from the market, we plan to reallocate resources from the broadscale effort to accelerate our proteoform application development.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Initial customer access to the Nautilus Voyager platform is being enabled through our Iterative Mapping Early Access Program (&#8220;Early Access Program&#8221;) in which we perform analysis and profiling of samples in our facility and such data and analysis is shared via a cloud platform. We announced the launch of our Early Access Program starting with target specific service offerings in January 2026 for the analysis of the microtubule-associated protein tau (&#8220;Tau&#8221;), which has been broadly associated with the onset and progression of Alzheimer&#8217;s disease in human patients. Our early access framework is expected to expand further to support additional targeted proteoforms assays in neuroscience and new disease areas like oncology, starting with RAC-alpha serine/threonine-protein kinase (or &#8220;AKT1&#8221;), which acts as a control hub for growth and survival signals and is a pathway active in many cancers. We do not anticipate that these early access activities will result in any material revenue. With data gained from our Early Access Program customers, we plan to leverage publications to drive awareness and customer demand to later sell instruments and reagents to select customers performing targeted proteoform research. We expect to initiate our commercial launch in early 2027 by opening the Nautilus Voyager platform for pre-orders, with instrument shipments beginning in mid 2027. At the time of these first commercial shipments, we expect general availability to include the Voyager instrument, our Tau Proteoforms assay, an AKT1 Proteoforms assay and an additional oncology proteoforms assay. As we continue expanding the platform&#8217;s assay portfolio, we concurrently expect to enable a broader diversity of sample types, including blood, which is the most prevalent sample type behind cells and tissues already enabled today. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Achieving the scientific and commercial objectives identified above within currently anticipated timelines will require substantial investments in our technologies and in the underlying science. Scientific and technological development of the nature being undertaken by us is extraordinarily complex, and there can be no assurances that any of these phases of commercial development will be successful, that they will be completed within the timelines currently anticipated, or that they will result in increased customer interest in our products and/or services. Given the scientific and technical complexity of our products and services, we could experience material delays in product development and commercial launch. In addition, if we are not able to supplement our initial platform release with  subsequent consumable releases to enable our platform to meet or exceed our previously announced product specifications or achieve expanded capabilities, we may lose customers or be limited in our ability to achieve market adoption. If our research and product development efforts do not result in commercially viable products and/or services within the anticipated timelines or if such products do not generate the interest in the market that we anticipate, our business, operating results, and financial condition will be adversely affected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commercialization of our products will require us to establish relationships and successfully collaborate with leading life science companies and research institutions, initially to test and validate our products and subsequently as we seek to expand the markets for our products. We may be unable to establish sufficient collaborations of this nature, and such collaborations could result in agreements that limit or otherwise impair our flexibility to pursue other strategic opportunities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, establishing collaborations and partnerships with large pharmaceutical and biotechnology companies and with major research institutions is a material element of our commercialization strategy. While early collaborations have focused, and are expected to continue to focus on the assessment and validation of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform with a focus in part on publication of results in peer-reviewed scientific journals, we also intend to pursue additional, potentially revenue-generating collaborations in areas of biological interest. Among other examples, we may pursue collaborations relating to the development and commercialization of therapeutic product candidates targeting proteins identified by our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that we will be successful in developing or maintaining collaborations or that, if established, these collaborations will achieve the desired objectives. Establishing collaborations is difficult and time-consuming. Discussions may not lead to collaborations on favorable terms, if at all, and particularly where we are negotiating against major pharmaceutical companies, we may have relatively less leverage in negotiating favorable terms. To the extent we agree to work exclusively with a party in a given field, our opportunities to collaborate with others in that field would be limited. Certain parties may seek to partner with other companies in addition to us in connection with a project. This, in turn, may limit the commercial potential of any products that are the subject of such collaborations. Potential collaborators may elect not to work with us based upon their assessment of our financial, regulatory, commercial or intellectual property position.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are successful in entering into collaborations, the success of such collaborations will depend heavily on the efforts and activities of our collaborators.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Scientific collaborations of the nature we propose to pursue are subject to numerous risks, including that:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may have significant discretion in determining the efforts and resources that they will apply to a specific project;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not pursue development and commercialization of products or may elect not to continue or renew development or commercialization programs based on trial or test results, changes in their strategic focus due to the acquisition of competitive products, availability of funding, or other external factors such as a business combination that diverts resources or creates competing priorities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may own intellectual property covering products that result from our collaboration with them, and in such cases, we would not have the right to develop or commercialize such intellectual property;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may co-own intellectual property covering products that result from our collaboration with them, and in such cases, we would not have the right to exclude others from developing or commercializing such intellectual property;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with product candidates that are being developed under the collaboration with us;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a collaborator with marketing, manufacturing, and distribution rights to one or more products may not commit sufficient resources to or otherwise not perform satisfactorily in carrying out these activities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes may arise between us and a collaborator that cause the delay or termination of the research, development, or commercialization of products or that result in costly litigation or arbitration that diverts management attention and resources;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborations may be terminated, and, if terminated, in addition to reducing our revenue, may reduce exposure to research and clinical trials that facilitate the collection and incorporation of new information into our platform; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a collaborator&#8217;s sales and marketing activities or other operations may not be in compliance with applicable laws resulting in civil or criminal proceedings.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, before obtaining marketing approval from regulatory authorities for the sale of product candidates subject to future collaborations, our collaborators must conduct extensive clinical trials to demonstrate the safety and efficacy of the product candidates. If clinical trials of product candidates resulting from collaborations are prolonged or delayed, collaborators may be unable to obtain required regulatory approvals and therefore be unable to commercialize product candidates on a timely basis or at all, which may have a material impact on the revenue recognized from such collaborations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we are able to complete development of our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform, we may not achieve or maintain significant commercial market acceptance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to complete development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform, the platform will be subject to market forces and adoption curves common to new technologies. The market for novel proteomics technologies and products like those being developed by us is in the early stages of development. While these technologies present the potential to displace legacy products, changing long-standing scientific workflows with new instruments requiring substantial capital expenditures will require us to invest substantial financial and management resources to educate potential customers on the benefits of our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager platform relative to existing technologies and to validate our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager platform&#8217;s ability to meet customer requirements. In that regard, we anticipate that our initial market focus will be pharmaceutical development and associated research, which are characterized by demanding and exacting requirements for product performance and accuracy. If widespread adoption of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager platform takes longer than anticipated or does not occur, our business will be materially and adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, the successful introduction of new technologies in life science markets requires substantial engagement with the scientific community in order to encourage community acceptance of the utility, performance, and cost of the technology relative to its benefits in the applicable field or fields of research. The life sciences scientific community is often led by a small number of early adopters and key opinion leaders who significantly influence the larger community through publications in peer-reviewed journals. In these journal publications, the researchers describe not only their discoveries but also the methods and typically the products used to fuel these discoveries. We expect that references to the use of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform in peer-reviewed journal publications will be critical to our ability to obtain widespread acceptance within the scientific community. In addition, continuing collaborative relationships with key opinion leaders will be vital to maintaining any market acceptance we achieve. If too few researchers describe the use of our products, too many researchers shift to a competing product and publish research outlining their use of that product, or too many researchers negatively describe the use of our products in publications, customers may be less willing to engage with us concerning our products, which could materially delay our commercialization plan and/or substantially extend our sales cycles. Moreover, these customers may ultimately be less willing to purchase our products, which would adversely affect our business and future revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Specific, material factors that will influence our ability to achieve market acceptance include the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our marketing and engagement initiatives to increase awareness of the capabilities of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform to demonstrate reliable performance in intended use applications, in particular, when the platform is used by customers in their own research;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to demonstrate that the functionality and performance of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform relative to alternative products and technologies justifies the substantial anticipated cost of the platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of prospective customers to adopt new products and workflows;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ease of use of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform and whether it reliably provides significant advantages over alternative products and technologies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the commercial value and customer acceptance of Nautilus&#8217; targeted proteoform analysis products and services;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate of adoption of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform by biopharmaceutical companies, laboratories, academic institutions and others;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prices at which we will be able to sell our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop new products, workflows, and solutions that meet customer requirements;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction or development and commercialization by competitors of new products or enhancements to existing products with functionality and/or performance similar to our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of our investments in product innovation and commercial growth.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that we will be successful in addressing any of these criteria or any additional criteria that might affect the market acceptance of our products. If we are unsuccessful in achieving and maintaining market acceptance of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform, our business, financial condition and results of operations would be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have no experience in manufacturing our products at commercial scale. If we are unable to establish manufacturing capacity by ourselves or with partners in a timely manner after completing development, commercialization of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform would be delayed, which would result in lost revenue and harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In order for us to commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform in volume, we will need to establish internal manufacturing capacity or to contract with one or more manufacturing partners, or both. Our technology is complex, and the manufacturing process for our products will be similarly complex, involving a large number of unique precision parts in addition to the production of various reagents and antibodies. We may encounter unexpected difficulties in manufacturing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform, including our proteome analysis system and related consumables. Among other factors, we will need to develop reliable supply chains for the various components in our platform instruments and consumables to support large-scale commercial production. In connection with our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform, we may utilize long lead time instrument system components, such as cameras and lasers, and as a result, it may impact our ability to consistently source such components.  Additionally, we intend to utilize hundreds of unique multi-affinity reagents and various standard antibodies in order to generate deep proteomic information at the speed and scale which we expect our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform to perform. Such reagents and antibodies are expected to be more difficult to manufacture and more expensive to procure. There are no assurances that we will be able to build manufacturing or consumable production capacity internally or find one or more suitable manufacturing or production partners, or both, to meet the volume and quality requirements necessary to be successful in the proteomics market. In addition, in connection with establishing third party relationships or sourcing component supplies, including with respect to instrument components, reagents and antibodies, we may incur costs that are higher than currently expected and that may adversely affect our gross margins and operating results following commercialization. Assuming we complete development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform, we may experience manufacturing and product quality issues as we increase the scale of our production. Any delay or inability in establishing or expanding our manufacturing capacity could diminish our ability to develop or sell our products, result in increased or unanticipated costs, result in lost revenue, and seriously harm our business, results of operations and financial condition.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish an effective commercial organization, including effective distribution channels and sales and marketing functions, we may not be successful in commercializing our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are only beginning to establish an internal organization focused specifically on the commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform. Our initial hiring has focused on senior commercial leadership, and although this leadership has considerable industry experience, in order to achieve substantial revenue growth and profitability, we will be required to develop sales, marketing, distribution, customer service, and customer support capabilities. Staffing of these functions will frequently require individuals with the requisite technical and scientific expertise to establish and support sales of a sophisticated and complex platform for life sciences experimentation. We will be required to expend substantial financial resources to hire personnel and develop our commercial operations prior to commercial launch of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager platform. Accordingly, these initiatives will adversely affect our operating expenses prior to us having material off-setting revenue, if any.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To develop these functions successfully, we will face a number of additional risks, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, retain, and manage the sales, marketing, customer service, and customer support force necessary to commercialize and gain market acceptance for our technology, with the additional challenge that many of these new hires will require specific scientific and technological expertise that may be more difficult to find; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and cost of establishing a specialized sales, marketing and customer service and support force.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our internal organization, we may seek to enlist one or more third parties to assist with sales, distribution, and customer service and support globally or in certain regions of the world. In certain markets, we could seek to establish partnerships with larger market participants to provide access to their distribution channels and which could also involve scientific or technological collaboration. There is no guarantee, if we do seek to enter into any of these arrangements, that we will be successful in attracting desirable partners or that we will be able to enter into such arrangements on commercially favorable terms. If our commercialization efforts, or those of any third-party partners, are not successful, our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> p</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">latform may not gain market acceptance, which could materially impact our business and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The size of the markets for our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform may be smaller than estimated, and new market opportunities may not develop as quickly as we expect, or at all, limiting our ability to successfully sell our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The market for proteomics technologies and products is evolving, making it difficult to predict with any accuracy the size of the markets for our current and future products, including our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Our estimates of the total addressable market for our current and future products, including with respect to the proteomics market, the diagnostic market, and the mass spectrometry market, are based on a number of internal and third-party estimates and assumptions, as well as assumptions about the specifications and functionality of our Nautilus Voyager platform to address such demand. In particular, our estimates are based on our expectations that researchers in the market for certain life sciences research tools and technologies will view our products as competitive alternatives to, or better options than, existing tools and technologies. We also expect researchers will recognize the ability of our products to complement, enhance and enable new applications of their current tools and technologies. We expect them to recognize the value proposition offered by our products enough to purchase our products in addition to the tools and technologies they already own. Underlying each of these expectations are a number of estimates and assumptions that may be incorrect, including the assumptions that government or other sources of funding will continue to be available to life sciences researchers at times and in amounts necessary to allow them to purchase our products and that researchers have sufficient samples and an unmet need for performing proteomics studies at scale across thousands of samples. In addition, sales of new products into new market opportunities may take years to develop and mature and we cannot be certain that these market opportunities will develop as we expect. New life sciences technology may not be adopted until the consistency and accuracy of such technology, method or device has been proven. As a result, the sizes of the annual total addressable market for new markets and new products are even more difficult to predict. Our product is an innovative new product, and while we draw comparisons between the evolution and growth of the genomics market, the proteomics market may </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">develop more slowly or differently. In addition, our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> may not impact the field of proteomics in the same manner or degree, or within the same time frame, that NGS technologies have impacted the field of genomics, or at all, including as a result of development challenges that we have faced and continue to face that may delay or inhibit our ability to commercialize our platform assays in one or more application areas. While we believe our assumptions and the data underlying our estimates of the total addressable market for our products are reasonable, these assumptions and estimates may not be correct and the conditions supporting our assumptions or estimates, or those underlying the third-party data we have used, may change at any time, thereby reducing the accuracy of our estimates. As a result, our estimates of the total addressable market for our products may be incorrect.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The future growth of the market for our current and future products depends on many factors beyond our control, including recognition and acceptance of our products by the scientific community and the growth, prevalence and costs of competing products and solutions. Such recognition and acceptance may not occur in the near term, or at all. If the markets for our current and future products are smaller than estimated or do not develop as we expect, our growth may be limited and our business, financial condition and operational results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on single source suppliers for some of the components and materials used in our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nautilus </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform, and the loss of any of these suppliers could harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We rely on single source suppliers for certain components and materials used in our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform. The loss of any of these single source suppliers would require us to expend significant time and effort to locate and qualify an alternative source of supply for these components. Though we do not c</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">urrently have contracts for third parties to provide manufacturing capabilities for each component of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform for which we expect to employ such third party manufacturers</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, if we are successful in reaching the point of manufacturing our products for commercialization, we may rely on a single company for such manufacturing. Any contractual disputes between us and such manufacturer or loss of manufacturing ability by such manufacturer could similarly require significant time, effort and expense to locate and qualify an alternative source of manufacturing, which could materially harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also rely, and expect to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies needed to generate the deep proteomic information at the speed and scale which we expect our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to perform. With respect to any antibodies or reagents that are single sourced, the loss of any suppliers would require significant time and effort to locate and qualify an alternative source of supply. Such reagents and antibodies may also become scarce, more expensive to procure, or not meet quality standards, and we may not be able to obtain favorable terms in agreements with suppliers. Given their complexity, our suppliers may not be able to provide these reagents and antibodies in a cost-effective manner or in a time frame that is consistent with our expected future needs. If our suppliers cease or interrupt production or if suppliers fail to supply materials, products or services to us for any reason, such interruption could delay development, or interrupt the commercial supply, with the potential for additional costs and lost revenue. If this were to occur, we might also need to seek alternative means to fulfill our manufacturing needs. Any such transition would require significant efforts in testing and validation and could result in delays or other issues, which could materially harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The life sciences technology market is highly competitive. If we fail to compete effectively, our business and results of operation will suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in the life sciences technology market. We currently compete with technology and diagnostic companies tha</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">t supply components, products, and services to customers engaged in proteomics analysis. Major competitors include Thermo Fisher Scientific (including Olink); Bruker Corporation; Agilent Technologies; Danaher; (SCIEX); Becton, Dickinson and Company; Quanterix; and Illumina, Inc. (through its acquisition of the former Somalogic business from Standard Biotools Inc.). We also compete with a number of emerging companies that are developing proteomic products and solut</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ions.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Some of our current competitors are large publicly-traded companies, or are divisions of large publicly-traded companies, and enjoy a number of competitive advantages over us, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater name and brand recognition;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater financial and human resources;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">broader product lines;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger sales forces and more established distributor networks;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial intellectual property portfolios;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger and more established customer bases and relationships; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">better established, larger scale and lower cost manufacturing capabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure investors that our products will compete favorably or that we will be successful in the face of increasing competition from products and technologies introduced by our existing or future competitors or by companies entering our markets or that are developed by our customers internally. In addition, we cannot assure investors that our competitors do not have or will not develop products or technologies that currently or in the future will enable them to produce competitive products with superior functionality or performance or at lower costs than ours or that are able to run comparable experiments at a lower total experiment cost. Additionally, the merger or consolidation of significant competitors would result in competitors with greater resources, which may enable them to offer a different market approach, or a lower cost structure through economies of scale or other efficiencies that we may be unable to match and which may intensify competition. Further, our competitors may seek to vertically integrate by buying suppliers that also supply products or components to us, which could enable them to further reduce prices, or could increase our costs. Any failure to compete effectively could materially and adversely affect our business, financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform is commercialized and achieves broad scientific and market acceptance, if we fail to improve it or introduce compelling new products, our revenue and our prospects could be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The life sciences industry is characterized by rapid and significant technological changes, frequent new product introductions and enhancements and evolving industry standards. Even if we are able to commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform, with respect to both targeted proteoform analysis and eventually broadscale proteomics analysis, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and achieve broad scientific and market acceptance, our ability to attract new customers and increase revenue from existing customers will depend in large part on our ability to enhance and improve our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and to introduce compelling new products. The success of any enhancement to our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> or introduction of new products depends on several factors, including timely completion and delivery, competitive pricing, adequate quality testing, integration with existing technologies, freedom from intellectual property encumbrance, appropriately timed and staged introduction and overall market acceptance. Any new product or enhancement to our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> that we develop may not be introduced in a timely or cost-effective manner, may contain defects, errors, vulnerabilities or bugs, or may not achieve the market acceptance necessary to generate significant revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The typical development cycle of new life sciences products can be lengthy and complicated, and may require new scientific discoveries or advancements, considerable resources and complex technology and engineering. Such developments may involve external suppliers and service providers, making the management of development projects complex and subject to risks and uncertainties regarding timing, timely delivery of required components or services and satisfactory technical performance of such components or assembled products. If we do not achieve the required technical specifications or successfully manage new product development processes, or if development work is not performed according to schedule, then such new technologies or products may be adversely impacted. If we are unable to successfully develop new products, enhance our proteomics product platform to meet customer </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">requirements, compete with alternative products, or otherwise gain and maintain market acceptance, our business, results of operations and financial condition could be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for development of certain aspects of the Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform, and any failure of these third parties to perform their respective obligations in a timely manner or to our specifications could negatively impact our timelines, costs or product performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged with a number of third party collaborators who assist us in co-development of certain aspects of the Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform, including, for example, certain affinity reagents and array chip substrates.  Our agreements with these third party collaborators include obligations for these third parties to deliver certain aspects of technology to be used in the Nautilus Voyager platform in accordance with certain defined timelines, in accordance with defined specifications, and in accordance with certain cost limitations.  We have also sought to include redundancy and contingency planning with respect to the efforts of our third party collaborators where practicable.  Despite our contractual assurances and contingency planning, it is possible that one or more of our third party collaborators may fail to deliver their respective technologies to us on time or in accordance with our specifications, and such failure could negatively impact the timing of the commercialization of the Nautilus Voyager platform, its performance, or its cost.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business will depend significantly on research and development spending by pharmaceutical companies as well as by academic and other research institutions. Any reduction in spending could limit demand for our products and adversely affect our business, results of operations, financial condition and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our revenue in the foreseeable future will be derived primarily from sales of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> to biotechnology companies and life science laboratories worldwide, and to a lesser extent, academic institutions and non-profit organizations. Our success will depend upon demand for and use of our products. Accordingly, the spending policies of these customers could have a significant effect on the demand for our technology. These policies may be based on a wide variety of factors, including the resources available to make purchases, the spending priorities among various types of equipment, policies regarding spending during recessionary periods and changes in the political climate. In addition, academic, governmental and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results may fluctuate substantially due to reductions and delays in research and development expenditures by these customers. For example, reductions in capital expenditures by these customers may result in lower than expected system sales and, similarly, reductions in operating expenditures by these customers could result in lower than expected sales of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. These reductions and delays may result from factors that are not within our control, such as:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in government funding of research and development, including any reductions in funding to the U.S. National Institutes of Health;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in economic conditions, including recessionary effects, inflationary pressures </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and volatility in the global financial markets, including with respect to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">any</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> future financial institution failures</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government programs that provide funding to research institutions and companies, including changes in the amount of funds allocated to different areas of research or changes that have the effect of increasing the length of time of the funding process;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax legislation that may indirectly impact research institutions&#8217; ability to allocate funds to different areas of research;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the regulatory environment affecting life science and Ag-Bio companies engaged in research and commercial activities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of AI and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> based research and development approaches, such as in drug discovery, that could impact funding allocations for R&amp;D in the pharmaceutical and biotechnology industry;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differences in budget cycles across various geographies and industries;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market-driven pressures on companies to consolidate operations and reduce costs;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mergers and acquisitions in the life science and Ag-Bio industries; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors affecting research and development spending.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any decrease in our customers&#8217; budgets or expenditures or in the size, scope or frequency of capital or operating expenditures as a result of the foregoing or other factors could materially and adversely affect our business, results of operations, financial condition, and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results. In the near term, as we devote substantially all of our resources towards the development and commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform, specific factors that may result in fluctuations include, without limitation:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and cost of, and level of investment in, research and development and commercialization activities relating to our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully establish and successfully maintain appropriate collaborations and derive revenue from those collaborations; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact that economic inflation may have on our costs for manufacturing our products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any litigation or governmental investigations involving us, our industry or both; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully develop and commercialize our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform on our anticipated timeline and with our expected functionality.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As we transition from a company with a focus on research and development to a company capable of supporting manufacturing, these fluctuations may also occur due to a variety of other factors, many of which are outside of our control, including, but not limited to:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of demand for any products we are able to commercialize, particularly our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform, which may vary significantly from period to period;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to drive adoption of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform in our target markets and our ability to expand into any future target markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact that economic inflation may have on our costs for manufacturing our products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prices at which we will be able to sell our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the volume and mix of our sales between consumables, instruments and software, or changes in the manufacturing or sales costs related to our products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of expenditures that we may incur to develop, commercialize or acquire additional products and technologies or for other purposes, such as the expansion of our facilities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in governmental funding of life sciences research and development or changes that impact budgets and budget cycles;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seasonal spending patterns of our customers;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of when we recognize any material revenue;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future accounting pronouncements or changes in our accounting policies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher than anticipated service, replacement and warranty costs;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased and/or unpredictable tariffs on our products, and/or on parts or materials that we source from foreign suppliers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">geopolitical conflicts, such as the conflicts in Eastern Europe and the Middle East, any potential future financial institution failures</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and other national and global events on the economy, investment in life sciences and research industries, our business operations, and resources and operations of our customers, suppliers, and distributors; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general industry, economic and market conditions and other factors, including factors unrelated to our operating performance or the operating performance of our competitors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative effects of the factors discussed above could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. Investors should not rely on our past results as an indication of our future performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This variability and unpredictability could also result in us failing to meet the expectations of industry or financial analysts or investors for any period. If we are unable to commercialize products or generate revenue, or if our operating results fall below the expectations of analysts or investors or below any guidance we may provide, or if the guidance we provide is below the expectations of analysts or investors, it could cause the market price of our Common Stock to decline.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited operating history, which may make it difficult to evaluate our current business and the prospects for our future viability, and to predict our future performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are a life sciences technology company with a limited operating history. We have not completed development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform or any other products and have not generated any material revenue to date. Our operations to date have been limited to developing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager platform. Our prospects must be considered in light of the uncertainties, risks, expenses, and difficulties frequently encountered by companies in their early stages of operations. Consequently, predictions about our future success or viability are highly uncertain and may not be as accurate as they could be if we had a longer operating history or a company history of successfully developing and commercializing products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown obstacles. We will need to transition from a company with a focus on research and development to a company capable of supporting manufacturing and commercial activities as well, and we may not be successful in such a transition. We have encountered in the past, and will encounter in the future, risks and uncertainties frequently experienced by growing companies with limited operating histories in emerging and rapidly changing industries. If our assumptions regarding these risks and uncertainties, which we use to plan and operate our business, are incorrect or change, or if we do not address these risks successfully, our results of operations could differ materially from our expectations, and our business, financial condition and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect that we will need to raise additional capital to fund our development and commercialization plans.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current plans, we believe that our available resources and existing cash, cash equivalents and short-term investments, will be sufficient to meet our anticipated cash requirements for at least 12 months from the date of this Quarterly Report on Form 10-Q. If our available resources and existing cash and cash equivalents and short-term investments are insufficient to satisfy our liquidity requirements, including because of the realization of other risks described in this Quarterly Report on Form 10-Q, we may be required to raise additional capital prior to such time through issuances of equity or convertible debt securities, enter into a credit facility or another form of third-party funding or seek other debt financing.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We expect that we will need to raise additional capital in the future to expand our business, to pursue strategic investments, to take advantage of financing or acquisition opportunities or for other reasons, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">funding development and marketing efforts of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform or any other future products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our sales and marketing and other commercialization efforts to drive market adoption of our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform, once commercialized;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding our technologies into additional markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparing, filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring, licensing or defending against third party intellectual property rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring or investing in complementary technologies, businesses or assets; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financing capital expenditures and selling, general and administrative expenses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our present and future funding requirements will depend on many factors, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in execution of our development plans;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and timing of our investment in our sales, marketing, and distribution capabilities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes we may make to our business that affect ongoing operating expenses;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes we may make in our business or commercialization strategy;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes we may make in our research and development spending plans;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of competing technological and market developments;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our need to implement additional infrastructure and internal systems;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global geopolitical conflicts, including war, trade embargoes, tariff policies and boycotts, changing interest rates, volatility in the global financial markets and general economic downturns</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other items affecting our forecasted level of expenditures and use of cash resources including potential acquisitions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The various ways we could raise additional capital carry potential risks. If we raise funds by issuing equity securities, dilution to our stockholders could result. If we raise funds by issuing debt securities, those debt securities could have rights, preferences and privileges senior to those of holders of our Common Stock. The terms of debt securities issued or borrowings pursuant to a credit agreement could impose significant restrictions on our operations. If we raise funds through collaborations or licensing arrangements, we might be required to relinquish significant rights to our technologies or products or grant licenses on terms that are not favorable to us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. We filed (i) on February 28, 2024, a shelf registration statement on Form S-3 with the SEC that became effective on March 6, 2024 and allows us to undertake various equity and debt offerings up to $300.0 million; and (ii) on March 6, 2024, a prospectus supplement to the shelf registration statement that covers the offering, issuance and sale of up to $125.0 million of our common stock from time to time through an &#8220;at-the-market&#8221; program under the Securities Act. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and disruptions to, and volatility in, the credit and financial markets </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">in the United States and worldwide, global geopolitical conflicts, and otherwise. If we are unable to obtain adequate financing or financing on terms satisfactory to us, if we require it, our ability to continue to pursue our business objectives and to respond to business opportunities, challenges, or unforeseen circumstances could be significantly limited, and could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, actual events involving limited liquidity or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, the collapse of Silicon Valley Bank and other financial institutions in March 2023 has caused and could continue to cause volatility in the global financial markets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although we assess our banking relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect us, the financial institutions with which we have arrangements directly, or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, disruptions or volatility in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally. Credit and banking costs, generally, may also be adversely impacted by these factors, resulting in higher costs for the Company. For example, as part of our efforts to diversify our banking and credit arrangements following the collapse of Silicon Valley Bank, we have incurred higher banking related costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain and maintain sufficient intellectual property protection for our products and technology, or if the scope of our intellectual property protection obtained is not sufficiently broad, competitors could develop and commercialize products similar or identical to ours, and our ability to successfully commercialize our products may be impaired.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of copyright, trade secret and trademark laws, and nondisclosure, confidentiality and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. If we fail to obtain, maintain and protect our intellectual property, third parties may be able to compete more effectively against us. In addition, we may incur substantial costs related to litigation or other patent proceedings in our attempts to recover or restrict use of our intellectual property.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our intellectual property offers inadequate protection, or is found to be invalid or unenforceable, we would be exposed to a greater risk of direct competition. If our intellectual property does not provide adequate coverage of our competitors&#8217; products, our competitive position could be adversely affected, as could our business, financial condition, results of operations and prospects. Both the patent application process and the process of managing patent and other intellectual property disputes are generally unpredictable, time-consuming and expensive.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our and any future licensor&#8217;s ability to obtain and maintain protection of the intellectual property we may own or license, whether solely or jointly, particularly patents, in the United States and other countries with respect to our products and technologies. We apply for patents to protect our products, technologies and commercial activities, as we deem appropriate. However, obtaining and enforcing patents is costly, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">time-consuming and complex, and we may fail to apply for patents on important products and technologies in a timely fashion or at all, or we may fail to apply for patents in potentially relevant jurisdictions. We may not be able to file and prosecute all necessary or desirable patent applications, or maintain, enforce and license any patents that may issue from such patent applications, at a reasonable cost or in a timely manner or in all jurisdictions. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Moreover, we may not develop additional proprietary products, methods and technologies that are patentable. We may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the rights to patents which may be licensed from or to third parties. In connection with any future licensing arrangements with third parties, these patents and applications may not be prosecuted and enforced by such third parties in a manner consistent with the best interests of our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the patent position of life sciences technology companies generally is highly uncertain, involves complex legal and factual questions, and has been the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">subject of much litigation in recent years. Changes in either the patent laws or in interpretations of patent laws in the United States or other jurisdictions may diminish the value of our intellectual property. As a result, the issuance, scope, validity, enforceability, and commercial value of our patent rights are highly uncertain. It is possible that none of our pending patent applications will result in issued patents in a timely fashion or at all, and even if issued, the patents may not provide a basis for intellectual property protection of commercially viable products or services, may not provide us with any competitive advantages, or may be challenged, narrowed or invalidated by third parties. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. It is possible that third parties will design around our current or future patents such that we cannot prevent such third parties from using similar technologies and commercializing similar products to compete with us. Some of our owned or any future licensed patents or patent applications may be challenged at a future point in time and we may not be successful in defending any such challenges made against our patents or patent applications. Any successful third-party challenge to our patents could result in diminished or lost rights, for example, due to narrowing, unenforceability or invalidity of such patents and increased competition to our business. The outcome of patent litigation or other proceedings is generally uncertain, and any attempt by us to enforce our patent rights against others or to challenge the patent rights of others may not be successful, or, regardless of success, may take substantial time and result in substantial cost, and may divert our efforts and attention from other aspects of our business. Any of the foregoing events could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The U.S. law relating to the patentability of certain inventions in the life sciences technology industry is uncertain and rapidly changing, which may adversely impact our existing patents or our ability to obtain patents in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in either the patent laws or interpretation of the patent laws in the United States or in other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. In the last decade, the US Congress made sweeping changes to patent law in passing the America Invents Act (&#8220;AIA&#8221;). These changes include, among others, allowing third-party submission of prior art to the United States Patent and Trademark Office (&#8220;USPTO&#8221;) during patent prosecution and additional procedures to challenge the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, inter partes review and derivation proceedings. The changes brought about by the AIA have not been extensively tested, and therefore increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Various courts, including the U.S. Supreme Court, have recently rendered decisions that impact the scope of patentability of certain inventions or discoveries relating to our technology and commercial goals. Specifically, these </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">decisions have substantially increased the probability that patent claims will be ruled patent ineligible for reciting a natural phenomenon, law of nature or abstract idea. Furthermore, in view of these decisions, since December 2014, the USPTO has published and continues to publish revised guidelines for patent examiners to apply when examining claims for patent eligibility. Patent claims relating to software algorithms, biologically-derived reagents, methods for analyzing biological systems and other subject matters that underlies our technology and commercial goals are impacted by these changes.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Actions taken by the U.S. Congress, federal courts and USPTO have from time to time narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. Similar changes have been made by authorities in other jurisdictions. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, such changes create uncertainty with respect to the value of patents, once obtained. Depending on decisions by authorities in various jurisdictions, the laws and regulations governing patents could change in unpredictable ways that may have a material adverse effect on our ability to obtain new patents and to defend and enforce our existing patents and patents that we might obtain in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that our patent portfolio will not be negatively impacted by the current uncertain state of the law, new court rulings or changes in guidance or procedures issued by governments or patent offices around the world. From ti</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">me to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability, scope and validity of patents within the life sciences technology and any such changes, or any similar adverse changes in the patent laws of other jurisdictions, could have a negative impact on our business, financial condition, prospects and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect our intellectual property rights throughout the world.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting and defending patents on our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States, and we and any future licensor may encounter difficulties in protecting and defending such rights in foreign jurisdictions. Consequently, we and any future licensor may not be able to prevent third parties from practicing our inventions in some or all countries outside the United States, or from selling or importing products made using our or any future licensor&#8217;s inventions in and into the United States or other jurisdictions. Competitors and other third parties may be able to use our technologies in jurisdictions where we have not obtained patent protection to develop our own products and technologies and may also export infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our products. We and any future licensor&#8217;s patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. In addition, certain countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to other parties. Furthermore, many countries limit the enforceability of patents against other parties, including government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of any patents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Many companies have enc</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of many other countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the misappropriation or other violations of our intellectual property rights including infringement of our patents in such countries. The legal systems in certain countries may also favor state-sponsored companies or companies headquartered in particular jurisdictions over our patents and other intellectual property protection. The absence of harmonized intellectual property protection laws and effective enforcement makes it difficult to ensure consistent respect for patent, trade secret, and other intellectual property rights on a worldwide basis. As a result, it is possible that we will not be able to enforce our rights against third parties that misappropriate our proprietary technology in those countries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Proceedings to enforce our or any future licensor&#8217;s patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business, could put our and any future licensor&#8217;s patents at risk of being invalidated or interpreted narrowly and our and any future licensor&#8217;s patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We and any future licensor may not prevail in any lawsuits that we and any future licensor initiates, or that are initiated against us or any future licensor, and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our products, services and other technologies and the enforcement of intellectual property. Accordingly, our efforts to enforce our intellectual property rights around the world may be </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in lawsuits to defend against third-party claims of infringement, misappropriation or other violations of intellectual property or to protect or enforce our intellectual property, any of which could be expensive, time consuming and unsuccessful, and may prevent or delay our development and commercialization efforts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Litigation may be necessary for us to enforce our patent and proprietary rights and/or to determine the scope, coverage and validity of others&#8217; proprietary rights. Litigation on these matters has been prevalent in our industry and we expect that this will continue. To determine the priority of inventions, we may have to initiate and participate in interference proceedings declared by the USPTO that could result in substantial legal fees and could substantially affect the scope of our patent protection. Also, our intellectual property may be subject to significant administrative and litigation proceedings such as invalidity, unenforceability, re-examination and opposition proceedings against our patents. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us, and we might not be able to obtain licenses to technology that we require or a competitor may have already obtained an exclusive license to such technology in all fields. Even if such licenses are obtainable, they may not be available at a reasonable cost. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins. In some cases, the outcome of litigation may be to enjoin us from commercializing a patent protected technology. We could encounter delays in product introductions, or interruptions in product sales, as we develop alternative methods or products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we resort to legal proceedings to enforce our intellectual property rights or to determine the validity, scope and coverage of the intellectual property or other proprietary rights of others, the proceedings could be burdensome and expensive, even if we were to prevail.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties. Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in the life sciences market and competitors may assert that our products infringe their intellectual property rights as part of a business strategy to impede our successful entry into those markets. Third parties may assert that we are employing our proprietary technology without authorization. We are aware that there are issued third party patents that are in the general proteomics field. Specifically, we are aware of various U.S. patents and U.S. non-provisional applications assigned to Washington University and the National Institute of Health, with claims directed to characterizing and identifying a polypeptide strand.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our competitors and others may have patents or may in the future obtain patents and may claim that use of our products infringes these patents. For example, we have received and may from time to time in the future receive letters, notices or &#8220;invitations to license&#8221; related to the use of intellectual property in our products or services, or may become the subject of claims that our products and business operations infringe or violate the intellectual property rights of others. Even if we were to prevail in any future litigation, litigation could also result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results or financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As we move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us, alleging that our products or services infringe, misappropriate or otherwise violate their intellectual property rights, including patents and trade secrets, as a means of slowing or preventing our entry into such markets, or as a means to extract substantial license and royalty payments from us. The defense of these matters can be time consuming, costly to defend in litigation, divert management&#8217;s attention and resources, damage our reputation and brand and cause us to incur significant expenses or make substantial payments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issued patents covering our products could be found invalid or unenforceable if challenged.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our owned and any future licensed patents and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> patent applications may be subject to validity, enforceability and priority disputes. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Some of our patents or patent applications may be challenged at a future point in time in opposition, derivation, reexamination, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review or interference or other similar proceedings. Any successful third-party challenge to our patents in this or any other proceeding could result in the unenforceability or invalidity of such patents, which may lead to increase</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d competition to our business, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, if we or any future licensor initiates legal proceedings against a third party to enforce a patent covering our products, the defendant could counterclaim that such patent covering our products, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. There are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including, but not limited to, lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the relevant patent office, or made a m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">isleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include ex parte re-examination, </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review, derivation and equivalent proceedings in non-U.S. jurisdictions, such as opposition proceedings. Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer cover and protect our products. With respect to the validity of our patents, for example, we cannot be certain that there is no invalidating prior art of which us, any future licensor, our patent counsel and the patent examiner were unaware during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant or other third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection for our products and technologies, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license intellectual property or develop or commercialize current or future products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may not be aware of all third-party intel</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">lectual property rights potentially relating to our products. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We might not have been the first to make the inventions covered by each of our pending patent applications and we might not have been the first to file patent applications for these inventions. To determine the priority of these inventions, we may have to participate in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO, or other similar proceedings in non-U.S. jurisdictions, that could result in substantial cost to us and the loss of valuable patent protection. The outcome of such proceedings is uncertain. No assurance can be given that other patent applications will not have priority over our patent applications. In addition, changes to the patent laws of the United States in the last decade allow for various post-grant opposition proceedings that have not been extensively tested, and their outcome is therefore uncertain. Furthermore, if third parties bring these proceedings against our patents, regardless of the merit of such proceedings and regardless of whether we are successful, we could experience significant costs and our management may be distracted. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected, and our business could be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We rely heavily on trade secrets and confidentiality agreements to protect our unpatented know-how, technology and other proprietary information, including parts of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and to maintain our competitive position. However, trade secrets and know-how can be difficult to protect. In particular, we anticipate that with respect to our technologies, these trade secrets and know how will over time be disseminated within the industry through independent development, the publication of journal articles describing the methodology, and the movement of personnel between academic and industry scientific positions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition to pursuing patents on our technology, we take steps to protect our intellectual property and proprietary technology by entering into agreements, including confidentiality agreements, non-disclosure agreements and intellectual property assignment agreements, with our employees, consultants, academic institutions, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">corporate partners and, when needed, our advisers. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors or other third parties will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. For example, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure, which could adversely impact our ability to establish or maintain a competitive advantage in the market, business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce a claim that a third party had wrongfully obtained and was using our trade secrets, it would be expensive and time-consuming, it could distract our personnel, and the outcome would be unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also seek to preserve the integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems, but it is possible that these security measures could be breached. If any of our confidential proprietary information were to be lawfully obtained or independently developed by a competitor or other third party, absent patent protection, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. Competitors or third parties could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts, design around our protected technology</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, develop their own competitive technologies that fall outside the scope of our intellectual property rights or independently develop our technologies without reference to our trade secrets. If any of our trade secrets were to be disclosed to or independently discovered by a competitor or other third party, it could materially and adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We or any future licensor may be subject to claims that former employees, collaborators or other third parties have an interest in our patents, trade secrets or other intellectual property. For example, us or any future licensor may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our products. In addition, counterparties to our consulting, software development, and other agreements may assert that they have an ownership interest in intellectual property developed under such arrangements. Litigation may be necessary to defend against claims challenging ownership or inventorship of our or any future licensor&#8217;s ownership of our patents, trade secrets or other intellectual property. If we or any future licensor fails in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is im</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">portant to our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, including our software, workflows, consumables and reagent kits. In such an event, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture or commercialization of our products and technologies. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and certain customers or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect and enforce our trademarks and trade names or build name recognition in our markets of interest thereby harming our competitive position.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The registered or unregistered trademarks or trade names that we own may be challenged, infringed, circumvented, declared generic, lapsed or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition. In </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">addition, third parties have filed, and may in the future file, for registration of trademarks similar or identical to our trademarks, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Further, we have and may in the future enter into agreements with owners of such third-party trade names or trademarks to avoid potential trademark litigation which may limit our ability to use our trade names or trademarks in certain fields of business. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively, and our business, financial condition, results of operations and prospects may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources. Any of the foregoing events could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent terms may be inadequate to protect our competitive position on our Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform for an adequate amount of time.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. While extensions may be available, the life of a patent, and the protection it affords, is limited. In the United States, a patent&#8217;s term may, in certain cases, be lengthened by patent term adjustment, which comp</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ensates a patentee for administrative delays by the USPTO in examining and granting a patent, or may be shortened</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> if a patent is terminally disclaimed over a commonly owned patent or a patent naming a common inventor and having an earlier expiration date. Even if patents covering our products are obtained, once the patent life has expired, we may be open to competition from competitive products. If one of our products requires extended development, testing and/or regulatory review, patents protecting such products might expire before or shortly after such products are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining our patent protection depends on compliance with various required procedures, document submissions, fee payments and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or applications will be due to be paid to the USPTO and various governmental patent agencies outside of the United States at several stages over the lifetime of the patents and/or applications. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In certain circumstances, we may rely on any future licensor to pay these fees due to the U.S. and non-U.S. patent agencies and to take the necessary action to comply with these requirements with respect to any future licensed intellectual property. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors may be able to enter the market without infringing our patents and this circumstance would have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed trade secrets of our former employers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have employed and expect to employ individuals who were previously employed at universities or other companies, including, for example, our competitors or potential competitors. Although we try to ensure that our employees, consultants, advisors and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that our employees, advisors, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">proprietary information of their former employers or other third parties, or to claims that we have improperly used or obtained such trade secrets. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights and face increased competition to our business. Any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with advisors, contractors and consultants. A loss of key research personnel work product could hamper or prevent our ability to commercialize potential products, which could harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management. This type of litigation or proceeding could substantially increase our operating losses and reduce our resources available for development activities. Some of our competitors may be able to sustain the costs of this type of litigation or proceedings more effectively than we can because of their substantially greater financial resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while it is our policy to require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Furthermore, individuals executing agreements with us may have pre-existing or competing obligations to a third party, such as an academic institution, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we or any future licensor may in the futur</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">e be subject to claims by former or current employees, consultants or other third parties asserting an ownership right or inventorship in our owned, or any future licensed, patents or patent applications. For example, our Founder and Chief Scientist is employed by Stanford University and a member of the Stanford Cancer Institute. Stanford University and the Stanford Cancer Institute may assert an ownership right in any of our owned patents or patent applications. We may have </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">other consultants that are or have been employed by third parties, which may assert an ownership right in any of our owned patents or patent applications. In addition, we are aware that we might not be able to obtain ownership of or seek a license to any intellectual property developed during a research collaboration with a third party. An adverse determination in any such proceeding may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar technology, without payment to us, or could limit the duration of the patent protection covering our technology and products. Such challenges may also result in our inability to develop, manufacture or commercialize our products without infringing third-party patent rights. Any of the foregoing could harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot license rights to use technologies on reasonable terms, we may not be able to commercialize new products in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may identify third-party technology that we may need to license or acquire in order to develop or commercialize our products or technologies, including our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. However, we may be unable to secure such licenses or acquisitions. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources, or greater development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. In return for the use of a third party&#8217;s technology, we may agree to pay the licensor royalties based on sales of our products or services. Royalties are a component of cost of products or technologies and affect the margins on our products. We may also need to negotiate licenses to patents or patent applications before or after introducing a commercial product. We may not be able to obtain necessary licenses to patents or patent applications, and our business may suffer if we are unable to enter into the necessary </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">licenses on acceptable terms or at all, if any necessary licenses are subsequently terminated, if the licensor fails to abide by the terms of the license or fails to prevent infringement by third parties, or if the licensed intellectual property rights are found to be invalid or unenforceable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of open source software and failure to comply with the terms of the underlying open source software licenses could impose limitations on our ability to commercialize our products and provide third parties to our proprietary software.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our products utilize open source software that contain modules licensed for use from third-party authors under open source licenses. In particular, some of the software may be provided under license arrangements that allow use of the software for research or other noncommercial purposes. Use and distribution of open source software may entail greater risks than use of third-party commercial software, as open source software licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. Some open source software licenses contain requirements that the licensee make its source code publicly available if the licensee creates modifications or derivative works using the open source software, depending on the type of open source software the licensee uses and how the licensee uses it. If we combine our proprietary software with open source software in a certain manner, we could, under certain open source software licenses, be required to release the source code of our proprietary software to the public for free. This would allow our competitors and other third parties to create similar products with less development effort and time and ultimately could result in a loss of our product sales and revenue, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, some companies that use third-party open source software have faced claims challenging their use of such open source software and their compliance with the terms of the applicable open source license. We may be subject to suits by third parties claiming ownership of what we believe to be open source software or claiming non-compliance with the applicable open source licensing terms. Use of open source software may also present additional security risks because the public availability of such software may make it easier for hackers and other third parties to compromise or attempt to compromise our technology platform and systems.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although we review and monitor our use of open source software to avoid subjecting our proprietary software to conditions we do not intend, the terms of many open source software licenses have not been interpreted by United States courts, and there is a risk that these licenses could be construed in a way that could impose unanticipated conditions or restrictions on our ability to commercialize our products and proprietary software. Moreover, we cannot assure investors that our processes for monitoring and controlling our use of open source software in our products will be effective. If we are held to have breached the terms of an open source software license, we could be subject to damages, required to seek licenses from third parties to continue offering our products on terms that are not economically feasible, to re-engineer our products, to discontinue the sale of our products if re-engineering could not be accomplished on a timely basis, or to make generally available, in source code form, our proprietary code, any of which could adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights do not necessarily address all potential threats.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may be able to make products that are similar to products and technologies we may develop or may be able to utilize similar technologies that are not covered by the claims of the patents that we own or licenses now or in the future;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we, or any future licensor(s), might not have been the first to make the inventions covered by the issued patent or pending patent application that we license or may own in the future;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we, or any future licensor(s), might not have been the first to file patent applications covering certain of our or their inventions;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating or otherwise violating our owned or future licensed intellectual property rights;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it is possible that our pending patent applications or those that we may license or own in the future will not lead to issued patents;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not develop additional proprietary technologies that are patentable;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of others may harm our business; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may choose not to file a patent for certain trade secrets or know-how, and a third party may independently derive, use, commercialize, publish or patent such intellectual property.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Should any of these events occur, they could materially adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in litigation to enforce or defend our intellectual property rights, or defend ourselves from claims that we infringe the intellectual property rights of others, which litigation could consume significant resources and management time, and in which an adverse result could result in loss of our intellectual property rights, a requirement that we pay significant damages, and could prevent us from selling our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The life sciences industry is highly competitive, and companies in this industry routinely engage in litigation and governmental proceedings to enforce and defend the intellectual property rights that they believe they possess. We may become involved in litigation or governmental and/or administrative proceedings to enforce or defend our intellectual property rights.  Additionally, we have and may continue to become involved in litigation and/or governmental or administrative proceedings to defend ourselves from claims that our products or services infringe the intellectual property rights of others, or to challenge the claimed intellectual property rights of others where we believe they may not be entitled to such rights.  Such litigation and governmental proceedings are inherently unpredictable and costly, and can require significant time and attention of management.  In addition to the costs and distraction of litigation, if we are unsuccessful in enforcing our intellectual property rights, or in defending our intellectual property rights from challenges of others, which could result in our loss of our ability to exclude others from practicing aspects of our technology which could lead to greater competition for our products and services.  Additionally, if we are unable to successfully defend ourselves from claims that we infringe the intellectual property rights of others and are unable to develop non-infringing alternative approaches for our products and services, we may be required to pay significant damages and ongoing royalties, or we may be prohibited from selling our products and services.  Our success depends upon our ability to successfully enforce and defend our own intellectual property rights, and to defend ourselves from claims that we infringe the intellectual property rights of others.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products could have unknown defects or errors, which may give rise to claims against us and adversely affect market adoption of our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> utilizes novel and complex technology applied on a microscopic scale, using key components that are not amenable to full characterization or quality assessment using conventional techniques or instrumentation, and such systems may develop or contain undetected defects or errors. We cannot assure you that material performance problems, defects or errors will not arise, and as we increase the density and integration of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, these risks may increase. We expect to provide warranties that our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> will meet performance expectations or be free from defects. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In manufacturing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, we depend upon third parties for the supply of various components. Many of these components require a significant degree of technical expertise to produce. If our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">suppliers fail to produce components to specification, or if the suppliers, or we, use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If our products contain defects, we may experience:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a failure to achieve market acceptance or expansion of our product sales;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of customer orders and delay in order fulfillment;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to our brand reputation;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased cost of our warranty program due to product repair or replacement;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product recalls or replacements;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to attract new customers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of resources from our manufacturing and research and development departments into our service department; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legal claims against us, including product liability claims, which could be costly and time consuming to defend and result in substantial damages. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any one or more of the foregoing could negatively affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are sued for product liability, we could face substantial liabilities that exceed our resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The marketing, sale and use of our products could lead to the filing of product liability claims were someone to allege that our products identified inaccurate or incomplete information regarding the proteins analyzed or otherwise failed to perform as designed. We may also be subject to liability for errors in, a misunderstanding of or inappropriate reliance upon, the information we provide in the ordinary course of our business activities. A product liability claim could result in substantial damages and be costly and time-consuming for us to defend. We maintain product liability insurance, but this insurance may not fully protect us from the financial impact of defending against product liability claims. Any product liability claim brought against us, with or without merit, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any product liability lawsuit could damage our reputation, or cause current customers to terminate existing agreements and potential partners to seek other partners, any of which could adversely impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory and Legal Compliance Matters</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although our products currently are not labeled or intended for any use which would subject us to regulation by the FDA or other regulatory authorities, if we elect to label and promote any of our products as clinical or medical device products, we would be subject to regulation in the future and would be required to obtain prior approval or clearance by the FDA or other regulatory authorities, which could take significant time and expense and could fail to result in FDA clearance or approval for the intended uses we believe are commercially attractive.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our products are currently labeled and promoted, and are, and in the n</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ear-future will be, sold primarily to research companies and academic and research institutions as research use only (&#8220;RUO&#8221;) products, and are not currently intended to be used, for clinical diagnostic tests or as medical devices. If we elect to label and market our products for use as, or in the performance of, clinical diagnostics in the United States, thereby subjecting them to FDA regulation as medical devices, we would be required to obtain premarket 510(k) clearance or premarket approval from the FDA, unless an exception applies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future register with the FDA as a medical device manufacturer and list some of our products with the FDA pursuant to an FDA Class I listing for general purpose laboratory equipment. While this regulatory </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">classification is exempt from certain FDA requirements, such as the need to submit a premarket notification commonly known as a 510(k) application, and some of the requirements of the FDA&#8217;s Quality System Regulation (the &#8220;QSR&#8221;), which include compliance with FDA regulations for labeling, inspections by the FDA, complaint evaluation, corrections and removals reporting, promotional restrictions, reporting adverse events or malfunctions for our products, and general prohibitions against misbranding and adulteration. The FDA&#8217;s new Quality Management System Regulation (&#8220;QMSR&#8221;), effective February 2, 2026, which incorporates by reference certain requirements under ISO 13485. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may in the future submit 510(k) premarket notification applications to the FDA to obtain FDA clearance of certain of our products on a selective basis. It is possible, in the event we elect to submit 510(k) applications for certain of our products, that the FDA would take the position that a more burdensome premarket application, such as a premarket approval application (&#8220;PMA&#8221;) or a de novo application is required for some of our products. If such applications were required, greater time and investment would </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">be required to obtain FDA approval. Even if the FDA agreed that a 510(k) was appropriate, FDA clearance can be expensive and time consuming. It can take a significant amount of time to prepare and submit a 510(k) application, including conducting appropriate testing on our products, and several months to years for the FDA to review a submission. Notwithstanding the effort and expense, FDA clearance or approval could be denied for some or all of our products for which we choose to market as a medical device or a clinical diagnostic device. Even if we were to seek and obtain regulatory approval or clearance, it may not be for the intended uses we request or that we believe are important or commercially attractive. There can be no assurance that future products for which we may seek premarket clearance or approval will be cleared or approved by the FDA or a comparable foreign regulatory authority on a timely basis, if at all, nor can there be assurance that labeling claims will be consistent with our anticipated claims or adequate to support continued adoption of such products. Compliance with FDA or comparable foreign regulatory authority regulations will require substantial costs, and subject us to heightened scrutiny by regulators and substantial penalties for failure to comply with such requirements or the inability to market our products. The lengthy and unpredictable premarket clearance or approval process, as well as the unpredictability of the results of any required clinical studies, may result in our failing to obtain regulatory clearance or approval to market such products, which would significantly harm our business, results of operations, reputation, and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">e sought and received regulatory clearance or approval for certain of our products, we would be subject to ongoing FDA obligations and continued regulatory oversight and review, including the general controls listed above and the FDA&#8217;s QMSRs for our development and manufacturing operations. In addition, we may be required to obtain a new 510(k) clearance before we could introduce subsequent modifications or improvements to such products. We could also be subject to additional FDA post-marketing obligations for such products, any or all of which would increase our costs and divert resources away from other projects. If we sought and received regulatory clearance or approval and are not able to maintain regulatory compliance with applicable laws, we could be prohibited from marketing our products for use as, or in the performance of, clinical diagnostics and/or could be subject to enforcement actions, including warning letters and adverse publicity, fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions; and criminal prosecution.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we could decide to seek regulatory clearance or approval for certain of our products in countries outside of the United States. Sales of such products outside the United States will likely be subject to foreign regulatory requirements, which can vary greatly from country to country. As a result, the time required to obtain clearances or approvals outside the United States may differ from that required to obtain FDA clearance or approval and we may not be able to obtain foreign regulatory approvals on a timely basis or at all. These foreign regulations and any future requirements that may be implemented by regulatory authorities will increase the difficulty of obtaining and maintaining regulatory approvals and compliance in Europe in the future. In addition, the FDA regulates exports of medical devices. Failure to comply with these regulatory requireme</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">nts or obtain and maintain required approvals, clearances or certifications could impair our ability to commercialize our products for diagnostic use outside of the United States.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products could become subject to government regulation as medical devices by the FDA and other regulatory agencies even if we do not elect to seek regulatory clearance or approval to market our products for diagnostic purposes, which would adversely impact our ability to market and sell our products and harm our business. If our products become subject to FDA regulation, the regulatory clearance or approval and the maintenance of continued and post-market regulatory compliance for such products will be expensive, time-consuming, and uncertain both in timing and in outcome.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We do not currentl</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">y expect our Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform to be subject to the clearance or approval of the FDA, as it is not intended to be used for the diagnosis, treatment or prevention of disease. However, as we expand our product line and the applications and uses of our current or products into new fields, certain of our future products could become subject to regulation by the FDA, or comparable international agencies, including requirements for regulatory clearance or approval of such products before they can be marketed. Also, even if our products are labeled, promoted, and intended as RUO, the FDA or comparable agencies of other countries could disagree with our conclusion that our products are intended for research use only or deem our sales, marketing and promotional efforts as being inconsistent with RUO products. For example, our customers may independently elect to use our RUO labeled products in their own laboratory developed tests (&#8220;LDTs&#8221;) for clinical diagnostic use. Regulatory requirements related to marketing, selling, and distribution of RUO products could change or be uncertain, even if clinical uses of our RUO products by our customers were done without our consent. If the FDA or other regulatory authorities assert that any of our RUO products are subject to regulatory clearance or approval, our business, financial condition, or results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against laboratories offering LDTs. In May 2024, FDA issued a final rule that amends FDA&#8217;s regulations to make explicit that </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostics (&#8220;IVDs&#8221;) are devices under the Federal Food, Drug, and Cosmetic Act, including when the manufacturer of the IVD is a laboratory, and phases out its enforcement discretion for LDTs. On March 31, 2025, the U.S. District Court for the Eastern District of Texas vacated and set aside the FDA LDT Final Rule in its entirety. Further, in June 2024, the U.S. Supreme Court overruled the </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chevron </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">doctrine, which gives deference to regulatory agencies&#8217; statutory interpretations in litigation against federal government agencies, such as the FDA, where the law is ambiguous. This landmark Supreme Court decision may invite more companies and other stakeholders to bring lawsuits against the FDA to challenge FDA&#8217;s statutory interpretations, which can lead to uncertainties in the industry. The adoption of new restrictions on RUO products, whether by the FDA or Congress, could adversely affect demand for our specialized reagents and instruments. Further, we could be required to obtain premarket clearance or approval before we can sell our products to certain customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Further, sales of devices for diagnostic purposes may subject us to additional healthcare regulation and enforcement by the applicable government agencies. Such laws include, without limitation, state and federal anti-kickback or anti-referral laws, healthcare fraud and abuse laws, false claims laws, privacy and security laws, the Physician Payments Sunshine Act and related transparency and manufactu</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">rer reporting laws, and other laws and regulations applicable to medical device manufacturers. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any applicable FDA or healthcare laws and regulations, we may be subject to penalties, monetary damages, disgorgement, imprisonment, the curtailment or restructuring of our operations, loss of eligibility to obtain clearance or approvals from the FDA, fees from regulators, fines, significant settlements or judgments, or exclusion from participation in government contracting, healthcare reimbursement or other government programs, including Medicare and Medicaid, or other restrictions on our operations, any of which could adversely impact our financial results. Any action against us for an alleged or suspected violation by a private party or governmental agency could cause us to incur significant legal expenses, adversely impact our reputation, and could divert our management&#8217;s attention from the operation of our business, even if our defense is successful. In addition, achieving and sustaining compliance with applicable laws and regulations may be costly to us in terms of money, time and resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on November 25, 2013, the FDA issued Final Guidance &#8220;Distribution of In Vitro Diagnostic Products Labeled for Research Use Only.&#8221; This guidance emphasizes that the FDA will review the totality of the circumstances when it comes to evaluating whether equipment and testing components are properly labeled as RUO. This guidance states that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA&#8217;s clearance, approval, and other regulatory requirements if the circumstances surrounding the distribution, marketing and promotional practices indicate that the m</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">anufacturer </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">knows its products are, or intends for its products to be, used for clinical diagnostic purposes. These circumstances may include written or verbal sales and marketing claims or links to articles regarding a product&#8217;s performance in clinical applications and a manufacturer&#8217;s provision of technical support for clinical applications.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the leadership of FDA and other federal agencies under the Trump administration, including mass layoffs and potential changes in future policies and regulations that can impact our industry, have resulted in significant uncertainties in the industry, including product developers and businesses of customers who use our products. Reduction in federal funding for research could negatively impact our customers and thus reduce the demand for our products. To the extent we are required to conduct clinical trials or to obtain regulatory authorization for our marketed products or future products due to changes in the regulatory requirements, delays in the commencement of our product launches or our changes to our current marketing strategy could significantly increase our costs and delay our commercialization plans, which could harm our financial prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are currently subject to, and may in the future become subject to additional, U.S. federal and state laws and regulations imposing obligations on how we collect, store and process personal information. Our actual or perceived failure to comply with such obligations could harm our business. Ensuring compliance with such laws could also impair our efforts to maintain and expand our future customer base, and thereby decrease our revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we currently, and, in the future, will, collect, store, transfer, use or process sensitive data, including personal information of employees, and intellectual property and proprietary business information owned or controlled by us and other parties. The secure processing, storage, maintenance, and transmission of this critical information are vital to our operations and business strategy. We are, and may increasingly become, subject to various laws and regulations, as well as contractual obligations, relating to data privacy and security in the jurisdictions in which we operate. The regulatory environment related to data privacy and security is increasingly rigorous, with new and constantly changing requirements applicable to our business, and enforcement practices are likely to remain uncertain for the foreseeable future. These laws and regulations may be interpreted and applied differently over time and from jurisdiction to jurisdiction, and it is possible that they will be interpreted and applied in ways that may have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, various federal and state regulators have adopted, or are considering adopting, laws and regulations concerning personal information and data security. Certain state laws may be more stringent or broader in scope, or offer greater individual rights, with respect to personal information than federal, international or other state laws, and such laws may differ from each other, all of which may complicate compliance efforts. For example, the California Consumer Privacy Act (the &#8220;CCPA&#8221;), which provides for certain privacy rights for California residents and imposes obligations on companies that process their personal information, came into effect on January 1, 2020. Among other things, the CCPA requires covered companies to provide certain disclosures to California consumers and provide such co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">nsumers with certain data protection and privacy rights, including the ability to opt-out of certain sales of personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for certain data breaches that result in the loss of personal information. This private right of action may increase the likelihood of, and risks associated with, data breach litigation. In November 2020, California passed the California Privacy Rights Act (the &#8220;CPRA&#8221;), which amended and expanded the CCPA as of January 1, 2023. Although the CCPA includes exemptions for certain clinical trial data, the law may increase our compliance costs and potential liability with respect to other personal information we collect about California customers. In addition to the CCPA, numerous other states&#8217; legislatures are considering or have enacted similar data privacy laws. For example, Virginia, Colorado, Utah and Connecticut have each passed laws similar to but different from the CCPA and CPRA that took effect in 2023; Florida, Montana, Oregon and Texas have enacted similar laws that took effect in 2024; Tennessee, Delaware, Iowa, Maryland, Minnesota, New Hampshire, Nebraska and New Jersey have enacted similar laws that took effect in 2025; Indiana, Rhode Island and Kentucky have enacted similar laws that have taken effect in 2026; Alabama and Oklahoma have enacted similar laws that take effect in 2027; and Vermont has enacted similar legislation that will take effect in 2028. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain other state laws govern the privacy and security of health information in certain circumstances, such as Washington&#8217;s My Health, My Data Act, which contains a private right of action. These new </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">state laws will require ongoing compliance efforts and investment. In addition, laws in all 50 U.S. states require businesses to provide notice to consumers whose personal information has been disclosed or otherwise processed as a result of a data breach. State laws are changing rapidly. The U.S. Department of Justice also has issued rules regarding certain bulk sensitive personal data transfers, and there is discussion in the U.S. Congress of comprehensive federal data privacy legislation. It is possible that these or other laws, regulations, or other actual or asserted obligations relating to privacy or security matters, or otherwise relating to the collection, use, transfer, or other processing of personal information, may be interpreted and applied in a manner that is inconsistent with our practices. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, regulations promulgated pursuant to the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) establish privacy and security standards that limit the use and disclosure of certain individually identifiable health information defined in HIPAA as &#8220;protected health information&#8221; and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and ensure the confidentiality, integrity and availability of electronic protected health information. Determining whether protected health information has been handled in compliance with applicable privacy standards and our contractual obligations can require complex factual and statistical analyses and may be subject to changing interpretation. Although we take measures to protect sensitive data from unauthorized access, use or disclosure, our information technology and infrastructure may be vulnerable to attacks by hackers or viruses or breached, subject to a security incident, or otherwise compromised or disrupted due to various causes, including employee error, malfeasance or other malicious or inadvertent actions. Any such breach, incident, compromise or disruption could compromise our networks and the information stored there could be accessed by unauthorized parties, manipulated, publicly disclosed, lost, stolen, corrupted, made unavailable, or misused or otherwise processed without authorization. Any such access, breach or other loss of information could result in legal claims or proceedings, and liability under federal or state laws that protect the privacy of personal information, such as the HIPAA, the Health Information Technology for Economic and Clinical Health Act, and regulatory penalties. Notice of breaches must be made to affected individuals, the Secretary of the Department of Health and Human Services, and for extensive breaches, notice may need to be made to the media or State Attorneys General. Such a notice could harm our reputation and our ability to compete.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">While we have implemented policies and contractual safeguards designed to address compliance with U.S. and foreign privacy laws and data transfer regulations, the complex and evolving landscape of privacy and data security laws and regulations both domestically and internationally, including the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">evolving compliance and operatio</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">nal requirements for such laws and regulations, impose significant costs, such as costs related to organizational changes, implementing additional protection technologies, training employees and engaging consultants, which are likely to increase over time. In addition, such requirements may require us to modify our data processing practices and policies, which may distract management or divert resources from other initiatives and projects, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Any failure or perceived failure by us or our third-party vendors, collaborators, contractors or consultants to comply with any applicable federal, state or similar foreign laws and regulations, contractual obligations or any other actual or asserted obligations relating to privacy, security, or the collection, use, transfer, or other processing of personal information could result in damage to our reputation, as well as claims, demands, proceedings or litigation by governmental agencies or other third parties, including class action privacy litigation in certain jurisdictions, which would subject us to significant fines, sanctions, awards, penalties, judgments and other liabilities, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of artificial intelligence and machine learning technologies may result in reputational harm or liability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have incorporated and may continue to incorporate additional artificial intelligence and machine learning, or AIML, technologies into our platform, including within our decoding pipelines and otherwise within our business, and these solutions and features are key elements of our technological approach and to our future growth over time. We rely and expect to rely on AIML technologies in our platform, but there can be no assurance that we will realize the desired or anticipated benefits from AIML or any at all. We may also fail to properly implement or utilize AIML technologies. Our competitors, customers, or other third parties may incorporate AIML into their products and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">services or otherwise within their business more quickly or more successfully than us, which could impair our ability to compete with or serve them  effectively, which could adversely affect our results of operations. Additionally, our use of AIML technologies may expose us to additional claims, demands and proceedings by private parties and regulatory authorities and subject us to legal liability as well as brand and reputational harm. For example, if output from AIML technologies or that they assist in producing are or are alleged to be deficient, inaccurate, or biased, or for such output, or such technologies or their development or deployment, including the collection, use, or other processing of data used to train or create such AIML technologies, to alleged to infringe upon or to have misappropriated third-party intellectual property rights, to violate other rights, or to violate applicable laws, regulations, or other actual or asserted legal obligations to which we are or may become subject, then our business, financial condition, and results of operations may be adversely affected. The legal, regulatory, and policy environments around AIML are evolving rapidly, and we may become subject to new and evolving legal and other obligations. These and other developments may require us to make significant changes to our use of AIML, including by limiting or restricting our use of AIML, and may require us to make significant changes to our policies and practices, which may necessitate expenditure of significant time, expense, and other resources, AIML also presents emerging ethical issues, and if our use of AIML becomes controversial, we may experience brand or reputational harm. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we commercialize our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> platform outside of the United States, our international business could expose us to business, tax, regulatory, political, operational, financial, and economic risks associated with doing business outside of the United States.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we commercialize our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> outside of the United States, our international business may be adversely affected by changing economic, political and regulatory conditions in foreign countries, as well as changes resulting from new political administrations in the United States. Engaging in international business inherently involves a number of difficulties and risks, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with existing and changing foreign regulatory requirements and laws;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with U.S. laws such as the Foreign Corrupt Practices Act, and other U.S. federal laws and regulations established by the office of Foreign Asset Control;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">export or import restrictions;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and business practices favoring local companies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign currency exchange, longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and economic volatility;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in social, economic, and political conditions or in laws, regulations and policies governing foreign trade, tariffs, intellectual property, manufacturing, research and development, and investment both domestically as well as in the other countries and jurisdictions in which we operate and into which we may sell our products including as a result of the separation of the United Kingdom from the European Union (Brexit);</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements and other trade barriers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties and costs of staffing and managing foreign operations, including compliance with diverse and complex local employment laws and practices; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties protecting, maintaining, enforcing or procuring intellectual property rights.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If one or more of these risks occurs, it could require us to dedicate significant resources to remedy such occurrence, and if we are unsuccessful in finding a solution, our financial results will suffer.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For example, on January 15, 2025, the United States Department of Commerce Bureau of Industry and Security (&#8220;BIS&#8221;) issued an </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Interim Final Rule (&#8220;IFR&#8221;) implementing targeted export controls on certain laboratory instruments</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. This IFR imposes certain new restrictions and license requirements on export to certain countries of certain analytical instruments that are highly suitable for generating large, detailed biological datasets, which can be analyzed to discover complex patterns governing the function of biological molecules, cells, and organisms.  The IFR seeks to regulate exports of these analytical instruments based upon the potential to exploit these techniques for asymmetric military advantage. The analytical instruments subject to the IFR, as written, include high-parameter and spectral flow cytometers and cell sorters</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">and certain liquid chromatography mass spectrometers</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(LC/MS) specially designed for proteomics.  While the Company&#8217;s platform would not be included under the current IFR, given the platform&#8217;s anticipated ability to generate large proteomic datasets, future BIS or other government regulations could potentially encompass our products and/or negatively impact our ability to export those products to certain countries and markets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> outside of the United States, we may rely on distributors for sales of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and related products. To do so we must attract distributors and maintain distributors to maximize the commercial opportunity for our platform. There is no guarantee that we will be successful in attracting or retaining desirable sales and distribution partners or that we will be able to enter into such arrangements on favorable terms. Distributors may not commit the necessary resources to market and sell our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and related products to the level of our expectations or may choose to favor marketing the products of our competitors. If current or future distributors do not perform adequately, or we are unable to enter into effective arrangements with distributors in particular geographic areas, we may not realize long-term international revenue growth and our financial results will suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we expand our development and commercialization activities outside of the United States, we will be subject to an increased risk of conducting activities in a manner that violates the U.S. Foreign Corrupt Practices Act and similar laws. If that occurs, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">we may be subject to civil or criminal penalties and other adverse consequences which could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the U.S. Foreign Corrupt Practices Act, or the FCPA, and similar anti-corruption laws which generally prohibit companies, their employees, agents, representatives, business partners, and third-party intermediaries from authorizing, offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, the FCPA which prohibits corporations and individuals from paying, offering to pay, or authorizing the payment of anything of value to any foreign government official, government staff member, political party, or political candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity. We are also subject to the UK Bribery Act, which prohibits both domestic and international bribery, as well as bribery across both public and private sectors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we choose to establish and expand our commercial operations outside of the United States we will need to comply with non-U.S. regulatory requirements, may need to establish and expand business relationships with various third parties, and we, our employees, agents, representatives, business partners and third-party intermediaries may interact more frequently with foreign officials, including regulatory authorities, and we may be held liable for the corrupt or other illegal activities of these employees, agents, representatives, business partners or third-party intermediaries, even if we do not explicitly authorize such activities. Any interactions with any such parties or individuals where improper payments are provided that are found to be in violation of such laws could result in substantial fines and penalties and could materially harm our business. We cannot assure you that all of our employees, agents, representatives, business partners and third-party intermediaries will not take actions in violation of applicable law for which we may ultimately be held responsible.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These laws also require that we keep accurate books and records and maintain internal controls and compliance procedures designed to prevent any such actions. While we have policies and procedures to address compliance with such laws, we cannot assure you that none of our employees, agents, representatives, business partners or third-party intermediaries will take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. Further, as we increase our international sales and business, our risks under these laws may increase and expanded programs to maintain compliance with such laws may be costly and may not be effective.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, any finding of a violation under one country&#8217;s laws may increase the likelihood that we will be prosecuted and be found to have violated another country&#8217;s laws. If our business practices are alleged to be or are found to be in violation of the FCPA, UK Bribery Act or other similar anti-corruption laws, we may be subject to whistleblower complaints, sanctions, settlements, prosecution, enforcement actions, fines, damages, adverse media coverage, investigations, loss of export privileges, significant civil and criminal penalties, or suspension or debarment from government contracts, all of which co</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">uld have a material adverse effect on our reputation, financial condition and results of operations. Responding to any investigation or action will likely result in materially significant diversion of management&#8217;s attention and resources and significant defense costs and other professional fees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental and health safety laws may result in liabilities, expenses and restrictions on our operations. Failure to comply with environmental laws and regulations could subject us to significant liability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state, local and foreign laws regarding environmental protection, hazardous substances and human health and safety may adversely affect our business. Our research and development operations involve the use of hazardous substances and are subject to a variety of federal, state, local and foreign environmental laws and regulations relating to the storage, use, discharge, disposal, remediation of, and human exposure to, hazardous substances and the sale, labeling, collection, recycling, treatment and disposal of products containing hazardous substances. These operations are permitted by regulatory authorities, and the resultant waste materials are disposed of in material compliance with environmental laws and regulations. Using hazardous substances in our operations exposes us to the risk of accidental injury, contamination or other liability from the use, storage, importation, handling or disposal of hazardous materials. If we or our suppliers&#8217; operations result in the contamination of the environment or expose individuals to hazardous substances, we could be liable for damages and fines, and any liability could significantly exceed our insurance coverage and have a material adverse effect on our business, financial condition and results of operations. Liability under environmental laws and regulations can be joint and several and without regard to fault or negligence. Compliance with environmental laws and regulations may be expensive and noncompliance could result in substantial liabilities, fines and penalties, personal injury and third-party property damage claims and substantial investigation and remediation costs. Environmental laws and regulations could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We cannot assure you that violations of these laws and regulations will not occur in the future or have not occurred in the past as a result of human error, accidents, equipment failure or other causes. The expense associated with environmental regulation and remediation could harm our financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, consultants, commercial partners, distributors and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors, consultants, commercial collaborators, distributors, suppliers and vendors may engage in misconduct or other improper activities. Misconduct by these parties could include failures to comply with applicable FDA regulations, provide accurate information to the FDA, comply with federal and state health care fraud and abuse laws and regulations, accurately report financial information or data or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the health care industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Misconduct by these parties could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by these parties, and the precautions we take to detect and prevent such misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending our self or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings and the curtailment or restructuring of our operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand for our technology could be reduced by legal, social and ethical concerns surrounding the use of genetic information and biological materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our products may be used to provide genetic information or analyze biological materials from humans and other living organisms. The information obtained from our products could be used in a variety of applications, which may have underlying legal, social and ethical concerns, including the genetic engineering or modification of agricultural products, testing for genetic predisposition for certain medical conditions and stem cell research. Governmental authorities could, for safety, social or other purposes, call for limits on or impose regulations on the use of genetic testing or the use of certain biological materials. Such concerns or governmental restrictions could limit the use of our products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant developments or changes in national laws or policies to protect or promote domestic interests and/or address foreign competition could have an adverse effect on our business and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Significant developments or changes in national laws or policies to protect or promote domestic interests and/or address foreign competition, including laws and policies in areas such as trade, manufacturing, government purchasing, health care, intellectual property and investment/development, could  adversely affect our business, financial condition and results of operations. For example, certain governments have implemented policies to induce &#8220;re-shoring&#8221; of supply chains, reduce reliance on imported supplies and promote national production. The Chinese government has issued a series of policies in the past several years to promote the development and use of local medical devices. In addition, in recent years the U.S. has increased tariffs on certain imported goods and trade tensions between the U.S. and China escalated, with each country imposing significant, additional tariffs on a wide range of goods imported from the other country. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Operations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience a significant disruption in our information technology systems or breaches of data security, our business could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology systems to keep financial records, facilitate our research and development initiatives, manage our manufacturing operations, maintain quality control, fulfill customer orders, process customer data and information, maintain corporate records, communicate with staff and external parties and operate other critical functions. Our information technology systems and those of our vendors and partners are potentially vulnerable to disruption, failure and compromise due to breakdown, malicious intrusion and computer viruses, ransomware or other malicious software, or other disruptive events, including, but not limited to, natural disasters and catastrophes. Like other life sciences technology companies, we have experienced security incidents in the past, and we may experience them again in the future. For example, in January 2024, we experienced an incident involving unauthorized access to an employee account. The Company has worked, and continues to work with external cybersecurity experts, in detecting, blocking, containing, remediating, and investigating any security incidents and risks, and in further enhancing our cybersecurity safeguards. This incident did not, and other incidents have not impacted the availability of our systems, materially disrupted our operations, or had any material impact on our financial or operating results. Cybersecurity risks are constantly evolving, and as such, we anticipate additional work and expense in the future as we continue to further enhance our security processes and initiatives to meet the changing landscape of cybersecurity risks. While cyber insurance may be available for companies, any available insurance for cyber events, may be limited in amount, subject to deductibles, and may not be adequate to cover us for all costs arising from security incidents. Given increasing cybersecurity risks, cyber insurance may not be available to us in the future, or may not be available on commercially reasonable terms.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cyberattacks and other malicious internet-based activity continue to increase and cloud-based platform providers of services have been and are expected to continue to be targeted. Furthermore, there may be a heightened risk of potential cyberattacks by state actors or others since the escalation of the conflicts in Eastern Europe and intensified conflicts in the Middle East. Methods of attacks on information technology systems and attempting or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">effecting data security breaches and incidents change frequently, are increasingly complex and sophisticated, including social engineering and phishing scams, and can originate from a wide variety of sources. In addition to traditional computer &#8220;hackers,&#8221; malicious code, such as viruses and worms, employee theft or misuse, denial-of-service attacks and sophisticated nation-state and nation-state supported actors now engage in attacks, including advanced persistent threat intrusions. Despite our efforts to create security barriers to such threats, it is virtually impossible for us to entirely mitigate these risks. Despite any of our current or future efforts to protect against cyberattacks and security breaches and incidents, there is no guarantee that our efforts are adequate to safeguard against all such attacks, breaches, and incidents. Moreover, it is possible that we may not be able to anticipate, detect, appropriately react and respond to, or implement effective preventative measures against, all security incidents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If our security measures, or those of our vendors and partners, are compromised due to cyberattacks or security breaches or incidents, including as a result of third-party action, employee or customer error, malfeasance, stolen or fraudulently obtained credentials or otherwise, or if any of these events is perceived to have occurred, our reputation could be damaged, our business and reputation may be harmed, we could become subject to claims, demands and litigation by private parties, and regulatory investigations and other proceedings, and we could incur significant liability. If we were to experience a prolonged system disruption in our information technology systems or those of certain of our vendors and partners, it could negatively impact our ability to serve our customers, which could adversely impact our business, financial condition, results of operations and prospects. If operations at our facilities were disrupted, it may cause a material disruption in our business. In addition, our information technology systems, and those of our vendors and partners, are potentially vulnerable to security breaches and incidents, whether by internal bad actors, such as employees or other third parties with legitimate access to our or our third-party providers&#8217; systems, or external bad actors, which could lead to the exposure of personal data, sensitive data and confidential information to unauthorized persons. Any such security breaches or incidents could lead to the loss of trade secrets or other intellectual property, or could lead to the loss, unavailability, exposure, unauthorized modification, alteration or other processing of personal information, including sensitive personal information, of our employees, customers and others, any of which could have a material adverse effect on our business, reputation, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any such access, disclosure or other loss or unauthorized use of information or data could result in legal claims or proceedings, regulatory investigations or actions, and other types of liability under federal, state and foreign laws and regulations relating to the privacy and security of personal information, violations of which could result in significant penalties and fines. Furthermore, defending a suit, regardless of its merit, could be costly, divert management&#8217;s attention and harm our reputation. In addition, although we seek to detect and investigate security incidents, security breaches and other incidents of unauthorized access to our information technology systems and data, these can be difficult to detect and any delay in identifying such breaches or incidents may lead to increased harm and legal exposure of the type described above. Moreover, there could be public announcements regarding any actual or perceived security breaches or incidents and any steps we take to respond to or remediate such breaches or incidents, and if securities analysts or investors perceive these announcements to be negative, it could, among other things, have a material adverse effect on the price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The cost of protecting against, investigating, mitigating and responding to potential breaches of and other incidents impacting our information technology systems and data security breaches and incidents and complying with applicable breach notification obligations to individuals, regulators, partners and others can be significant. As security incidents continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate information security vulnerabilities. Any failure to implement, maintain and upgrade adequate safeguards, or for this to be believed or asserted to be the case, could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to manage our anticipated growth effectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our anticipated growth will place significant strains on our management, operational and manufacturing systems and processes, sales and marketing team, financial systems and internal controls and other aspects of our business. We must upgrade our internal business processes and capabilities to create the scalability that a growing business demands. As of June&#160;30, 2026, we had 127 employees. While in the first quarter of 2025 we implemented </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">our workforce reductions, to execute our anticipated growth successfully, we must continue to attract and retain qualified personnel and manage and train them effectively. Developing and commercializing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> will require us to hire and retain scientific, sales and marketing, software, manufacturing, customer service, distribution and quality assurance personnel. In addition, we expect that we will need to hire additional accounting, finance and other personnel as a public company and as we begin commercialization. As a public company, our management and other personnel will need to devote a substantial amount of time towards maintaining compliance with these requirements and effectively manage our expected growth activities. We may face challenges integrating, developing and motivating our employee base.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Further, our anticipated growth will place additional strain on our suppliers and manufacturing facilities, resulting in an increased need for us to carefully monitor quality assurance. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and commercialization goals.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to successfully manage our expected growth is uncertain given the fact that we have been in operation only since 2016. As we continue to grow, we will be required to implement more complex organizational management structures and may find it increasingly difficult to maintain the benefits of our corporate culture, including our ability to quickly develop and launch new and innovative products. If we do not successfully manage our anticipated growth, our business, results of operations, financial condition and prospects will be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to recruit and retain key executives and scientists, we may be unable to achieve our goals.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our performance is substan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">tially dependent on the performance of our senior management and key scientific and technical personnel, particularly Sujal Patel, one of our founders and our Chief Executive Officer, and Parag Mallick, one of our founders and our Chief Scientist.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The loss of the services of any member of our senior management or our scientific or technical staff might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management&#8217;s attention to transition matters and identification of suitable replacements, if any, and could have a material adverse effect on our business. We do not maintain fixed term employment contracts with any of our employees and do not maintain key man life insurance on any of our employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our research and product development efforts could be delayed or curtailed if we are unable to attract, train and retain highly skilled employees, particularly, senior scientists and engineers. To expand our research and product development efforts, we need additional people skilled in areas such as molecular and cellular biology, biochemistry, surface chemistry, software, bioinformatics, assay development, mechanical engineering, electrical engineering, optics, fluidics and manufacturing. Competition for these people is intense. Because of the complex and technical nature of our system and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our technology.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Workforce reductions, such as the workforce reduction implemented during the first quarter of 2025, may be negatively received by potential or current employees and accordingly result in attrition or difficulty in recruiting desirable candidates. As part of our retention and incentive efforts, in addition to salary and cash incentives, we have issued stock options that vest over time. The value to employees of stock options that vest over time may be significantly affected by decreases in our stock price (whether or not related to or proportional to our operating performance) and may at any time be insufficient to counteract more lucrative offers from other companies. We may face challenges in retaining and recruiting such individuals due to sustained declines in our stock price that could reduce the retention value of equity awards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire other companies or technologies, which could divert our management&#8217;s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future seek to acquire or invest in businesses, applications or technologies that we believe could complement or expand our Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform or future products, enhance our technical capabilities or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of our management and cause us to incur various costs and expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. We may not be able to identify desirable acquisition targets or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">be successful in entering into an agreement with any particular target or obtain the expected benefits of any acquisition or investment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience in acquiring other businesses or technologies. We may not be able to successfully integrate acquired personnel, operations and technologies, or effectively manage the combined business following an acquisition. Acquisitions could also result in dilutive issuances of equity securities, the use of our available cash, or the incurrence of debt, which could harm our operating results. In addition, if an acquired business fails to meet our expectations, our operating results, business and financial condition may suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable U.S. or global economic conditions as a result of multiple global events, including global pandemics, geopolitical conflicts, such as the conflicts in Eastern Europe and the Middle East, changing tariff environments, potential trade wars and embargoes, changing interest rates, instability in the global financial markets, and general economic downturns, could adversely affect our ability to raise capital and our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">While the potential economic impact brought by multiple adverse global circumstances, such as the global pandemics, geopolitical conflicts such as the conflicts in Eastern Europe and the Middle East, potential uncertainty related to Taiwan and its relationship with China, changing tariff environments and potential for trade wars and embargoes, changing interest rates and general economic downturns, and related volatility in the global financial markets, are difficult to assess or predict, both as to magnitude and duration, these events have resulted in, and may continue to result in, extreme volatility and disruptions in the capital and credit markets, reducing our ability to raise additional capital through equity, equity-linked or debt financings, which could negatively impact our short-term and long-term liquidity and our ability to operate in accordance with our operating plan, or at all.  Additionally, these events have resulted, and in the future may result, in disruptions in our supply chains or the supply chains of those entities providing services or products to us, restrictions in our ability to deploy our workforce in our own facilities, locally, nationally or internationally, restrictions on the operating capacity of the laboratories or research facilities of our customers, decreases in government funding of research and development, or changes to programs that provide funding to research laboratories that may have the impact of redirecting funding to other areas of research, or prolonging or delaying funding cycles, any of which could adversely impact our ability to manufacture and sell our products.  Moreover, our results of operations could be adversely affected by general conditions in the global economy and financial markets. A severe or prolonged economic downturn could result in a variety of risks to our business, including weakened demand for our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and our ability to raise additional capital when needed on favorable terms, if at all. A weak or declining economy could strain our customers&#8217; budgets or cause delays in their payments to us. As a result of such events, we or our contractors, partners and/or suppliers could experience shortages, business disruptions or delays for materials sourced or manufactured in countries affected by such events, and their ability to supply us with services or components may be adversely affected. In addition, our contractors and suppliers have raised and may continue to raise prices for goods and services we employ in our research and development efforts and for components or materials used in our Nautilus Voyager platform. Tariffs imposed upon products and materials used in manufacturing our products, or responsive tariffs imposed upon our exported products could impact our costs of manufacturing and ability to sell products in foreign countries, which could have a negative impact on our business. On February 20, 2026, the Supreme Court ruled against President Trump&#8217;s use of the International Emergency Economic Powers Act, or IEEPA, to impose tariffs on global trade partners. The case has been returned to the Court of International Trade for reconsideration in accordance with the Supreme Court ruling, and thus, the impact of this decision on previous tariffs is not yet clear. In addition, President Trump has already stated that he will impose new tariffs under different authorities including Section 122.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Further, changes in U.S. government spending </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">resulting from new political administrations </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">could have adverse consequences on our financial position, results of operations and business Additionally, there is ongoing uncertainty regarding the federal budget and federal spending levels, including the possible impacts of a failure to increase the &#8220;debt ceiling.&#8221; Any U.S. government default on its debt could have broad macroeconomic effects that could, among other things, disrupt access to capital markets and deepen recessionary conditions. Further, as of June&#160;30, 2026, we had cash, cash equivalents and investments of $129.2 million, consisting of U.S. treasury securities, mutual funds, corporate debt securities, commercial paper, and agency securities. Any default by the U.S. government or credit downgrade of the securities we hold could impact the liquidity or valuation of our investments.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any of the foregoing could harm our business, financial condition and results of operations, and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our ability to raise capital, business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our facilities become unavailable or inoperable, our research and development program and commercialization launch plan could be adversely impacted and manufacturing of our instruments and consumables could be interrupted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our Seattle, Washington, facility primarily houses our corporate executive team and our software development operations, while our facilities in San Carlos and San Diego, California primarily house our research and development teams.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities in Seattle and San Carlos are vulnerable to natural disasters, public health crises, and other catastrophic events. For example, our San Carlos facilities are located near earthquake fault zones and are vulnerable to damage from earthquakes as well as other types of disasters, including fires, floods, power loss, communications failures and similar events. If any disaster, public health crisis or catastrophic event were to occur, our ability to operate our business would be seriously, or potentially completely, impaired. If our facilities become unavailable for any reason, we cannot provide assurances that we will be able to secure alternative facilities with the necessary capabilities and equipment on acceptable terms, if at all. We may encounter particular difficulties in replacing our San Carlos facilities given the specialized equipment housed within it. The inability to manufacture our instruments or consumables, combined with our limited inventory of manufactured instruments and consumables, may result in the loss of future customers or harm our reputation, and we may be unable to re-establish relationships with those customers in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If our research and development program or planned commercialization program were disrupted by a disaster or catastrophe, the launch of new products, including our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, and the timing of improvements to our products could be significantly delayed and could adversely impact our ability to compete with other available products and solutions. If our capabilities are impaired, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business. Although we possess insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We use hazardous chemicals and biological materials in our business. Any claims relating to improper handling, storage or disposal of these materials could be time consuming and costly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development processes involve the controlled use of hazardous materials, including select chemicals that may be flammables, toxic or corrosives, as well as potential biohazard materials. We cannot eliminate the risk of accidental contamination or discharge and any resultant injury from these materials. In addition, our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Voyager platform</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> involves the use of a high-powered laser system, which could result in injury. We may be sued for any injury or contamination that results from our use or the use by third parties of these materials. We do not currently maintain separate environmental liability coverage and any such contamination or discharge could result in significant cost to us in penalties, damages and suspension of our operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An active trading market for our Common Stock may never develop or be sustained.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, there was no public trading market for Legacy Nautilus&#8217; Common Stock. Although our Common Stock is listed on the Nasdaq Capital Market, the market for our shares has demonstrated varying levels of trading activity. If an active trading market does not develop, or develops but is not maintained, you may have difficulty selling any of our Common Stock due to the limited public float. We cannot predict the prices at which our Common Stock will trade. It is possible that in one or more future periods our results of operations and progression of our product pipeline may not meet the expectations of public market analysts and investors, and, as a result of these and other factors, the price of our Common Stock may fall. Accordingly, we cannot assure you of your ability to sell your shares of our Common Stock when desired or at prices at or above the price you paid for your shares or at all.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our Common Stock has been and may continue to be volatile, which could result in substantial losses for investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our Common Stock has been and may continue to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our Common Stock may fluctuate due to a variety of factors, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of the launch and commercialization of our products and degree to which such launch and commercialization meets the expectations of securities analysts and investors;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our operating results, including fluctuations in our quarterly and annual results;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating expenses being more than anticipated;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure or discontinuation of any of our product development and research programs;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure or funding of research at academic and research laboratories and institutions, including changes that would affect their ability to purchase our instruments or consumables;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of existing or new competitive businesses or technologies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements about new research programs or products of our competitors;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning patent applications, issued patents or other proprietary rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the recruitment or departure of key personnel;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation and governmental investigations involving us, our industry or both;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory or legal developments in the United States and other countries;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility and variations in market conditions in the life sciences technology sector generally, or the proteomics or genomics sectors specifically;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investor perceptions of us or our industry;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of expenses related to any of our research and development programs or products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in our estimates as to our financial results or development timelines, variations in our financial results or those of companies that are perceived to be similar to us or changes in estimates or recommendations by securities analysts, if any, that cover our Common Stock or companies that are perceived to be similar to us;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether our financial results meet the expectations of securities analysts or investors;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the announcement or expectation of additional financing efforts;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our Common Stock by us or by our insiders or other stockholders;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry and market conditions; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global pandemics, natural disasters or major catastrophic events.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Recently, stock markets in general, and the market for life sciences technology companies in particular, have experienced significant price and volume fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. Broad market and industry factors may seriously affect the market price of our Common Stock, regardless of our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">actual operating performance. These fluctuations may be even more pronounced in the trading market for our Common Stock. Following periods of such volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. Because of the potential volatility of our Common Stock price, we may become the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management&#8217;s attention and resources from our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not continue to satisfy the Nasdaq continued listing requirements, our Common Stock could be delisted from Nasdaq. Our ability to publicly or privately sell equity securities and the liquidity of our Common Stock could be adversely affected if our Common Stock is delisted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We must continue to satisfy the Nasdaq Capital Market&#8217;s continued listing requirements, including, among other things, a minimum closing bid price requirement of $1.00 per share for 30 consecutive business days. If a company fails for 30 consecutive business days to meet the $1.00 minimum closing bid price requirement, The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) will send a deficiency notice to the company, advising that it has been afforded a &#8220;compliance period&#8221; of 180 calendar days to regain compliance with the applicable requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A delisting of our common stock from the Nasdaq Capital Market could materially reduce the liquidity of our common stock and result in a corresponding material reduction in the price of our common stock. In addition, delisting could harm our ability to raise capital through alternative financing sources on terms acceptable to us, or at all, and may result in the potential loss of confidence by investors and employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On May 1, 2025, we received a letter from the Listing Qualifications Staff (&#8220;Staff&#8221;) of Nasdaq indicating that, based upon the closing bid price of shares of our Common Stock for the 30 consecutive business day period between March 19, 2025, through April 30, 2025, we did not meet the Minimum Bid Price Requirement for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1). On November 3, 2025, the Staff notified us that since the Company&#8217;s stock had achieved a closing bid price of greater than $1.00 for at least 10 consecutive business days, that we had regained compliance with the Nasdaq listing requirements. If the closing bid price of our Common Stock should fall below $1 for 30 consecutive business days in the future, we could again fail to meet the Minimum Bid Price Requirement for continued listing on the Nasdaq Capital Market and face a risk of delisting.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Even though we have regained compliance with the Nasdaq Capital Market&#8217;s minimum closing bid price requirement, there is no guarantee that we will remain in compliance with such listing requirements or other listing requirements in the future. Any failure to maintain compliance with continued listing requirements of the Nasdaq Capital Market could result in delisting of our common stock from the Nasdaq Capital Market and negatively impact our company and holders of our common stock, including by reducing the willingness of investors to hold our common stock because of the resulting decreased price, liquidity and trading of our common stock, limited availability of price quotations and reduced news and analyst coverage. Delisting may adversely impact the perception of our financial condition, cause reputational harm with investors, our employees and parties conducting business with us and limit our access to debt and equity financing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our principal stockholders and management own a significant percentage of our Common Stock and will be able to exercise significant influence over matters subject to stockholder approval.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2026, our directors, executive officers, holders of more than 5% of our outstanding shares of Common Stock and their respective affiliates beneficially owned a substantial portion of the outstanding shares of our Common Stock. As a result, these stockholders, if they act together, may significantly influence all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying or preventing a change in control of our company that our other stockholders may believe is in their best interests. This in turn could have a material adverse effect on our stock price and may prevent attempts by our stockholders to replace or remove the board of directors or management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The sale or the perception of future sales of a substantial number of shares of our Common Stock could cause the market price of our Common Stock to drop significantly, even if our business is doing well.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our Common Stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended and Restated Registration Rights and Lock-Up Agreement (the &#8220;Registration Rights and Lock-Up Agreement&#8221;) and the Subscription Agreements entered into in connection with the PIPE Financing, we have filed resale registration statements to provide for the resale of the shares issued in the PIPE Financing and the shares of our Common Stock held by the parties to the Registration Rights and Lock-Up Agreement. The market price of our Common Stock could decline if the holders whose shares are registered under such registration statements sell their shares or are perceived by the market as intending to sell their shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will have broad discretion over the use of the proceeds to us from our &#8220;at the market&#8221; equity offering program and may apply the proceeds to uses that do not improve our operating results or the value of your securities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will have broad discretion to use the net proceeds to us from our &#8220;at the market&#8221; equity offering program, and investors will be relying solely on the judgment of our board of directors and management regarding the application of these proceeds. Although we expect to use the net proceeds from our &#8220;at the market&#8221; equity offering program for general corporate purposes and working capital, including for continued product development of our Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> platform other research and development activities, and commercialization of our Nautilus Voyager platform, we have not allocated these net proceeds for specific purposes. Investors will not have the opportunity, as part of their investment decision, to assess whether the proceeds are being used appropriately. Our use of the proceeds may not improve our operating results or increase the value of the securities offered pursuant to the &#8220;at the market&#8221; equity offering program.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any dividends for the foreseeable future. Investors may never obtain a return on their investment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely on an investment in our Common Stock to provide dividend income. We do not anticipate that we will pay any dividends to holders of our Common Stock in the foreseeable future. Instead, we plan to retain any earnings to maintain and expand our existing operations, fund our research and development programs and continue to invest in our commercial infrastructure. In addition, any future credit facility or financing we obtain may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our Common Stock. Accordingly, investors must rely on sales of our Common Stock after price appreciation, which may never occur, as the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our bylaws designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all disputes between us and our stockholders, and also provide that the federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, each of which could limit our stockholders&#8217; ability to choose the judicial forum for disputes with us or our directors, officers, stockholders, or employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our bylaws provide that, unless we consent in writing to the selection of an alternative forum (an &#8220;Alternative Forum Consent&#8221;), the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court in Delaware or the federal district court for the District of Delaware) will, to the fullest extent permitted by law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, stockholders or other employees to us or our stockholders, (iii) any action arising pursuant to any provision of the Delaware General Corporation Law or our certificate of incorporation or bylaws (each, as may be amended from time to time), or (iv) any action asserting a claim governed by the internal affairs doctrine of the State of Delaware, except for any claim as to which the court does not have jurisdiction over an indispensable party to that claim. The foregoing shall not apply to any claims under the Exchange Act or the Securities Act of 1933, as amended (the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Securities Act&#8221;). In addition, unless we give an Alternative Forum Consent, the federal district courts of the United States shall be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act against any person in connection with any offering of the Company&#8217;s securities, including any auditor, underwriter, expert, control person or other defendant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our bylaws also provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring or holding or owning (or continuing to hold or own) any interest in any of our securities shall be deemed to have notice of and consented to the foregoing bylaw provisions. Although we believe these exclusive forum provisions benefit us by providing increased consistency in the application of Delaware law and federal securities laws in the types of lawsuits to which each applies, the exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, stockholders, or other employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, officers, stockholders, or other employees. In addition, a stockholder that is unable to bring a claim in the judicial forum of its choosing may be required to incur additional costs in the pursuit of actions which are subject to the exclusive forum provisions described above. Our stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provisions. Further, in the event a court finds either exclusive forum provision contained in our bylaws to be unenforceable or inapplicable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware law and provisions in our certificate of incorporation and bylaws might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our status as a Delaware corporation and the anti-takeover provisions of the Delaware General Corporation Law may discourage, delay or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomes an interested stockholder without the approval of holders of 66 2/3% of the voting power of our stockholders other than the interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, our certificate of incorporation and bylaws contain provisions that may make the acquisition of our company more difficult, including the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our board of directors is classified into three classes of directors with staggered three-year terms and directors are only able to be removed from office for cause by the affirmative vote of holders of at least two-thirds of the voting power of our then outstanding capital stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain amendments to our certificate of incorporation require the approval of stockholders holding two-thirds of the voting power of our then outstanding capital stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any stockholder-proposed amendment to certain provisions of our bylaws require the approval of stockholders holding two-thirds of the voting power of our then outstanding capital stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our stockholders are only able to take action at a meeting of stockholders and are not able to take action by written consent for any matter;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">vacancies on our board of directors are able to be filled only by our board of directors and not by stockholders;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">only the chair of our board of directors, our chief executive officer, our president or a majority of our board of directors are authorized to call a special meeting of stockholders;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain litigation against us can only be brought in Delaware;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our certificate of incorporation authorizes undesignated preferred stock, the terms of which may be established by our Board and shares of which may be issued, without the approval of the holders of our capital stock; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">These anti-takeover defenses could discourage, delay, or prevent a transaction involving our change in control. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions they desire, any of which, under certain circumstances, could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will continue to incur significant increased costs and management resources as a result of operating as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we will continue to incur significant legal, accounting, compliance and other expenses that we did not incur as a private company and these expenses may increase even more given we are no longer an &#8220;emerging growth company.&#8221; Our management and other personnel will need to devote a substantial amount of time and incur significant expense in connection with compliance initiatives. As a public company, we will continue to bear all of the internal and external costs of preparing and distributing periodic public reports in compliance with our obligations under the securities laws.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, regulations and standards relating to corporate governance and public disclosure, including the SOX, and the related rules and regulations implemented by the SEC and The Nasdaq Stock Market LLC, have increased legal and financial compliance costs and will make some compliance activities more time-consuming. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment will result in increased selling, general and administrative expenses and may divert management&#8217;s time and attention from our other business activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to practice, regulatory authorities may initiate legal proceedings against us, and our business may be harmed. In the future, it may be more expensive or more difficult for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members for our board of directors, particularly to serve on our audit committee and compensation committee, and qualified executive officers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion in the use of the net proceeds from the Business Combination and the PIPE Financing and may not use them effectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We cannot specify with certainty the particular uses of the net proceeds we received from the Business Combination and the PIPE Financing. Our management will have broad discretion in the application of the net proceeds. Our management may spend a portion or all of the net proceeds in ways that our stockholders may not desire or that may not yield a favorable return. The failure by our management to apply these funds effectively could harm our business, financial condition, results of operations and prospects. Pending their use, we may invest the net proceeds from the Business Combination and the PIPE Financing in a manner that does not produce income or that loses value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating losses and certain other tax attributes to offset future taxable income may be subject to certain limitations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal and state net operating loss carryforwards (&#8220;NOLs&#8221;) may be unavailable to offset future taxable income because of restrictions under U.S. federal and/or state law. U.S. federal NOLs that arose in tax years beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such U.S. federal NOLs will be limited to 80% of our current year taxable income. State NOLs may be subject to similar or different limitations.  As of December&#160;31, 2025, we had U.S. federal NOLs of $203.7 million, of which $203.2 million do not expire, and state NOLs of $197.9 million that will begin to expire in 2037.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Section 382 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), may limit the NOLs we may use in any year for U.S. federal income tax purposes in the event of certain changes in our ownership. A Code Section 382 &#8220;ownership change&#8221; generally occurs if one or more stockholders or groups of stockholders who own at least 5% of a company&#8217;s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. We have not conducted a Code Section 382 study to determine whether the use of our NOLs is impaired. We may have previously undergone an &#8220;ownership change.&#8221; In addition, future issuances or sales of our stock, including certain transactions involving our stock that are outside of our control, could result in future &#8220;ownership changes.&#8221; &#8220;Ownership changes&#8221; that have occurred in the past or that may occur in the future could result in the imposition of an annual limit on the amount of pre-ownership change NOLs and other tax attributes we can use to reduce our taxable income, potentially increasing and accelerating our liability for income taxes, and also potentially causing those tax attributes to expire unused. States may impose other limitations on the use of our NOLs and other tax attributes. Any limitation on using NOLs could, depending on the extent of such limitations and the NOLs previously used, result in our retaining less cash after payment of U.S. federal and state income taxes during any year in which we have taxable income, rather than losses, than we would be entitled to retain if such NOLs were available as an offset against such taxable income for U.S. federal and state income tax reporting purposes, which coul</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">d adversely impact our operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws could have a material adverse effect on our future business, cash flows, results of operations or financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to tax laws, regulations, and policies of U.S. federal, state and local taxing jurisdictions and may in the future be subject to the tax laws, regulations, and policies of other taxing jurisdictions. Changes in tax laws, as well as other factors, could cause us to experience fluctuations in our tax obligations and effective tax rates and otherwise adversely affect our tax positions and/or our tax liabilities. In addition, many countries and local jurisdictions and organizations such as the Organisation for Economic Co-operation and Development (the &#8220;OECD&#8221;) have proposed or implemented new tax laws or changes to existing tax laws, including additional taxes on payroll or employees and a proposed 15% global minimum tax (&#8220;Pillar 2&#8221;) that is being implemented by several countries and is being considered for implementation by others. On January 5, 2026, the OECD announced a side-by-side elective safe harbor that exempts electing U.S.-parented multinational entities from certain provisions of Pillar Two for fiscal years beginning on or after January 1, 2026. Any new tax laws or changes to existing tax laws could adversely affect our future effective tax rate, operating results, tax credits or incentives or tax payments, which could have a material adverse effect on our future business, cash flows, results of operations or financial condition, including if we expand internationally.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner or prevent fraud, which would harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could cause us to fail to meet our reporting ob</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">ligations in a timely manner, or at all. In addition, any testing by us conducted in connection with Section 404(a) of the Sarbanes-Oxley Act of 2002 (&#8220;SOX&#8221;) or any subsequent testing by our independent registered public accounting firm in connection with Sectio</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">n 404(b) of SOX, may reveal deficiencies in our internal controls over financial reporting that are deemed to be significant deficiencies or material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Ineffective internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">We will be required to disclose material changes made in our internal controls over financial reporting and procedures on a quarterly basis and our management will be required to assess the effectiveness of these controls annually. We will be required to make a formal assessment of the effectiveness of our internal control over financial reporting, and once we cease to be a non-accelerated filer as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), we will be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, for as long as we remain a non-accelerated filer, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404(b) of SOX.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">To achieve compliance with Section 404(a) of SOX within the prescribed period, we have engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a plan to assess and document the adequacy of our internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are designed and operating effectively and implement a continuous reporting and improvement process for internal control over financial reporting.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">An independent assessment of the effectiveness of our internal controls could detect problems that our management&#8217;s assessment might not identify. Undetected material weaknesses in our internal controls could lead to financial statement restatements and require us to incur the expense of remediation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operation could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. We base our estimates on historical experience and estimates and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, and expenses that are not readily apparent from other sources. For example, in connection with the implementation of the new revenue accounting standard if and when we have product sales, management makes judgments and assumptions based on our interpretation of the new standard. The new revenue standard is principle-based, and interpretation of those principles may vary from company to company based on their unique circumstances. It is possible that interpretation, industry practice and guidance may evolve as we apply the new standard. If our assumptions underlying our estimates and judgements relating to our critical accounting policies change or if actual circumstances differ from our assumptions, estimates or judgements, our operating results may be adversely affected and could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a &#8220;smaller reporting company&#8221; within the meaning of the Securities Act, and the reduced disclosure requirements applicable to smaller reporting companies may make our Common Stock less attractive to investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Although we ceased to be an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, on December 31, 2025, we are currently a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. Smaller reporting companies may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not smaller reporting companies, including, among others, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and not being required to furnish a stock performance graph in our annual report. Additionally, as a smaller reporting company, we are only required to provide two years of audited financial statements in our SEC reports. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held by non-affiliates equals or exceeds $250 million as of the prior June 30, or (2) our annual revenues equal or exceed $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates equals or exceeds $700 million as of the prior June 30.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If we take advantage of some or all of the reduced disclosure requirements available to smaller reporting companies, investors may find our common stock less attractive, which may result in a less active trading market for our common stock and greater stock price volatility.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities research analysts may establish and publish their own periodic projections for us. These projections may vary widely and may not accurately predict the results we actually achieve. The share price of our Common Stock may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, the share price of our Common Stock could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, the share price or trading volume of our Common Stock could decline. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased scrutiny of our environmental, social or governance responsibilities may result in additional costs and risks, and may adversely impact our reputation, employee retention, and willingness of customers and suppliers to do business with us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Investor advocacy groups, proxy advisory services, investment funds, institutional investors, stockholders, and customers are increasingly focused on environmental, social, and governance (&#8220;ESG&#8221;) practices of companies. If our ESG practices fail to meet regulatory requirements or investor or other industry stakeholders' evolving expectations and standards for responsible corporate citizenship in areas including environmental stewardship, support for local communities, board and employee diversity, human capital management, employee health and safety practices, product quality, supply chain management, corporate governance and transparency, and employing ESG strategies in our operations, our brand, reputation and employee retention may be negatively impacted and customers and suppliers may be unwilling to do business with us. In addition, ESG reporting and disclosure may result in additional costs and require additional resources as well as additional attention from our board of directors and management. If we fail to adopt ESG standards or practices as quickly as stakeholders desire, report on our ESG efforts or practices accurately, or satisfy the expectations of stakeholders, or comply with applicable regulatory requirements, our reputation, business, financial performance, and growth may be adversely impacted. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_136"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_139"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_142"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_145"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Securities Trading Plans of Directors and Executive Officers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), <ix:nonNumeric contextRef="c-13" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-751"><ix:nonNumeric contextRef="c-13" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-752">adopted</ix:nonNumeric></ix:nonNumeric> and/or <ix:nonNumeric contextRef="c-13" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-753"><ix:nonNumeric contextRef="c-13" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-754">terminated</ix:nonNumeric></ix:nonNumeric> a &#8220;Rule 10b5-1 trading arrangement&#8221; or a &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as defined in Regulation S-K Item 408. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_148"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021011892/exhibit31-form8xkclosing.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1808805/000162828021011892/exhibit31-form8xkclosing.htm">Certificate of Incorporation of Nautilus Biotechnology, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 10, 2021)</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1808805/000180880523000069/exhibit32-nautilusbiotechn.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1808805/000180880523000069/exhibit32-nautilusbiotechn.htm">Amended and Restated Bylaws of Nautilus Biotechnology, Inc. (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on August 2, 2023)</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-q226.htm">31.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-q226.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-q226.htm">31.2*</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-q226.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q226.htm">32.1*</a></span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q226.htm">&#8224;</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-q226.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-q226.htm">32.2*</a></span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-q226.htm">&#8224;</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-q226.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover page Interactive Data File (embedded with the Inline XBRL document)</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">* Filed herewith.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">&#8224; The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Nautilus Biotechnology, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="ibe513a7507ca44a6b324aa5f298cbb8b_151"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"/><td style="width:33.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.290%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:60.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">NAUTILUS BIOTECHNOLOGY, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date: July&#160;28, 2026</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sujal Patel </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Sujal Patel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Chief Executive Officer (Principal Executive Officer)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date: July&#160;28, 2026</span></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Anna Mowry</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Anna Mowry</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Chief Financial Officer (Principal Financial and Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311-q226.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i07628bd06ae34ee5b6d9fbdb5d629841_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">I, Sujal Patel, certify that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Nautilus Biotechnology, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; July&#160;28, 2026</font></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sujal Patel </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">President and Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312-q226.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="iea68033fecc746919dc84d89f287bc51_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">I, Anna Mowry, certify that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Nautilus Biotechnology, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">c.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">d.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; July&#160;28, 2026</font></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Anna Mowry</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Anna Mowry</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321-q226.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="id87792423ed1448393166e00798a692e_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Quarterly Report of Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Sujal Patel, hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; July&#160;28, 2026</font></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sujal Patel </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">President and Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322-q226.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="ie3c16787894c4248af4d48d869ec8b5e_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Quarterly Report of Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Anna Mowry, hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; July&#160;28, 2026</font></div></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Anna Mowry</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Anna Mowry</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>naut-20260630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e9007-3d81-7923-8b9d-11e8abe8f7df,g:a24f2a1f-f751-4ff8-9f53-5ed913cc112d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naut="http://www.nautilus.bio/20260630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nautilus.bio/20260630">
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.nautilus.bio/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofPresentation" roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation">
        <link:definition>9952157 - Disclosure - Description of Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.nautilus.bio/role/SignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.nautilus.bio/role/FairValueMeasurements">
        <link:definition>9952159 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItems" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems">
        <link:definition>9952160 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStock" roleURI="http://www.nautilus.bio/role/CommonStock">
        <link:definition>9952161 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.nautilus.bio/role/IncomeTaxes">
        <link:definition>9952162 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensation" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensation">
        <link:definition>9952163 - Disclosure - Equity Incentive Plans and Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.nautilus.bio/role/CommitmentsandContingencies">
        <link:definition>9952164 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShare" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShare">
        <link:definition>9952165 - Disclosure - Basic and Diluted Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.nautilus.bio/role/SegmentInformation">
        <link:definition>9952166 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.nautilus.bio/role/FairValueMeasurementsTables">
        <link:definition>9955512 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables">
        <link:definition>9955513 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockTables" roleURI="http://www.nautilus.bio/role/CommonStockTables">
        <link:definition>9955514 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensationTables" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables">
        <link:definition>9955515 - Disclosure - Equity Incentive Plans and Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesTables">
        <link:definition>9955516 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareTables" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables">
        <link:definition>9955517 - Disclosure - Basic and Diluted Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.nautilus.bio/role/SegmentInformationTables">
        <link:definition>9955518 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofPresentationDetails" roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails">
        <link:definition>9955519 - Disclosure - Description of Business and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails">
        <link:definition>9955520 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails_1" roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails_1">
        <link:definition>9955520 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails" roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails">
        <link:definition>9955521 - Disclosure - Fair Value Measurements - Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails_1" roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails_1">
        <link:definition>9955521 - Disclosure - Fair Value Measurements - Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails">
        <link:definition>9955522 - Disclosure - Fair Value Measurements - Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.nautilus.bio/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955523 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955524 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails">
        <link:definition>9955525 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails">
        <link:definition>9955526 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Accrued Expenses and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>9955527 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockNarrativeDetails" roleURI="http://www.nautilus.bio/role/CommonStockNarrativeDetails">
        <link:definition>9955528 - Disclosure - Common Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails" roleURI="http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails">
        <link:definition>9955529 - Disclosure - Common Stock - Schedule of Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.nautilus.bio/role/IncomeTaxesDetails">
        <link:definition>9955530 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensationNarrativeDetails" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails">
        <link:definition>9955531 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensationNarrativeDetails_1" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails_1">
        <link:definition>9955531 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails">
        <link:definition>9955532 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Significant Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails">
        <link:definition>9955533 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Option Award Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9955534 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails_1" roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails_1">
        <link:definition>9955534 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNarrativeDetails" roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails">
        <link:definition>9955535 - Disclosure - Commitments and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails" roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails">
        <link:definition>9955536 - Disclosure - Commitments and Contingencies - Schedule of Future Principal Contractual Obligations for Operating Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1" roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1">
        <link:definition>9955536 - Disclosure - Commitments and Contingencies - Schedule of Future Principal Contractual Obligations for Operating Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>9955537 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails">
        <link:definition>9955538 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.nautilus.bio/role/SegmentInformationDetails">
        <link:definition>9955539 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" abstract="false" name="AccruedLiabilitiesAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_GrantRevenueMember" abstract="true" name="GrantRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_ServiceRevenueMember" abstract="true" name="ServiceRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" abstract="false" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" abstract="false" name="ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_PaymentsOfReverseRecapitalizationTransactionCosts" abstract="false" name="PaymentsOfReverseRecapitalizationTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_GrantLiabilityCurrent" abstract="false" name="GrantLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" abstract="false" name="InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="naut_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_FurnitureFixturesAndOfficeEquipmentMember" abstract="true" name="FurnitureFixturesAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_PrototypeEquipmentMember" abstract="true" name="PrototypeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_AccruedResearchAndDevelopmentCurrent" abstract="false" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_GrantLiabilitiesCurrent" abstract="false" name="GrantLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_A2021EquityIncentivePlanMember" abstract="true" name="A2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_A2021EmployeeStockPurchasePlanMember" abstract="true" name="A2021EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="naut_NumberOfFinancialInstitution" abstract="false" name="NumberOfFinancialInstitution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_ProfessionalServicesAndLaboratoryExpenses" abstract="false" name="ProfessionalServicesAndLaboratoryExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_FacilityExpenses" abstract="false" name="FacilityExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>naut-20260630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e9007-3d81-7923-8b9d-11e8abe8f7df,g:a24f2a1f-f751-4ff8-9f53-5ed913cc112d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e9007-3e4c-79ad-aae2-e23d978e3090" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-7307-b67f-e5141463cb99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e9007-3e4c-79ad-aae2-e23d978e3090" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-7307-b67f-e5141463cb99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e9007-3e4c-718d-a55a-228ad5de7295" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e9007-3e4c-79ad-aae2-e23d978e3090" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e9007-3e4c-718d-a55a-228ad5de7295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7007-8dde-4f6326c8743f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e9007-3e4c-7d3b-9ef0-9d661c7d0d80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7007-8dde-4f6326c8743f" xlink:to="loc_us-gaap_PreferredStockValue_019e9007-3e4c-7d3b-9ef0-9d661c7d0d80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e9007-3e4c-730b-adb9-b3995f883978" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7007-8dde-4f6326c8743f" xlink:to="loc_us-gaap_CommonStockValue_019e9007-3e4c-730b-adb9-b3995f883978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019e9007-3e4c-7b15-9902-e9f9a7450a70" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7007-8dde-4f6326c8743f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019e9007-3e4c-7b15-9902-e9f9a7450a70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e9007-3e4c-7bad-98a0-e79369d0deb0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7007-8dde-4f6326c8743f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e9007-3e4c-7bad-98a0-e79369d0deb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-775c-8027-624e523ea521" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7007-8dde-4f6326c8743f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-775c-8027-624e523ea521" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e9007-3e4c-7f94-90a3-3f91190f511b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e9007-3e4c-7e2c-9f8c-64a17865ad51" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e9007-3e4c-7f94-90a3-3f91190f511b" xlink:to="loc_us-gaap_AssetsCurrent_019e9007-3e4c-7e2c-9f8c-64a17865ad51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-77ef-b119-817c7e46d53c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e9007-3e4c-7f94-90a3-3f91190f511b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-77ef-b119-817c7e46d53c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e9007-3e4c-7bc8-9d9e-d90da550d4df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e9007-3e4c-7f94-90a3-3f91190f511b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e9007-3e4c-7bc8-9d9e-d90da550d4df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e9007-3e4c-7a58-9ae5-84a9a7d742c8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e9007-3e4c-7f94-90a3-3f91190f511b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e9007-3e4c-7a58-9ae5-84a9a7d742c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019e9007-3e4c-75ee-b47b-9796da2862c4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e9007-3e4c-7f94-90a3-3f91190f511b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019e9007-3e4c-75ee-b47b-9796da2862c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e9007-3e4c-714e-91a8-8272dd0c5eea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-7e4f-89f7-36a9d75ededc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e9007-3e4c-714e-91a8-8272dd0c5eea" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-7e4f-89f7-36a9d75ededc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e9007-3e4c-7b2d-9ed8-3a52c1e2fa4a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e9007-3e4c-714e-91a8-8272dd0c5eea" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e9007-3e4c-7b2d-9ed8-3a52c1e2fa4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e9007-3e4c-7db4-9c1a-c41275021f30" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e9007-3e4c-714e-91a8-8272dd0c5eea" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e9007-3e4c-7db4-9c1a-c41275021f30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-792d-bdea-5911f59be315" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e9007-3e4c-7040-803b-2e08893bd668" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-792d-bdea-5911f59be315" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e9007-3e4c-7040-803b-2e08893bd668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b3f-81a1-2f2ae8c4b5d0" xlink:href="naut-20260630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-792d-bdea-5911f59be315" xlink:to="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b3f-81a1-2f2ae8c4b5d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e9007-3e4c-7f42-9d98-f65f5b9f2f32" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-792d-bdea-5911f59be315" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e9007-3e4c-7f42-9d98-f65f5b9f2f32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e9007-3e4c-7e86-a711-5e222608eba0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e9007-3e4c-73a4-a078-5b7815a1db88" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e9007-3e4c-7e86-a711-5e222608eba0" xlink:to="loc_us-gaap_StockholdersEquity_019e9007-3e4c-73a4-a078-5b7815a1db88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e9007-3e4c-704f-aa7a-b6f4e7a2d427" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e9007-3e4c-7e86-a711-5e222608eba0" xlink:to="loc_us-gaap_Liabilities_019e9007-3e4c-704f-aa7a-b6f4e7a2d427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e9007-3e4c-759e-a6ea-0af21c105bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e9007-3e4c-7e86-a711-5e222608eba0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e9007-3e4c-759e-a6ea-0af21c105bfa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e9007-3e4c-78cd-91e9-9752067d431e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e9007-3e4c-7894-b4e9-01f1bf1de7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e9007-3e4c-78cd-91e9-9752067d431e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e9007-3e4c-7894-b4e9-01f1bf1de7cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e9007-3e4c-767f-9ee8-d5a441465ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e9007-3e4c-78cd-91e9-9752067d431e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e9007-3e4c-767f-9ee8-d5a441465ba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7fc9-b649-50c41893c902" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019e9007-3e4c-701c-bcac-1076b081e41b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7fc9-b649-50c41893c902" xlink:to="loc_us-gaap_Revenues_019e9007-3e4c-701c-bcac-1076b081e41b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019e9007-3e4c-7725-b7b6-a376631b500a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7fc9-b649-50c41893c902" xlink:to="loc_us-gaap_CostOfRevenue_019e9007-3e4c-7725-b7b6-a376631b500a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019f8c12-6ced-7903-a4f2-30b69691a4df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7fc9-b649-50c41893c902" xlink:to="loc_us-gaap_OperatingExpenses_019f8c12-6ced-7903-a4f2-30b69691a4df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019f8c12-6ced-7b84-a627-781a2a108a66" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7fc9-b649-50c41893c902" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019f8c12-6ced-7b84-a627-781a2a108a66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e9007-3e4c-7cef-849b-4ba7b0562797" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019e9007-3e4c-7e38-816f-fa99394a555d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e9007-3e4c-7cef-849b-4ba7b0562797" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019e9007-3e4c-7e38-816f-fa99394a555d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e9007-3e4c-7b49-ab7e-98ec137e03b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e9007-3e4c-7cef-849b-4ba7b0562797" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e9007-3e4c-7b49-ab7e-98ec137e03b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-7c48-b80b-847dd33738f6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_019e9007-3e4c-7875-b3d3-4c8d3a4c9200" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-7c48-b80b-847dd33738f6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_019e9007-3e4c-7875-b3d3-4c8d3a4c9200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e9007-3e4c-79be-a312-e7493d6c1850" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-7b67-850a-82f703013ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e9007-3e4c-79be-a312-e7493d6c1850" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-7b67-850a-82f703013ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7e9b-8cbe-2d270756ca41" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e9007-3e4c-79be-a312-e7493d6c1850" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7e9b-8cbe-2d270756ca41" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e9007-3e4c-7c9f-b058-c339040dd17c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7a4e-acab-0579a456ebf2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e9007-3e4c-7c9f-b058-c339040dd17c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7a4e-acab-0579a456ebf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-75d8-9637-c28858d47f63" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e9007-3e4c-7c9f-b058-c339040dd17c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-75d8-9637-c28858d47f63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3e4c-732f-af6f-965b2be0e33b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e9007-3e4c-7c9f-b058-c339040dd17c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3e4c-732f-af6f-965b2be0e33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3e4c-76fc-97b1-8c6677dae9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_019ea695-81d1-79ba-be77-87553d62931d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3e4c-76fc-97b1-8c6677dae9c3" xlink:to="loc_us-gaap_ProceedsFromStockPlans_019ea695-81d1-79ba-be77-87553d62931d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019e9007-3e4c-79f1-af48-add1109676d9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3e4c-76fc-97b1-8c6677dae9c3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019e9007-3e4c-79f1-af48-add1109676d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e9007-3e4c-73e2-85ac-2be562f9837c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e9007-3e4c-73e2-85ac-2be562f9837c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-71a8-bc7c-3bcc42231b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-71a8-bc7c-3bcc42231b0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e9007-3e4c-7b2e-a03b-bb1baac72fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e9007-3e4c-7b2e-a03b-bb1baac72fb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e9007-3e4c-7418-a94c-e06a609e1510" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e9007-3e4c-7418-a94c-e06a609e1510" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e9007-3e4c-7562-8700-0816c765fa6e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_ShareBasedCompensation_019e9007-3e4c-7562-8700-0816c765fa6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e9007-3e4c-7fde-869f-17b7749bb790" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e9007-3e4c-7fde-869f-17b7749bb790" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019e9007-3e4c-7d84-8450-87003d86d609" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_Depreciation_019e9007-3e4c-7d84-8450-87003d86d609" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e9007-3e4c-73cf-9c63-08a9835823b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e9007-3e4c-73cf-9c63-08a9835823b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e9007-3e4c-7b84-aa15-0faef53d2200" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7378-8ccb-52a346c7e9ab" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e9007-3e4c-7b84-aa15-0faef53d2200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7c39-997d-59e215c59724" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e9007-3e4c-72b2-b2e4-9116c1e5a795" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7c39-997d-59e215c59724" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e9007-3e4c-72b2-b2e4-9116c1e5a795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e9007-3e4c-7847-9996-9e1627a08ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7c39-997d-59e215c59724" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e9007-3e4c-7847-9996-9e1627a08ae9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e9007-3e4c-7e99-b9eb-eee03295f60e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7c39-997d-59e215c59724" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e9007-3e4c-7e99-b9eb-eee03295f60e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-7ba9-a8ff-0a455c8e6b45" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7f09-8fcb-de204fdc9b49" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-7ba9-a8ff-0a455c8e6b45" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7f09-8fcb-de204fdc9b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7d62-a224-5e3979ebf9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-7ba9-a8ff-0a455c8e6b45" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7d62-a224-5e3979ebf9ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7c63-b6b9-30cb5013792d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-7ba9-a8ff-0a455c8e6b45" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7c63-b6b9-30cb5013792d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3e4c-76c6-8485-fc2deb6c46c6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e9007-3e4c-7f12-a3c5-489aaffbea87" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3e4c-76c6-8485-fc2deb6c46c6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e9007-3e4c-7f12-a3c5-489aaffbea87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e9007-3e4c-755c-bb76-53ae6e8b52e8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3e4c-76c6-8485-fc2deb6c46c6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e9007-3e4c-755c-bb76-53ae6e8b52e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3e4c-7171-843d-dd03eaed06f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e9007-3e4c-727b-b8e8-fa67a17286ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3e4c-7171-843d-dd03eaed06f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e9007-3e4c-727b-b8e8-fa67a17286ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e9007-3e4c-7e5b-882f-7423759b8c51" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3e4c-7171-843d-dd03eaed06f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e9007-3e4c-7e5b-882f-7423759b8c51" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7437-87b7-fcc79d6e07ec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019e9007-3e4c-79c6-b374-ea1f04206da6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7437-87b7-fcc79d6e07ec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019e9007-3e4c-79c6-b374-ea1f04206da6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019e9007-3e4c-71a3-9fce-6ce7ff5cfbae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7437-87b7-fcc79d6e07ec" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019e9007-3e4c-71a3-9fce-6ce7ff5cfbae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b99-a71b-7ece2e25f3ea" xlink:href="naut-20260630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e9007-3e4c-7070-90e1-14a344f34986" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b99-a71b-7ece2e25f3ea" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e9007-3e4c-7070-90e1-14a344f34986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedResearchAndDevelopmentCurrent_019e9007-3e4c-72d8-a6c4-ec7c340b9b88" xlink:href="naut-20260630.xsd#naut_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b99-a71b-7ece2e25f3ea" xlink:to="loc_naut_AccruedResearchAndDevelopmentCurrent_019e9007-3e4c-72d8-a6c4-ec7c340b9b88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019e9007-3e4c-7529-ac42-1f29e7aaffc1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b99-a71b-7ece2e25f3ea" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019e9007-3e4c-7529-ac42-1f29e7aaffc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantLiabilitiesCurrent_019e9007-3e4c-7086-9e31-64c6a4cdc3ca" xlink:href="naut-20260630.xsd#naut_GrantLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b99-a71b-7ece2e25f3ea" xlink:to="loc_naut_GrantLiabilitiesCurrent_019e9007-3e4c-7086-9e31-64c6a4cdc3ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_019f609d-4c64-7243-86bc-71e9a7bb1b49" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7b99-a71b-7ece2e25f3ea" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_019f609d-4c64-7243-86bc-71e9a7bb1b49" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-75d6-acfa-9dd123bebbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_019e9007-3e4c-7dbb-9496-7b07e7fea6f1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-75d6-acfa-9dd123bebbb5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_019e9007-3e4c-7dbb-9496-7b07e7fea6f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-7b53-aa08-05715e2f994a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-75d6-acfa-9dd123bebbb5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-7b53-aa08-05715e2f994a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3e4c-7380-b571-7cd46d9348ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4c-7a69-a87d-c6263d447d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3e4c-7380-b571-7cd46d9348ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4c-7a69-a87d-c6263d447d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4c-75ae-978d-4d50f329a283" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3e4c-7380-b571-7cd46d9348ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4c-75ae-978d-4d50f329a283" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-7f46-a3a9-db4c42c3d4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e9007-3e4d-7afc-98d3-3d424f4769e9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-7f46-a3a9-db4c42c3d4a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e9007-3e4d-7afc-98d3-3d424f4769e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019e9007-3e4d-7584-8a1d-6a74eff3722a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-7f46-a3a9-db4c42c3d4a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019e9007-3e4d-7584-8a1d-6a74eff3722a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e9007-3e4d-7bda-8c0d-9b1a16be2691" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-7f46-a3a9-db4c42c3d4a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e9007-3e4d-7bda-8c0d-9b1a16be2691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_019e9007-3e4d-7d1f-bfbc-c6904e1a4674" xlink:href="naut-20260630.xsd#naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-7f46-a3a9-db4c42c3d4a7" xlink:to="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_019e9007-3e4d-7d1f-bfbc-c6904e1a4674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e9007-3e4d-7484-a30b-8e61b6953b52" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-7f46-a3a9-db4c42c3d4a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e9007-3e4d-7484-a30b-8e61b6953b52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e9007-3e4d-7321-8f1b-023de7c2647c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-7f46-a3a9-db4c42c3d4a7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e9007-3e4d-7321-8f1b-023de7c2647c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="naut-20260630.xsd#CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-750a-b2f9-2ac35d52dfda" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e9007-3e4d-70d1-a385-b70222daa45b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-750a-b2f9-2ac35d52dfda" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e9007-3e4d-70d1-a385-b70222daa45b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019e9007-3e4d-7e99-9d72-cbcaa513e70d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-750a-b2f9-2ac35d52dfda" xlink:to="loc_us-gaap_OperatingLeaseLiability_019e9007-3e4d-7e99-9d72-cbcaa513e70d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SegmentInformationDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e9007-3e4d-716e-99e8-bd54dd03666c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019e9007-3e4d-7a67-931d-eee2ea66eaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e9007-3e4d-716e-99e8-bd54dd03666c" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019e9007-3e4d-7a67-931d-eee2ea66eaa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProfessionalServicesAndLaboratoryExpenses_019e9007-3e4d-74fc-9289-4316bb6faabc" xlink:href="naut-20260630.xsd#naut_ProfessionalServicesAndLaboratoryExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e9007-3e4d-716e-99e8-bd54dd03666c" xlink:to="loc_naut_ProfessionalServicesAndLaboratoryExpenses_019e9007-3e4d-74fc-9289-4316bb6faabc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FacilityExpenses_019e9007-3e4d-7e9d-b993-abb0940833df" xlink:href="naut-20260630.xsd#naut_FacilityExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e9007-3e4d-716e-99e8-bd54dd03666c" xlink:to="loc_naut_FacilityExpenses_019e9007-3e4d-7e9d-b993-abb0940833df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e9007-3e4d-737e-90be-cd1c7c57766e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e9007-3e4d-716e-99e8-bd54dd03666c" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e9007-3e4d-737e-90be-cd1c7c57766e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019e9007-3e4d-7390-9d44-07e2bf23962b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e9007-3e4d-716e-99e8-bd54dd03666c" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019e9007-3e4d-7390-9d44-07e2bf23962b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019f8c51-b93f-7d98-8dad-42d49e3b3249" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019f8c51-b93f-701e-b2a5-c154d541f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f8c51-b93f-7d98-8dad-42d49e3b3249" xlink:to="loc_us-gaap_Revenues_019f8c51-b93f-701e-b2a5-c154d541f97f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019f8c51-b93f-79af-ae7b-c832eec6d179" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f8c51-b93f-7d98-8dad-42d49e3b3249" xlink:to="loc_us-gaap_CostOfRevenue_019f8c51-b93f-79af-ae7b-c832eec6d179" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019f8c51-b93f-7c7b-a0c1-30df43bed805" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f8c51-b93f-7d98-8dad-42d49e3b3249" xlink:to="loc_us-gaap_OperatingExpenses_019f8c51-b93f-7c7b-a0c1-30df43bed805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019f8c51-b93f-7179-813e-45fde1e45be2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f8c51-b93f-7d98-8dad-42d49e3b3249" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019f8c51-b93f-7179-813e-45fde1e45be2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019f8c51-b93f-75b5-99c1-9295b262cca0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019f8c51-b93f-7d98-8dad-42d49e3b3249" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019f8c51-b93f-75b5-99c1-9295b262cca0" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>naut-20260630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e9007-3d81-7923-8b9d-11e8abe8f7df,g:a24f2a1f-f751-4ff8-9f53-5ed913cc112d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019ea618-41fc-741d-80ce-cbf4165cc026" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_StatementTable_019ea618-41fc-741d-80ce-cbf4165cc026" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019ea618-41fc-76b1-822a-a48d552b3bb9" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019ea618-41fc-741d-80ce-cbf4165cc026" xlink:to="loc_srt_ProductOrServiceAxis_019ea618-41fc-76b1-822a-a48d552b3bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019ea618-41fc-76b1-822a-a48d552b3bb9_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019ea618-41fc-76b1-822a-a48d552b3bb9" xlink:to="loc_srt_ProductsAndServicesDomain_019ea618-41fc-76b1-822a-a48d552b3bb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019ea618-41fc-76b1-822a-a48d552b3bb9" xlink:to="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantRevenueMember_019ea619-3327-7911-bad2-167a7458bf76" xlink:href="naut-20260630.xsd#naut_GrantRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:to="loc_naut_GrantRevenueMember_019ea619-3327-7911-bad2-167a7458bf76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ServiceRevenueMember_019ea619-7c1d-78dc-9096-cdd18790a11a" xlink:href="naut-20260630.xsd#naut_ServiceRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:to="loc_naut_ServiceRevenueMember_019ea619-7c1d-78dc-9096-cdd18790a11a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019ea617-34b6-7671-abe5-9bbff3b0fe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_RevenuesAbstract_019ea617-34b6-7671-abe5-9bbff3b0fe5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019ea617-89bb-7c3c-b45e-4bda2edcf406" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_019ea617-34b6-7671-abe5-9bbff3b0fe5b" xlink:to="loc_us-gaap_Revenues_019ea617-89bb-7c3c-b45e-4bda2edcf406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_019ea619-f76b-7000-9c6d-119dd5a9d1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_CostOfRevenueAbstract_019ea619-f76b-7000-9c6d-119dd5a9d1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019ea61a-80f8-71b1-acdc-4886d79d3799" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019ea619-f76b-7000-9c6d-119dd5a9d1cf" xlink:to="loc_us-gaap_CostOfRevenue_019ea61a-80f8-71b1-acdc-4886d79d3799" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e9007-3e4c-71d9-bcc2-6294dd9b2a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e9007-3e4c-71d9-bcc2-6294dd9b2a8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e9007-3e4c-7735-83c6-edda023df1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e9007-3e4c-7735-83c6-edda023df1dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e9007-3e4c-7f98-8233-3a4805d4adf0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:to="loc_us-gaap_OperatingExpenses_019e9007-3e4c-7f98-8233-3a4805d4adf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019e9007-3e4c-7406-8343-7bce7eb03f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019e9007-3e4c-7406-8343-7bce7eb03f3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e9007-3e4c-7fe5-8f9b-c89dee80ec79" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e9007-3e4c-7fe5-8f9b-c89dee80ec79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e9007-3e4c-7cd1-badc-8f693be75af6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019e9007-3e4c-7cd1-badc-8f693be75af6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7343-9b7c-c122742f9901" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7343-9b7c-c122742f9901" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019e9007-3e4c-7759-b145-67d6bf3ede33" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_EarningsPerShareBasic_019e9007-3e4c-7759-b145-67d6bf3ede33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019e9007-3e4c-7859-ab8a-51138b762944" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019e9007-3e4c-7859-ab8a-51138b762944" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3e4c-7a2e-b5f8-6794f04add45" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3e4c-7a2e-b5f8-6794f04add45" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3e4c-7796-861c-539e9547227c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3e4c-7796-861c-539e9547227c" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e9007-3e4c-7a1e-b230-1132815cd726" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e9007-3e4c-717c-a3a7-51626a99d45a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_019e9007-3e4c-7a1e-b230-1132815cd726" xlink:to="loc_us-gaap_StatementTable_019e9007-3e4c-717c-a3a7-51626a99d45a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e9007-3e4c-7d6b-be81-ffe112a6420c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_019e9007-3e4c-717c-a3a7-51626a99d45a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e9007-3e4c-7d6b-be81-ffe112a6420c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7d6b-be81-ffe112a6420c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e9007-3e4c-7d6b-be81-ffe112a6420c" xlink:to="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7d6b-be81-ffe112a6420c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e9007-3e4c-7d6b-be81-ffe112a6420c" xlink:to="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e9007-3e4c-7957-83ca-7ef7da623810" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_CommonStockMember_019e9007-3e4c-7957-83ca-7ef7da623810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019e9007-3e4c-710f-a5f4-a143216bcd17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019e9007-3e4c-710f-a5f4-a143216bcd17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019e9007-3e4c-7b6f-8ab2-e88bf318c44d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019e9007-3e4c-7b6f-8ab2-e88bf318c44d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019e9007-3e4c-7257-9546-2013fdbf56fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_RetainedEarningsMember_019e9007-3e4c-7257-9546-2013fdbf56fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_019e9007-3e4c-7a1e-b230-1132815cd726" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7a53-96c2-b66a9f20a32a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7a53-96c2-b66a9f20a32a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e9007-3e4c-708c-98c2-ff21467f0a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockholdersEquity_019e9007-3e4c-708c-98c2-ff21467f0a1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3e4c-78b6-9a27-fd80b7681368" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3e4c-78b6-9a27-fd80b7681368" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e9007-3e4c-7ca7-978e-41d7ce5a00b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e9007-3e4c-7ca7-978e-41d7ce5a00b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019ea690-8f67-7811-9aa0-6b157d2c1304" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019ea690-8f67-7811-9aa0-6b157d2c1304" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019ea690-8f67-77ab-87d8-e100de92f983" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019ea690-8f67-77ab-87d8-e100de92f983" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e9007-3e4c-7060-94d6-35c36e4c6154" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e9007-3e4c-7060-94d6-35c36e4c6154" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-71d6-8003-7bbc4cd05cef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-71d6-8003-7bbc4cd05cef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7d35-bbba-2006659bb610" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7d35-bbba-2006659bb610" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7d86-b245-942ecbf53371" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7e2c-942c-805aa9301a25" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#DescriptionofBusinessandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3e4c-74f4-9a3b-9d8768419b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3e4c-74f4-9a3b-9d8768419b5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3e4c-73e5-b846-14a3d455c579" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3e4c-74f4-9a3b-9d8768419b5b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3e4c-73e5-b846-14a3d455c579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-73e5-b846-14a3d455c579_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3e4c-73e5-b846-14a3d455c579" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-73e5-b846-14a3d455c579_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-79e4-a9a7-d510521870b4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3e4c-73e5-b846-14a3d455c579" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-79e4-a9a7-d510521870b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019e9007-3e4c-7037-97b9-0982dff1c978" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-79e4-a9a7-d510521870b4" xlink:to="loc_us-gaap_PrivatePlacementMember_019e9007-3e4c-7037-97b9-0982dff1c978" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e9007-3e4c-7e0d-aa1b-06e0eaf55338" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e9007-3e4c-7e0d-aa1b-06e0eaf55338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019e9007-3e4c-77f8-a58d-a9cb88fdb552" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019e9007-3e4c-77f8-a58d-a9cb88fdb552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e9007-3e4c-772d-8cfb-da83c3df6a95" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e9007-3e4c-772d-8cfb-da83c3df6a95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-7c10-9464-e06e29aa59a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-7c10-9464-e06e29aa59a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_019e9007-3e4c-70de-8792-9bd5515d7f0e" xlink:href="naut-20260630.xsd#naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_019e9007-3e4c-70de-8792-9bd5515d7f0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_019e9007-3e4c-7d06-82af-342525d6a71a" xlink:href="naut-20260630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_019e9007-3e4c-7d06-82af-342525d6a71a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_019e9007-3e4c-73db-a554-12bf45edce3a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_019e9007-3e4c-73db-a554-12bf45edce3a" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#SignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:to="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7450-906a-5eaa258b4d6d_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:to="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7450-906a-5eaa258b4d6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:to="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantRevenueMember_019f883a-fb9e-7347-858a-d94b02a69d4a" xlink:href="naut-20260630.xsd#naut_GrantRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:to="loc_naut_GrantRevenueMember_019f883a-fb9e-7347-858a-d94b02a69d4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019f883a-fb9e-7f74-a709-4dedf5ce4fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019f883a-fb9e-7f74-a709-4dedf5ce4fdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019f883a-fb9e-7cfe-9d9a-1aae104098dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019f883a-fb9e-7cfe-9d9a-1aae104098dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019f883a-fb9e-730d-81bf-b7257c29216b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_NumberOfReportableSegments_019f883a-fb9e-730d-81bf-b7257c29216b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019f883a-fb9e-792a-b1bd-4499ae8ad37e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_Revenues_019f883a-fb9e-792a-b1bd-4499ae8ad37e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantLiabilityCurrent_019f883a-fb9e-764c-b57c-1802581c4905" xlink:href="naut-20260630.xsd#naut_GrantLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_naut_GrantLiabilityCurrent_019f883a-fb9e-764c-b57c-1802581c4905" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019f8bb8-d30e-765e-a83e-46a0d2a68c40" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019f8bb8-d30e-765e-a83e-46a0d2a68c40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_019f8bb8-d30e-7989-a459-9ca728805763" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_019f8bb8-d30e-7989-a459-9ca728805763" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019f8bb8-d30e-7264-b278-5e3446d6baff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019f8bb8-d30e-7264-b278-5e3446d6baff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_019f883b-39c2-750c-85b6-1cb42c0cab9a" xlink:href="naut-20260630.xsd#naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_019f883b-39c2-750c-85b6-1cb42c0cab9a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019f883b-39c2-7545-878b-cbfa319c7b46" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_InventoryNet_019f883b-39c2-7545-878b-cbfa319c7b46" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails_1" xlink:type="simple" xlink:href="naut-20260630.xsd#SignificantAccountingPoliciesDetails_1"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:to="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7450-906a-5eaa258b4d6d_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:to="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7450-906a-5eaa258b4d6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:to="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantRevenueMember_019f883a-fb9e-7347-858a-d94b02a69d4a" xlink:href="naut-20260630.xsd#naut_GrantRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:to="loc_naut_GrantRevenueMember_019f883a-fb9e-7347-858a-d94b02a69d4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019f883a-fb9e-7cfe-9d9a-1aae104098dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019f883a-fb9e-7cfe-9d9a-1aae104098dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019f883a-fb9e-730d-81bf-b7257c29216b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_NumberOfReportableSegments_019f883a-fb9e-730d-81bf-b7257c29216b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019f883a-fb9e-792a-b1bd-4499ae8ad37e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_Revenues_019f883a-fb9e-792a-b1bd-4499ae8ad37e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantLiabilityCurrent_019f883a-fb9e-764c-b57c-1802581c4905" xlink:href="naut-20260630.xsd#naut_GrantLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_naut_GrantLiabilityCurrent_019f883a-fb9e-764c-b57c-1802581c4905" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019f8bb8-d30e-765e-a83e-46a0d2a68c40" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019f8bb8-d30e-765e-a83e-46a0d2a68c40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_019f8bb8-d30e-7989-a459-9ca728805763" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_019f8bb8-d30e-7989-a459-9ca728805763" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019f8bb8-d30e-7264-b278-5e3446d6baff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019f8bb8-d30e-7264-b278-5e3446d6baff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_019f883b-39c2-750c-85b6-1cb42c0cab9a" xlink:href="naut-20260630.xsd#naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_019f883b-39c2-750c-85b6-1cb42c0cab9a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019f883b-39c2-7545-878b-cbfa319c7b46" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_InventoryNet_019f883b-39c2-7545-878b-cbfa319c7b46" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-7fbc-9fb7-f165a681929f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-7fbc-9fb7-f165a681929f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019e9007-3e4c-7844-b20a-60eb500acc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019e9007-3e4c-7844-b20a-60eb500acc9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019e9007-3e4c-7877-9730-da9b562cd8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019e9007-3e4c-7877-9730-da9b562cd8ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7751-8ad1-a8a77d67dede_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7751-8ad1-a8a77d67dede_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_019e9007-3e4c-7038-bd71-2aaee5cce76c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_MutualFundMember_019e9007-3e4c-7038-bd71-2aaee5cce76c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-798a-bbf6-0e1ee8ce8cab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-798a-bbf6-0e1ee8ce8cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-7f13-a7a6-c9717ea0e81c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-7f13-a7a6-c9717ea0e81c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-765f-ba48-259bebb69977" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-765f-ba48-259bebb69977" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-733e-a3a8-c55f05d27520" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-733e-a3a8-c55f05d27520" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e9007-3e4c-7367-823d-1f23712a0fec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e9007-3e4c-7367-823d-1f23712a0fec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-78b4-8db7-fab02b012287" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-78b4-8db7-fab02b012287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7840-b847-d80710e7bfed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7840-b847-d80710e7bfed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7eeb-a3d1-6c6ae4a02ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7eeb-a3d1-6c6ae4a02ab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7168-a11f-920660eb599a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7168-a11f-920660eb599a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails_1" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails_1"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-7fbc-9fb7-f165a681929f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-7fbc-9fb7-f165a681929f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019e9007-3e4c-7844-b20a-60eb500acc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019e9007-3e4c-7844-b20a-60eb500acc9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019e9007-3e4c-7877-9730-da9b562cd8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019e9007-3e4c-7877-9730-da9b562cd8ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7751-8ad1-a8a77d67dede_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7751-8ad1-a8a77d67dede_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_019e9007-3e4c-7038-bd71-2aaee5cce76c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_MutualFundMember_019e9007-3e4c-7038-bd71-2aaee5cce76c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-798a-bbf6-0e1ee8ce8cab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-798a-bbf6-0e1ee8ce8cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-7f13-a7a6-c9717ea0e81c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-7f13-a7a6-c9717ea0e81c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-765f-ba48-259bebb69977" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-765f-ba48-259bebb69977" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-733e-a3a8-c55f05d27520" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-733e-a3a8-c55f05d27520" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-78b4-8db7-fab02b012287" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-78b4-8db7-fab02b012287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7840-b847-d80710e7bfed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7840-b847-d80710e7bfed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7eeb-a3d1-6c6ae4a02ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7eeb-a3d1-6c6ae4a02ab6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7168-a11f-920660eb599a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7168-a11f-920660eb599a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-79f2-b7d4-1c3ca0618b43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-79f2-b7d4-1c3ca0618b43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-71ec-a358-6bca4efacc11" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-79f2-b7d4-1c3ca0618b43" xlink:to="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-71ec-a358-6bca4efacc11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-71ec-a358-6bca4efacc11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-71ec-a358-6bca4efacc11" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-71ec-a358-6bca4efacc11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-71ec-a358-6bca4efacc11" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-705d-bcf3-0567342458ce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-705d-bcf3-0567342458ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-737b-b186-4ebe700d0a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-737b-b186-4ebe700d0a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-7356-b5fd-189a50aa8686" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-7356-b5fd-189a50aa8686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-71bd-a8b2-7a940fff9b85" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-71bd-a8b2-7a940fff9b85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e9007-3e4c-78a4-bcb2-fa52eae72785" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e9007-3e4c-78a4-bcb2-fa52eae72785" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e9007-3e4c-7251-be17-cc713aa6f88b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e9007-3e4c-7251-be17-cc713aa6f88b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3e4c-7eb1-aeba-440665aa469a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3e4c-7eb1-aeba-440665aa469a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:href="naut-20260630.xsd#naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:to="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e9007-3e4c-72ad-8960-1cda2b814acb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e9007-3e4c-72ad-8960-1cda2b814acb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e9007-3e4c-7ef1-9732-cd7ba931fe8d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e9007-3e4c-7ef1-9732-cd7ba931fe8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3e4c-7d6e-8bc5-59d5e8fda356" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3e4c-7d6e-8bc5-59d5e8fda356" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3e4c-7964-9d12-5f8e31c5aa88" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3e4c-7964-9d12-5f8e31c5aa88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3e4c-7713-942e-32a5e3c1545d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3e4c-7964-9d12-5f8e31c5aa88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3e4c-7713-942e-32a5e3c1545d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-7713-942e-32a5e3c1545d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3e4c-7713-942e-32a5e3c1545d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-7713-942e-32a5e3c1545d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3e4c-7713-942e-32a5e3c1545d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LaboratoryEquipmentMember_019e9007-3e4c-7546-9b8d-f710181b0884" xlink:href="naut-20260630.xsd#naut_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_naut_LaboratoryEquipmentMember_019e9007-3e4c-7546-9b8d-f710181b0884" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019e9007-3e4c-76a9-ad10-41dfd08cb293" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019e9007-3e4c-76a9-ad10-41dfd08cb293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_019e9007-3e4c-703c-9213-57c02f87b483" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_us-gaap_ComputerEquipmentMember_019e9007-3e4c-703c-9213-57c02f87b483" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_019e9007-3e4c-7b79-88ad-6a508e975771" xlink:href="naut-20260630.xsd#naut_FurnitureFixturesAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_019e9007-3e4c-7b79-88ad-6a508e975771" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PrototypeEquipmentMember_019e9007-3e4c-752d-92db-2b64f82c6e7c" xlink:href="naut-20260630.xsd#naut_PrototypeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_naut_PrototypeEquipmentMember_019e9007-3e4c-752d-92db-2b64f82c6e7c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_019e9007-3e4c-7dfb-ac3c-7866eaf6577c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_us-gaap_ConstructionInProgressMember_019e9007-3e4c-7dfb-ac3c-7866eaf6577c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019e9007-3e4c-7eb2-81a6-8d3a72767966" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019e9007-3e4c-7eb2-81a6-8d3a72767966" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019e9007-3e4c-78a5-adee-9295c6c6996b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019e9007-3e4c-78a5-adee-9295c6c6996b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7314-a385-b4aa5d01cfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7314-a385-b4aa5d01cfc2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019e9007-3e4c-7d85-a69c-e135985a9605" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019e9007-3e4c-7d85-a69c-e135985a9605" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019e9007-3e4c-76f7-8e7d-b33b25f2431e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019e9007-3e4c-7d85-a69c-e135985a9605" xlink:to="loc_us-gaap_PlanNameAxis_019e9007-3e4c-76f7-8e7d-b33b25f2431e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-76f7-8e7d-b33b25f2431e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-76f7-8e7d-b33b25f2431e" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-76f7-8e7d-b33b25f2431e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-76f7-8e7d-b33b25f2431e" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-75b1-b0f4-4d07bbb729c0" xlink:href="naut-20260630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:to="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-75b1-b0f4-4d07bbb729c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-7128-897e-178800990ab5" xlink:href="naut-20260630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-7128-897e-178800990ab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4c-779e-bf40-b7a89ae33c55" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4c-779e-bf40-b7a89ae33c55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4c-789b-ba3c-9bc5684b34c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4c-789b-ba3c-9bc5684b34c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3e4c-7575-a406-5e31f249ba51" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3e4c-7575-a406-5e31f249ba51" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-7ebc-9227-78d3f8989055_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-7ebc-9227-78d3f8989055_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-7532-bbb2-1af6713c8e74" xlink:href="naut-20260630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:to="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-7532-bbb2-1af6713c8e74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-74e2-9ce0-134c9561929f" xlink:href="naut-20260630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-74e2-9ce0-134c9561929f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-78e4-833d-aba9e10082f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-78e4-833d-aba9e10082f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019e9007-3e4d-775c-9bbb-9d9dd37ae643" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:to="loc_us-gaap_EmployeeStockMember_019e9007-3e4d-775c-9bbb-9d9dd37ae643" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ad2-a36a-02004c6bf24c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ad2-a36a-02004c6bf24c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019f8830-1c98-7076-8c13-88b8bf069392" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019f8830-1c98-7076-8c13-88b8bf069392" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4d-7115-bb01-0d59ee99dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4d-7115-bb01-0d59ee99dfeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019e9007-3e4d-731c-b37f-2645bbe96c28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019e9007-3e4d-731c-b37f-2645bbe96c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019e9007-3e4d-7837-9bc7-220d105974c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019e9007-3e4d-7837-9bc7-220d105974c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_019e9007-3e4d-7356-a680-8d36eade89b9" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_019e9007-3e4d-7356-a680-8d36eade89b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_019e9007-3e4d-744f-8969-0fa7b0802e94" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_019e9007-3e4d-744f-8969-0fa7b0802e94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019e9007-3e4d-7f0a-9865-7a2d2dd3a9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019e9007-3e4d-7f0a-9865-7a2d2dd3a9ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_019e9007-3e4d-7eb3-a5d1-58627a68878f" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_019e9007-3e4d-7eb3-a5d1-58627a68878f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019e9007-3e4d-7b18-926b-76ccaa916472" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019e9007-3e4d-7b18-926b-76ccaa916472" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7e1d-bd5d-5cb835894b87" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7e1d-bd5d-5cb835894b87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_019e9007-3e4d-76ed-b805-9bf0c923698b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_019e9007-3e4d-76ed-b805-9bf0c923698b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019e9007-3e4d-7024-b9b6-9450ae9aa685" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019e9007-3e4d-7024-b9b6-9450ae9aa685" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019f8830-1c98-74f8-a2c4-35e91c964abb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019f8830-1c98-74f8-a2c4-35e91c964abb" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails_1" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-7ebc-9227-78d3f8989055_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-7ebc-9227-78d3f8989055_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-7532-bbb2-1af6713c8e74" xlink:href="naut-20260630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:to="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-7532-bbb2-1af6713c8e74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-74e2-9ce0-134c9561929f" xlink:href="naut-20260630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-74e2-9ce0-134c9561929f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-78e4-833d-aba9e10082f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-78e4-833d-aba9e10082f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019e9007-3e4d-775c-9bbb-9d9dd37ae643" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:to="loc_us-gaap_EmployeeStockMember_019e9007-3e4d-775c-9bbb-9d9dd37ae643" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ad2-a36a-02004c6bf24c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ad2-a36a-02004c6bf24c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4d-7115-bb01-0d59ee99dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4d-7115-bb01-0d59ee99dfeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019e9007-3e4d-731c-b37f-2645bbe96c28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019e9007-3e4d-731c-b37f-2645bbe96c28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019e9007-3e4d-7837-9bc7-220d105974c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019e9007-3e4d-7837-9bc7-220d105974c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_019e9007-3e4d-7356-a680-8d36eade89b9" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_019e9007-3e4d-7356-a680-8d36eade89b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_019e9007-3e4d-744f-8969-0fa7b0802e94" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_019e9007-3e4d-744f-8969-0fa7b0802e94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019e9007-3e4d-7f0a-9865-7a2d2dd3a9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019e9007-3e4d-7f0a-9865-7a2d2dd3a9ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_019e9007-3e4d-7eb3-a5d1-58627a68878f" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_019e9007-3e4d-7eb3-a5d1-58627a68878f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019e9007-3e4d-7b18-926b-76ccaa916472" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019e9007-3e4d-7b18-926b-76ccaa916472" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7e1d-bd5d-5cb835894b87" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7e1d-bd5d-5cb835894b87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_019e9007-3e4d-76ed-b805-9bf0c923698b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_019e9007-3e4d-76ed-b805-9bf0c923698b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019e9007-3e4d-7024-b9b6-9450ae9aa685" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019e9007-3e4d-7024-b9b6-9450ae9aa685" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019f8830-1c98-74f8-a2c4-35e91c964abb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019f8830-1c98-74f8-a2c4-35e91c964abb" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-74a1-9ca2-370cc8fe40d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-74a1-9ca2-370cc8fe40d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-74a1-9ca2-370cc8fe40d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-74a1-9ca2-370cc8fe40d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-74a1-9ca2-370cc8fe40d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7e33-a1dd-d48e87c097de" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-74a1-9ca2-370cc8fe40d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7e33-a1dd-d48e87c097de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7d02-85e3-6ad940ccea89" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7e33-a1dd-d48e87c097de" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7d02-85e3-6ad940ccea89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019eaa5c-4910-7879-8b2d-232c0a700124" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:to="loc_srt_RangeAxis_019eaa5c-4910-7879-8b2d-232c0a700124" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019eaa5c-4910-7879-8b2d-232c0a700124_default" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_019eaa5c-4910-7879-8b2d-232c0a700124" xlink:to="loc_srt_RangeMember_019eaa5c-4910-7879-8b2d-232c0a700124_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_019eaa5c-4910-7879-8b2d-232c0a700124" xlink:to="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019eaa5c-a903-700a-93f6-eb09dd3bf661" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:to="loc_srt_MinimumMember_019eaa5c-a903-700a-93f6-eb09dd3bf661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019eaa5d-0b34-7489-97d5-c89bf7a5d1a8" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:to="loc_srt_MaximumMember_019eaa5d-0b34-7489-97d5-c89bf7a5d1a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019e9007-3e4d-7b43-90c8-028640cb7fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019e9007-3e4d-7b43-90c8-028640cb7fe2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019e9007-3e4d-785f-a36f-7f59e330bc00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019e9007-3e4d-785f-a36f-7f59e330bc00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019e9007-3e4d-7226-a271-c4dfebe0fca3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019e9007-3e4d-7226-a271-c4dfebe0fca3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7202-b50a-0196f563c6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7202-b50a-0196f563c6a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019e9007-3e4d-76a3-b955-4adb08007c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019e9007-3e4d-76a3-b955-4adb08007c9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019e9007-3e4d-78f4-bc37-3a5b54a82129" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019e9007-3e4d-78f4-bc37-3a5b54a82129" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7dab-9cdd-f99bde17ed07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7dab-9cdd-f99bde17ed07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7bcd-a3cb-40fa34dcf490" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7bcd-a3cb-40fa34dcf490" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019e9007-3e4d-7d9e-b481-9408bd4a7a12" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:to="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019e9007-3e4d-7d9e-b481-9408bd4a7a12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e9007-3e4d-70bf-a7fc-f62a028d0103" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e9007-3e4d-70bf-a7fc-f62a028d0103" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails_1" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails_1"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7dab-9cdd-f99bde17ed07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7dab-9cdd-f99bde17ed07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7bcd-a3cb-40fa34dcf490" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7bcd-a3cb-40fa34dcf490" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e9007-3e4d-70bf-a7fc-f62a028d0103" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e9007-3e4d-70bf-a7fc-f62a028d0103" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e9007-3e4d-780c-badd-67bf783ec1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3e4d-70c8-99fc-2f6e7db2e7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e9007-3e4d-780c-badd-67bf783ec1fc" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3e4d-70c8-99fc-2f6e7db2e7f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3e4d-7b5d-8cc5-048f4901fae3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3e4d-70c8-99fc-2f6e7db2e7f3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3e4d-7b5d-8cc5-048f4901fae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7b5d-8cc5-048f4901fae3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3e4d-7b5d-8cc5-048f4901fae3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7b5d-8cc5-048f4901fae3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3e4d-7b5d-8cc5-048f4901fae3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ed1-8344-71f09f8b7961" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ed1-8344-71f09f8b7961" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_EmployeeStockPurchasePlanMember_019e9007-3e4d-76bf-8456-2c901ec322ee" xlink:href="naut-20260630.xsd#naut_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:to="loc_naut_EmployeeStockPurchasePlanMember_019e9007-3e4d-76bf-8456-2c901ec322ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e9007-3e4d-7c56-ae97-5fadaabc1e06" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e9007-3e4d-780c-badd-67bf783ec1fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e9007-3e4d-7c56-ae97-5fadaabc1e06" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SegmentInformationDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3e4d-7944-a109-6ff7ab4cd52f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3e4d-7944-a109-6ff7ab4cd52f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019e9007-3e4d-7945-a606-a7c8b0405360" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3e4d-7944-a109-6ff7ab4cd52f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019e9007-3e4d-7945-a606-a7c8b0405360" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019e9007-3e4d-7945-a606-a7c8b0405360_default" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019e9007-3e4d-7945-a606-a7c8b0405360" xlink:to="loc_us-gaap_SegmentDomain_019e9007-3e4d-7945-a606-a7c8b0405360_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019e9007-3e4d-77eb-be8d-405580e0dfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019e9007-3e4d-7945-a606-a7c8b0405360" xlink:to="loc_us-gaap_SegmentDomain_019e9007-3e4d-77eb-be8d-405580e0dfc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReportableSegmentMember_019e9007-3e4d-7142-b7f4-e8f3dcedea16" xlink:href="naut-20260630.xsd#naut_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_019e9007-3e4d-77eb-be8d-405580e0dfc5" xlink:to="loc_naut_ReportableSegmentMember_019e9007-3e4d-7142-b7f4-e8f3dcedea16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019f7dd2-4751-7876-81a0-88fb551b3bea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_Revenues_019f7dd2-4751-7876-81a0-88fb551b3bea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019eaa6a-432b-7d62-9c19-9d249ce5335e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_CostOfRevenue_019eaa6a-432b-7d62-9c19-9d249ce5335e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019e9007-3e4d-7cae-a86b-1652286f27c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019e9007-3e4d-7cae-a86b-1652286f27c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProfessionalServicesAndLaboratoryExpenses_019e9007-3e4d-7434-b588-77899fd744d6" xlink:href="naut-20260630.xsd#naut_ProfessionalServicesAndLaboratoryExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_naut_ProfessionalServicesAndLaboratoryExpenses_019e9007-3e4d-7434-b588-77899fd744d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FacilityExpenses_019e9007-3e4d-7922-99d8-c23eaebb6f87" xlink:href="naut-20260630.xsd#naut_FacilityExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_naut_FacilityExpenses_019e9007-3e4d-7922-99d8-c23eaebb6f87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e9007-3e4d-7fb7-ac3f-d9f2150621e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e9007-3e4d-7fb7-ac3f-d9f2150621e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019e9007-3e4d-7a9e-a414-516cb2322dce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019e9007-3e4d-7a9e-a414-516cb2322dce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e9007-3e4d-7e06-9810-60b99bdc86a4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_OperatingExpenses_019e9007-3e4d-7e06-9810-60b99bdc86a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019f7dd0-b164-7d18-bc30-5d9507f081c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019f7dd0-b164-7d18-bc30-5d9507f081c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019f8c4f-19c3-7fbf-bd73-d889f184c438" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019f8c4f-19c3-7fbf-bd73-d889f184c438" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019f7dd0-b164-7b79-a02c-05611fcf2493" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:to="loc_us-gaap_NetIncomeLoss_019f7dd0-b164-7b79-a02c-05611fcf2493" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019e9007-3e4d-7253-bf6f-02489337752f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_NumberOfReportableSegments_019e9007-3e4d-7253-bf6f-02489337752f" xlink:type="arc" order="4"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>naut-20260630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e9007-3d81-7923-8b9d-11e8abe8f7df,g:a24f2a1f-f751-4ff8-9f53-5ed913cc112d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_019e9007-3f10-72cc-9d50-a39a2e932028_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_019eaa5c-4910-7d4a-b4b1-e7a24187a34e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_GrantRevenueMember_019ea619-3327-7147-abd1-05eeaf7b283e_terseLabel_en-US" xlink:label="lab_naut_GrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant revenue</link:label>
    <link:label id="lab_naut_GrantRevenueMember_label_en-US" xlink:label="lab_naut_GrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant Revenue [Member]</link:label>
    <link:label id="lab_naut_GrantRevenueMember_documentation_en-US" xlink:label="lab_naut_GrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantRevenueMember" xlink:href="naut-20260630.xsd#naut_GrantRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_GrantRevenueMember" xlink:to="lab_naut_GrantRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019e9007-3f0f-7b1a-830d-b40f3985b7d2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019e9007-3f10-7c73-96ea-e4d2a1427bd9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss attributable to common stockholders, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019e9007-3f0f-7695-9e04-ca21358e0c31_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_019e9007-3f10-7c74-bf5c-c7a84d469bac_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_019e9007-3f10-704d-a7b2-648c86b09afa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_019e9007-3f10-7f14-a4a4-a65d8099d311_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.0001 par value, 1,000,000,000 shares authorized as of June&#160;30, 2026 and December&#160;31, 2025; 127,224,640 and 126,469,610 shares issued and outstanding as of June&#160;30, 2026 and December&#160;31, 2025, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e9007-3f10-7944-a9ed-e7e4a3c1b179_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e9007-3f10-7e4a-b43f-6151b55e8f35_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ProfessionalServicesAndLaboratoryExpenses_019e9007-3f0f-74fc-9792-8b534139b698_terseLabel_en-US" xlink:label="lab_naut_ProfessionalServicesAndLaboratoryExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional services and laboratory expenses</link:label>
    <link:label id="lab_naut_ProfessionalServicesAndLaboratoryExpenses_label_en-US" xlink:label="lab_naut_ProfessionalServicesAndLaboratoryExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Services And Laboratory Expenses</link:label>
    <link:label id="lab_naut_ProfessionalServicesAndLaboratoryExpenses_documentation_en-US" xlink:label="lab_naut_ProfessionalServicesAndLaboratoryExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Professional services and laboratory expense includes costs for support services related to contracted projects, outsourced management, technical support, and the cost of consumable lab supplies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProfessionalServicesAndLaboratoryExpenses" xlink:href="naut-20260630.xsd#naut_ProfessionalServicesAndLaboratoryExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ProfessionalServicesAndLaboratoryExpenses" xlink:to="lab_naut_ProfessionalServicesAndLaboratoryExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019e9007-3f10-7746-a2ed-8c2fdc1ece8b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019e9007-3f10-7d22-9877-1ec4b04a9a86_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_019e9007-3f0f-7d43-aa32-8397e0d49b6a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_019e9007-3f10-7e39-a0be-dfca934a164e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019e9007-3f10-7a93-9180-d0168e613a28_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_019e9007-3f0f-706d-8a2d-319d48d4bb72_terseLabel_en-US" xlink:label="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of stock and reverse recapitalization transaction</link:label>
    <link:label id="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_label_en-US" xlink:label="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Sale Of Stock And Reverse Recapitalization Transaction</link:label>
    <link:label id="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_documentation_en-US" xlink:label="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Sale Of Stock And Reverse Recapitalization Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:href="naut-20260630.xsd#naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:to="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_A2021EquityIncentivePlanMember_019e9007-3f10-7d13-8cf1-4d239a61216e_terseLabel_en-US" xlink:label="lab_naut_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant under 2021 Equity Incentive Plan</link:label>
    <link:label id="lab_naut_A2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_naut_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_naut_A2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_naut_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember" xlink:href="naut-20260630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_A2021EquityIncentivePlanMember" xlink:to="lab_naut_A2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3f10-7d0e-b887-97c4c599090c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_019e9007-3f10-7406-8493-1608ba02cdb2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019e9007-3f10-76a7-9f89-543550fd9180_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019e9007-3f10-736a-94c7-3db40247a294_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019e9007-3f10-7647-86fa-694b789b5eef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3f10-7284-a4f8-ed464a9c6c17_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019e9007-3f10-7f45-942a-e84f5e52e860_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3f10-70d5-bb7a-ea0c38dd0849_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_019e9007-3f10-761b-8abd-8857580f4963_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_019e9007-3f10-78c6-9009-60379fc30201_terseLabel_en-US" xlink:label="lab_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory for long-term contracts or programs, research and development expense, included in inventory</link:label>
    <link:label id="lab_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_label_en-US" xlink:label="lab_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory For Long-Term Contracts Or Programs, Research And Development Expense, Included In Inventory</link:label>
    <link:label id="lab_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_documentation_en-US" xlink:label="lab_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory For Long-Term Contracts Or Programs, Research And Development Expense, Included In Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" xlink:href="naut-20260630.xsd#naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" xlink:to="lab_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e9007-3f10-7536-853f-d811b777b8ae_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3f0f-70ab-820c-669a3a54ebed_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3f0f-739b-bc10-adb11528226e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_AccruedResearchAndDevelopmentCurrent_019e9007-3f10-7b3f-88a2-97d1868f1777_terseLabel_en-US" xlink:label="lab_naut_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued research and development</link:label>
    <link:label id="lab_naut_AccruedResearchAndDevelopmentCurrent_label_en-US" xlink:label="lab_naut_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:label id="lab_naut_AccruedResearchAndDevelopmentCurrent_documentation_en-US" xlink:label="lab_naut_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedResearchAndDevelopmentCurrent" xlink:href="naut-20260630.xsd#naut_AccruedResearchAndDevelopmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_AccruedResearchAndDevelopmentCurrent" xlink:to="lab_naut_AccruedResearchAndDevelopmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e9007-3f0f-794f-8d97-f12860726d00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization (accretion) of premiums (discounts) on securities, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_019e9007-3f10-7b71-b865-c6b893f35e48_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_019e9007-3f10-7167-a436-4f939192718e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019e9007-3f10-7cbf-bcbf-b8cc3628eee8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019e9007-3f10-7465-96c6-7c57609db2bf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3f10-7eff-b96b-fd98578e8ce5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3f10-77fe-99ad-1f43b51bc5ca_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019e9007-3f10-731d-9fcd-09f0160cd814_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019e9007-3f10-7b6f-9801-b67f795b7835_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss attributable to common stockholders, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_019e9007-3f10-7a77-ad1b-e6cb18b5a754_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_019e9007-3f0f-7053-a4bb-538c9c62f16b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3f10-7628-9118-a2b75f9fd2b7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019e9007-3f10-79d4-b6df-8702c64c87b3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_EmployeeStockPurchasePlanMember_019e9007-3f10-781f-822d-ce1287f10015_terseLabel_en-US" xlink:label="lab_naut_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_naut_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_naut_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_naut_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_naut_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_EmployeeStockPurchasePlanMember" xlink:href="naut-20260630.xsd#naut_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_EmployeeStockPurchasePlanMember" xlink:to="lab_naut_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019e9007-3f0f-7133-9ace-f860940b67c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Significant Segment Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_019e9007-3f0f-78dd-bdfa-7cd49dabe763_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3f10-7109-ab67-afece61b4c7e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3f10-7d98-b0c4-bd4e1bae1658_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019e9007-3f0f-7da7-9d74-fe2c5dd1f6aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-7ce8-b6fe-9b684252c244_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation to net loss:</link:label>
    <link:label id="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_label_en-US" xlink:label="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:to="lab_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019e9007-3f10-739a-a3bf-b1e4eb296a67_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Principal Contractual Obligations for Operating Lease Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019e9007-3f10-74d7-b20a-14f4063c3876_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e9007-3f0f-76b1-b5d9-c88e64ab5044_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3f10-78bb-baed-d25af81795ea_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_019e9007-3f10-7cf8-b3cc-c9b08885a22b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e9007-3f10-774a-97e4-360451b02eb8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019e9007-3f0f-70f3-9d87-1d08cbaad836_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019e9007-3f10-7491-aa36-3010dc720492_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019e9007-3f10-7765-918e-8996e4b52286_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e9007-3f10-7217-b752-7a78095cd5bc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019e9007-3f10-7c74-8717-5c014cab49d2_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts_019e9007-3f0f-786e-944e-2399ff0d2747_terseLabel_en-US" xlink:label="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of transaction costs</link:label>
    <link:label id="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts_label_en-US" xlink:label="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Of Reverse Recapitalization Transaction Costs</link:label>
    <link:label id="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts_documentation_en-US" xlink:label="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments Of Reverse Recapitalization Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:href="naut-20260630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:to="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_019e9007-3f10-75f2-98dd-e02137fa6f66_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e9007-3f10-7c8c-b97e-987b1f9ff7bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities in Unrealized Loss Position Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_019e9007-3f10-7649-a924-88911c8e5e74_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_019e9007-3f0f-79f9-9822-ed5b807973b1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_019e9007-3f10-79b8-8960-437a8975416a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_019e9007-3f10-7801-9c6a-29d897ba3626_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019e9007-3f0f-7f2c-887e-b96252a2a994_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_019e9007-3f0f-79bd-8dba-cf6121bed74b_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Open purchase commitment to be received through next 12 months</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_019e9007-3f10-700b-99ae-3a3c19cc4fc4_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019e9007-3f10-7640-af22-4fe846ee339b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e9007-3f10-71c9-be56-7421a574af30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_GrantLiabilityCurrent_019f7dca-1dfc-7ecf-b930-b44277975d2a_terseLabel_en-US" xlink:label="lab_naut_GrantLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant liability, current</link:label>
    <link:label id="lab_naut_GrantLiabilityCurrent_label_en-US" xlink:label="lab_naut_GrantLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant Liability, Current</link:label>
    <link:label id="lab_naut_GrantLiabilityCurrent_documentation_en-US" xlink:label="lab_naut_GrantLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grant Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantLiabilityCurrent" xlink:href="naut-20260630.xsd#naut_GrantLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_GrantLiabilityCurrent" xlink:to="lab_naut_GrantLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3f10-7acf-9933-e26dd2fd3026_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e9007-3f0f-7df5-ab34-b43e58ccace0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_019e9007-3f0f-7385-9207-2213b59b8391_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_019e9007-3f10-70e7-a9cc-e71c228eb45c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_019e9007-3f10-79a9-8e7f-2dfbea889ac3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Open purchase commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Purchase Commitment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3f0f-7088-a6b7-c041284e7a72_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3f10-7b91-97a2-a6228867c7da_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3f10-7058-b257-c5c43f5ddd85_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019e9007-3f10-767f-ad16-773ef00ffa70_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_019e9007-3f10-7bb7-9931-d1eca1eec6d1_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_019e9007-3f0f-74a2-a9ef-52a2913abd82_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e9007-3f0f-72b1-bc8c-39f62ae0cf46_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3f10-711c-93ce-175cf58b1c5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_019e9007-3f0f-75e3-9eaa-2aeae8c2e94e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for lease liabilities included in operating activities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_019ea619-f76b-70d6-88c1-8485f08af9cf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_019e9007-3f0f-7282-84cd-873bad25d057_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash-collateralized letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e9007-3f10-7e3f-80cb-09e8c2074422_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_019e9007-3f0f-7c0c-83dd-5fd70f06a81d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019e9007-3f10-78ae-8557-894c8de55772_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3f10-728d-9085-fbe36d939da3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3f10-71d3-8361-a12aaf45b43b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_019e9007-3f10-767f-b598-45d9e7056d89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e9007-3f10-7b26-bb58-d0522ddaf546_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_019e9007-3f10-781e-942e-ca2cf04cdb01_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_019e9007-3f0f-7a2d-bd01-460176b0fb19_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_019e9007-3f0f-7b8a-9981-a35d7f626ed0_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_019e9007-3f0f-7e47-b435-52e586cfd8f6_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3f10-72b2-a9c5-641df4104952_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019e9007-3f10-72b3-b228-64b3176ff023_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019e9007-3f10-7837-9dec-07415895ffb2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_019e9007-3f10-76a4-a7cf-bf0224b2eb91_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019e9007-3f10-7931-924b-b9e18bf9400d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_019e9007-3f10-7f1c-902d-2759c7b1aa06_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019e9007-3f10-7e0c-ad6e-7c5b1d978af6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate, maximum (as percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_019e9007-3f10-7753-9736-d93db5bcf277_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_019e9007-3f10-7c70-a686-738f9fa1a3d7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_019e9007-3f10-79a4-bc26-231fad321a2e_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019e9007-3f10-7fc8-a46f-092f2f75f346_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeLocationBalanceAxis_019e9007-3f10-7757-84db-3442153f8001_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeLocationBalanceAxis_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Location, Statement of Income, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:to="lab_us-gaap_StatementOfIncomeLocationBalanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_019e9007-3f10-7d44-930e-e7ad803b5ecf_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash included in other long-term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019e9007-3f10-77d0-8701-b471079c91d2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3f10-78c7-a5d1-30e03b071a9e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_019e9007-3f10-7b15-bc94-0aad3168f887_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3f10-75b8-a454-54f92f429a6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-7f66-9df2-cd117350493c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e9007-3f10-746a-af9d-e2b07d71ec80_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e9007-3f0f-7d72-ae46-4ea0cf1aab3c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_019e9007-3f10-79f7-a071-b3294cb85c94_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_019e9007-3f10-705d-b389-2f401fa6a6f6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e9007-3f10-7ece-8c8b-f5d0ee6090e3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from maturities of securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_019e9007-3f0f-71b4-9114-6065bea2dc38_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_019e9007-3f0f-7b06-aa83-3d023cdfb0dd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3f10-7e97-8560-cadc993640c7_terseLabel_en-US" xlink:label="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant under 2021 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_naut_A2021EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_naut_A2021EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember" xlink:href="naut-20260630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_A2021EmployeeStockPurchasePlanMember" xlink:to="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_019e9007-3f0f-7b20-ab17-6d2d28e1bba4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e9007-3f10-732e-be58-f384642f8f4e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate gross proceeds</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_019e9007-3f10-7600-9f7e-7a862d416715_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_019e9007-3f10-7aa8-a5de-28c474523968_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019e9007-3f10-7846-a383-36d3347c7e57_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_019e9007-3f10-749c-9dca-7d9459b1bdc5_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_019e9007-3f10-776d-a715-c941a3a15721_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_019e9007-3f0f-71d4-8a36-a61703c51dd5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3f10-7d3d-a0cc-8ab4284fb6ab_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_019e9007-3f10-7be1-8f55-c2c13a7c3262_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_019e9007-3f0f-7cb2-ba51-6eb56b571b06_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3f10-763d-b4fb-f89446f121fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options issued and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3f10-7a3a-813c-f520a70b92c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3f10-773b-a2cc-020eab9b4ef7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_019f8bb8-d30e-7e19-aff9-e3747c23ba7b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, allowance for credit loss, current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e9007-3f10-7123-898d-e5b6bf2888fe_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_019e9007-3f10-74b1-b7c0-98959cf12ae5_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_019e9007-3f10-7245-bf17-19b4ad44ebec_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_019e9007-3f10-7e0a-8fa9-77214c89e972_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Composition of Certain Condensed Consolidated Financial Statement Line Items</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_LaboratoryEquipmentMember_019e9007-3f10-7b10-9c82-cce8ad304b56_terseLabel_en-US" xlink:label="lab_naut_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_naut_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_naut_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_naut_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_naut_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Laboratory Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LaboratoryEquipmentMember" xlink:href="naut-20260630.xsd#naut_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_LaboratoryEquipmentMember" xlink:to="lab_naut_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019e9007-3f10-774c-b3b1-6effc6e5d362_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of outstanding stock maximum (as percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_019e9007-3f10-7746-8df4-69dd2f47fc8a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019e9007-3f0f-7559-a380-637e3c61e466_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e9007-3f10-7d49-915f-b7f68be900d6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total potentially dilutive common share equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_019e9007-3f0f-7a6d-9ac1-172f12fa8f9b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019e9007-3f10-78d8-9427-ed4029c64962_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019e9007-3f0f-71f4-bceb-2e4c891e895e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CIK</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019e9007-3f10-7ac0-bd6c-266743258710_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_019e9007-3f0f-7ab9-a0fc-be141816bed1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3f10-7710-b3f4-446d325fb7d6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_019e9007-3f10-7f8c-8c57-c8023022414d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_019e9007-3f10-7999-9f43-e3916bc9c763_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019e9007-3f0f-75e1-9761-60360781e7c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019e9007-3f0f-75e8-9ac5-5a0641f5b133_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3f10-7756-a665-36e000eda324_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_019e9007-3f10-7570-acad-713175a2c156_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_019e9007-3f10-7844-ba5d-d80648f9fcd5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019e9007-3f10-7a61-8414-45d01a0d9514_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Significant Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3f0f-730f-a785-73066926f888_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stock Option Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019e9007-3f10-71ba-b6b5-2689cf35ad73_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019e9007-3f10-7a7b-9711-06e58938c713_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e9007-3f0f-7d69-8e4b-b0ffc97f37a6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019e9007-3f0f-78ba-86b9-76327da3a88b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense, period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_019e9007-3f10-78f9-96ec-9194a574f95f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_019e9007-3f0f-787a-a6a5-a99f4289f37b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3f10-7246-b32c-c2cb32570f49_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_019eaa4b-e77a-753b-95b4-929ff14a9f48_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable and Allowance for Expected Credit Losses</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_019e9007-3f10-724f-bdb0-d07e739339ea_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3f10-7fcd-be00-a180ea7bbb0d_totalLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shares of common stock reserved (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e9007-3f10-7466-824c-317490e50a3d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Benefits and Share-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_FacilityExpenses_019e9007-3f10-7944-9bce-674353c4992c_terseLabel_en-US" xlink:label="lab_naut_FacilityExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facilities expenses</link:label>
    <link:label id="lab_naut_FacilityExpenses_label_en-US" xlink:label="lab_naut_FacilityExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Expenses</link:label>
    <link:label id="lab_naut_FacilityExpenses_documentation_en-US" xlink:label="lab_naut_FacilityExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facility Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FacilityExpenses" xlink:href="naut-20260630.xsd#naut_FacilityExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_FacilityExpenses" xlink:to="lab_naut_FacilityExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_NumberOfFinancialInstitution_019e9007-3f0f-794c-b32e-481a77553f39_terseLabel_en-US" xlink:label="lab_naut_NumberOfFinancialInstitution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of financial institution</link:label>
    <link:label id="lab_naut_NumberOfFinancialInstitution_label_en-US" xlink:label="lab_naut_NumberOfFinancialInstitution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Financial Institution</link:label>
    <link:label id="lab_naut_NumberOfFinancialInstitution_documentation_en-US" xlink:label="lab_naut_NumberOfFinancialInstitution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Financial Institution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_NumberOfFinancialInstitution" xlink:href="naut-20260630.xsd#naut_NumberOfFinancialInstitution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_NumberOfFinancialInstitution" xlink:to="lab_naut_NumberOfFinancialInstitution" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_019e9007-3f10-7940-8191-bb3557f60bbd_terseLabel_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in shares available for grant (in shares)</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Increase In Number Of Shares Available For Grant</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_documentation_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Increase In Number Of Shares Available For Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:to="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019e9007-3f10-7d54-9913-c8b23ce9149a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3f0f-787d-85b8-fffa55d21940_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019e9007-3f0f-7d81-a617-e082fe2dded5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Incentive Plans and Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019e9007-3f0f-7f92-acfd-002e300d96b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_019e9007-3f0f-7e3d-b727-5dfbd0799740_terseLabel_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offering purchase period (in months)</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_label_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Purchase Period</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_documentation_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" xlink:to="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_019e9007-3f10-76d7-87af-4fe7799cacf6_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_019e9007-3f10-79cf-b70b-25bb9cfcfa18_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_019f883a-fb9e-78ce-b3f5-0ca693f9f530_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019e9007-3f10-7a74-9020-858271e59986_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3f10-7667-98f5-1f42b2249f93_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of vested stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3f10-782f-b457-71b6f7d60576_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_019e9007-3f10-7492-a251-2a552037fad7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_019e9007-3f10-70cc-8012-86bfa63c6115_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_019e9007-3f10-711a-82b6-84818315739e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019e9007-3f0f-7d95-90ad-ad947ec2c6d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3f0f-7a83-9103-1f94f6136e48_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019e9007-3f10-7e5a-8715-d156603fd1e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019e9007-3f10-707d-beab-47644fc85655_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_019e9007-3f10-7ca6-97e5-6736bd60a9e1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_019e9007-3f0f-7cd8-9d21-2f30919dba1a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_019e9007-3f10-7fb4-860f-4bd62aae53a6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019e9007-3f10-7079-b692-ad4dd7923593_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3f0f-7dc6-9442-fb847bed6ba1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019e9007-3f0f-78c1-bd91-587a655800df_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, maximum (as percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_019e9007-3f0f-719a-b4c3-402d1844ae54_terseLabel_en-US" xlink:label="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2031 and thereafter</link:label>
    <link:label id="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_label_en-US" xlink:label="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four</link:label>
    <link:label id="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_documentation_en-US" xlink:label="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:href="naut-20260630.xsd#naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:to="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e9007-3f0f-7d1b-aac0-5c9fa4b050fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_019e9007-3f10-71e5-ad60-3079af43ba81_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3f10-78e0-bf09-89e4c6489775_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019f8840-62bc-7e81-af39-ff59df7adbfe_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, write-offs</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_FurnitureFixturesAndOfficeEquipmentMember_019e9007-3f0f-75c4-8589-7b7faae45bdd_terseLabel_en-US" xlink:label="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture, fixtures and office equipment</link:label>
    <link:label id="lab_naut_FurnitureFixturesAndOfficeEquipmentMember_label_en-US" xlink:label="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture, Fixtures And Office Equipment [Member]</link:label>
    <link:label id="lab_naut_FurnitureFixturesAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Furniture, Fixtures And Office Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:href="naut-20260630.xsd#naut_FurnitureFixturesAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:to="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e9007-3f10-748b-937f-cea7b3e66f7e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3f10-7453-be24-63e3f11758c5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3f10-730d-bd1b-9ff6a2433ca1_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3f10-763b-a54c-5381629c5feb_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019e9007-3f10-73c1-af29-c5d815f9e693_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e9007-3f10-762f-bcd3-cea9b4db13c0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of vested stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019e9007-3f10-7cce-bdbd-1523b135d7fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019e9007-3f0f-7454-b81d-967b4e5bd2bb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_019e9007-3f0f-78b1-ba5b-49da3a77d155_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019e9007-3f0f-7951-a6b9-7bea855c4cb9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate, minimum (as percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3f10-71df-be76-ef50f215b554_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3f10-701d-bd1b-95b1b117635f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3f10-70af-8749-cd2e5fd2a9c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019e9007-3f10-75d5-8b74-0ac44c8172e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, maximum employee subscription rate (as percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_019e9007-3f10-7f57-a8b2-e402450b0678_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer hardware</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3f10-7a73-ba82-f2857a2f2e78_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3f0f-711f-8ae2-19187d71cb78_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e9007-3f10-72b4-be21-e84da877de10_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities in Unrealized Loss Position Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019e9007-3f10-7e48-89af-706a0eed51ea_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_GrantLiabilitiesCurrent_019f609d-baed-7583-a84b-aa8ffd377c1b_terseLabel_en-US" xlink:label="lab_naut_GrantLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant liabilities</link:label>
    <link:label id="lab_naut_GrantLiabilitiesCurrent_label_en-US" xlink:label="lab_naut_GrantLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant Liabilities, Current</link:label>
    <link:label id="lab_naut_GrantLiabilitiesCurrent_documentation_en-US" xlink:label="lab_naut_GrantLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grant Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantLiabilitiesCurrent" xlink:href="naut-20260630.xsd#naut_GrantLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_GrantLiabilitiesCurrent" xlink:to="lab_naut_GrantLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019e9007-3f10-7519-9052-e77c505db74d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ServiceRevenueMember_019ea619-7c1d-71eb-b5c7-212f5b328344_terseLabel_en-US" xlink:label="lab_naut_ServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_naut_ServiceRevenueMember_label_en-US" xlink:label="lab_naut_ServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Revenue [Member]</link:label>
    <link:label id="lab_naut_ServiceRevenueMember_documentation_en-US" xlink:label="lab_naut_ServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ServiceRevenueMember" xlink:href="naut-20260630.xsd#naut_ServiceRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ServiceRevenueMember" xlink:to="lab_naut_ServiceRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3f0f-7324-a28d-ef1e723fa776_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e9007-3f10-7037-90c0-434c8b831ae6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_019e9007-3f10-7b19-be0f-9a73d5f780fc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_019e9007-3f10-79b2-bacc-f9956559d6f9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of Business and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_019e9007-3f10-7c6e-9d91-15e38e1f512e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e9007-3f0f-77f4-9398-d972f609e013_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Securities in Unrealized Loss Position Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e9007-3f0f-78ad-ac3b-c65e7ca25f96_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_019e9007-3f0f-7f90-8ffb-ccf19e2f3be6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_019ea618-41fc-7832-85eb-63ecd27e83c6_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_019e9007-3f0f-7387-bc3c-447edc822ecb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019e9007-3f10-7634-9eda-3947776b05bd_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_019e9007-3f10-7c8f-9959-df466ddec1d7_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of property and equipment included in accounts payable</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_019e9007-3f10-73d7-a8c7-f8160062be90_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_019e9007-3f10-7b85-808c-93a8964d36e2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_PrototypeEquipmentMember_019e9007-3f0f-7cfe-bed4-b6af53d1e294_terseLabel_en-US" xlink:label="lab_naut_PrototypeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prototype equipment</link:label>
    <link:label id="lab_naut_PrototypeEquipmentMember_label_en-US" xlink:label="lab_naut_PrototypeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prototype Equipment [Member]</link:label>
    <link:label id="lab_naut_PrototypeEquipmentMember_documentation_en-US" xlink:label="lab_naut_PrototypeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prototype Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PrototypeEquipmentMember" xlink:href="naut-20260630.xsd#naut_PrototypeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_PrototypeEquipmentMember" xlink:to="lab_naut_PrototypeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e9007-3f10-79bd-8f77-6edb3bb1c447_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3f10-7af8-a0ad-d724b7950baf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3f10-72ca-9d3e-41a987fb8f10_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019e9007-3f10-7e81-8de5-9a288c920158_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_019e9007-3f0f-7c30-9a67-aeed925cd31d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019e9007-3f10-7445-b83f-f1ceac7f7cd3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3f10-78cd-be52-60e56169ced8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_019e9007-3f10-795c-8cc6-7c75e963e356_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_019e9007-3f10-7b3a-b366-b29a982b8376_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_019e9007-3f0f-71a0-9fa8-22a2da043c19_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019e9007-3f10-77f8-8d6a-4239b9d17382_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019e9007-3f10-7d06-9626-48c0d5df1e2d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019e9007-3f10-74f2-9ff5-626cff76298d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e9007-3f0f-7aa0-a884-6646b9be27fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Securities in Unrealized Loss Position Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ReportableSegmentMember_019e9007-3f0f-79fc-975c-d30efde6f79c_terseLabel_en-US" xlink:label="lab_naut_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_naut_ReportableSegmentMember_label_en-US" xlink:label="lab_naut_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_naut_ReportableSegmentMember_documentation_en-US" xlink:label="lab_naut_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReportableSegmentMember" xlink:href="naut-20260630.xsd#naut_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ReportableSegmentMember" xlink:to="lab_naut_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_019e9007-3f0f-744b-bd20-ebabca6c09c7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 8)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_019ea617-89bb-7725-9f66-f84ecacfebac_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_019f8c23-6d09-7a28-a17e-6ac9a7ea4a9f_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3f10-72d9-b19d-edfff171c700_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_019e9007-3f10-73aa-84c9-9dce198ef99a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3f0f-7db6-814a-6eb21cc2a05f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_019e9007-3f0f-75b2-98b4-578f9a586006_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3f10-7ce4-9488-6723943e7cf6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e9007-3f10-7a03-ae6d-f4c1efd02aaf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Six months ending December&#160;31, 2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_019e9007-3f10-77a7-802c-01883d91dbed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3f10-74c9-94ef-1ae9051f261d_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019e9007-3f10-74b3-81c8-6a0e56acc14e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_019e9007-3f10-7073-bbe1-9b708f89c811_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and exercisable, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_019e9007-3f10-77d6-99ac-d42795bb0a6f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_019e9007-3f10-767b-b4bd-ad9d4542d6c5_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and short-term investments</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_019e9007-3f10-7fb1-aa3c-ecd08c2012cc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3f10-7aad-a995-786a0234a40d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_019e9007-3f10-7fb0-86b2-c17a3c667839_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019e9007-3f10-7cb5-8ac6-aeaecf91b052_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_019e9007-3f10-79a4-bd4b-7e514a3b9a95_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit losses on investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_019e9007-3f10-7014-94b9-32f009ab156b_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mutual funds</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019e9007-3f10-7f42-915e-dcc24ede82c5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019e9007-3f0f-7fcc-9e45-e3e02ff6cd56_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_019ef517-e08e-7a49-8856-a0620da4a660_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition and Grant Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3f0f-7c4a-a924-33fb77f12f02_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3f0f-737f-b340-80e2764b2140_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3f0f-7275-9640-6b519698e525_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_019e9007-3f10-7d4d-ab77-adfa8e2a8521_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional and consulting fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_019e9007-3f0f-78d4-8379-414c6c0cabd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019e9007-3f10-710b-8d96-d2bc7ce86278_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_019e9007-3f10-71c7-8555-62af97af4083_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_019e9007-3f0f-75a4-9010-5e4b801b8597_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Salaries and related benefits</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019e9007-3f0f-7730-8287-788a68b9a912_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price of common stock (as percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_019e9007-3f10-71bf-8840-c8de38d1086e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019e9007-3f10-7570-a891-d60fb72c294a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_019e9007-3f10-7f97-a019-f910fc710e3f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share attributable to common stockholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_019e9007-3f10-7509-82fd-9321ec99d07c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_019e9007-3f10-7e2a-ba57-1368b7a40b2e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_019ea61a-80f8-7814-ab25-622be0a6bd53_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_019f7dd3-ae52-798c-a0f0-346273c2b979_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of service revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_019e9007-3f10-7f0b-98ac-2be442a52054_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_019f8840-62bc-71e2-92d5-489affeec451_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, after allowance for credit loss, current (less than)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_019e9007-3f10-75a5-803d-824d3393dae7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on securities available-for-sale</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3f10-7b6a-b879-63894005aede_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3f10-7a25-bdab-a5dae60fe49c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_019ea618-41fc-7a75-a5f5-764ad81b68cd_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_019e9007-3f10-7621-91b8-ca91f75c0c1d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_019e9007-3f10-7501-8308-5eb71b7387e0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3f10-7f41-8b36-f54c8fb31321_terseLabel_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3f10-7594-b917-7e41964678f1_totalLabel_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities And Other Liabilities, Current</link:label>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Liabilities And Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:href="naut-20260630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:to="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3f10-7384-8f76-5b5626cbff86_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_019e9007-3f0f-74f8-ae04-168c6a833155_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3f10-74c2-9443-bccf23040a64_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend rate (as percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3f10-7863-8eea-14d098e8ffe5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_019e9007-3f10-7483-9e19-7b39adec9b31_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019e9007-3f10-7afa-af9a-abeafbc392f1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019e9007-3f10-7950-8d10-da07abdd15da_netLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_019e9007-3f10-7087-b9fc-c2c28ec8d36f_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_019e9007-3f10-7d70-a4be-187549fee5a3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_019e9007-3f10-72a5-9429-ffe83042e706_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_019e9007-3f10-743a-bd24-2ab7605ed6ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_019e9007-3f0f-72e6-84c9-37b1e5aaa5b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019e9007-3f0f-7547-8c0f-a591ed121f6c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_019e9007-3f10-74f6-a7f9-82126763e40b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3f0f-73ec-8583-c1536b35fa83_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Asset, Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_019e9007-3f10-7a1c-806e-2e73a7427325_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_019e9007-3f0f-732a-bef7-fe66ccf60868_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3f10-72ad-96e5-d4b64a614643_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_019e9007-3f0f-702b-8c25-8f4aef10c4cf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.0001 par value, 200,000,000 authorized as of June&#160;30, 2026 and December&#160;31, 2025; 0 shares issued and outstanding as of June&#160;30, 2026 and December&#160;31, 2025</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_019e9007-3f10-7c0b-aff2-2061a13acc1c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_019e9007-3f10-7b78-b0f8-24f3b9fcf3f6_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019e9007-3f10-7989-b195-43a09c5ea252_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_019e9007-3f10-776d-9596-1c628597b28a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_019e9007-3f0f-7c9e-8d2e-c87696ebe187_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3f0f-73b3-a22c-3c9a262befc7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_019e9007-3f0f-7a27-8c86-acc28e9d14bd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019e9007-3f0f-7158-94e4-81e972671962_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3f10-7024-a6a3-55f4e190dd47_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_019e9007-3f10-72eb-823d-9183c296fc84_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplementary cash flow information on non-cash activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3f10-7b14-9ca6-bca1a90190d0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3f10-761c-8834-22236b175836_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_019e9007-3f10-747f-a08f-491454ba0393_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Option Award Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock Options Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_019e9007-3f10-7b43-9979-52df47e69a9e_terseLabel_en-US" xlink:label="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Reserved for Future Issuance</link:label>
    <link:label id="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_label_en-US" xlink:label="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]</link:label>
    <link:label id="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_documentation_en-US" xlink:label="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Common Stock Reserved For Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:href="naut-20260630.xsd#naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3f10-73af-8015-c342234657f6_terseLabel_en-US" xlink:label="lab_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Market Value</link:label>
    <link:label id="lab_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="naut-20260630.xsd#naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_019e9007-3f10-7634-8e92-204d67682a8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_019e9007-3f10-711b-94e7-d5d43c670b66_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019e9007-3f0f-7c75-aeff-ccf956b0ee9c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3f10-7817-b968-cd1a51a16b01_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_019e9007-3f10-7100-a35e-cb48e5a4de85_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_019e9007-3f10-7539-8595-622eb3763b12_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_019e9007-3f10-7857-a35d-570f259efe13_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e9007-3f0f-7bd7-aad4-92bc977daf5d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019e9007-3f10-75d1-9120-8ad37fc5eeb0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, minimum (as percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_019e9007-3f0f-746a-a46f-31f4b6651b71_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019e9007-3f0f-78ea-b4d4-cc702000b19a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_019e9007-3f0f-7bae-ac09-4777c865721b_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e9007-3f10-7438-b7e3-0bd17a08cb07_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Location, Statement of Financial Position, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:to="lab_us-gaap_StatementOfFinancialPositionLocationBalanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_019e9007-3f10-7ede-af1a-cd6341239305_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_019e9007-3f10-7367-88e5-80a53490607c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_019e9007-3f10-750a-b1ad-28e2b7182683_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_019ea617-34b6-7cfc-b359-2611569671b0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019e9007-3f10-7e1f-970f-0215322823f8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>naut-20260630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e9007-3d81-7923-8b9d-11e8abe8f7df,g:a24f2a1f-f751-4ff8-9f53-5ed913cc112d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.nautilus.bio/role/CoverPage" xlink:type="simple" xlink:href="naut-20260630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e9007-3e4c-7ab7-83a2-68a09d9c7002" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_DocumentType_019e9007-3e4c-7ab7-83a2-68a09d9c7002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_019e9007-3e4c-7550-ad4f-74674e5bbf54" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_DocumentQuarterlyReport_019e9007-3e4c-7550-ad4f-74674e5bbf54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e9007-3e4c-74b5-abf5-6972b2c7ab33" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_DocumentPeriodEndDate_019e9007-3e4c-74b5-abf5-6972b2c7ab33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019e9007-3e4c-7c6f-9506-ba8038d22282" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_DocumentTransitionReport_019e9007-3e4c-7c6f-9506-ba8038d22282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e9007-3e4c-7145-b46b-e073be488413" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityFileNumber_019e9007-3e4c-7145-b46b-e073be488413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e9007-3e4c-7560-8b1e-a208cf19b960" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityRegistrantName_019e9007-3e4c-7560-8b1e-a208cf19b960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019e9007-3e4c-7277-8ea9-ba2c902f652c" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019e9007-3e4c-7277-8ea9-ba2c902f652c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e9007-3e4c-79ac-9cad-2f8019e25ec7" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e9007-3e4c-79ac-9cad-2f8019e25ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e9007-3e4c-7aa8-a877-983fe400095b" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityAddressAddressLine1_019e9007-3e4c-7aa8-a877-983fe400095b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e9007-3e4c-7ff7-8b1e-3fbf3c8e7e19" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityAddressCityOrTown_019e9007-3e4c-7ff7-8b1e-3fbf3c8e7e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e9007-3e4c-77f0-a575-f5d8bb92ecde" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityAddressStateOrProvince_019e9007-3e4c-77f0-a575-f5d8bb92ecde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e9007-3e4c-7efd-a52c-215b768026cc" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityAddressPostalZipCode_019e9007-3e4c-7efd-a52c-215b768026cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019e9007-3e4c-75e1-b9b2-85f0533a43df" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_CityAreaCode_019e9007-3e4c-75e1-b9b2-85f0533a43df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019e9007-3e4c-7768-9cee-efa6f6bf5f07" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_LocalPhoneNumber_019e9007-3e4c-7768-9cee-efa6f6bf5f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019e9007-3e4c-7b35-ae2b-8911ff434ccc" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_Security12bTitle_019e9007-3e4c-7b35-ae2b-8911ff434ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019e9007-3e4c-7a82-b31d-fb6450b54971" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_TradingSymbol_019e9007-3e4c-7a82-b31d-fb6450b54971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019e9007-3e4c-7a2d-afff-13e430790ee4" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_SecurityExchangeName_019e9007-3e4c-7a2d-afff-13e430790ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019e9007-3e4c-7abf-a1e1-581cbc002c8c" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityCurrentReportingStatus_019e9007-3e4c-7abf-a1e1-581cbc002c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019e9007-3e4c-71fb-8220-8f1f99b976b4" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityInteractiveDataCurrent_019e9007-3e4c-71fb-8220-8f1f99b976b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019e9007-3e4c-7a6c-b086-eefff8416459" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityFilerCategory_019e9007-3e4c-7a6c-b086-eefff8416459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_019e9007-3e4c-7889-a0ca-7dd8ac097844" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntitySmallBusiness_019e9007-3e4c-7889-a0ca-7dd8ac097844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019e9007-3e4c-71f9-b6db-bea8ed064345" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityEmergingGrowthCompany_019e9007-3e4c-71f9-b6db-bea8ed064345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019e9007-3e4c-7a38-a105-2d26384dc094" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityShellCompany_019e9007-3e4c-7a38-a105-2d26384dc094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019e9007-3e4c-7501-a6bd-5ea76394eb08" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019e9007-3e4c-7501-a6bd-5ea76394eb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e9007-3e4c-79ee-ba6c-4cc23c33aff9" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_EntityCentralIndexKey_019e9007-3e4c-79ee-ba6c-4cc23c33aff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e9007-3e4c-7c55-9786-928e827f0791" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_AmendmentFlag_019e9007-3e4c-7c55-9786-928e827f0791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019e9007-3e4c-722f-8d2d-842c6da67da4" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_CurrentFiscalYearEndDate_019e9007-3e4c-722f-8d2d-842c6da67da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019e9007-3e4c-76cc-93fc-b394d9ad3ae8" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_DocumentFiscalYearFocus_019e9007-3e4c-76cc-93fc-b394d9ad3ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019e9007-3e4c-7a1b-9da6-03749f39a133" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e9007-3e4c-7941-9b2b-2bb3d9713421" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019e9007-3e4c-7a1b-9da6-03749f39a133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-706c-bc72-8a4f34e596aa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-706c-bc72-8a4f34e596aa" xlink:to="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_019e9007-3e4c-7ac1-9e23-d160e58d9e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_019e9007-3e4c-7ac1-9e23-d160e58d9e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-71af-87fe-25d9f990ddd3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e9007-3e4c-7ac1-9e23-d160e58d9e3c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-71af-87fe-25d9f990ddd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e9007-3e4c-7c5d-a7c6-63e33a09c9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e9007-3e4c-7ac1-9e23-d160e58d9e3c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e9007-3e4c-7c5d-a7c6-63e33a09c9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e9007-3e4c-71bc-b481-941ff3f21fab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e9007-3e4c-7ac1-9e23-d160e58d9e3c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e9007-3e4c-71bc-b481-941ff3f21fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e9007-3e4c-72de-89ef-dd6a1fede118" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_019e9007-3e4c-7ac1-9e23-d160e58d9e3c" xlink:to="loc_us-gaap_AssetsCurrent_019e9007-3e4c-72de-89ef-dd6a1fede118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7647-9064-9b57cdcb9891" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7647-9064-9b57cdcb9891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e9007-3e4c-7ead-9ab5-898e11e0186d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e9007-3e4c-7ead-9ab5-898e11e0186d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019e9007-3e4c-7128-b71b-101ddb79cda5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019e9007-3e4c-7128-b71b-101ddb79cda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e9007-3e4c-77be-9344-a99f45c7acef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e9007-3e4c-77be-9344-a99f45c7acef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e9007-3e4c-7dec-8f0c-2eb79d7f7d43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_019e9007-3e4c-7692-a716-8bae1993c55f" xlink:to="loc_us-gaap_Assets_019e9007-3e4c-7dec-8f0c-2eb79d7f7d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-706c-bc72-8a4f34e596aa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_019e9007-3e4c-7f96-b64e-42a991e24fed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_019e9007-3e4c-7f96-b64e-42a991e24fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e9007-3e4c-774f-b36b-9bc01c653146" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e9007-3e4c-7f96-b64e-42a991e24fed" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e9007-3e4c-774f-b36b-9bc01c653146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7a16-a16e-3347b1617469" xlink:href="naut-20260630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e9007-3e4c-7f96-b64e-42a991e24fed" xlink:to="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7a16-a16e-3347b1617469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e9007-3e4c-7048-904e-a338d463201a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e9007-3e4c-7f96-b64e-42a991e24fed" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e9007-3e4c-7048-904e-a338d463201a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-7d45-b3f8-099dcbe4aa52" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_019e9007-3e4c-7f96-b64e-42a991e24fed" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e9007-3e4c-7d45-b3f8-099dcbe4aa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e9007-3e4c-7381-873f-149dbe49b5af" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e9007-3e4c-7381-873f-149dbe49b5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e9007-3e4c-746d-82ae-4d797dd1d529" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:to="loc_us-gaap_Liabilities_019e9007-3e4c-746d-82ae-4d797dd1d529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e9007-3e4c-7c8a-993a-9f3319b36244" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e9007-3e4c-7c8a-993a-9f3319b36244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:to="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e9007-3e4c-7fc6-9000-50067d87bc3e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:to="loc_us-gaap_PreferredStockValue_019e9007-3e4c-7fc6-9000-50067d87bc3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e9007-3e4c-7953-83db-4465895cd8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:to="loc_us-gaap_CommonStockValue_019e9007-3e4c-7953-83db-4465895cd8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019e9007-3e4c-7115-b78e-90ceffa7c483" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019e9007-3e4c-7115-b78e-90ceffa7c483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e9007-3e4c-74e9-b4b5-d6cfa1177a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e9007-3e4c-74e9-b4b5-d6cfa1177a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-7a3f-a0f0-8f03862a70aa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-7a3f-a0f0-8f03862a70aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e9007-3e4c-769f-a4b4-278fb7716eee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_019e9007-3e4c-7a2d-ae89-9f73ee0236a7" xlink:to="loc_us-gaap_StockholdersEquity_019e9007-3e4c-769f-a4b4-278fb7716eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e9007-3e4c-7abc-a5f8-4d917e422cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_019e9007-3e4c-7a15-9202-193f2065b32e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e9007-3e4c-7abc-a5f8-4d917e422cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019e9007-3e4c-763c-ad5e-09a14dbb20d0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_019e9007-3e4c-763c-ad5e-09a14dbb20d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_019e9007-3e4c-76cf-bf70-6887779b3521" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_019e9007-3e4c-76cf-bf70-6887779b3521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_019e9007-3e4c-77cd-b8b0-7a7448bc19ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_PreferredStockSharesIssued_019e9007-3e4c-77cd-b8b0-7a7448bc19ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_019e9007-3e4c-73a9-9457-ecc3f172422e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_019e9007-3e4c-73a9-9457-ecc3f172422e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_019e9007-3e4c-7c0a-be06-dab03f2b9610" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_019e9007-3e4c-7c0a-be06-dab03f2b9610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_019e9007-3e4c-7982-b2f1-6724832fba2d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_019e9007-3e4c-7982-b2f1-6724832fba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019e9007-3e4c-7952-8e96-3907ecb05fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_CommonStockSharesIssued_019e9007-3e4c-7952-8e96-3907ecb05fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7aaf-b7a9-9183e3ee2b33" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_019e9007-3e4c-7582-b9f9-170b7ace3eca" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7aaf-b7a9-9183e3ee2b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_019e9007-3e4c-7cde-8676-2404670711e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019ea618-41fc-741d-80ce-cbf4165cc026" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_019e9007-3e4c-7cde-8676-2404670711e3" xlink:to="loc_us-gaap_StatementTable_019ea618-41fc-741d-80ce-cbf4165cc026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019ea618-41fc-76b1-822a-a48d552b3bb9" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ea618-41fc-741d-80ce-cbf4165cc026" xlink:to="loc_srt_ProductOrServiceAxis_019ea618-41fc-76b1-822a-a48d552b3bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019ea618-41fc-76b1-822a-a48d552b3bb9" xlink:to="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantRevenueMember_019ea619-3327-7911-bad2-167a7458bf76" xlink:href="naut-20260630.xsd#naut_GrantRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:to="loc_naut_GrantRevenueMember_019ea619-3327-7911-bad2-167a7458bf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ServiceRevenueMember_019ea619-7c1d-78dc-9096-cdd18790a11a" xlink:href="naut-20260630.xsd#naut_ServiceRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019ea618-41fc-7008-a8f2-becd73accd13" xlink:to="loc_naut_ServiceRevenueMember_019ea619-7c1d-78dc-9096-cdd18790a11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019ea618-41fc-741d-80ce-cbf4165cc026" xlink:to="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_019ea617-34b6-7671-abe5-9bbff3b0fe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_RevenuesAbstract_019ea617-34b6-7671-abe5-9bbff3b0fe5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019ea617-89bb-7c3c-b45e-4bda2edcf406" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_019ea617-34b6-7671-abe5-9bbff3b0fe5b" xlink:to="loc_us-gaap_Revenues_019ea617-89bb-7c3c-b45e-4bda2edcf406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_019ea619-f76b-7000-9c6d-119dd5a9d1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_CostOfRevenueAbstract_019ea619-f76b-7000-9c6d-119dd5a9d1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019ea61a-80f8-71b1-acdc-4886d79d3799" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_019ea619-f76b-7000-9c6d-119dd5a9d1cf" xlink:to="loc_us-gaap_CostOfRevenue_019ea61a-80f8-71b1-acdc-4886d79d3799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e9007-3e4c-71d9-bcc2-6294dd9b2a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e9007-3e4c-71d9-bcc2-6294dd9b2a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e9007-3e4c-7735-83c6-edda023df1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e9007-3e4c-7735-83c6-edda023df1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e9007-3e4c-7f98-8233-3a4805d4adf0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4c-7421-88a5-aa3ad632e66c" xlink:to="loc_us-gaap_OperatingExpenses_019e9007-3e4c-7f98-8233-3a4805d4adf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019e9007-3e4c-7406-8343-7bce7eb03f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019e9007-3e4c-7406-8343-7bce7eb03f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e9007-3e4c-7fe5-8f9b-c89dee80ec79" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e9007-3e4c-7fe5-8f9b-c89dee80ec79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e9007-3e4c-7cd1-badc-8f693be75af6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_019e9007-3e4c-73de-9469-0ea4875ea684" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019e9007-3e4c-7cd1-badc-8f693be75af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7343-9b7c-c122742f9901" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7343-9b7c-c122742f9901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019e9007-3e4c-7759-b145-67d6bf3ede33" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_EarningsPerShareBasic_019e9007-3e4c-7759-b145-67d6bf3ede33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019e9007-3e4c-7859-ab8a-51138b762944" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019e9007-3e4c-7859-ab8a-51138b762944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3e4c-7a2e-b5f8-6794f04add45" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3e4c-7a2e-b5f8-6794f04add45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3e4c-7796-861c-539e9547227c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019ea618-41fc-7b47-bdc6-030eb79d0ccb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3e4c-7796-861c-539e9547227c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019e9007-3e4c-73b1-8a29-b3c3870f3a25" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7f4f-8677-a3f702571e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019e9007-3e4c-73b1-8a29-b3c3870f3a25" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7f4f-8677-a3f702571e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019e9007-3e4c-7644-9ef7-a7a9af14cad8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019e9007-3e4c-73b1-8a29-b3c3870f3a25" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019e9007-3e4c-7644-9ef7-a7a9af14cad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_019e9007-3e4c-7ca9-ac93-35da0e731b42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019e9007-3e4c-7644-9ef7-a7a9af14cad8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_019e9007-3e4c-7ca9-ac93-35da0e731b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-7163-afab-834b882906d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_019e9007-3e4c-7644-9ef7-a7a9af14cad8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-7163-afab-834b882906d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e9007-3e4c-70e2-a3c2-8d5665c06287" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_019e9007-3e4c-73b1-8a29-b3c3870f3a25" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e9007-3e4c-70e2-a3c2-8d5665c06287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_019e9007-3e4c-7f27-906b-1e833083f63e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_019e9007-3e4c-717c-a3a7-51626a99d45a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_019e9007-3e4c-7f27-906b-1e833083f63e" xlink:to="loc_us-gaap_StatementTable_019e9007-3e4c-717c-a3a7-51626a99d45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_019e9007-3e4c-7d6b-be81-ffe112a6420c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e9007-3e4c-717c-a3a7-51626a99d45a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_019e9007-3e4c-7d6b-be81-ffe112a6420c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_019e9007-3e4c-7d6b-be81-ffe112a6420c" xlink:to="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_019e9007-3e4c-7957-83ca-7ef7da623810" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_CommonStockMember_019e9007-3e4c-7957-83ca-7ef7da623810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_019e9007-3e4c-710f-a5f4-a143216bcd17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_019e9007-3e4c-710f-a5f4-a143216bcd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019e9007-3e4c-7b6f-8ab2-e88bf318c44d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_019e9007-3e4c-7b6f-8ab2-e88bf318c44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_019e9007-3e4c-7257-9546-2013fdbf56fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_019e9007-3e4c-7296-bb7c-643f9fb56e35" xlink:to="loc_us-gaap_RetainedEarningsMember_019e9007-3e4c-7257-9546-2013fdbf56fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_019e9007-3e4c-7a1e-b230-1132815cd726" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_019e9007-3e4c-717c-a3a7-51626a99d45a" xlink:to="loc_us-gaap_StatementLineItems_019e9007-3e4c-7a1e-b230-1132815cd726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_019e9007-3e4c-7a1e-b230-1132815cd726" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7a53-96c2-b66a9f20a32a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7a53-96c2-b66a9f20a32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e9007-3e4c-708c-98c2-ff21467f0a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockholdersEquity_019e9007-3e4c-708c-98c2-ff21467f0a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3e4c-78b6-9a27-fd80b7681368" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3e4c-78b6-9a27-fd80b7681368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e9007-3e4c-7ca7-978e-41d7ce5a00b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_019e9007-3e4c-7ca7-978e-41d7ce5a00b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019ea690-8f67-7811-9aa0-6b157d2c1304" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_019ea690-8f67-7811-9aa0-6b157d2c1304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019ea690-8f67-77ab-87d8-e100de92f983" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_019ea690-8f67-77ab-87d8-e100de92f983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e9007-3e4c-7060-94d6-35c36e4c6154" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_019e9007-3e4c-7060-94d6-35c36e4c6154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-71d6-8003-7bbc4cd05cef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e9007-3e4c-71d6-8003-7bbc4cd05cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7d35-bbba-2006659bb610" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7d35-bbba-2006659bb610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7d86-b245-942ecbf53371" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-7d86-b245-942ecbf53371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7e2c-942c-805aa9301a25" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_019e9007-3e4c-70e8-8bf2-286633e71c12" xlink:to="loc_us-gaap_StockholdersEquity_019e9007-3e4c-7e2c-942c-805aa9301a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="naut-20260630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-795b-bb76-41b34e0123d1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-795b-bb76-41b34e0123d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7809-b652-de679b73db16" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-795b-bb76-41b34e0123d1" xlink:to="loc_us-gaap_NetIncomeLoss_019e9007-3e4c-7809-b652-de679b73db16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-742c-b6b3-dd6085a312e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-795b-bb76-41b34e0123d1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-742c-b6b3-dd6085a312e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e9007-3e4c-7367-a9d5-f4f632732cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-742c-b6b3-dd6085a312e3" xlink:to="loc_us-gaap_ShareBasedCompensation_019e9007-3e4c-7367-a9d5-f4f632732cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e9007-3e4c-75db-b40c-dd288815d186" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-742c-b6b3-dd6085a312e3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e9007-3e4c-75db-b40c-dd288815d186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019e9007-3e4c-74d2-8e88-c232eb51ee8a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-742c-b6b3-dd6085a312e3" xlink:to="loc_us-gaap_Depreciation_019e9007-3e4c-74d2-8e88-c232eb51ee8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e9007-3e4c-7309-a19d-01e435a67077" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-742c-b6b3-dd6085a312e3" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e9007-3e4c-7309-a19d-01e435a67077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e9007-3e4c-7602-b8e3-5cfbdb727e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-742c-b6b3-dd6085a312e3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e9007-3e4c-7602-b8e3-5cfbdb727e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e9007-3e4c-7017-b1ab-6581e0f0e92a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e9007-3e4c-7602-b8e3-5cfbdb727e3f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e9007-3e4c-7017-b1ab-6581e0f0e92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e9007-3e4c-730c-96d2-6537b218f872" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e9007-3e4c-7602-b8e3-5cfbdb727e3f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e9007-3e4c-730c-96d2-6537b218f872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e9007-3e4c-78bc-befd-6f0f9781054b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e9007-3e4c-7602-b8e3-5cfbdb727e3f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019e9007-3e4c-78bc-befd-6f0f9781054b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e9007-3e4c-75df-a2a1-894656202d11" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_019e9007-3e4c-7602-b8e3-5cfbdb727e3f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019e9007-3e4c-75df-a2a1-894656202d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7976-8ec6-f46417026a80" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_019e9007-3e4c-795b-bb76-41b34e0123d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e9007-3e4c-7976-8ec6-f46417026a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e9007-3e4c-7d28-ab6a-c56076bfdabd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e9007-3e4c-7d28-ab6a-c56076bfdabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e9007-3e4c-71c3-8961-58409ecc616e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e9007-3e4c-7d28-ab6a-c56076bfdabd" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e9007-3e4c-71c3-8961-58409ecc616e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e9007-3e4c-761a-ad79-3ae7f56a7e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e9007-3e4c-7d28-ab6a-c56076bfdabd" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e9007-3e4c-761a-ad79-3ae7f56a7e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e9007-3e4c-779a-8587-86ae4da9abff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e9007-3e4c-7d28-ab6a-c56076bfdabd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e9007-3e4c-779a-8587-86ae4da9abff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7ba2-8cca-4cacbca4116e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_019e9007-3e4c-7d28-ab6a-c56076bfdabd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e9007-3e4c-7ba2-8cca-4cacbca4116e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e9007-3e4c-7d28-9b4c-981bc71c5866" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e9007-3e4c-7d28-9b4c-981bc71c5866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019e9007-3e4c-7964-833b-1a24f3102a58" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e9007-3e4c-7d28-9b4c-981bc71c5866" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019e9007-3e4c-7964-833b-1a24f3102a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_019ea695-4eee-75c4-9478-a2d5332224fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e9007-3e4c-7d28-9b4c-981bc71c5866" xlink:to="loc_us-gaap_ProceedsFromStockPlans_019ea695-4eee-75c4-9478-a2d5332224fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3e4c-7140-a938-6ad303e4365c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_019e9007-3e4c-7d28-9b4c-981bc71c5866" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e9007-3e4c-7140-a938-6ad303e4365c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e9007-3e4c-708f-80c2-6cc4fcf74114" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e9007-3e4c-708f-80c2-6cc4fcf74114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-7172-9ed9-b4b3b2f4ac4e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-7172-9ed9-b4b3b2f4ac4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-7242-9552-aa8f09bef132" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-7242-9552-aa8f09bef132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_019e9007-3e4c-7747-8257-e5715d12c03a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_019e9007-3e4c-7508-ab56-fef18ab69b42" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_019e9007-3e4c-7747-8257-e5715d12c03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_019e9007-3e4c-7191-910d-57cf6550d893" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_019e9007-3e4c-7747-8257-e5715d12c03a" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_019e9007-3e4c-7191-910d-57cf6550d893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation" xlink:type="simple" xlink:href="naut-20260630.xsd#DescriptionofBusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-798b-9355-cbbdf247772e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_019e9007-3e4c-7f8d-b1db-48e028059e12" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-798b-9355-cbbdf247772e" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_019e9007-3e4c-7f8d-b1db-48e028059e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="naut-20260630.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-73b4-9d99-2bc0cb9b10a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019e9007-3e4c-7f1b-b934-681aaa28dcae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-73b4-9d99-2bc0cb9b10a8" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_019e9007-3e4c-7f1b-b934-681aaa28dcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurements" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7255-ac19-7cd7acfe7355" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_019e9007-3e4c-7655-ae0b-dc8924db10a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7255-ac19-7cd7acfe7355" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_019e9007-3e4c-7655-ae0b-dc8924db10a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItems"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78bd-aa40-73c875394719" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_019e9007-3e4c-753a-9095-3395a560d8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78bd-aa40-73c875394719" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_019e9007-3e4c-753a-9095-3395a560d8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStock" xlink:type="simple" xlink:href="naut-20260630.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e9007-3e4c-72b2-85c1-0b16d92562b7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019e9007-3e4c-7da8-8c5d-7587a2879f17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e9007-3e4c-72b2-85c1-0b16d92562b7" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_019e9007-3e4c-7da8-8c5d-7587a2879f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/IncomeTaxes" xlink:type="simple" xlink:href="naut-20260630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019e9007-3e4c-7496-8ff5-3242a3701a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_019e9007-3e4c-70c1-b3ed-b30ff2d63fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019e9007-3e4c-7496-8ff5-3242a3701a9d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_019e9007-3e4c-70c1-b3ed-b30ff2d63fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensation" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensation"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-75bf-81e3-125577d68e74" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019e9007-3e4c-7052-be5e-cfd8df81c5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-75bf-81e3-125577d68e74" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_019e9007-3e4c-7052-be5e-cfd8df81c5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="naut-20260630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-76e5-aed3-e18c2c80ca43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019e9007-3e4d-7dd3-9cbc-1a76ab02846d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-76e5-aed3-e18c2c80ca43" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_019e9007-3e4d-7dd3-9cbc-1a76ab02846d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShare" xlink:type="simple" xlink:href="naut-20260630.xsd#BasicandDilutedNetLossperShare"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-7862-8ea9-91ba547ed2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_019e9007-3e4d-76ea-ba30-b2ad88f3aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-7862-8ea9-91ba547ed2c6" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_019e9007-3e4d-76ea-ba30-b2ad88f3aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SegmentInformation" xlink:type="simple" xlink:href="naut-20260630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019e9007-3e4d-7c70-8940-2cc526e2a7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_019e9007-3e4d-77a7-85dd-14baead123f5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019e9007-3e4d-7c70-8940-2cc526e2a7b8" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_019e9007-3e4d-77a7-85dd-14baead123f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="naut-20260630.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019e9007-3e4c-7e64-b48c-97f9221cef48" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_019e9007-3e4c-7e64-b48c-97f9221cef48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_019e9007-3e4c-7310-99be-bc0f6704e863" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_019e9007-3e4c-7310-99be-bc0f6704e863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_019e9007-3e4c-7f76-8171-28fd4a8ce2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_UseOfEstimates_019e9007-3e4c-7f76-8171-28fd4a8ce2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_019e9007-3e4c-7c4d-b6ca-0a79566fdb81" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_019e9007-3e4c-7c4d-b6ca-0a79566fdb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_019e9007-3e4c-7170-a97b-210109216b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_019e9007-3e4c-7170-a97b-210109216b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_019ef517-e08e-77e0-af6c-c9d7162f396d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_019ef517-e08e-77e0-af6c-c9d7162f396d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019e9007-3e4c-74bd-83c1-e9b6d2a7e5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_019e9007-3e4c-74bd-83c1-e9b6d2a7e5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_019eaa4b-e77a-7d5a-afe9-9d2786fcd536" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_019eaa4b-e77a-7d5a-afe9-9d2786fcd536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_019e9007-3e4c-7bb0-8a4b-3a8513044542" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_019e9007-3e4c-7bb0-8a4b-3a8513044542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_019e9007-3e4c-761e-b8c8-229da6562277" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_019e9007-3e4c-761e-b8c8-229da6562277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_019e9007-3e4c-7bd1-8580-59adb22a67a0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_019e9007-3e4c-7bd1-8580-59adb22a67a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_019e9007-3e4c-7547-b966-00e9b5dd9784" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_019e9007-3e4c-7547-b966-00e9b5dd9784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_019e9007-3e4c-73b4-9cdd-0730f3c8b2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_019e9007-3e4c-73b4-9cdd-0730f3c8b2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019e9007-3e4c-7ac7-af5a-a6f417bf3e25" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-774b-819b-3fd36a754f7b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_019e9007-3e4c-7ac7-af5a-a6f417bf3e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7fd0-a1aa-94bd1cd4f9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_019e9007-3e4c-71a4-a243-55dad2a8c7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7fd0-a1aa-94bd1cd4f9b3" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_019e9007-3e4c-71a4-a243-55dad2a8c7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_019e9007-3e4c-7023-b9a4-3e4cda754d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7fd0-a1aa-94bd1cd4f9b3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_019e9007-3e4c-7023-b9a4-3e4cda754d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78ba-8956-21b9fa90af31" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019e9007-3e4c-75f8-9f58-e97d5f43437a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78ba-8956-21b9fa90af31" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_019e9007-3e4c-75f8-9f58-e97d5f43437a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019e9007-3e4c-7dac-b3d0-8845dbe7e460" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78ba-8956-21b9fa90af31" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_019e9007-3e4c-7dac-b3d0-8845dbe7e460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_019e9007-3e4c-7997-8a57-c359bb129ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78ba-8956-21b9fa90af31" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_019e9007-3e4c-7997-8a57-c359bb129ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019e9007-3e4c-7142-b611-7209036bc529" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78ba-8956-21b9fa90af31" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_019e9007-3e4c-7142-b611-7209036bc529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_019e9007-3e4c-79d6-beae-aedbeea8fb44" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78ba-8956-21b9fa90af31" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_019e9007-3e4c-79d6-beae-aedbeea8fb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockTables" xlink:type="simple" xlink:href="naut-20260630.xsd#CommonStockTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e9007-3e4c-7816-bf6a-651e8576d466" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_019e9007-3e4c-7349-b2ed-46a03fa62057" xlink:href="naut-20260630.xsd#naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e9007-3e4c-7816-bf6a-651e8576d466" xlink:to="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_019e9007-3e4c-7349-b2ed-46a03fa62057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-7fd3-b68c-7424351d7d32" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019e9007-3e4c-7d2f-bfa5-df0eb798bd84" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-7fd3-b68c-7424351d7d32" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_019e9007-3e4c-7d2f-bfa5-df0eb798bd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_019e9007-3e4c-7f56-9f72-c235b75cf081" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-7fd3-b68c-7424351d7d32" xlink:to="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_019e9007-3e4c-7f56-9f72-c235b75cf081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019e9007-3e4c-70d0-a71d-326f7ccd0b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-7fd3-b68c-7424351d7d32" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_019e9007-3e4c-70d0-a71d-326f7ccd0b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="naut-20260630.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-7e9f-a70f-7a75d39adddf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019e9007-3e4d-73ad-bc17-ea290955f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-7e9f-a70f-7a75d39adddf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_019e9007-3e4d-73ad-bc17-ea290955f97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables" xlink:type="simple" xlink:href="naut-20260630.xsd#BasicandDilutedNetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-7278-bb47-520c794dda4e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019e9007-3e4d-7c59-a1bf-4a5d5f6d8d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-7278-bb47-520c794dda4e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_019e9007-3e4d-7c59-a1bf-4a5d5f6d8d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019e9007-3e4d-7c96-8221-9ef5d2dd6fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-7278-bb47-520c794dda4e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_019e9007-3e4d-7c96-8221-9ef5d2dd6fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SegmentInformationTables" xlink:type="simple" xlink:href="naut-20260630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019e9007-3e4d-7bde-bf76-a14f9b3b2b57" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019e9007-3e4d-7071-8548-4fb8e4b30bea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019e9007-3e4d-7bde-bf76-a14f9b3b2b57" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_019e9007-3e4d-7071-8548-4fb8e4b30bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#DescriptionofBusinessandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-72d3-b7ad-37450b8ea18f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3e4c-74f4-9a3b-9d8768419b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-72d3-b7ad-37450b8ea18f" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3e4c-74f4-9a3b-9d8768419b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3e4c-73e5-b846-14a3d455c579" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3e4c-74f4-9a3b-9d8768419b5b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3e4c-73e5-b846-14a3d455c579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-79e4-a9a7-d510521870b4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_019e9007-3e4c-73e5-b846-14a3d455c579" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-79e4-a9a7-d510521870b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_019e9007-3e4c-7037-97b9-0982dff1c978" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_019e9007-3e4c-79e4-a9a7-d510521870b4" xlink:to="loc_us-gaap_PrivatePlacementMember_019e9007-3e4c-7037-97b9-0982dff1c978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_019e9007-3e4c-74f4-9a3b-9d8768419b5b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e9007-3e4c-7e0d-aa1b-06e0eaf55338" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_019e9007-3e4c-7e0d-aa1b-06e0eaf55338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_019e9007-3e4c-77f8-a58d-a9cb88fdb552" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_019e9007-3e4c-77f8-a58d-a9cb88fdb552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e9007-3e4c-772d-8cfb-da83c3df6a95" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_019e9007-3e4c-772d-8cfb-da83c3df6a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-7c10-9464-e06e29aa59a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e9007-3e4c-7c10-9464-e06e29aa59a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_019e9007-3e4c-70de-8792-9bd5515d7f0e" xlink:href="naut-20260630.xsd#naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_019e9007-3e4c-70de-8792-9bd5515d7f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_019e9007-3e4c-7d06-82af-342525d6a71a" xlink:href="naut-20260630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_019e9007-3e4c-7d06-82af-342525d6a71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_019e9007-3e4c-73db-a554-12bf45edce3a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_019e9007-3e4c-7da0-9abc-d47020eecabc" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_019e9007-3e4c-73db-a554-12bf45edce3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-70f6-a918-b4753d38cb46" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_019e9007-3e4c-70f6-a918-b4753d38cb46" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:to="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_019f883a-fb9e-7450-906a-5eaa258b4d6d" xlink:to="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantRevenueMember_019f883a-fb9e-7347-858a-d94b02a69d4a" xlink:href="naut-20260630.xsd#naut_GrantRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_019f883a-fb9e-7ea6-a967-8b89617fdc26" xlink:to="loc_naut_GrantRevenueMember_019f883a-fb9e-7347-858a-d94b02a69d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019f883a-fb9e-7f74-a709-4dedf5ce4fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019f883a-fb9e-7f74-a709-4dedf5ce4fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_019f883a-fb9e-76a8-98c7-5b84ae47fd62" xlink:to="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_019f883a-fb9e-7cfe-9d9a-1aae104098dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_NumberOfOperatingSegments_019f883a-fb9e-7cfe-9d9a-1aae104098dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019f883a-fb9e-730d-81bf-b7257c29216b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_NumberOfReportableSegments_019f883a-fb9e-730d-81bf-b7257c29216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019f883a-fb9e-792a-b1bd-4499ae8ad37e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_Revenues_019f883a-fb9e-792a-b1bd-4499ae8ad37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantLiabilityCurrent_019f883a-fb9e-764c-b57c-1802581c4905" xlink:href="naut-20260630.xsd#naut_GrantLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_naut_GrantLiabilityCurrent_019f883a-fb9e-764c-b57c-1802581c4905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019f8bb8-d30e-765e-a83e-46a0d2a68c40" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019f8bb8-d30e-765e-a83e-46a0d2a68c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_019f8bb8-d30e-7989-a459-9ca728805763" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_019f8bb8-d30e-7989-a459-9ca728805763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019f8bb8-d30e-7264-b278-5e3446d6baff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_019f8bb8-d30e-7264-b278-5e3446d6baff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_019f883b-39c2-750c-85b6-1cb42c0cab9a" xlink:href="naut-20260630.xsd#naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory_019f883b-39c2-750c-85b6-1cb42c0cab9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019f883b-39c2-7545-878b-cbfa319c7b46" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_019f883a-fb9e-7b91-a35f-5dea32230095" xlink:to="loc_us-gaap_InventoryNet_019f883b-39c2-7545-878b-cbfa319c7b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-75b1-b1a8-03706aae2083" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-75b1-b1a8-03706aae2083" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_019e9007-3e4c-7fbc-9fb7-f165a681929f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_019e9007-3e4c-7844-b20a-60eb500acc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_019e9007-3e4c-7844-b20a-60eb500acc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_019e9007-3e4c-7877-9730-da9b562cd8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_019e9007-3e4c-79b9-8fc4-416c7276bca1" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_019e9007-3e4c-7877-9730-da9b562cd8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-7751-8ad1-a8a77d67dede" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_019e9007-3e4c-7038-bd71-2aaee5cce76c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_MutualFundMember_019e9007-3e4c-7038-bd71-2aaee5cce76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-798a-bbf6-0e1ee8ce8cab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-798a-bbf6-0e1ee8ce8cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-7f13-a7a6-c9717ea0e81c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-7f13-a7a6-c9717ea0e81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-765f-ba48-259bebb69977" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-765f-ba48-259bebb69977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-733e-a3a8-c55f05d27520" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7742-a197-a781d8923313" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-733e-a3a8-c55f05d27520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e9007-3e4c-7367-823d-1f23712a0fec" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfFinancialPositionLocationBalanceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_StatementOfFinancialPositionLocationBalanceAxis_019e9007-3e4c-7367-823d-1f23712a0fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-7f1c-b2a7-e2ce134d7c0d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-78b4-8db7-fab02b012287" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e9007-3e4c-78b4-8db7-fab02b012287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7840-b847-d80710e7bfed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e9007-3e4c-7840-b847-d80710e7bfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7eeb-a3d1-6c6ae4a02ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e9007-3e4c-7eeb-a3d1-6c6ae4a02ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7168-a11f-920660eb599a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7275-b926-5d3874ecc989" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e9007-3e4c-7168-a11f-920660eb599a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7285-9d30-54688263e7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-79f2-b7d4-1c3ca0618b43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7285-9d30-54688263e7d8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-79f2-b7d4-1c3ca0618b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-71ec-a358-6bca4efacc11" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-79f2-b7d4-1c3ca0618b43" xlink:to="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-71ec-a358-6bca4efacc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_019e9007-3e4c-71ec-a358-6bca4efacc11" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-705d-bcf3-0567342458ce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_019e9007-3e4c-705d-bcf3-0567342458ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-737b-b186-4ebe700d0a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_CommercialPaperMember_019e9007-3e4c-737b-b186-4ebe700d0a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-7356-b5fd-189a50aa8686" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_019e9007-3e4c-7356-b5fd-189a50aa8686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-71bd-a8b2-7a940fff9b85" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_019e9007-3e4c-7b95-b777-294b2a26c077" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_019e9007-3e4c-71bd-a8b2-7a940fff9b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_019e9007-3e4c-79f2-b7d4-1c3ca0618b43" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e9007-3e4c-78a4-bcb2-fa52eae72785" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_019e9007-3e4c-78a4-bcb2-fa52eae72785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e9007-3e4c-7251-be17-cc713aa6f88b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_019e9007-3e4c-7251-be17-cc713aa6f88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3e4c-7eb1-aeba-440665aa469a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_019e9007-3e4c-7528-8a73-c71ea239a859" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_019e9007-3e4c-7eb1-aeba-440665aa469a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:href="naut-20260630.xsd#naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_019e9007-3e4c-7be5-a936-81501b83b699" xlink:to="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e9007-3e4c-72ad-8960-1cda2b814acb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_019e9007-3e4c-72ad-8960-1cda2b814acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e9007-3e4c-7ef1-9732-cd7ba931fe8d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_019e9007-3e4c-7ef1-9732-cd7ba931fe8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3e4c-7d6e-8bc5-59d5e8fda356" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_019e9007-3e4c-766e-b212-f716da3df818" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_019e9007-3e4c-7d6e-8bc5-59d5e8fda356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7145-9aac-d68e88431a62" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_019e9007-3e4c-7593-8697-1ccaccc57d40" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7145-9aac-d68e88431a62" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_019e9007-3e4c-7593-8697-1ccaccc57d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_019e9007-3e4c-75ba-ac6d-fb5c01a6a114" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_019e9007-3e4c-7145-9aac-d68e88431a62" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_019e9007-3e4c-75ba-ac6d-fb5c01a6a114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7a4c-ad9a-0711e7911ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3e4c-7964-9d12-5f8e31c5aa88" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7a4c-ad9a-0711e7911ec2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3e4c-7964-9d12-5f8e31c5aa88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3e4c-7713-942e-32a5e3c1545d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3e4c-7964-9d12-5f8e31c5aa88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3e4c-7713-942e-32a5e3c1545d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_019e9007-3e4c-7713-942e-32a5e3c1545d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LaboratoryEquipmentMember_019e9007-3e4c-7546-9b8d-f710181b0884" xlink:href="naut-20260630.xsd#naut_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_naut_LaboratoryEquipmentMember_019e9007-3e4c-7546-9b8d-f710181b0884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_019e9007-3e4c-76a9-ad10-41dfd08cb293" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_019e9007-3e4c-76a9-ad10-41dfd08cb293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_019e9007-3e4c-703c-9213-57c02f87b483" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_us-gaap_ComputerEquipmentMember_019e9007-3e4c-703c-9213-57c02f87b483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_019e9007-3e4c-7b79-88ad-6a508e975771" xlink:href="naut-20260630.xsd#naut_FurnitureFixturesAndOfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_019e9007-3e4c-7b79-88ad-6a508e975771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PrototypeEquipmentMember_019e9007-3e4c-752d-92db-2b64f82c6e7c" xlink:href="naut-20260630.xsd#naut_PrototypeEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_naut_PrototypeEquipmentMember_019e9007-3e4c-752d-92db-2b64f82c6e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_019e9007-3e4c-7dfb-ac3c-7866eaf6577c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_019e9007-3e4c-70a0-8af8-0b64e86d57fa" xlink:to="loc_us-gaap_ConstructionInProgressMember_019e9007-3e4c-7dfb-ac3c-7866eaf6577c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_019e9007-3e4c-7964-9d12-5f8e31c5aa88" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019e9007-3e4c-7eb2-81a6-8d3a72767966" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019e9007-3e4c-7eb2-81a6-8d3a72767966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019e9007-3e4c-78a5-adee-9295c6c6996b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019e9007-3e4c-78a5-adee-9295c6c6996b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7314-a385-b4aa5d01cfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_019e9007-3e4c-74fe-b097-e8f51edb77a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e9007-3e4c-7314-a385-b4aa5d01cfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-71c1-a988-1ae9851202b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019e9007-3e4c-7b85-bcdb-f2a216d79c99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-71c1-a988-1ae9851202b3" xlink:to="loc_us-gaap_Depreciation_019e9007-3e4c-7b85-bcdb-f2a216d79c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019e9007-3e4c-73a9-be34-bfac20ad8788" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-71c1-a988-1ae9851202b3" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019e9007-3e4c-73a9-be34-bfac20ad8788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_019e9007-3e4c-7e31-9945-2df7927672a4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-71c1-a988-1ae9851202b3" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_019e9007-3e4c-7e31-9945-2df7927672a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7607-905e-aeae5b26e063" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e9007-3e4c-7aa0-aed1-5eaa9cefb6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7607-905e-aeae5b26e063" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e9007-3e4c-7aa0-aed1-5eaa9cefb6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedResearchAndDevelopmentCurrent_019e9007-3e4c-796e-91ee-8e175244780b" xlink:href="naut-20260630.xsd#naut_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7607-905e-aeae5b26e063" xlink:to="loc_naut_AccruedResearchAndDevelopmentCurrent_019e9007-3e4c-796e-91ee-8e175244780b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019e9007-3e4c-7d33-8770-d75c5a93ecc5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7607-905e-aeae5b26e063" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019e9007-3e4c-7d33-8770-d75c5a93ecc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_GrantLiabilitiesCurrent_019f609c-be09-70f3-9072-0ccc739d3f20" xlink:href="naut-20260630.xsd#naut_GrantLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7607-905e-aeae5b26e063" xlink:to="loc_naut_GrantLiabilitiesCurrent_019f609c-be09-70f3-9072-0ccc739d3f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_019e9007-3e4c-7fa0-ac6a-0f634efbf53c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7607-905e-aeae5b26e063" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_019e9007-3e4c-7fa0-ac6a-0f634efbf53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7448-9df8-457c54ebd061" xlink:href="naut-20260630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-7607-905e-aeae5b26e063" xlink:to="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_019e9007-3e4c-7448-9df8-457c54ebd061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78a3-97e6-67f4a0b01e28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-7126-a9f5-51c0b9bf1563" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78a3-97e6-67f4a0b01e28" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e9007-3e4c-7126-a9f5-51c0b9bf1563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_019e9007-3e4c-7b87-ab3a-1bcc3e9d9478" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78a3-97e6-67f4a0b01e28" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_019e9007-3e4c-7b87-ab3a-1bcc3e9d9478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-78fa-854e-7f489a6d58cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_019e9007-3e4c-78a3-97e6-67f4a0b01e28" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e9007-3e4c-78fa-854e-7f489a6d58cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockNarrativeDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CommonStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e9007-3e4c-7bd4-881b-2835dfb058ab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_019e9007-3e4c-7805-bc5b-c14a75517015" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e9007-3e4c-7bd4-881b-2835dfb058ab" xlink:to="loc_us-gaap_CommonStockSharesIssued_019e9007-3e4c-7805-bc5b-c14a75517015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-728b-92b5-18826a13c720" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e9007-3e4c-7bd4-881b-2835dfb058ab" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_019e9007-3e4c-728b-92b5-18826a13c720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_019e9007-3e4c-729e-9725-f8f0be5e0a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_019e9007-3e4c-7d85-a69c-e135985a9605" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_019e9007-3e4c-729e-9725-f8f0be5e0a3f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_019e9007-3e4c-7d85-a69c-e135985a9605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019e9007-3e4c-76f7-8e7d-b33b25f2431e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019e9007-3e4c-7d85-a69c-e135985a9605" xlink:to="loc_us-gaap_PlanNameAxis_019e9007-3e4c-76f7-8e7d-b33b25f2431e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-76f7-8e7d-b33b25f2431e" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-75b1-b0f4-4d07bbb729c0" xlink:href="naut-20260630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:to="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-75b1-b0f4-4d07bbb729c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-7128-897e-178800990ab5" xlink:href="naut-20260630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-77db-8efa-427c080e1782" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-7128-897e-178800990ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_019e9007-3e4c-7d85-a69c-e135985a9605" xlink:to="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4c-779e-bf40-b7a89ae33c55" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4c-779e-bf40-b7a89ae33c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4c-789b-ba3c-9bc5684b34c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4c-789b-ba3c-9bc5684b34c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3e4c-7575-a406-5e31f249ba51" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_019e9007-3e4c-7550-ae7d-e763b6cf5e5a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_019e9007-3e4c-7575-a406-5e31f249ba51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_019e9007-3e4c-7071-9f71-e90b1e9413e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019e9007-3e4c-7ca6-bf54-c6a750c4ebda" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019e9007-3e4c-7071-9f71-e90b1e9413e3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019e9007-3e4c-7ca6-bf54-c6a750c4ebda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019e9007-3e4c-72c9-9317-2fd79440e873" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_019e9007-3e4c-7071-9f71-e90b1e9413e3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_019e9007-3e4c-72c9-9317-2fd79440e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-7689-9f8d-eca50679d403" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4c-7689-9f8d-eca50679d403" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_019e9007-3e4c-7ebc-9227-78d3f8989055" xlink:to="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-7532-bbb2-1af6713c8e74" xlink:href="naut-20260630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:to="loc_naut_A2021EquityIncentivePlanMember_019e9007-3e4c-7532-bbb2-1af6713c8e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-74e2-9ce0-134c9561929f" xlink:href="naut-20260630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_019e9007-3e4c-79d5-a2cf-3656c49592a3" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_019e9007-3e4c-74e2-9ce0-134c9561929f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4c-78e4-833d-aba9e10082f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_019e9007-3e4d-775c-9bbb-9d9dd37ae643" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:to="loc_us-gaap_EmployeeStockMember_019e9007-3e4d-775c-9bbb-9d9dd37ae643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ad2-a36a-02004c6bf24c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4c-7162-968b-2a8420f71952" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ad2-a36a-02004c6bf24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019f8830-1c98-7076-8c13-88b8bf069392" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019f8830-1c98-7076-8c13-88b8bf069392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4c-75a1-92f9-b8a07ae28bf4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4d-7115-bb01-0d59ee99dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_019e9007-3e4d-7115-bb01-0d59ee99dfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019e9007-3e4d-731c-b37f-2645bbe96c28" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_019e9007-3e4d-731c-b37f-2645bbe96c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019e9007-3e4d-7837-9bc7-220d105974c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_019e9007-3e4d-7837-9bc7-220d105974c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_019e9007-3e4d-7356-a680-8d36eade89b9" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod_019e9007-3e4d-7356-a680-8d36eade89b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_019e9007-3e4d-744f-8969-0fa7b0802e94" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_019e9007-3e4d-744f-8969-0fa7b0802e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019e9007-3e4d-7f0a-9865-7a2d2dd3a9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_019e9007-3e4d-7f0a-9865-7a2d2dd3a9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_019e9007-3e4d-7eb3-a5d1-58627a68878f" xlink:href="naut-20260630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_019e9007-3e4d-7eb3-a5d1-58627a68878f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019e9007-3e4d-7b18-926b-76ccaa916472" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_019e9007-3e4d-7b18-926b-76ccaa916472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7e1d-bd5d-5cb835894b87" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7e1d-bd5d-5cb835894b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_019e9007-3e4d-76ed-b805-9bf0c923698b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_019e9007-3e4d-76ed-b805-9bf0c923698b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019e9007-3e4d-7024-b9b6-9450ae9aa685" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_019e9007-3e4d-7024-b9b6-9450ae9aa685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019f8830-1c98-74f8-a2c4-35e91c964abb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-79f3-8a58-c9a5a582a2a1" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019f8830-1c98-74f8-a2c4-35e91c964abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7102-8a44-b6d730596802" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7102-8a44-b6d730596802" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-74a1-9ca2-370cc8fe40d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-74a1-9ca2-370cc8fe40d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7e33-a1dd-d48e87c097de" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-74a1-9ca2-370cc8fe40d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7e33-a1dd-d48e87c097de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7d02-85e3-6ad940ccea89" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7e33-a1dd-d48e87c097de" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7d02-85e3-6ad940ccea89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_019eaa5c-4910-7879-8b2d-232c0a700124" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:to="loc_srt_RangeAxis_019eaa5c-4910-7879-8b2d-232c0a700124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_019eaa5c-4910-7879-8b2d-232c0a700124" xlink:to="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_019eaa5c-a903-700a-93f6-eb09dd3bf661" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:to="loc_srt_MinimumMember_019eaa5c-a903-700a-93f6-eb09dd3bf661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_019eaa5d-0b34-7489-97d5-c89bf7a5d1a8" xlink:href="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_019eaa5c-4910-7e04-8754-0ad52fa9d761" xlink:to="loc_srt_MaximumMember_019eaa5d-0b34-7489-97d5-c89bf7a5d1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-7522-a1de-0fcd2406b122" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019e9007-3e4d-7b43-90c8-028640cb7fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_019e9007-3e4d-7b43-90c8-028640cb7fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019e9007-3e4d-785f-a36f-7f59e330bc00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_019e9007-3e4d-785f-a36f-7f59e330bc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019e9007-3e4d-7226-a271-c4dfebe0fca3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_019e9007-3e4d-7226-a271-c4dfebe0fca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7202-b50a-0196f563c6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_019e9007-3e4d-7202-b50a-0196f563c6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019e9007-3e4d-76a3-b955-4adb08007c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_019e9007-3e4d-76a3-b955-4adb08007c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019e9007-3e4d-78f4-bc37-3a5b54a82129" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7914-bc21-78869685b003" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_019e9007-3e4d-78f4-bc37-3a5b54a82129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3e4d-7dcc-87af-76e953f00efe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3e4d-7dcc-87af-76e953f00efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4d-773b-9b52-0c4913e035bd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3e4d-7dcc-87af-76e953f00efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4d-773b-9b52-0c4913e035bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019e9007-3e4d-7458-ad27-64b4d3fd70bf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3e4d-7dcc-87af-76e953f00efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_019e9007-3e4d-7458-ad27-64b4d3fd70bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3e4d-7a6a-b9c1-c3f24127efd9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3e4d-7dcc-87af-76e953f00efe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_019e9007-3e4d-7a6a-b9c1-c3f24127efd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019e9007-3e4d-7375-b687-4b1977e3ffd6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3e4d-7dcc-87af-76e953f00efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_019e9007-3e4d-7375-b687-4b1977e3ffd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4d-7206-b82b-b5e85dca9762" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_019e9007-3e4d-7dcc-87af-76e953f00efe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_019e9007-3e4d-7206-b82b-b5e85dca9762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019e9007-3e4d-763b-bc67-0747e6728aae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_019e9007-3e4d-763b-bc67-0747e6728aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019e9007-3e4d-7872-a8bd-e5709761c4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_019e9007-3e4d-7872-a8bd-e5709761c4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3e4d-7658-ba4f-a53bc924ddde" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3e4d-7658-ba4f-a53bc924ddde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019e9007-3e4d-705a-bb0d-01de6a9d6011" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3e4d-7658-ba4f-a53bc924ddde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019e9007-3e4d-705a-bb0d-01de6a9d6011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019e9007-3e4d-7f46-a817-f9d3ed9ca980" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3e4d-7658-ba4f-a53bc924ddde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_019e9007-3e4d-7f46-a817-f9d3ed9ca980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019e9007-3e4d-7502-bd98-c465b7903489" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3e4d-7658-ba4f-a53bc924ddde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_019e9007-3e4d-7502-bd98-c465b7903489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019e9007-3e4d-7694-b68e-ab2d22de42f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3e4d-7658-ba4f-a53bc924ddde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_019e9007-3e4d-7694-b68e-ab2d22de42f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019e9007-3e4d-7c0d-983e-bd446afe478a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_019e9007-3e4d-7658-ba4f-a53bc924ddde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_019e9007-3e4d-7c0d-983e-bd446afe478a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019e9007-3e4d-7a2e-851c-ae010848e83e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_019e9007-3e4d-7a2e-851c-ae010848e83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019e9007-3e4d-71e9-b847-5bfe6b3817ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_019e9007-3e4d-71e9-b847-5bfe6b3817ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019e9007-3e4d-7cc1-b22a-107c2380681d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_019e9007-3e4d-7cc1-b22a-107c2380681d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_019e9007-3e4d-75aa-8bd3-e144e4a44931" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_019e9007-3e4d-75aa-8bd3-e144e4a44931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019e9007-3e4d-7102-9a01-f2e69fe4298d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_019e9007-3e4d-7102-9a01-f2e69fe4298d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_019e9007-3e4d-7fdf-96b2-85ab58e8320d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-7d05-8924-4fa21c604f1c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_019e9007-3e4d-7fdf-96b2-85ab58e8320d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-70dc-adb4-3c16dfc72fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_019e9007-3e4d-70dc-adb4-3c16dfc72fd0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:to="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_019e9007-3e4d-7dab-9cdd-f99bde17ed07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7bcd-a3cb-40fa34dcf490" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_019e9007-3e4d-7aa0-a169-f39c6b470120" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7bcd-a3cb-40fa34dcf490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019e9007-3e4d-7d9e-b481-9408bd4a7a12" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementOfIncomeLocationBalanceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:to="loc_us-gaap_StatementOfIncomeLocationBalanceAxis_019e9007-3e4d-7d9e-b481-9408bd4a7a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_019e9007-3e4d-78a9-b23f-0e1185428a15" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e9007-3e4d-70bf-a7fc-f62a028d0103" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_019e9007-3e4d-7c6a-9b71-0e092a1fada6" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e9007-3e4d-70bf-a7fc-f62a028d0103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-74ca-964d-b3b9968849a0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_019e9007-3e4d-78e6-b2a6-9dca5b568304" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-74ca-964d-b3b9968849a0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_019e9007-3e4d-78e6-b2a6-9dca5b568304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_019e9007-3e4d-760b-b07a-69d1a3e33652" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-74ca-964d-b3b9968849a0" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_019e9007-3e4d-760b-b07a-69d1a3e33652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_019e9007-3e4d-74a8-a06c-b2b090c4f442" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-74ca-964d-b3b9968849a0" xlink:to="loc_us-gaap_OperatingLeasePayments_019e9007-3e4d-74a8-a06c-b2b090c4f442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_019e9007-3e4d-7f8b-9811-67c39463f3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-74ca-964d-b3b9968849a0" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_019e9007-3e4d-7f8b-9811-67c39463f3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_NumberOfFinancialInstitution_019e9007-3e4d-767b-9848-fe5c7f919581" xlink:href="naut-20260630.xsd#naut_NumberOfFinancialInstitution"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-74ca-964d-b3b9968849a0" xlink:to="loc_naut_NumberOfFinancialInstitution_019e9007-3e4d-767b-9848-fe5c7f919581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-7fd4-bc92-fa9cd1edc8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_019e9007-3e4d-7fd4-bc92-fa9cd1edc8d0" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e9007-3e4d-78a1-b2da-8900549413ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e9007-3e4d-78a1-b2da-8900549413ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e9007-3e4d-7024-b124-7df4be7933ef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e9007-3e4d-7024-b124-7df4be7933ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e9007-3e4d-76e1-aa54-401eaffd4dde" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e9007-3e4d-76e1-aa54-401eaffd4dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e9007-3e4d-7ed7-9efc-e61b0b85735f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e9007-3e4d-7ed7-9efc-e61b0b85735f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019e9007-3e4d-78bc-9208-dae56729021b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019e9007-3e4d-78bc-9208-dae56729021b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_019e9007-3e4d-7db6-be69-c003c75129ff" xlink:href="naut-20260630.xsd#naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_019e9007-3e4d-7db6-be69-c003c75129ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-763d-af2a-3efb4dc5bd90" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e9007-3e4d-763d-af2a-3efb4dc5bd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e9007-3e4d-71d7-bc43-9e7c7957e5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e9007-3e4d-71d7-bc43-9e7c7957e5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019e9007-3e4d-7226-bb66-facdb20b60f1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_019e9007-3e4d-7d66-a2e6-40c66b71657b" xlink:to="loc_us-gaap_OperatingLeaseLiability_019e9007-3e4d-7226-bb66-facdb20b60f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-728b-9c60-1697e4dfadc2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019e9007-3e4d-76be-bb36-59cfc741fa4e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-728b-9c60-1697e4dfadc2" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019e9007-3e4d-76be-bb36-59cfc741fa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019e9007-3e4d-7801-86ad-2d7af10ea552" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019e9007-3e4d-76be-bb36-59cfc741fa4e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019e9007-3e4d-7801-86ad-2d7af10ea552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019e9007-3e4d-7554-b036-5c2839eff16a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_019e9007-3e4d-76be-bb36-59cfc741fa4e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019e9007-3e4d-7554-b036-5c2839eff16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019e9007-3e4d-7cf3-aedd-54112372f920" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-728b-9c60-1697e4dfadc2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019e9007-3e4d-7cf3-aedd-54112372f920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3e4d-74f1-9031-7b53b4f0a7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019e9007-3e4d-7cf3-aedd-54112372f920" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019e9007-3e4d-74f1-9031-7b53b4f0a7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3e4d-7b08-9188-8cd353419125" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019e9007-3e4d-7cf3-aedd-54112372f920" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019e9007-3e4d-7b08-9188-8cd353419125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_019e9007-3e4d-7d76-860a-b5969b31f7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019e9007-3e4d-7cf3-aedd-54112372f920" xlink:to="loc_us-gaap_EarningsPerShareBasic_019e9007-3e4d-7d76-860a-b5969b31f7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_019e9007-3e4d-7812-b8ef-813dbfcac02f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_019e9007-3e4d-7cf3-aedd-54112372f920" xlink:to="loc_us-gaap_EarningsPerShareDiluted_019e9007-3e4d-7812-b8ef-813dbfcac02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-7a22-b149-5898ba442307" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3e4d-70c8-99fc-2f6e7db2e7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_019e9007-3e4d-7a22-b149-5898ba442307" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3e4d-70c8-99fc-2f6e7db2e7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3e4d-7b5d-8cc5-048f4901fae3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3e4d-70c8-99fc-2f6e7db2e7f3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3e4d-7b5d-8cc5-048f4901fae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_019e9007-3e4d-7b5d-8cc5-048f4901fae3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ed1-8344-71f09f8b7961" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_019e9007-3e4d-7ed1-8344-71f09f8b7961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_EmployeeStockPurchasePlanMember_019e9007-3e4d-76bf-8456-2c901ec322ee" xlink:href="naut-20260630.xsd#naut_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_019e9007-3e4d-7099-a091-aebae76af19d" xlink:to="loc_naut_EmployeeStockPurchasePlanMember_019e9007-3e4d-76bf-8456-2c901ec322ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e9007-3e4d-780c-badd-67bf783ec1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_019e9007-3e4d-70c8-99fc-2f6e7db2e7f3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e9007-3e4d-780c-badd-67bf783ec1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e9007-3e4d-7c56-ae97-5fadaabc1e06" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_019e9007-3e4d-780c-badd-67bf783ec1fc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_019e9007-3e4d-7c56-ae97-5fadaabc1e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SegmentInformationDetails" xlink:type="simple" xlink:href="naut-20260630.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_019e9007-3e4d-7df9-85a3-f0e5f40284f7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3e4d-7944-a109-6ff7ab4cd52f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_019e9007-3e4d-7df9-85a3-f0e5f40284f7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3e4d-7944-a109-6ff7ab4cd52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_019e9007-3e4d-7945-a606-a7c8b0405360" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3e4d-7944-a109-6ff7ab4cd52f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_019e9007-3e4d-7945-a606-a7c8b0405360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_019e9007-3e4d-77eb-be8d-405580e0dfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_019e9007-3e4d-7945-a606-a7c8b0405360" xlink:to="loc_us-gaap_SegmentDomain_019e9007-3e4d-77eb-be8d-405580e0dfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReportableSegmentMember_019e9007-3e4d-7142-b7f4-e8f3dcedea16" xlink:href="naut-20260630.xsd#naut_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_019e9007-3e4d-77eb-be8d-405580e0dfc5" xlink:to="loc_naut_ReportableSegmentMember_019e9007-3e4d-7142-b7f4-e8f3dcedea16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_019e9007-3e4d-7944-a109-6ff7ab4cd52f" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_019f7dd2-4751-7876-81a0-88fb551b3bea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_Revenues_019f7dd2-4751-7876-81a0-88fb551b3bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_019eaa6a-432b-7d62-9c19-9d249ce5335e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_CostOfRevenue_019eaa6a-432b-7d62-9c19-9d249ce5335e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019e9007-3e4d-7cae-a86b-1652286f27c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019e9007-3e4d-7cae-a86b-1652286f27c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProfessionalServicesAndLaboratoryExpenses_019e9007-3e4d-7434-b588-77899fd744d6" xlink:href="naut-20260630.xsd#naut_ProfessionalServicesAndLaboratoryExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_naut_ProfessionalServicesAndLaboratoryExpenses_019e9007-3e4d-7434-b588-77899fd744d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FacilityExpenses_019e9007-3e4d-7922-99d8-c23eaebb6f87" xlink:href="naut-20260630.xsd#naut_FacilityExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_naut_FacilityExpenses_019e9007-3e4d-7922-99d8-c23eaebb6f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e9007-3e4d-7fb7-ac3f-d9f2150621e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_019e9007-3e4d-7fb7-ac3f-d9f2150621e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019e9007-3e4d-7a9e-a414-516cb2322dce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019e9007-3e4d-7a9e-a414-516cb2322dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e9007-3e4d-7e06-9810-60b99bdc86a4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_019e9007-3e4d-76eb-b584-ce92035e1b0d" xlink:to="loc_us-gaap_OperatingExpenses_019e9007-3e4d-7e06-9810-60b99bdc86a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019f7dd0-b164-7d18-bc30-5d9507f081c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_019f7dd0-b164-7d18-bc30-5d9507f081c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019f8c4f-19c3-7fbf-bd73-d889f184c438" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019f8c4f-19c3-7fbf-bd73-d889f184c438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019f7dd0-b164-7b79-a02c-05611fcf2493" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract_019f8c06-343d-74c5-a6ba-aab45a1179db" xlink:to="loc_us-gaap_NetIncomeLoss_019f7dd0-b164-7b79-a02c-05611fcf2493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_019e9007-3e4d-7253-bf6f-02489337752f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_019e9007-3e4d-7478-b51d-045f52dce667" xlink:to="loc_us-gaap_NumberOfReportableSegments_019e9007-3e4d-7253-bf6f-02489337752f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>naut-20260630_g1.jpg
<TEXT>
begin 644 naut-20260630_g1.jpg
M_]C_X  02D9)1@ ! @$ > !X  #__@ 23$5!1%1/3TQ3('8R,"XP /_; (0
M!04%" 4(# <'# P)"0D,#0P,# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0$%" @*!PH,!P<,#0P*# T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\0!H@
M 04! 0$! 0$           $" P0%!@<("0H+ 0 # 0$! 0$! 0$!
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M\O/T]?;W^/GZ_\  $0@$+ =Z P$1  (1 0,1 ?_:  P# 0 "$0,1 #\ ^RZ
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MG5&:GM]QW%9F@4 % !0 4 % !0!S^L^*](\/.D6J7<%F\BED6:0(64'!(SU
M/%4HN7PILER4=W8NZ3K5CKT/VK39X[J$,4\R)@R[@ 2N1QD C(]Q0TXZ-6&F
MGJC3J1A0 4 % !0 4 % 'REX]^.FN>%M=N])LX+%X+5U5&ECG,A!C1SN*7**
M3ECT4<8^M=L*,914FWKZ?Y''.K*,G%6T_KN>@?"+XKOX_P#/L]22&"_M\2*L
M(94D@.%)59))&W1O@/\ -C#H0!S652G[.S6WZFM.ISZ/<]MKG-SRGXL?$?\
MX5]81O:K'-J%T^V".4,4"+@RR.J.C%0"%7# EW'4*U;TX<[UV1C4GR+3<\<\
M(_'S7M?UFRTRYM[!(;NYBA=HXK@.%=@I*EKIE#8/!*L/8UO*C&,6TWHO+_(P
MC5DVDTM7Y_YGUS7"=H4 % !0 4 % !0!\[?%SXN:MX!U:'3M.AM)8I;1+@FX
M29G#M-/&0#'/$-N(E(!4G)/., ==.FIJ[OO;3Y>1S5*C@[*VQZ5\,O%5UXST
M*'5KY(HYY7F4K"KK&!'(R# =Y&R0.<L>>F.E8U(J$N5&L).4;L[^LC0* "@
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M]K+?S_S/L&N [0H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@#-UG5(=#L;C4;CB*TADF?U(12V
M![G&!ZDBFE=I+J)OE3;Z'YKZGJ6H^.]8,\I,][J$ZI&F> 78)%$G]U$R%7T
MR><FO724(V6R/+;<WYL^S?"GP)\/Z+:HNIPKJ5X5'FR2,_EACU6*,,JA!T#.
M"YQG*YVCSY5I-Z:([HTHQ6NK&^+O@5H&L6;C2H!IU\JDPO$S>6S ?*DL;,R[
M6/!90KKG=E@-I<:THO75"E2BU[NC/E3PC;>(?"&KV^IV]C? V\@\Q1;SXDB)
MQ+&<)A@RY'< X8<@&NV7+).+:^]')'FBTTG]Q^C0.>1TKR3TSB_%?Q!T/P6
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MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M]M-\LM]<2W2VL!/WF\Y\R.,Y$4>06(^\Q5 1NR,Y0YZC732Y<9\D%WUL>3^
MO!>H?%;69+N_>1K82>;?71ZL6.1%&<8\QQPH VQ1C.,!$;><E2C9;]$8PBZC
MN]NK/N._GM/!NC2S01K%:Z9:NZ1)P-L2%E0=3EB ,G)).22237G*\Y6>[9Z#
MM!:;)'Y\:3!/\1?$2+J=P(GU"9GGN'("QHJEVQN(4!439$I(&=B#M7J/]W'W
M5MLCS5[\M7OU/JB;X/\ @%[4VZ2K'-C N1?YE!QUVM(8#SR1Y(_"N+VM2]_P
MM_3.OV<+6_&Y\N:9JEU\-/$ADM91+]@N&B=HS\ES 'PPX)!65 &7).UMK [E
M!KL:52.O5?<SD3=.6G1_>?<OBOX?:+\0?L]UJ0ED$*'R3%(8P4EVMD\<YPI&
M>E>=&<J=TCT)04[-GYZVMG'+J4=HV?*:Y6(\\[3*%//KCO7J-Z7\CS.MO,_0
M#PI\*="\&7O]HZ8LRSF-HLR2EUVN5)X('.5'->9*I*:L]CTHTXP=T>DUB:G/
M>+O^0)J'_7C=?^B'JX_$O5?F3+X7Z,_.'PGK$?A_5[/4YE:2.SN(YF5,;F",
M&(7) R<<9(%>M)<R<5U1Y<7RM/LSZL?]I?1PIV6-X6QP"80"?<AV('O@_0UP
M^P?='9[9=F?,/C/Q9=>.]6DU.= CR[(XH4RP1%X2-3@%B222<#<[$A5!"CLA
M%07*CDE)S=S[H^$WA>;PCX<M[*[79<R%[B9.Z/*<A#C/S(@16_V@<<5YU27-
M)M;;'H4X\L4GN?"?_,Q_]Q+_ -N:]+[/R_0\_P"U\_U/TUKQSU3XS^)?PU\9
M>+?$%UJ$5F9K8OY=L?M-HH\B,;4PKSJR[N7(90=S$D9->A3G"$4KZ]='O]QP
MSA.4F[:=-5_F>L6GP7\&:19"UU)4DN"BB2>6Z>-R^.60"2-$&[)4;.1@/OK!
MU9MW6W:QLJ<$K/?U/CS7[0>$]=G@TV;>+"Z)MYT8$X1@T3;EX+ ;<D<%@<<5
MWQ]Z*NMUJCB?NRLNCT/TKTZZ-[:PW+ *9HHY"!T!= V![#->0]'8]1:JY^8#
M+,VHE;4E9S<XB*G:1(9/D(;(VD-C!R,'G(KV.FO8\GKIW/K/1/V;M.%H&UFZ
MN9+V1<O]G:-(HW/)"[XW:0J>-S%0W)V+GCB==W]U*WF=JHJWO-W\CY=\5Z%)
MX0UFYTL2%VLIMJ2K\K$</&_!^5MI4D _*V0"<9KLB^:*?<XY+E;78_1WPO?O
MJNCV-]+_ *RZL[:9_P#>EA1V_5C7DR5FUV;/4B[I/R1NU)04 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !TH ;O7U'YT
M[ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G1
M8 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+
M &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18
M WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+
M&]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18
MWKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &
M]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 WKZC\Z+ &]?4?G18 W
MKZC\Z+ .!!Z4@"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H *  G SZ4 47<N?Z5HE8@93$% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 H)7D<4 78WWC-9M
M6+0^D,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * (Y?NG_/>FMQ,I5H0% !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % %FW[_A4,I%BI*"@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MTO\ R3_Y:'_"9ZG_ - BY_.7_P"1J/KU?_H$J?\ DW_RL/[-PW_0;2_\D_\
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MPW_0;2_\D_\ EH?\)GJ?_0(N?SE_^1J/KU?_ *!*G_DW_P K#^S<-_T&TO\
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M *!*G_DW_P K#^S<-_T&TO\ R3_Y:'_"9ZG_ - BY_.7_P"1J/KU?_H$J?\
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MTO\ R3_Y:'_"9ZG_ - BY_.7_P"1J/KU?_H$J?\ DW_RL/[-PW_0;2_\D_\
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M?\+WT+_GA?\ _?N#_P"2:/J=3O'[W_\ (A_:-+^6?W1_^2#_ (7OH7_/"_\
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M^2#_ (7OH7_/"_\ ^_<'_P DT?4ZG>/WO_Y$/[1I?RS^Z/\ \D'_  O?0O\
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M2#_A>^A?\\+_ /[]P?\ R31]3J=X_>__ )$/[1I?RS^Z/_R0?\+WT+_GA?\
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M#_A>^A?\\+__ +]P?_)-'U.IWC][_P#D0_M&E_+/[H__ "0?\+WT+_GA?_\
M?N#_ .2:/J=3O'[W_P#(A_:-+^6?W1_^2'Q_'307.#%>H/5HH<?^.W#']*7U
M.IWC][_R&LPI=IKY+_Y([+0_B'H7B%EBM+I1,YP(I08I"?10X <^R%JYYT*E
M/64=.ZU7X?J==/$TJND)*_9Z/\=_D=K7,=@4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % $<OW3_ )[TUN)E*M" H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H LV_?\/ZU+*18J"@H * "@ H * "@ H
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M'W9B:\^52<]92;^9ZT*5.GI"*7R_7<VZR-@H * "@ H * "@ H * "@ H *
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M_GO36XF4JT("@ H \J^('_(8\._]A%__ $2:VAM+T,I;Q]3E;CXD^(H--O\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H \Y\:PG2KBVUV#(>&01RX_B0Y(S]1N0GT91V%?
M/X^/L)T\;#>,E&5NJ\_E=?-'U.626(IU<NJ?#*+E"_22MM\[27H^YZ(CK(H=
M3E6 (/J#R#^5>^FFDUL]4?+M.+<7HT[/U0ZF(* "@ H * "@ H * "@ H *
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MXHOE?RV_ ])KC/1"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MD5E'ML9DWPLTVYMM0M9[B^E_MD6GVJ626-YB;-]\;*S0D L>'!5D"@+$L:@
M/G:LTEI>WS%R+5:ZVO\ (T=1^'NG:GJ,^IR27*&^A\B[@CE"6]RGDM"AF386
M+1HV8V5UVLJGG!!2FTK::;=T-P3=]==RKI_PULM/N+:Z-U?W,EC#-;P^?,CJ
ML,T0B\L*(5 $:C*$88D_O&D 4*W-ZJRU$H)6=WH4;#X2:781VUK]HOY[.RD$
MR6DLZFW:96+"1T6)"3N.=JLL9/)0EF+#J-W=E=]>HE32TULNAHW?PVTR]@O+
M>1[D?VC>_P!H,ZR(LD-P,;6@81_(%QQO$AY.2:7.U9Z:*WR'R+5=W?YEBT\
M6$#7CSRW-Z=3M8K2Y-S(C%XXHS&&W)&C"5E)+/G[V"H7%'.]+65G=6'RK7?5
M6.:\1> Y[7PQ<:%I376J23M L O+B/\ T54>/:T;[8ML<"IN5%W.3\H!!(JE
M+WE)V7HMR'&T>57?KT/2="T>'P_86^F6W^JM(DB4]"VT<L?]IVRS>Y-9MW=V
M:I<JLNAJU(PH LV_?\/ZU+*18J"@H * "@ H * "@ H * "@ H * "@ H *
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MU9EA0 4 % !0 4 % !0 4 5[R[BL()+JX;9# CR2-@G:B*68X4%CA03@ D]
M"::3;26[T$W97>R*FC:S:>(+./4=.D\ZUN 3')M=-P#%3\LBJX^92/F4=,],
M54HN#<9:-?UT%&2DN:.S-.H*"@ H * "@#C_ !X@;1IR?X3$1_W]0?R)KR<Q
M5\-/RY7_ .317ZGN92[8RFNZFO\ R23_ $-S0W,FG6KGJUO"3^,:FNW#N]&D
MWUIP_P#24>?BERXBLETJ5%]TF:E=)QA0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % 'BOPW_TCQ'XBG;[R70B'T\ZY7^42UZ5?2E17]V_X1_S/'PNM
M;$2[2M^,O\CVJO-/8"@ H * "@ H * . \<>/K?P:(;=(9+_ %*^;9:V</#R
M'IN9L-L0,0,[6))^52 Q7HI4G5N[\L5NWT,*E14[*UY/9(YM-1^)$J?:!9:+
M$IY^S/+<&XP<G;YBR&#<. 3G&3Z9QK;#K3FGZV5ONW,[UM[0]+N_^1U_@SQ-
M?>(8YX]4L)M*O+*012HY#Q.2NX-#(,;UQ@G@J-R[7?)QC4@H6Y)*2:NN_P T
M:PDY7YHN+7W?([2L#8* "@ H * "@ H * "@ H * "@ H * .)UB^\20:W9V
M^FVMO-HTBC[;<.RB6)MS@B-3<1DC:$/$,G)//8;Q5/DDY-J?V5T?X?JC&3FI
M)12Y>KZK\?T.VK V"@#SKQIXNN_#FIZ-86J0O%JUX;><R*Y94!B&8BLB!6^<
M\NKCIQUSTTZ:G&<G>\5=6^>YA.;A*$5;WG9_@>BUS&YB^(M?M/"^GS:K?L4@
MMEW-C&YB2%5$!(!=V(51D#)&2!DU<(.I)0CNR)24$Y2V1Y?9>(_'OB*%=0TO
M3],L;.9?,A34)9WGDC.-C8@**A=3N =5X[]"W6X48/EG*3:WY4K?B<ZE5DN:
M,8I=.:]_P.G\*>*=9O;V32/$&FM874<1F6XA<2V<R!E0[).JON<8C)=]N2VW
M'.4X0BN>G*ZO:STDOZ[FD)R;Y)QL[7NMF1^&O&%YK'B35]#G2%;?2O(\ED5Q
M(WFKN;S"TC*<'IM1/?-$Z:A3A45[RO?MIV%&;E.4':T;6^9Z/7,=!Q.O7WB2
MWU:Q@TBUM[C2I6'VZ>1E$L*[P"8P;B(DA,GB*7GL>E;P5-QDYMJ2^%+9^NC_
M #1C)S4DH)./5]OQ7Y,[:L#8* "@ H * "@ H * "@ H \5^%7[C5/$%JOW(
M;_Y?QENE_D@KTL3K"E+O'](_YGCX/2I7CT4_UDOT/:J\T]@* "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H CE^Z?\]Z:W$RE6A 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 6;?O^']:EE(L5!04 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!
MYW\3/^09%_U\I_Z*FKP,V_@1_P"OB_\ 29GT^2?[S/\ Z]2_]+@>B5[Y\P%
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M$C&$)5'RP5V:RDJ:YI.R.!MOC+I#RQI>VVI:;#.P6*ZO;0Q6SDG Q('? /\
M>954#EB #70\/*WNN,FMU%W?W&"KQZJ44^K5D=AXO\86?@JR34+]99(9)HX
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M7-"QS@.F2!NP<%692589RK <52E*D[2Z[-;,ZH5(U%>/3=/='75B:A0 4 %
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M74JKGBU"/16N_G<Z/P1XPU.75;KPKXE6(:I9QB>*> %8KJW) WA3C:ZEER%
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MVY('(Z:$U2J*4MM4_*YSUH.<'&.^YPFC_'&QTB*+3_$]G>:3>0(L;[H2T3%
M%+)C$F#C.!&P . [=3T2PSDW*E*,D_/7_+\3&-=1M&HG%KRT/8O#_BK2O%4)
MN-(N8KM%QNV$ATSTWQL%D3/.-ZC.#CH:XIPE3=IIHZXSC/6#N?/^FRZT_CGQ
M!9:!Y,4]Q]F:2ZN%+QV\4<:Y*QC_ %DKLZB-2=N [-D#CT7R*C3E4O97LEU;
M??HNYPKF]K-0LF[:OI_P3IGUWQ1X$US3K'7KR'6=.UF?[*DJVT=M+#,Q14^6
M( 8+.OWB^5W\H5&<N6G5A*5.+A*"O:[::^9IS3I2BIM2C)VO:S3^1TWCCQ)J
M&C^(?#^GV<OE6VI3W*72;(V\Q8Q;E!N=&=,;VYC9"<\DX&,J4(RA4E):Q2MO
MI>YI4DXSA%/1MW_ P_B%XRUO0/$NEZ9H^V=+Z&8&U=8PDDQ#I$\DI0RI'$Y6
M63RW7*(P[UI2IPG3G*>EFM>RZZ;7>RN14G*$XQAU3T\^GGIN0Z[%X^\+VLFM
MC4;34X[53-/8?8TA01*-TGE2K^^?8H+#<ZL0#@,0%8C["HU3Y7&^BES7UZ76
MPI>U@N?F3MJU:VGD]SU?POX@@\5:7;:O:@K%=Q[PI()1@2KH2."4=60D=2,X
M%<DX.G)P>Z.J$E.*DNIO5F6% !0 4 % !0 4 >*_##_D.^)/^O\ '_H^^KTL
M1_#H_P"'](GCX3^+B/\ '_[=,]JKS3V H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M<DNWY![6'?\ !_Y!_P +O\&_]!#_ ,E;W_Y'HY)=OR#VL._X/_(/^%W^#?\
MH(?^2M[_ /(]')+M^0>UAW_!_P"0?\+O\&_]!#_R5O?_ )'HY)=OR#VL._X/
M_(/^%W^#?^@A_P"2M[_\CT<DNWY![6'?\'_D'_"[_!O_ $$/_)6]_P#D>CDE
MV_(/:P[_ (/_ "#_ (7?X-_Z"'_DK>__ "/1R2[?D'M8=_P?^0?\+O\ !O\
MT$/_ "5O?_D>CDEV_(/:P[_@_P#(/^%W^#?^@A_Y*WO_ ,CT<DNWY![6'?\
M!_Y!_P +O\&_]!#_ ,E;W_Y'HY)=OR#VL._X/_(/^%W^#?\ H(?^2M[_ /(]
M')+M^0>UAW_!_P"0?\+O\&_]!#_R5O?_ )'HY)=OR#VL._X/_(/^%W^#?^@A
M_P"2M[_\CT<DNWY![6'?\'_D'_"[_!O_ $$/_)6]_P#D>CDEV_(/:P[_ (/_
M "#_ (7?X-_Z"'_DK>__ "/1R2[?D'M8=_P?^0?\+O\ !O\ T$/_ "5O?_D>
MCDEV_(/:P[_@_P#(!\;O!IX_M#_R5O/_ )'HY)=OR#VL._X/_(ZK1/'>@^(F
M\O3;ZWGD/2/?LE/^['($D/U"D"I<6MT6I1ELSK*DL* +-OW_  _K4LI%BH*"
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MIXKXXV_D7KN]Q8;X97_F?Y(F_9[_ .133_KZN/\ T):,7_%^2'AOX?S9[?7
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M  _FA/COSIFF?]ANS_\ 15S1A?BG_@E^:#$?#'_&OR9Z)X^_Y%O5O^P;>_\
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M^X/^$:TG_GRM/_ >'_XBB[#E79?<'_"-:3_SY6G_ (#P_P#Q%%V'*NR^X/\
MA&M)_P"?*T_\!X?_ (BB[#E79?<'_"-:3_SY6G_@/#_\11=ARKLON#_A&M)_
MY\K3_P !X?\ XBB[#E79?<,/AK2?^?*T_P# >'_XBK1DTNR(SX;TK_GRM/\
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M^_2?_$U/LH?R1_\  5_D6JU3^>?_ ($_\QATNS_YX0_]^T_^)J?9P_EC_P"
MK_(T56I_/+_P)_YC3I=G_P \(?\ OVG_ ,32]G#^6/W+_(M5:G\\O_ G_F,.
MF6G_ #PA_P"_:?X5/LX?RQ^Y%JK/^>7_ ($_\QITRT_YX0_]^T_PJ?9P_EC]
MR-%4G_-+[W_F,.FVG_/&+_OVG^%3R0_EC]R+52?\TOO8TZ;:?\\8O^_:?X4N
M2/\ *ON1HIR_F?WL8=.M?^>,7_?M/\*GDC_*ON1:G+^9_>QITZU_YXQ?]^T_
MPJ>2/\J^Y%J4N[^]C#I]K_SQB_[]K_A4\D>R^Y&BE+N_O&G3[;_GC%_WPO\
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M')J=6]7VT.ZM?R270F%.U/V4_/;S;9@:9X0\<:=:IH2ZG8+ID2"%+I893?I
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M3G]UM^[;JWW?GV.-PJ*I*I#EU26M^R[>AL?\7)_ZEK_RI5'^S_\ 3W_R4O\
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MP^LJ?NY&_P"!2(Q'H#7CR5FT>K!\T4SM;?O^']:S9JBQ4%!0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ')>.
M+$WNDRA.6AVR@>R'YOR0L?PKRLPINIAY6WC:7W;_ (7/:RNJJ.*A?:5X?^!;
M?^361J>'M074]/@N%(),8#8[.HVL/;D$CV(-=.&J*M1A47\J3]5H_P 3DQE%
MX>O4I/92;7^%ZK\']YLUV' % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M93]"L@(]B*\>?Q,].FK11ZA;]_P_K63-T6*@H* "@ H * "@ H * "@ H *
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M5R'>% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 C,$!9B%50223@ #DDD]
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MW_?$O_QZC^UJ_P#+3^Z7_P F']B8;^>K_P"!0_\ D _X69J?_/*V_P"^)?\
MX]1_:U?^6G]TO_DP_L3#?SU?_ H?_(!_PLS4_P#GE;?]\2__ !ZC^UJ_\M/[
MI?\ R8?V)AOYZO\ X%#_ .0+-G\0-8OYEMK>"VDED.%4+(,G&>IF   !))(
M R36D,RQ-62ITX4W)[*TOUG8RJ91A*$'5JU*L81U;O'3[J=_N.D_M+Q;_P ^
M5M_WTO\ \E5Z/M<P_P"?-/[U_P#+3RO8Y5_T$5?N?_RD/[2\6_\ /E;?]]+_
M /)5'M<P_P"?-/[U_P#+0]CE7_015^Y__*0_M+Q;_P ^5M_WTO\ \E4>US#_
M )\T_O7_ ,M#V.5?]!%7[G_\I#^TO%O_ #Y6W_?2_P#R51[7,/\ GS3^]?\
MRT/8Y5_T$5?N?_RD/[2\6_\ /E;?]]+_ /)5'M<P_P"?-/[U_P#+0]CE7_01
M5^Y__*0_M+Q;_P ^5M_WTO\ \E4>US#_ )\T_O7_ ,M#V.5?]!%7[G_\I#^T
MO%O_ #Y6W_?2_P#R51[7,/\ GS3^]?\ RT/8Y5_T$5?N?_RD/[2\6_\ /E;?
M]]+_ /)5'M<P_P"?-/[U_P#+0]CE7_015^Y__*0_M+Q;_P ^5M_WTO\ \E4>
MUS#_ )\T_O7_ ,M#V.5?]!%7[G_\I#^TO%O_ #Y6W_?2_P#R51[7,/\ GS3^
M]?\ RT/8Y5_T$5?N?_RD/[2\6_\ /E;?]]+_ /)5'M<P_P"?-/[U_P#+0]CE
M7_015^Y__*0_M+Q;_P ^5M_WTO\ \E4>US#_ )\T_O7_ ,M#V.5?]!%7[G_\
MI#^TO%O_ #Y6W_?2_P#R51[7,/\ GS3^]?\ RT/8Y5_T$5?N?_RD/[2\6_\
M/E;?]]+_ /)5'M<P_P"?-/[U_P#+0]CE7_015^Y__*0_M+Q;_P ^5M_WTO\
M\E4>US#_ )\T_O7_ ,M#V.5?]!%7[G_\I$+^+;SY-EM:9_B!4X_\>F_D32OF
M%32U.GYZ.WXS_(=LJI:\U6K;IJK_ (4_S+6G^"4\[[9JTK7]P,$!L^6,=!@Y
M+ =@=J]ME:TLO7-[7%2=6?G\*^77\%Y&-;,WR>PP4%0I^7Q/YK;UU?\ >.[
MQP. *]L^="@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /.
MO%GPUT_Q+)]MA9K#41RMS#P2P^Z9%!7<1_>5DDZ?.0 *[*6(E27*_>AV?Z?U
M8\^MA85GSKW)_P R_5?KH_,Y=;+XA:'^Z@FM=5B'W6EVA\>C%O);)]Y'_P!Z
MMKX:>K4H/RV_7\D<W+C*6D7&HNE]_P ;?FQ_]N?$;_H%V'_?Q/\ Y84<F&_G
ME]S_ /D!^TQO_/J'WK_Y8']N?$;_ *!5A_W\3_Y84<F&_GE]S_\ D ]IC?\
MGU#[U_\ + _MSXC?] JP_P"_B?\ RPHY,-_/+[G_ /(![3&_\^H?>O\ Y8']
MN?$;_H%6'_?Q/_EA1R8;^>7W/_Y /:8W_GU#[U_\L#^W/B-_T"K#_OXG_P L
M*.3#?SR^Y_\ R >TQO\ SZA]Z_\ E@?VY\1O^@58?]_$_P#EA1R8;^>7W/\
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M?] JP_[^)_\ +"CDPW\\ON?_ ,@'M,;_ ,^H?>O_ )8']N?$;_H%6'_?Q/\
MY84<F&_GE]S_ /D ]IC?^?4/O7_RP/[<^(W_ $"K#_OXG_RPHY,-_/+[G_\
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M_P _O_DO:_\ QBCZK2_E_&7^8?7:_P#/_P"2Q_\ D0_X6WXI_P"?W_R7M?\
MXQ1]5I?R_C+_ ##Z[7_G_P#)8_\ R)ZAH.N_$:6V6Z2U@OHK@*\;W'V:)@I'
M&%BGMB W7]XA/3& >>&<,,GR\SBUH[7?YJ7X'I4ZF-<>914D]4Y<JT]%*/XH
MV_[<^(W_ $"K#_OXG_RPK/DPW\\ON?\ \@;>TQO_ #ZA]Z_^6!_;GQ&_Z!5A
M_P!_$_\ EA1R8;^>7W/_ .0#VF-_Y]0^]?\ RP/[<^(W_0*L/^_B?_+"CDPW
M\\ON?_R >TQO_/J'WK_Y8']N?$;_ *!5A_W\3_Y84<F&_GE]S_\ D ]IC?\
MGU#[U_\ + _MSXC?] JP_P"_B?\ RPHY,-_/+[G_ /(![3&_\^H?>O\ Y8']
MN?$;_H%6'_?Q/_EA1R8;^>7W/_Y /:8W_GU#[U_\L#^W/B-_T"K#_OXG_P L
M*.3#?SR^Y_\ R >TQO\ SZA]Z_\ E@?VY\1O^@58?]_$_P#EA1R8;^>7W/\
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M?] JP_[^)_\ +"CDPW\\ON?_ ,@'M,;_ ,^H?>O_ )8']N?$;_H%6'_?Q/\
MY84<F&_GE]S_ /D ]IC?^?4/O7_RP/[<^(W_ $"K#_OXG_RPHY,-_/+[G_\
M(![3&_\ /J'WK_Y8']K_ !&F^7^SK"'_ &MZ''_DZ_\ Z#1RX9?;D_D__D4'
M/C7I[."^:_\ DV0-X#\3>*R!XFU$0VI.6M;7'('\)(58\^A;S\?7H_;4J7\"
M%Y?S2_J_Y$_5Z]?_ 'FI:/\ +'_ADOON>KZ%X>L?#5L+/3HA#&.6/5G;H6=C
MRS'U)P!PH   X)SE4?--W?Y>AZE.E"C'DIJR_%^;9M5F;!0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MG^S*7\J_\"G_ )B?\*C\=_\ 00TW\W_^0*?UVHOM/_P&/^1/]ET?Y%_X%/\
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M^H0_E7_@4@_X4EXS_P"?[3?^^I?_ )!H^MS[O[HC^H0[+_P*0G_"D?&?_/\
M:;_WU+_\@TOK<^[^Z(_J,.R^^0G_  I#QG_S_:;_ -]2_P#R#1]:EW?W1']2
MCV7WR#_A1_C+_G^TW_OJ7_Y!I?6I=W]R']3CV7WR$_X4=XR_Y_=-_P"^Y?\
MY!H^M2[O[D/ZFNR^^0G_  HWQC_S^Z;_ -]R_P#R%2^LR[O[D/ZHO+[V)_PH
MSQC_ ,_NF_\ ?<W_ ,A4?67W?W(?U7T^]A_PHOQC_P _NF_]]S?_ "%2^L/N
M_N0_JWI][$_X45XP_P"?W3?^^YO_ )"H^L/N_N0_J[\OO8?\*)\7GK>Z;C_?
MF_\ D(4OK#\_N0_J[\OO?^1OZ3^SO//('U_4?,C4@F&U4@,/^NDF OIQ"3CH
MP-9RK-_U^AI&A;=_<?1>@^'[#PS:)I^EPK;V\?(5<DL3U9V.6=SW9B3T&<
M<S;>K.I)15D;%(HLV_?\/ZU+*18J"@H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * / _'>@_V5>?:(AB"Z)88Z+)U=?0
M YW*/0D#[M?#9CA_85?:07N3NUY2ZK]5_P  _1\JQ?UBC[*;_>4[)^<?LO\
M1^B?4X:O%/H0H * "@#V;X=:#]GB.IS#YY@5B![1Y^9O8N1@'^Z/1J^ORO#\
MD7B9K66D?*/5_-_@O,^$SG%\\EA*;]V&L_.71?\ ;JW\WW1Z?7TA\D% !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 -=%D4HX#*P((/((/!!'H11L&^C/A[XA>%3X3U:2W0$6TV9;<_],V/
MW.@YC.5/L >]?34*GM8)]5H_7_@GQF)H^PJ.*^%ZQ].WRV.&KI.(* .Y^'OA
M5O%FK1V[@_9H<2W!_P"F:G[G0\R'Y1[$GM7-7J>R@VMWHO7_ (!VX:C[>HHO
MX5K+T[?/8^X418U"( JJ  !P !P !Z 5\R?9[:(=0 4 % !0 4 % !0 4 %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M''^T%XKLP]7V4]?A>C_1GGXNC[:F[?%'5?JOG^9\5D$'!X(KZ,^/  DX')-
M'VI\,/"8\+Z2AF7%W=XEF]5R/DCZG[BGG_:+<5\YB*OM9Z?"M%^K/L,)1]A3
M5_BEJ_T7R_,]'KC/0"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H C>(/ST--.PK$?V?W_3
M_P"O57%8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O^G_UZ+A8/L_O
M^G_UZ+A8<L 7KS2N.Q-4C"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * ./\4^.M*\(K_ILNZ<C*V\>&E;T)7("*<<,Y53S@D\5T4Z,ZOPK3N]OZ]#
MDK8BGA_C>O2*U?\ P/5GFQ\=^+/$'.CZ='8P'D2W))8CL1O\L$'K\L;_ .]C
MD]RH4H?Q).3[+^G^9YWUC$5?X--17>7_  ;?DQA7X@S?-]OLX?\ 9\N,_P#M
MF_\ Z%5<N'7V9/YO_P"20?[8_MP7R7_R#$\CX@_]!.S_ ._4?_R#1;#_ ,DO
MO?\ \D*V,_Y^0^Y?_(!Y'Q!_Z"=G_P!^H_\ Y!HMA_Y)?>__ )(+8S_GY#[E
M_P#(!Y'Q!_Z"=G_WZC_^0:+8?^27WO\ ^2"V,_Y^0^Y?_(!Y'Q!_Z"=G_P!^
MH_\ Y!HMA_Y)?>__ )(+8S_GY#[E_P#(!Y'Q!_Z"=G_WZC_^0:+8?^27WO\
M^2"V,_Y^0^Y?_(!Y'Q!_Z"=G_P!^H_\ Y!HMA_Y)?>__ )(+8S_GY#[E_P#(
M!Y'Q!_Z"=G_WZC_^0:+8?^27WO\ ^2"V,_Y^0^Y?_(!Y'Q!_Z"=G_P!^H_\
MY!HMA_Y)?>__ )(+8S_GY#[E_P#(!Y'Q!_Z"=G_WZC_^0:+8?^27WO\ ^2"V
M,_Y^0^Y?_("@_$&W^;[;97'^SLC'_MK%_.CEP[^S)?-_YL?^V1^W!_)?_(HD
M7XD>(O#O_(PZ:)8%^]<6IP /[QP9(R?0%H?P/6'AJ<_X4[/L_P"D_P Q_6JU
M'^/3NOYH_P!-?D>K>'?%>F^*8O.TV99"H&^,_++'G^^AY SP&&5;'RL:X*E*
M5)VFK=GT?HSTZ5:%97IN_==5ZK^D=%6)T!0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % 'C_P 1M!\MUU6$?*^$F [-T1_^!#Y3[A>[5\GF
MF&LUB8+1Z3]>C^>S^7<^WR;%\R>#J/57E#T^U'Y;KR;['E5?,'V(4 ?07@G0
M?[&LA)*,7%SAWSU5?X$_ ')_VB1V%?>9?AOJ]+FDO?GJ_)=%^K\WY'YIFF+^
MM5N2#_=T[QCYO[4OF]%Y)/J=G7KGA!0 4 % !0 4 % !0 4 % !0 4 % !0
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MUQU*$Z6K5X]UM_P#OHXFG7TB[2_E>C^7?Y?<=S7*=H4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 ?'7Q;\)?\ ".ZH;NW7%I?YD7 X27_EHG3
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M[=#VV+_Y]P^__P"W#_A+/'__ $#;#_OH?_)]'L</_/+^O^W0]MB_^?</O_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_9ATM_E^+ZZ'K,$$=L@BA58XT&%1 %51Z!1@ ?05RWOJSU$E%62LET1+2&%
M!0 4 % !0 4 % !0 4 % !0!PWBCP-:Z]_I5L?L>H(=T=Q'\I+#D>9MP3SC#
MCYUZ@D#:>B%5PT>L>S_0XJV'C5]Z/NS6TEIKYV_/<TOA[XVN-0EDT#7/W>JV
MF0&.!]H11G<,<%P/F.WAT(D7HV.:O14+5:?P/\'_ )?\,:X;$.3="MI4C_Y,
MO\_S6O<]8K@/4"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /%/CN
M!_8=N>XOHQGZP7.?SP/R%>E@_P"(_P#"_P T>/F/\*/^-?\ I,@^! ']ASGN
M;Z09^D%MC^9_,T8S^(O\*_-AEW\*7^-_^DQ/:Z\T]@* "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H X?QSXU@\'6@< 37L_P MM!SEVX!9@.=BY&<<
ML2$&"<CIHT76E;:*W?\ 74XL176'C?>;^&/?_@?\,>9Z-X(FUB8ZUXJ8W5Y+
MAE@8_NXEZJK*.#C/$8^1><[R21Z4JB@O9T=(KKU?]=SSH8=U'[;$^])_9Z+R
M_P"!MZGJ$<:PJ$C 15& J@  #L . /85R'I)6T6P^@ H * "@ H * "@ H *
M "@ H @N;6&]C:"X198G&&1U#*1[@Y%--K5:,32DN62379GE6H^&[WP-.=<\
M+D^6HS<V;%F1XQR<#.64#)QG>G+(W5:ZE*-9>SK?*75/^OEW/,E2EAG[;#;?
M:ANFOZ^:Z'M/A3Q1:^+;%+ZT."?EEC)^:*0#YD;^:MT92#QR!Y52FZ4N27R?
M='L4:T:\%.'S79]OZW.DK$Z H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M#"BV[+H-M+4AT3Q9::W-):JD]K<PKO:"YB,4NP_Q!<MD<COGD<<TW%QUTMY
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M5(QFMFD_O-*H- H * "@ H * "@ H * "@ H * "@ H * "@ H * /%?CO\
M\@*#_K_C_P#1%S7I8/\ B/\ PO\ .)X^8_PH_P"-?^DR#X$?\@*?_K_D_P#1
M%M1C/XB_PK\Y!EW\*7^-_P#I,3VJO-/8"@ H * "@ H * "@ H * "@ H *
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MB3PWXLMO$YF%M%<0FU95<3HJ'<V[Y1M=^5VG>#@C*^O!*+CO8%+FV.HJ"@H
M\IM&_P"$ \51M$-NFZX1&R#A8YMP ..@"2.".@"2N!]VNF:]M2?\T-?E_P -
M^*1YD?\ 9<0K:4ZNENS_ . W]S9]#UXQ[X4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MQGMX9"?4O&K9_'->1-<LI1[-K[F>Q3?-",N\4_O1IU!H% !0 4 % !0 4 %
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MD_!>[:Y\.(C'/V>>:(>PR),?^1*C%JU5OND_T_0RP$KT4NS:_7]3UBN ]0*
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MVH/FC&7=)_>B_4%A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MN_X(>S_O2^\/["/_ #]WG_?[_P"QH]I_<A]W_!#V?]Z7WA_81_Y^[S_O]_\
M8T>T_N0^[_@A[/\ O2^\/["/_/U>?]_O_L:/:?W(?^ _\$/9_P!Z7WA_8/\
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M?V O_/Q=_P#?X_\ Q-'M?[L/_ 0]G_>E]X?V O\ S\7?_?X__$T>U_NP_P#
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MDMU?S_4Y,#33H\S;5Y/9V[+]#U+_ (1Z'O+<'_MJU<7M7VC]QZ7LUWE]X?\
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M3#?:+-)(9 1>R+\CE1@06YZ#OSUHQ4W":2M\*W5^K# 04J3;O\;V?]V)Z_\
M\(Y;?WIO^_K5P>UEV7W(]7V4?/[P_P"$<M?6;_OZW^-'M9>7W(/91\_O8?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 U_NGZ&F@*%:&84 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $<T23HT4@W(ZE6!Z%6&"/Q!Q33
MMJA-75GLSPGP)*_AG4+KPI>'#1R--;,>/,0@$X^J;9 !T/F#JM>K4_>1C6CV
ML_)_UI]QXF';HSEA9]'>/FO^&U^\]:KD/4"@ H * "@ H * "@ H * "@ H
M* "@ H \DU+/C3Q/;:5#\UGI+>?<MU4N&4E#VZA8L=<M(?X:ZU^YI.;^*6B_
MK\?N/+E_M%>-)?#3UEZ]OR7WGO=>2>X% !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 .3[P^HI,9?K,L* /._B9_R#(O\ KY3_ -%35X&;?P(_]?%_
MZ3,^GR3_ 'F?_7J7_I<#T2O?/F H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * /G[5T/@SQB;F0;;'7% #=%6?*ALG@9$G)
M/0+/GL<>Q3?M:/*OBA^7_#?D>#/_ &?$\S^"K^#_ .'_  9ZA7.>D% !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M%>PI;+XGW?;_ #^XSPU&4I?6JZ]Y_#'LN_\ E]^Y[77F'L!0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % 'BOQW_Y 4'_7_'_Z(N:]+!_Q'_A?YQ/'
MS'^%'_&O_29!\"/^0%/_ -?\G_HBVHQG\1?X5^<@R[^%+_&__28GM5>:>P%
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MK%7_ )\3_P#)O_D _P"$YUW_ *%Z_P#RG_\ D.CV=/\ Y^Q^]?\ R0?6*O\
MSXG_ .3?_(!_PG.N_P#0O7_Y3_\ R'1[.G_S]C]Z_P#D@^L5?^?$_P#R;_Y
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MC@XTW[2H^>>]WLGY+]7^!ZG7">F% !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % 'BOQW_P"0%!_U_P ?_HBYKTL'_$?^%_G$\?,?X4?\:_\ 29!\
M"/\ D!3_ /7_ "?^B+:C&?Q%_A7YR#+OX4O\;_\ 28GM5>:>P% !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'FWBSX96'B24WUNS6&H]1<0\!F'
M0R(",G_;4H_3+$ "NREB)4EROWH]G^G]6/.K82%9\\;PG_,OU7ZJS.)-KXY\
M.?(\4&L0C@.C#S,=L_ZJ0GU)23_>/!/8IT*G5P?GM^J_%''RXJCHTJB[K?\
M1_@QA\:>(8?EE\/WC-ZH)B/TMG'ZU7)3Z58_A_F+V]9:.A/Y7_\ D6)_PG.N
M_P#0O7_Y3_\ R'1[.G_S]C]Z_P#D@^L5?^?$_P#R;_Y /^$YUW_H7K_\I_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@".:%+A#%* R,,$'H1_GH>H/(YIIN+NM&)
MI-6>QS\,KZ$XM[@E[1SB*4]8SVCD/I_=;^F0O0TJJYHZ26Z[^:,$W2?++X>C
M[>3.DZUS'0% !0 4 % !0 4 -?[I^AIH"A6AF% !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 .3[P^HI,9?
MK,L* /._B9_R#(O^OE/_ $5-7@9M_ C_ -?%_P"DS/I\D_WF?_7J7_I<#T2O
M?/F H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * /%?CO_R H/\ K_C_ /1%S7I8/^(_\+_.
M)X^8_P */^-?^DR#X$?\@*?_ *_Y/_1%M1C/XB_PK\Y!EW\*7^-_^DQ/:J\T
M]@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M3&7ZS+"@#SOXF?\ (,B_Z^4_]%35X&;?P(_]?%_Z3,^GR3_>9_\ 7J7_ *7
M]$KWSY@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * *&JZG!HMG
M-J%T=L%K$\TA'7:BEC@9&6(&%&>20!R:J,7)J*W;LB6U%.3V6I\U>'9_%OQC
M>;4DU&30-(CD,<*6NX2.PYQO1HG;:"OF2-(%+?*D?#;?4FJ6&M'E4YVN[[?K
M]WXGGQ]I7O+FY(]+?TCN="\%>+?#6JVS+K4FJ:4S,+I+L%I578S#:9'E8[G
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M@RLKY,C[4"NBJ@W,6;"GU(PA0I*K./-*6R>ROK^1Y[E.K4=.#Y5'>VYT-KX
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M!3_]?\G_ *(MJ,9_$7^%?G(,N_A2_P ;_P#28GM5>:>P% !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0[C=E<C:%'-7]I[OM;>374Z*7)K[/3NGT/7*XSI"@ H * "@ H * "@ H *
M"@ H * "@ H * "@!R?>'U%)C+]9EA0!YW\3/^09%_U\I_Z*FKP,V_@1_P"O
MB_\ 29GT^2?[S/\ Z]2_]+@>B5[Y\P% !0 4 % !0 4 % !0 4 % !0 4 %
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M 025'-7SNGAXRCOT?:[9/*IUW&6W_ 16U#P/I]M\1(_#-B)+73+Z)3<01RR
M/&D#7+PEMQ?RY'@4D%C@G@C PU5DZ#JRUDGH[=;VO^(G32K>SCI%K57\KV_
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M^4S+( Q^0JH8CYMN22<D^;7454?LVK/73;SV.^CS<BY[IK371GI-<IT!0 4
M% !0 4 % !0 4 % !0 4 >*_'?\ Y 4'_7_'_P"B+FO2P?\ $?\ A?YQ/'S'
M^%'_ !K_ -)D'P(_Y 4__7_)_P"B+:C&?Q%_A7YR#+OX4O\ &_\ TF)[57FG
ML!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 (S! 68@ #))X
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MH .9JU542C!6C'8JG3<+RD[R>YZE7*= 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 .3[P^HI,9?K,L* /._B9_R#(O\ KY3_ -%35X&;?P(_]?%_Z3,^
MGR3_ 'F?_7J7_I<#T2O?/F H * "@ H * "@ H * "@ H * "@ H * "@ H
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M H * "@ H * "@ H * "@#Q7X[_\@*#_ *_X_P#T1<UZ6#_B/_"_SB>/F/\
M"C_C7_I,@^!'_("G_P"O^3_T1;48S^(O\*_.09=_"E_C?_I,3VJO-/8"@ H
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M_EHON/SQTY9OB*U2/P0B^3Y75->7,[R?S/0_@[KYO=/?2IS^^L&^4'@^2Y)
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MGRR^'H^WDSI.M<QT!0 4 -?[I^AIH"A6AF% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!S.B>#M)\.W-Q?:=!Y5S>G=/*T
MLTK.2S.>99'VY9BQV[03C.=HQK*I*:49/1;*R7Y&<81@VXK5[[_J=-61H% !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 Y/O#ZBDQE^LRPH \[^)G_(,B_Z^4_\ 14U>!FW\"/\ U\7_ *3,^GR3
M_>9_]>I?^EP/1*]\^8"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M_P"O^3_T1;48S^(O\*_.09=_"E_C?_I,3VJO-/8"@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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ME2&!#(592".JL"1D'@D$C)Q=XZ,&E)6>Q++IUO-:-I[H/LSQ& Q@D#RBGEE
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M!R?>'U%)C+]9EA0!YW\3/^09%_U\I_Z*FKP,V_@1_P"OB_\ 29GT^2?[S/\
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MM1C/XB_PK\Y!EW\*7^-_^DQ/:J\T]@* "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@#GKN[EU&4V-B=H7B><=$'=$]7/MT
M_,CHC%07//\ [=CW\WY&$FYODA\WV\EYFQ:6D5C$(81M5?S)[DGN3W/]*QE)
MR=WN:QBHJR+-24% !0 4 % #7^Z?H:: H5H9A0 4 % !0 4 % !0 4 % !0
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MR*?AG4Y=9TNVOYPJRW$*R,$!"@L.0H8L0/JQ/O3DN63BNC%%W2;-RH*"@ H
M* "@ H * "@ H * .?L]?2[U6ZT@1LKV4<+M(2,,)EW  8R,=\GFK<;14N]_
MP)4KMQ['05!04 % !0 4 % !0 4 % !0 4 % #D^\/J*3&7ZS+"@#SOXF?\
M(,B_Z^4_]%35X&;?P(_]?%_Z3,^GR3_>9_\ 7J7_ *7 ]$KWSY@* "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@#Q7X[_P#("@_Z_P"/_P!$7->E@_XC_P +_.)X^8_PH_XU
M_P"DR#X$?\@*?_K_ )/_ $1;48S^(O\ "OSD&7?PI?XW_P"DQ/:J\T]@* "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M]AI M=0T73M0TV9+J ?:9E9$EC<X>.0O.[N) ?XDYYY SG97E>,Y1:L]%T_
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H :_W3]#30%"M#,* "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -?[I^AIH"A6AF% !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 .3[P^HI,9?K,L* /._B9_R#(O^OE/_ $5-7@9M_ C_ -?%_P"DS/I\D_WF
M?_7J7_I<#T2O?/F H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * /%?CO_R H/\ K_C_ /1%
MS7I8/^(_\+_.)X^8_P */^-?^DR#X$?\@*?_ *_Y/_1%M1C/XB_PK\Y!EW\*
M7^-_^DQ/:J\T]@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H :_W3]#30%"M#,* "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H <
MGWA]128R_6984 >=_$S_ )!D7_7RG_HJ:O S;^!'_KXO_29GT^2?[S/_ *]2
M_P#2X'HE>^?,!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >*_'?\ Y 4'_7_'_P"B+FO2
MP?\ $?\ A?YQ/'S'^%'_ !K_ -)D'P(_Y 4__7_)_P"B+:C&?Q%_A7YR#+OX
M4O\ &_\ TF)[57FGL!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: H5H9A0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% #D^\/J*3&7ZS+"@#SOXF?\@R+_ *^4_P#14U>!FW\"/_7Q?^DS/I\D_P!Y
MG_UZE_Z7 ]$KWSY@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Q7X[_\ ("@_Z_X__1%S
M7I8/^(_\+_.)X^8_PH_XU_Z3(/@1_P @*?\ Z_Y/_1%M1C/XB_PK\Y!EW\*7
M^-_^DQ/:J\T]@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M'_S]_P#)*G_R(?\ "PM+_P">Z_\ ?J?_ .(H_L^O_(__  *'^8?VQ@_^?O\
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M?^ 5/_D0_P"%DZ9_SV3_ +\S_P#Q-']FUOY'_P"!0_S#^V<'_P _5_X!4_\
MD0_X63IG_/9/^_,__P 31_9M;^1_^!0_S#^V<'_S]7_@%3_Y$/\ A9.F?\]D
M_P"_,_\ \31_9M;^1_\ @4/\P_MG!_\ /U?^ 5/_ )$/^%DZ9_SV3_OS/_\
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M5_X!4_\ D0_X63IG_/9/^_,__P 31_9M;^1_^!0_S#^V<'_S]7_@%3_Y$/\
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M^%DZ9_SV3_OS/_\ $T?V;6_D?_@4/\P_MG!_\_5_X!4_^1#_ (63IG_/9/\
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MS#^V<'_S]7_@%3_Y$/\ A9.F?\]D_P"_,_\ \31_9M;^1_\ @4/\P_MG!_\
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M %_R?^B+:C&?Q%_A7YR#+OX4O\;_ /28GM5>:>P% !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -?
M[I^AIH"A6AF% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MTU?MIU+J4JE%\M:$H2:NE*+B[;7LTM-'KY%:M#$* "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@"M-6,SLHD-CJ]U
MHLPN+.1HF!&0#\K ?PNO1E]C]1@\UY56$9JTE?\ 3T/IL-4E2:E!V_)^JZG<
M>./%L?BCPS"5^26*^B$L><[&\BYP5_V'Y*^F".H)/CTZ7LJK_P +L^^J_$^B
MQ%;VU"+V:FKKM[LOP9Z%\"/^0%/_ -?\G_HBVKAQG\1?X5^<CNR[^%+_ !O_
M -)B>U5YI[ 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M:*3^&,(NU]-W)WDEUOT2N,D\ QW,$LND7T.H26XR\2KL.,'[IWN&SCY>BMR
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M,SLHF//7G3/H:)C7#D+M!.TD$CL2 0#CU&3CTR?6N'J>M+X%ZK\F?4OP(_Y
M4_\ U_R?^B+:O#QG\1?X5^<CW\N_A2_QO_TF)[57FGL!0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % %:[M(KV(PS#<C?F#V(/
M8CL:J,G!WCN2XJ2L]C&M+N73)197IW(W$$YZ,.R.>SCH">OY$[RBIKGAO]J/
M;S7D91;@^2>W1_H_,Z*N8W"@ H * "@ H * &O\ =/T-- 4*T,PH * "@ H
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MDM?1GQ84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0!6FK&9V43'GKSIGT-$Q+G^M<74]:7P+U_1GU/\"/\ D!3_ /7_ "?^B+:O
M"QG\1?X5^<CW\N_A2_QO_P!)B>U5YI[ 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M"M#,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * *6H6RW4+(PR"""/56&&'XBM:<G"2:T=TUZK8RJ04XN$E=---=TU
M9H^7]<TB31;IK>0';DF-C_&F>#]>S#L<U]_0K*O!3COU79]5_EY'X]C,++!5
M9497MO%_S1Z/UZ/LS(KJ//"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M.K\,>)AX9\^2. 2W,T?EQRE]HBZG.W82V6VDC>N0H&1G->=B<-]:Y(N?+"+N
MXI7YOG=6TNEH]SV<#CEE_M)QI\U2<>6,G*W)\N5WULWJKVMYG*LQ<EF)))R2
M>22>I)]:]#;1'CMMN[U;$IB-W0M7ATB1VN+6&^CD4*5E'*X.<HV&"D]SM).!
M@CG/'7HRK)*%25-IWO'KZK2_WGHX7$0PTI.I1A6C)6M/IU]UZV\]'\CI9?',
M-M;2VVD6,6GM<+L>59#(^T@C@[$(//!)(7D@9Y'"L#*4XSQ-:551=U%JROYZ
MOY]SU99I"G3G2P6'A0<U:4E)RE;7;W8V>NFKMVN>>U[1\R% !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % %::L9G91,>>O.F?0T26]T":#21J\P*)+<)
M#"#_ !J8YF=_7 **JGO\WH,^=S+GY%T5W]Z/:G!JBIOK))?<SZ'^!'_("G_Z
M_P"3_P!$6U>-C/XB_P *_.1[>7?PI?XW_P"DQ/:J\T]@* "@ H * "@ H *
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M^??_ ,BP_P#QRCZ[A_Y__)9?_(A_9.-_Y]?^3T__ ),/^$*UC_GW_P#(L/\
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M^$*UC_GW_P#(L/\ \<H^NX?^?_R67_R(?V3C?^?7_D]/_P"3#_A"M8_Y]_\
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M?^?7_D]/_P"3#_A"M8_Y]_\ R+#_ /'*/KN'_G_\EE_\B']DXW_GU_Y/3_\
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M^??_ ,BP_P#QRCZ[A_Y__)9?_(A_9.-_Y]?^3T__ ),/^$*UC_GW_P#(L/\
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M^$*UC_GW_P#(L/\ \<H^NX?^?_R67_R(?V3C?^?7_D]/_P"3#_A"M8_Y]_\
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M?^?7_D]/_P"3#_A"M8_Y]_\ R+#_ /'*/KN'_G_\EE_\B']DXW_GU_Y/3_\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H \>^-O_($@
M_P"OV/\ ]$7%>QEW\67^!_\ I43Y?//]VA_U]C_Z1,R]#^$&D:GIUK>RS7BR
M7-O#,X62$*&DC5V"@P$A02< DG'4GK6U3'U83E!*%HRDE=.]DVOYCGH9/AZM
M*G5E*I><(2=G&UY13=O<>FNFIZ+X9\#:7X4+262,TS#:9I6#R;?[H("JH/?:
MHSQG.!7FUL34KZ3:271:+^O4]S"X"A@KRI)N3TYI.[MVV27R2N>2?#':/%&H
M?;,?:\3[=_WM_GCS<9YW8ZXYV[NV:]?&?[O3Y/A]W;:W+I\OUL?-97;Z[6]K
M_$]^U][\_O6\_P!+]+EOXY>3_H.,?:<S=,;O+_=XSCG&_.S/&=^.<U&6W_>?
MRZ>E]?TW^1KGO+^YM\?O>O+IOUWV^=NIB_&+S,Z9Y^?-^RGS,]=_[O=GWSG-
M;X"W[WEVYM/36QR9S?\ V?G^+V;OZZ7_ !/I6W@CM8U@A4)'&H5%' 55& ![
M 5\RVY-R>[U9][&*@E""M%*R2Z);'SYX3(3QY?!N"SW@ /&?G!X_ $_3FOH:
M_P#N<+=H?D?$X33-*R?>K^=_R.[^+O\ R+TO_76'_P!#%<& _CKTE^1[&<?[
MI+_%#\R?P)YO_")0>1GS?L]QY>.N_P R;;CWW8Q[TL3;ZS+FVYHW]+*Y> O]
M0AR?%R3M;OS2M^)PWP-\G%]G;]IS%UQO\OY\XSSC=]['&=N><5W9E?\ =_RZ
M^E]/TV^9Y&1<O[[;G]WUY=?POO\ *_0I?$S;_P )3I_V+'VO%ONV8W;_ #SY
M6['._&.O.S9VQ5X/_=ZG/\'O;]N77Y?K<RS.WUVC[+^)[E[;WYWRWMU_2W0D
M\8_NO'5@S_*I:S()X!'FLN0?3((SZ@CM2P^N#J)?W_R*QONYG1;T5Z7_ *4U
M^9T_QM_Y D'_ %^Q_P#HBXKER[^++_ __2HG?GG^[0_Z^Q_](F<G\0O-_P"$
M4T7;GR?*M]^.F[[(NS/OC?C\:[,+;ZS7[WE;TYW?]#S<QYOJ.$M?EY87[7]F
MK?J>U>'/LG]B6OE^7]E^R1YSMV;?+'F;_P"'KN\S=WW;N<UXE7F]K*]^;G?K
M>^EOT_ ^LPWL_JU/EM[/V<>UK<NM^G?FOUO<\;^"F[[;J'DY^R[4]<9WOY>>
MV=F_WZU[.8_!3O\ %=_DK_C8^6R2_M*W)?V=E]]WR_.USZ'KYT^W"@ H * "
M@ H * "@ H * "@ H * "@ H * "@"M=VD5[$89AN1OS![$'L1V-5&3@[QW)
M<5)6>QC6EW+IDHLKT[D;B"<]&'9'/9QT!/7\B=Y14USPW^U'MYKR,HMP?)/;
MH_T?F=%7,;A0 4 % #7^Z?H:: H5H9E>2Z2+J<X]/\XJU%LER2,>3Q-8PG#S
M0*?1IHP?U-=*PU5[0F_2+.*6,P\-)5::]:D5^I'_ ,)7IW_/Q;?^!$?^-5]5
MJ_R3_P# )?Y$?7L-_P _J7_@R'^8?\)7IW_/Q;?^!$?^-'U6K_)/_P  E_D'
MU[#?\_J7_@R'^8?\)7IW_/Q;?^!$?^-'U6K_ "3_ / )?Y!]>PW_ #^I?^#(
M?YA_PE>G?\_%M_X$1_XT?5:O\D__  "7^0?7L-_S^I?^#(?YA_PE>G?\_%M_
MX$1_XT?5:O\ )/\ \ E_D'U[#?\ /ZE_X,A_F'_"5Z=_S\6W_@1'_C1]5J_R
M3_\  )?Y!]>PW_/ZE_X,A_F'_"5Z=_S\6W_@1'_C1]5J_P D_P#P"7^0?7L-
M_P _J7_@R'^8?\)7IW_/Q;?^!$?^-'U6K_)/_P  E_D'U[#?\_J7_@R'^8?\
M)7IW_/Q;?^!$?^-'U6K_ "3_ / )?Y!]>PW_ #^I?^#(?YA_PE>G?\_%M_X$
M1_XT?5:O\D__  "7^0?7L-_S^I?^#(?YA_PE>G?\_%M_X$1_XT?5:O\ )/\
M\ E_D'U[#?\ /ZE_X,A_F'_"5Z=_S\6W_@1'_C1]5J_R3_\  )?Y!]>PW_/Z
ME_X,A_F'_"5Z=_S\6W_@1'_C1]5J_P D_P#P"7^0?7L-_P _J7_@R'^8?\)7
MIW_/Q;?^!$?^-'U6K_)/_P  E_D'U[#?\_J7_@R'^8?\)7IW_/Q;?^!$?^-'
MU6K_ "3_ / )?Y!]>PW_ #^I?^#(?YA_PE>G?\_%M_X$1_XT?5:O\D__  "7
M^0?7L-_S^I?^#(?YA_PE>G?\_%M_X$1_XT?5:O\ )/\ \ E_D'U[#?\ /ZE_
MX,A_F'_"5Z=_S\6W_@1'_C1]5J_R3_\  )?Y!]>PW_/ZE_X,A_F'_"5Z=_S\
M6W_@1'_C1]5J_P D_P#P"7^0?7L-_P _J7_@R'^8?\)7IW_/Q;?^!$?^-'U6
MK_)/_P  E_D'U[#?\_J7_@R'^8?\)7IW_/Q;?^!$?^-'U6K_ "3_ / )?Y!]
M>PW_ #^I?^#(?YA_PE>G?\_%M_X$1_XT?5:O\D__  "7^0?7L-_S^I?^#(?Y
MA_PE>G?\_%M_X$1_XT?5:O\ )/\ \ E_D'U[#?\ /ZE_X,A_F'_"5Z=_S\6W
M_@1'_C1]5J_R3_\  )?Y!]>PW_/ZE_X,A_F'_"5Z=_S\6W_@1'_C1]5J_P D
M_P#P"7^0?7L-_P _J7_@R'^8?\)7IW_/Q;?^!$?^-'U6K_)/_P  E_D'U[#?
M\_J7_@R'^8?\)7IW_/Q;?^!$?^-'U6K_ "3_ / )?Y!]>PW_ #^I?^#(?YA_
MPE>G?\_%M_X$1_XT?5:O\D__  "7^0?7L-_S^I?^#(?YB'Q3IIZSVQ_[;Q?X
MT?5:R^Q/_P  D'U[#?\ /ZE_X,A_F,_X2;2_^>UK_P!_HO\ &G]6K?R5/_ )
M!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'
M_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_
MC1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=P
MO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z
M7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6
MK?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/Z
MC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SV
MM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5
M/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,
MA_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\
MO]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )
M!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'
M_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_
MC1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=P
MO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z
M7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6
MK?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/Z
MC_X,A_F'_"2Z7_SVM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F'_"2Z7_SV
MM?\ O]%_C1]6K?R5/_ )!]=PO_/ZC_X,A_F \3:6#GSK7_O]%_C1]6K?R5/_
M  "0?7<+_P _J/\ X,A_F3?\)5I/_/2T_P"_T-3]5K_RU/\ P"0_KV%_Y^T?
M_!D/\P_X2K2?^>EI_P!_H:/JM?\ EJ?^ 2#Z]A?^?M'_ ,&0_P P_P"$JTG_
M )Z6G_?Z&CZK7_EJ?^ 2#Z]A?^?M'_P9#_,/^$JTG_GI:?\ ?Z&CZK7_ ):G
M_@$@^O87_G[1_P#!D/\ ,/\ A*M)_P">EI_W^AH^JU_Y:G_@$@^O87_G[1_\
M&0_S#_A*M)_YZ6G_ '^AH^JU_P"6I_X!(/KV%_Y^T?\ P9#_ ##_ (2K2?\
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M:G_@$@^O87_G[1_\&0_S#_A*M)_YZ6G_ '^AH^JU_P"6I_X!(/KV%_Y^T?\
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M_P P_P"$JTG_ )Z6G_?Z&CZK7_EJ?^ 2#Z]A?^?M'_P9#_,/^$JTG_GI:?\
M?Z&CZK7_ ):G_@$@^O87_G[1_P#!D/\ ,/\ A*M)_P">EI_W^AH^JU_Y:G_@
M$@^O87_G[1_\&0_S#_A*M)_YZ6G_ '^AH^JU_P"6I_X!(/KV%_Y^T?\ P9#_
M ##_ (2K2?\ GI:?]_H:/JM?^6I_X!(/KV%_Y^T?_!D/\P_X2K2?^>EI_P!_
MH:/JM?\ EJ?^ 2#Z]A?^?M'_ ,&0_P P_P"$JTG_ )Z6G_?Z&CZK7_EJ?^ 2
M#Z]A?^?M'_P9#_,/^$JTG_GI:?\ ?Z&CZK7_ ):G_@$@^O87_G[1_P#!D/\
M,EB\3Z8YPCVQ/^S+$3^E2\-6CO&:]8R1<<9AY.T*E)ORG!_DSHH+Z*; 4[3V
M!X_(]*XW!Q.]23V/(?CO_P @*#_K_C_]$7-=V#_B/_"_SB>5F/\ "C_C7_I,
M@^!'_("G_P"O^3_T1;48S^(O\*_.09=_"E_C?_I,3VJO-/8"@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M)\NM6E7ESS^26R7D?08;"T\'#V5%>;;WD^[_ $2T1T%<YVA0 4 % !0 4 %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MF::UBBV[C(7?;SGY>8UY&,GH #G)/%</]ITOL1J.5[<ME?UT;^1ZG]A8A/\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0!')TJ7L:0W,BXKSIGT- Q;F>18C &(C=U=E[%D#J
MI^H#N!_O&O.:UO\ UT/<;]RW2Z_)_P"9]0? C_D!3_\ 7_)_Z(MJ\+&?Q%_A
M7YR/H<N_A2_QO_TF)[57FGL!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MM_+'\M3\9QR:Q59/_GY-_)MM?@8U=9YP4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * (Y.E2]C2&YD7%>=,^AH&!=?UKSWN>V_@7JOR9]2_ C
M_D!3_P#7_)_Z(MJ\'&?Q%_A7YR/HLN_A2_QO_P!)B>U5YI[ 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'CWQM_Y D'_ %^Q_P#HBXKV,N_B
MR_P/_P!*B?+YY_NT/^OL?_2)F7H?P_U>]TZUN(M=O+>.:WAD2)1-MB5XU98U
MQ=J-J A1A5&!PHZ5M4Q5*,Y1="#:E)-NUVTWK\#WWW.>AE^(J4J<XXRI%2A!
MJ*YK13BFHK]XM%LM%Z'I?A?P]=:%!+!?WLNJ&5]P:</E5V[2@#RS<'J>0.>E
M>96JQJM2IP5.RVC;7ST2/?PN'GAHRA6JRK<SO>5]%:UM92T/G_QC$_P\UB4:
M'.(DO86W0J<M"LF05(Z#!R\!^\@^@+?08=K&4E[>-W"6_>W]6ET?Y?%XU/*\
M1+ZI/E52+O%;Q3Z??K![K\7ZQ\*_#5KI6FKJ*.MQ<WRAGE7G8N<^2">058?O
M.F7'<*IKR<;6E4J.FTXQ@]%W??Y]/+U/H\JPT*-%5TU*=17<ET7\J]'\7=^B
M/,O#NA6NO^,]0@O0'ABGO9C&20)"MSM53CJ 7WD=]O/&17IU:LJ.%IRAHW&"
MOVO&]_PM\SP,-AX8G,:T*JO&,ZLN7O:I9+\;V\C9^+GABPT:"WU/3HX[.4S^
M6RPCRPV49U=47"J4*?>4 _,,YXQC@:TZCE2J-R7+?77JDU?SOU['5F^%I8>,
M,10BJ<N?E:C[M]&TTEHK6W5MT=;XDU+0[G1M-N_$P:1I8HKA(X]V]W:%3(,*
M5^3+C=EE!.WGM7'1A6C5J0PNB3<6WLES.V_73L^IZ>)JX:6'H5,?=MQC-15[
MMN"YMK::ZZI;'G?C&YTF]THG3M%N[(1[&CO&M1"@S(%822*6WJP.U=SG]X5
MQCGT<.JD:G[RO"5[W@I7>W1.UFMW9;'AXR5"=#]QA*E.UFJCIJ"^))\TE>Z:
MT5WO8V]9G>Y^'MN\I+,#$N3R=J3LBC\%4#\*QII1QLDM-W]\4W^+.NM)RRF#
MD[OW5\E-I?@D;OPY\%:3=Z'%=7EO'<S7@<N\HW%5$C(JQD\QX"#YDPV2><8
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MK'S3W^Y_F?FN=X5PJ+%Q7NSLI>4DK)ORDK6\T^Z/.*]T^0"@ H * "@ H *
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M'(IR'5BK GJ0P((//7-;.*DN62379JZ^XYXSE"7/"34EJFFTU\UJ6;O4[O4
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MNRVUNEK;32][L]FOC:;P=+ 89223YJKDDN:6^EI2NN9WUM;EBO3B*]8^?"@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@".3I4O8TAN9%Q7G3/H:!3NM
M)F&GG4V&V'[0D"Y'WV9)'8J?1-@!]V '0UYCDN?DZVO^1[SB_9*?3F2_!GTE
M\"/^0%/_ -?\G_HBVKQ,9_$7^%?G(]_+OX4O\;_])B>U5YI[ 4 % !0 4 %
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MZ.8XRBZ=:,8J-FHQ<4ZCNMWS.*25WO'5+1LUKWPGJDW@R'1DAS?(REHO,B&
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M_P !C9A^:@BO36(HO:I#YR2_,\!X'%1T=&I\H2?Y)D?]AZC_ ,^MS_WYD_\
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ML/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\
MOS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?
M\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^
MIXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P
M7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?
M^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_
M\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?
M^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_
M )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\
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M''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\
MGQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(
M/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_
M +\R?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ
M7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,
M/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_
M\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U
M'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R
M?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R
M'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)
M_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_
M ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GU
MN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T
M>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<
M?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?
M%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_
ML/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\
MOS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?
M\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^
MIXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P
M7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?
M^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_
M\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?
M^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_
M )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\
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M''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\
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ML/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\
MOS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?
M\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^
MIXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P
M7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?
M^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_ )\5?_!<_P#(/[#U'_GUN?\ OS)_
M\31[>E_S\A_X''_,/J>)_P"?%7_P7/\ R#^P]1_Y];G_ +\R?_$T>WI?\_(?
M^!Q_S#ZGB?\ GQ5_\%S_ ,@_L/4?^?6Y_P"_,G_Q-'MZ7_/R'_@<?\P^IXG_
M )\5?_!<_P#(/[#U'_GUN?\ OS)_\31[>E_S\A_X''_,/J>)_P"?%7_P7/\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_P ]K;_P(3_XJCZO7_DG_P" /_(/KN%_Y_4O_!L/\P_X2'2O^>UM_P"!"?\
MQ5'U>O\ R3_\ ?\ D'UW"_\ /ZE_X-A_F'_"0Z5_SVMO_ A/_BJ/J]?^2?\
MX _\@^NX7_G]2_\ !L/\P_X2'2O^>UM_X$)_\51]7K_R3_\  '_D'UW"_P#/
MZE_X-A_F'_"0Z5_SVMO_  (3_P"*H^KU_P"2?_@#_P @^NX7_G]2_P#!L/\
M,/\ A(=*_P">UM_X$)_\51]7K_R3_P# '_D'UW"_\_J7_@V'^8?\)#I7_/:V
M_P# A/\ XJCZO7_DG_X _P#(/KN%_P"?U+_P;#_,/^$ATK_GM;?^!"?_ !5'
MU>O_ "3_ / '_D'UW"_\_J7_ (-A_F'_  D.E?\ /:V_\"$_^*H^KU_Y)_\
M@#_R#Z[A?^?U+_P;#_,/^$ATK_GM;?\ @0G_ ,51]7K_ ,D__ '_ )!]=PO_
M #^I?^#8?YA_PD.E?\]K;_P(3_XJCZO7_DG_ . /_(/KN%_Y_4O_  ;#_,/^
M$ATK_GM;?^!"?_%4?5Z_\D__  !_Y!]=PO\ S^I?^#8?YA_PD.E?\]K;_P "
M$_\ BJ/J]?\ DG_X _\ (/KN%_Y_4O\ P;#_ ##_ (2'2O\ GM;?^!"?_%4?
M5Z_\D_\ P!_Y!]=PO_/ZE_X-A_F'_"0Z5_SVMO\ P(3_ .*H^KU_Y)_^ /\
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M:O\ RS_\%O\ R#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\
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MO_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U:O\ RS_\%O\
MR#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\ \%O_ "#Z[A?^
M?M+_ ,&Q_P P_P"$CT?_ )Z6W_@4O_Q5'U:O_+/_ ,%O_(/KN%_Y^TO_  ;'
M_,/^$CT?_GI;?^!2_P#Q5'U:O_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM
M_P"!2_\ Q5'U:O\ RS_\%O\ R#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\
M%4?5J_\ +/\ \%O_ "#Z[A?^?M+_ ,&Q_P P_P"$CT?_ )Z6W_@4O_Q5'U:O
M_+/_ ,%O_(/KN%_Y^TO_  ;'_,/^$CT?_GI;?^!2_P#Q5'U:O_+/_P %O_(/
MKN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U:O\ RS_\%O\ R#Z[A?\ G[2_
M\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\ \%O_ "#Z[A?^?M+_ ,&Q_P P
M_P"$CT?_ )Z6W_@4O_Q5'U:O_+/_ ,%O_(/KN%_Y^TO_  ;'_,/^$CT?_GI;
M?^!2_P#Q5'U:O_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U
M:O\ RS_\%O\ R#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\
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MO_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U:O\ RS_\%O\
MR#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\ \%O_ "#Z[A?^
M?M+_ ,&Q_P P_P"$CT?_ )Z6W_@4O_Q5'U:O_+/_ ,%O_(/KN%_Y^TO_  ;'
M_,/^$CT?_GI;?^!2_P#Q5'U:O_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM
M_P"!2_\ Q5'U:O\ RS_\%O\ R#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\
M%4?5J_\ +/\ \%O_ "#Z[A?^?M+_ ,&Q_P P_P"$CT?_ )Z6W_@4O_Q5'U:O
M_+/_ ,%O_(/KN%_Y^TO_  ;'_,/^$CT?_GI;?^!2_P#Q5'U:O_+/_P %O_(/
MKN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U:O\ RS_\%O\ R#Z[A?\ G[2_
M\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\ \%O_ "#Z[A?^?M+_ ,&Q_P P
M_P"$CT?_ )Z6W_@4O_Q5'U:O_+/_ ,%O_(/KN%_Y^TO_  ;'_,/^$CT?_GI;
M?^!2_P#Q5'U:O_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U
M:O\ RS_\%O\ R#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\
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MO_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U:O\ RS_\%O\
MR#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\ %4?5J_\ +/\ \%O_ "#Z[A?^
M?M+_ ,&Q_P P_P"$CT?_ )Z6W_@4O_Q5'U:O_+/_ ,%O_(/KN%_Y^TO_  ;'
M_,/^$CT?_GI;?^!2_P#Q5'U:O_+/_P %O_(/KN%_Y^TO_!L?\P_X2/1_^>EM
M_P"!2_\ Q5'U:O\ RS_\%O\ R#Z[A?\ G[2_\&Q_S#_A(]'_ .>EM_X%+_\
M%4?5J_\ +/\ \%O_ "#Z[A?^?M+_ ,&Q_P P_P"$CT?_ )Z6W_@4O_Q5'U:O
M_+/_ ,%O_(/KN%_Y^TO_  ;'_,/^$CT?_GI;?^!2_P#Q5'U:O_+/_P %O_(/
MKN%_Y^TO_!L?\P_X2/1_^>EM_P"!2_\ Q5'U:O\ RS_\%O\ R#Z[A?\ G[2_
M\&Q_S)H=?TF0X1X&/HLZL?RW5$J%:/Q*2]8-?H:QQ6'GI"I3?I4B_P F=-;7
M4#_+'A#Z8 _^L:XI1DM7J=Z:V6AY%\=_^0%!_P!?\?\ Z(N:[L'_ !'_ (7^
M<3RLQ_A1_P :_P#29!\"/^0%/_U_R?\ HBVHQG\1?X5^<@R[^%+_ !O_ -)B
M>U5YI[ 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0!G:D;HH([, -(=ID)&(U[MCJ3Z8[]:TARWO/9=._D9RYK6AUZ]A^GZ?'
MIT?EQ\D\NY^\['JS'_.*4I.;N_DNPXQ4%9?-]R]4%A0 4 % !0 4 % #7^Z?
MH:: H5H9A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 C,$!)Z"GY!L>6^,/&G]FM]EM<-<8R<\K$#TR.[D<@'@#!.
M00#[^#P7M5[2II#\9?Y+S/DLSS3ZJ_84+.KU>Z@GM==9/HNF[[/QB\OI[]_,
MN9&E;U8DX]@.@'L ![5]3"G&DN6G%17DOZN?GM6M4KRYZTI2EW;O;TZ)>2T*
MM:F 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0!6FK&9V431T?Q?J&@./*<RP#K#(
M24QW"YR4/NO&>H/2O&K485+MJS[K?Y]SZW"8FI1LDVX_RO;Y=OD=K\2?$L/B
M3PQ;3P'(^W1Y!^\C""X#(_N,@@]U((X(KQZ-+V55I_RO\UJ>_BZJJT(M?SKY
M>[+1G7? C_D!3_\ 7_)_Z(MJY<9_$7^%?G(ZLN_A2_QO_P!)B>U5YI[ 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 U_NGZ&F@*%:&84 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5'VF'IN4=KWC%/T<FK_*Y+:>%-1DU!=-D@99AAV1F5?W0(#,K%@K#G&58\Y
MY!J9XJE&DZ\9KEV32;]ZVB:2NOFD73P&(E76%E3:GI)Q;2]RZNTVTFO1O7T.
MH\:^!I-+D-SIL)%A%"K2.95)#[F#<._F'C9T4CT[UY^"QRJI4Z\OWKDTDHM:
M65M4K=]V>OF>5RP\G5PM-_5XP3DW-.TKN^DI<VUMD<O8>#=8U.$7-M;,T3#*
ML6C3</50[J2#V(!![5Z%3&4*4O9SFE);JS=O6R:1Y%++<7B(*K2I-P>S;C&Z
M[I2DFUYI:F.-,NC<_81$_P!IW;/*VG?N],?3G/3'.<<UT^UAR>UYER6OS7TM
M_7XZ'#["K[3ZOR2]K>W);WK^GX]K:[&U>^"M9TZ$W-Q;,L2#+%6C<J.Y*QNS
M #J21@#DX KEAC</4DH0J+F>R::O\VDCT*N68NA!U:E)J*U;3C*R[M1DVDNK
MMIU.V\#>#6:"74[^U6YS$'LXF>,K*65C\PW$+G"*/,  W%BN0"/*QV,2E&A1
MJ.'O-5)).\;-;:7?5OEWM:^I[V5Y:W">+Q%%5/<3HP<HVFVF]5>RZ)<^BNW;
M0Y76-+O]8U5[2"PCM;B)%#V]N$"*"N\,S*?+!96&6+#L.O%>A1JTJ%%5)5G.
M#;M.=[O6UDG[VC3TMY['CXFA7Q.)=&GAXTZD4KTZ?+RK3F3;3Y=4UK?LM]#*
MU7PMJFB();VW:*,G&\%'4'L"T;,%SVW$9[5T4L51KOEI33?:S3^2:5_D<=?
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M;E=GHUKZM)/;I<JOA:V%Y'B(\O.KQUBVUINDVUOUM^#,FNDX@H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * *TU8S.RB8\]
M>=,^AHF9/=2+"UL"?*>1)"O;>BNJGZ@2,/Q]JX;>]?K;_(]>3_=VZ<R_)GT_
M\"/^0%/_ -?\G_HBVKP\9_$7^%?G(][+OX4O\;_])B>U5YI[ 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 U_NGZ&F@*%:&84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 </X]#'2Y]O]Q/R$JD_I7K8"WMX7[O_ -)=
MOQ/"S:_U2K;M'[N>-_P/G.ON#\F"@ H * "@ H * "@ H * "@ H * "@ H
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M5QLZ5*2C"E"<7&$%9;V5_17M:RUV.E^*>J746H1VD<LD<(MU8HC%5+,\@8L
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M^!'_ " I_P#K_D_]$6U>)C/XB_PK\Y'NY=_"E_C?_I,3VJO-/8"@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * &O]T_0TT!0K0S"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ (!&#TH \_P#%?@Z/65\U#Y<Z#"R8X(_N
MR <D>C#D>_0^SA,8\.^5ZP>Z_5>?EU_$^>S#+88U<\?=JI64NC7:7EV>Z\]C
MQ74/#M_IAQ/"VW^^@WH?^!+G'T;!]J^JIXFE5^"2OV>C^Y_I='YY7P.(PSM4
MIRM_-%<T?O6WH[/R,4@J<'@BNKT/.VT84Q!0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 1M!),=L:LY]%!)_05SU&H[M+UT.ZA&4G:*;]%<Z71?AUJ&K.K72FT@)YW#
M]ZP]%CZJ?=P,=<-TKPJV)A&Z@^9^6WW_ .1]GA<#5E9U$X1\_B^[=?.QU?Q7
MT*#0O#5K;VZB-$O8P%'O!<DECW9CRQ]:\O#U'4JR;_E?YH]K&4U2H1C'1*:_
M])D;_P "/^0%/_U_R?\ HBVKGQG\1?X5^<C?+OX4O\;_ /28GM5>:>P% !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 -?[I^AIH"A6AF% !0 4 % !0 4 % !0 4 % !0 4 % !0
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ME[_D/W?,UK4V_P#RQQG]?UYK"7-]HU5OLGD/QW_Y 4'_ %_Q_P#HBYKNP?\
M$?\ A?YQ/*S'^%'_ !K_ -)D'P(_Y 4__7_)_P"B+:C&?Q%_A7YR#+OX4O\
M&_\ TF)[57FGL!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: H5H9A0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #D
M^\/J*3&7))%A4NW %0E=V13=M3Q_QAX[-DYM;7#SC[V>4C^H!&Y^^.@[_P!V
MOI,'@/:+VE2ZAT[R_P E^?XGQ^99LL,W0H6E5ZM_##_.7ELNO8\>O-7O+]MU
MQ-(_L6(4?11A1^ %?3PHTZ2M"*7RU^_<^"JXJO7=ZM24O*^GR2LE\D9U;G&%
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 -,KP\QLR'U4D']*RFDU9HZ:,G&5XMKT=CH-'^(&H:
M/(!.QNH,C*N<R*/5)/O9QV8LOTZUX5?#0E=Q7*_+;YK_ "/L\)C:L+*;<X^>
MZ]'O]]SJ_BIK\&O>&K:XMVWHU[&0>A&(+D%7'9U/!'X\C!/D4*;I59)Z>Z_S
M6WD>]C*BJT(RCMSK_P!)EOYG1? C_D!3_P#7_)_Z(MJY\9_$7^%?G(Z,N_A2
M_P ;_P#28GM5>:>P% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -?[I^AIH"A6AF% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M?3<+GP3K5F$,EK)^]8(NTHYW'ID(S%1QR6P!W(HCC</._+46BN[W6B[72O\
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MK;-9 _N7E28KZ.B2("/3*R$-ZX7T%>>TN;FZVM^1[<F_9\O3F3_!GTW\"/\
MD!3_ /7_ "?^B+:O#QG\1?X5^<CW\N_A2_QO_P!)B>U5YI[ 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 U_NGZ&F@*%:&84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 Y/O#ZBDQGF/Q2W?8^.GG1Y^FQ__
M &;%>_E=O:?]NR_-?H?)Y]?ZNK?\_(W].67ZV/!Z^P/S0* "@ H * "@ H *
M "@ H ]6\(^'H=)MQXAU9&94PUK %+.[?POLQSDC,>> /WC$* :^=Q>(E6G]
M2PS2;TJ3O9)=5?\ ]*Z_96MS['+\'##4_P"T\;%M+6E32O*3Z2Y?QCT^T]+,
MYF[\3Z@FKKK<L8252WE1RJ^Q4VE @Y0D*'R2",L=Q'.*[X8:E[!X2,KQTYG%
MJ[=T[]4KM?=H>54QU=8I8^<;35^2,E+E4;./+]ENR=]&M7?K8HP>)[NUM9K.
M(1JMQ.MP7 ;>DB.KKL.[: &0?>5C[UK+#0E.-25[P@X):6:::=]+[/HT<\,=
M5ITYT(<J52HJCE9\RE%J2Y7>R5TMT_4U)O'EY,LX,%HCWD+PS2)$RR.'7;N+
M"3[P'3C;DY*G QSQP-.+A[]1J$E*,7).*:=[)6V_'S.R6:U9JHO9T5*K!PG)
M0:E)-6NWS;I;=.Z>EN-AE,#K(O5&##/3(.1G\J]1KF3B]FK?>>%&3@U);IIK
MY:GKGQ%T^36Q:ZWIZO/!) $8H"VP!F=2R@9'WV5L_=*X.#U^;RZHL/[3"UFH
MS4[J^E]$G9[=$UW3NC[3.:,L6J./PR<Z<J:B^57Y=7)72U7Q-/LU9V9)\/+2
M70(+S6+]6M[=8@%\P%2^#N.T'!.3M5<#YF;"Y(-+,)QQ$J6&HM2GS7=M;=-;
M?-OLE=E9/3E@H5\=B4X4U!)<RLY6UT3UWLEW;LM2/3+N:R\%SRV[F-_.*[E.
M& :6-6P>HRI(R.>>*=2$9YA",TFN6]GMI&37XDT*DZ63U)TFXRY[76CLYQ3L
M^ET[$:SR7/@F5IF:1EG !8EB!YT? )R>Y_.JY5#,8J*23@[VT^S(E2E/)IN;
M<FJB2;=VOWD>_JR]\03>F&Q.E^;]B\H;?L^_;NPNS.S_ &<>7G_:QWK'+_9\
MU;ZQR^TYM>>U[:WW\]_E<Z,W]MR8?ZGS>PY-/9WM?3E^'RMR_.POA/[8=.U7
M?YO]K&-<[MWG[?(_<]?FW8SM_BSC/.*,7[-5</;E^KW>UN2_/[VVEN_0,O\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H :_W3]#30%"M#,* "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H <GWA]128SF_&>CG5;.2)<;G7Y
M2>SJ=R\]MV-I/IFN_!UO8U(R>R>OH]']VYY>88?ZU0G27Q->[_B6J^_;T9\O
M.AC8JP(9200>""."#[BOOT[JZV/QYIQ;BU9K1KLT)3)"@ H * "@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@!K_ '3]#30%
M"M#,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MHKEIJRO?=O71=6^QM5F;!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: H5H9A0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!'_(/KF)_P"?]7_P9/\ S#^W-1_Y^KG_ +_2?_%4>PI?\^X?^ 1_R#ZYB?\
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MMS4?^?JY_P"_TG_Q5'L*7_/N'_@$?\@^N8G_ )_U?_!D_P#,/[<U'_GZN?\
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M )_U?_!D_P#,/[<U'_GZN?\ O])_\51["E_S[A_X!'_(/KF)_P"?]7_P9/\
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M5R'0% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: H5H9A0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #D^\/
MJ*3&7ZS+"@ H * "@ H * "@ H * "@ H * (;B7R(V?N!Q]3P*J*NTB6[*Y
M\Q>-M9?4KYH03Y-L2@&>"X^^Q]\_*/8>YK[S T52I*=O>GKZ+HONU]6?E&;8
MIXBNZ2?[NDW%+HY+XI>M]%Y+S9QM>J?/!0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * &O]T_0TT!0K0S"@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M ')]X?44F,OUF6% !0 4 % !0 4 % !0 4 % !0 4 9VJ'$0_P!X?R-;4]_D
M9SV/C^9B\C,WWBQ)^I/-?I<59)+:R/PR;;E)O=MM^MR.J("@ H * "@ H *
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MJ2;V;BVW?2V]HR[+F=MS+^)'B2^MKY]-@D,5LT*B1%"_/Y@.[<V-W*D+@$#
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M]ON.NKF-PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MM&I'F4=;Z6:>^NM[=+%74O%M_JMW#>W!0FU=7BC"D1*596QM!W'<5&XEMQ'
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@!K_=/T-- 4*T,PH * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 -?[I^AIH"A6AF% !0 4 % !0 4 % !0 4
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M.0?4,-_SYI?^"H?Y!_PAFG?\\+;_ ,!XZ/KE7^>?_@<@^H8;_GS2_P#!4/\
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M_@J'^0?\(9IW_/"V_P# >.CZY5_GG_X'(/J&&_Y\TO\ P5#_ "#_ (0S3O\
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M>?\ X'(/J&&_Y\TO_!4/\@_X0S3O^>%M_P" \='URK_//_P.0?4,-_SYI?\
M@J'^0?\ "&:=_P \+;_P'CH^N5?YY_\ @<@^H8;_ )\TO_!4/\@_X0S3O^>%
MM_X#QT?7*O\ //\ \#D'U##?\^:7_@J'^0?\(9IW_/"V_P# >.CZY5_GG_X'
M(/J&&_Y\TO\ P5#_ "#_ (0S3O\ GA;?^ \='URK_//_ ,#D'U##?\^:7_@J
M'^0?\(9IW_/"V_\  >.CZY5_GG_X'(/J&&_Y\TO_  5#_(C?PCI<7+Q6J_6W
MBJEBZSVG4_\  Y!]0PJWHT?_  5#_(KGPWHX_P"6=M_X#)_\35?6:_\ -/\
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M;?\ @*G_ ,31]8K_ ,T__ W_ )C^IX7_ )]4O_!4?\@_X1K1O^>5M_X"I_\
M$T?6*_\ -/\ \#?^8?4\-_SZI?\ @J/^0G_"-:-_SRMO_ 5/_B:7UBO_ #3_
M / W_F'U3#?\^Z7_ (+C_D'_  C.C?\ /*V_\!4_^)H]O7_FG_X&_P#,?U3#
M?\^Z?_@N/^0?\(SHO_/&V_\  5/_ (FCV];^:?\ X&_\P^JX;_GW3_\ !<?\
MA/\ A&=%_P">-K_X"I_\31[>MWG_ .!O_,?U7#_\^Z?_ (+C_D'_  C&B_\
M/&U_\!4_^)I>WK=Y?^!O_,/JN'_Y]T__  7'_(/^$8T7_GC:_P#@(G_Q-'MZ
MW>7_ (&Q_5L/_)3_ /!<?\A/^$7T3_GC:_\ @(G_ ,31[:MWE_X&P^K4/Y*?
M_@M?Y!_PB^B?\\;7_P !$_\ B:/;5N\O_ V/ZM0_DA_X O\ (/\ A%M$_P">
M-K_X")_\31[:KWE_X&P^KT/Y(?\ @"_R$_X1;0_^>%K_ . B?_$TO;5>\O\
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MH_\ @*#_ (1+0?\ GWM/_ ./_P")H]I4\_\ P(/94^T?_ 0_X1+0?^?>S_\
M ./_ .)I>TJ>?_@0>SI]E_X")_PB.@_\^]G_ . <?_Q-'M*GG_X$/V=/R_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M #]W/_?^3_XJI]A2_P"?</\ P&/^1:Q>)_Y_5?\ P9/_ #&G7M2_Y^[G_O\
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MRZ_[_P O_P 74^QI_P D/_ 5_D6L37_Y^U/_  .7^8W_ (2'5/\ G\NO^_\
M+_\ %TO8T_Y(_P#@*_R*6(K?\_:G_@<O\QI\0ZI_S^77_?\ E_\ BZGV5/\
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M_P#@3_S$/B35?^?V[_\  B7_ .+I>SA_+'[D6JM3^>7_ ($_\QG_  DNK?\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 U_NGZ&F@*%:&84 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -?[I^AIH"
MA6AF% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 .3[P^HI,9?K,L* "@ H * "@ H * "@ H * "@ H *
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M56JK6@Z4XIW:O[SBDK*[WZ6)OA__ ,AVV_[;?^B):C-/]TJ_]N?^G(FF0_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H :_P!T_0TT!0K0S"@ H *
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MZV7GU;;;[V2MC5VGF!0 4 =IH_CF\T2V2UMX;9EBW;7=',GS,S'++(O]X@8
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M0Y82Y5%QBFH-)MV:;??>]^UB34_B!?ZE;26GE6ENDXQ(88=K."<G)=W'..H
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M&VOS/;*\X[0H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@!K_ '3]#30%"M#,* "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H <GWA]128R_6984 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M Z9QP..@ [ =!7D2ES.YZ<5RJQ:J"@H * "@ H * "@ H * "@ H * "@ H
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M_GS1_P#!</\ (/\ A%-)_P">=I_WXAH^M5_YJG_@<A_4<+_SZH_^"X?Y"?\
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M$-T7_GC9?^ \%'MZG]__ ,"8?5Z7\L/_  &(G_"&Z+_SPLO_  '@H]O4_O\
MWL/J]+^6'_@,0_X0S1/^>%C_ . \%+V]3^]]['["EVA_X#$/^$,T3_GA8_\
M@/!1[:I_>^]A["EVA_X"A/\ A#-$_P">%C_X#P?X4>VJ?WOO8_84^T/_  %!
M_P (7HG_ #PL?_ >#_"CVU3^]][#V-/M'[D'_"%Z'_SPL?\ P&@_PH]M4_O?
M>P]C3[1^Y!_PA6A_\\+'_P !H/\ "E[:?][[V/V4/[OW(3_A"M#_ .?>Q_\
M :#_  H]K/M+[V'LH?W?N0?\(5H?_/O8_P#@-!_A1[6?:7WL?LH?W?N1I67A
M_3+ Y@6"'M^Z2*/\/E'2H=2;Z/YW92A%=5\K(WHFMX!A&0?\"&?SS6+YGNG]
MQJN5;6)?M,7]]/\ OH?XU/*^S^XJZ[H/M,7]]/\ OH?XT<K[/[@NNZ#[3%_?
M3_OH?XT<K[/[@NNZ#[3%_?3_ +Z'^-'*^S^X+KN@^T1?WT_[Z'^-'*^S^X+K
MNB175_ND'Z'-*UMP]!U(84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -?[I^AIH"A6AF% !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 .3[P^HI,9?K,L* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M'_\ $T7 /[?OO^>O_CD?_P 31< _M^^_YZ_^.1__ !-%P#^W[[_GK_XY'_\
M$T7 /[?OO^>O_CD?_P 31< _M^^_YZ_^.1__ !-%P#^W[[_GK_XY'_\ $T7
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M.3[P^HI,9?K,L* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H SM3N1:PDYQD')]% RQ_*M8*[OV,
MY.R/"]0OGOYC*W3HH_NKV'U]?4UT&!1H&% !0 4 % !0 4 % !0 4 % !0 4
M % !0!K:/I+ZO,8E=(@B[W9ST4$ D#OC/J!ZD5+?*-*YJ>)=#@T80&W=Y!,K
M$EBI!QLP5VJ, [CU)[<U,7>]RI+EV(;"RTO[.)[ZXD#N2/*B W+@XRQ(8<C!
M&0OH,X.&V[V2$DNK+.J>'[>*WBOK"8O;S.$)EXV$DC<Q"CY000WRY'49S24G
M>S6HVK:K8U)/#=I%?6T>Z-HI$3?%YC^8Y*N2ZX ^0X&"&'3I4\SLQ\J31@:G
MH#VBRW,3Q/#%*494<L\>6PH<$=1P#AF.>O0FK4NA+5M3G:LDZ'3;+3'@,]_<
M.C;BHBB4;^!G))##!SP< 9!&2>!#;V2*275ES4]!M4LAJ6G2O)"&VLL@&X9.
MW/ 7H<#&.AR#CJE)WY6-I6NAUKH5G;V:7VJ2R1B<_NTB W8Y())#=1ST& 1D
MY.*+N]H] LDKL2^\.1P2V\EO*&L[HC;)(=NWC.UL+U8 A?E!W?*0,9(I;WW0
M..UMF:R>&K1=3DM\QR1>6Q6(2/YB,%0@O]W&221\Q!!Y%3S.UQ\JO8Y._P!&
MEL(4N=\4T3L4#1/N 8#.TY"\X!Z9''7IG1.^A#5M1-"L(]4O8[64LJ2;\E2
MWRHS#!(8=5&>#Q1)V5T"5W8Z&XTS0;6=K66:Z1T;:2=A4'ZB/I^%1>6]D7:*
MTU,+7M&.B7'D[M\;KO1L8RI)&#VR".<<$8/&<"HNZ):Y3&VG&[!VYQG'&>N,
M^OM5$C:8&OHNDMK-Q]F5Q&=I;)&>F.,9'K4M\JN-*^AG7$/V>5XB<F-F7/KM
M)&?TIB(:8!0 4 =A::%906*7^IR2H)CA$B SWQG*MU +=@!@=3BLFW>T2[)*
M[.1?;N.S.W)QGKCMGWQUK0@;3 <JEL[03@9.!T'J?;WI -I@% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 3VUP]I()8CAE/Y^H/L>] 'N&A7XO8 1T(##V!
MX(_X">*QJ*WO(U@^AN5@:A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 -?[I^AIH"A6AF% !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 .3
M[P^HI,9?K,L* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M'!.69F[!L <J0(BOM,J3M[JZ FOV+SVU[*LXN+9$C95"&,JJL"5RP;)+9P<
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M^9&KMC@;LLI./<*,^IYZFM(;$2T9R-:$!0 4 % !0 4 % !0 4 % !0 4 %
M!0!Z?X(D)B"]@[K^&T-_,U$_A*CN>B5RG0% !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 U_NGZ&F@*%:&84
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M;P*6&#@N?J_0?]\_K6<W96+@M;G:US&X4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: H5H9A0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % #D^\/J*3&7ZS+"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * (YHA,A1NA_3WII\KNA-
M75CRCQ%X=D21IX%RQY91W_VE]<]QUS[Y%=B:DKHYFK:,X@@J<'@CM0 E !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 =5H?A^2[=9)E(0'*H1@M]1V7USU^G-&VK#R1[#:VXMDVCD]2?>N6
M4N9W.A+E5BQ4%!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M32E'9/[B79[V.?O-#LKHY8Q,?]K&?^^@0:W4GUBS/E71HS#X4L?^F7_?U_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MHN ?V_??\]?_ !R/_P")HN ?V_??\]?_ !R/_P")HN!-%XDO(SEBKCT*@?\
MH.VG<#MM%\5K<L(GRK?W&.<_[C<<^Q'T]:AQ4MM&6I->AW<4BRJ'0Y!KE:Y=
M&;IWU0^D,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M3ZWX7ET:".X+B0,0K@+CRV(R!G)W#J,D+VX^;B%*^A3CRZG+UH2% !0 4 %
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M"K8+$J"#RW)XXII-J]P;2=K&;X[_ .0@O_7!/_0I*<-OF3/<M?#_ /X^)O\
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MZC.\ER-T5NF\I_>)/&?4#!)'<X!XR*<G;845?<VM*FL/$KR63VD5L=A:-X@
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MC./5TZ<JETG\/]?H*K6C246U\2O^7^9@^-K2#3;J-K=1&LT88HHP P)!('0
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M'_H9KRL=14(1E_>M]Z?^1]%E&)=6K.GK\'-]TDO_ &X^AZ^2/O0H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M &O]T_0TT!P?BJT,]NQ7JH#C_@/WO_'<FNJ.UCFEN>550@H * "@ H * "@
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M4.B2R23J["1 HV!2<@YYW,O%*2OL$7RG+UH2=-X?UF'28[E)E=C<(%78%."
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MA^1SK/K:"_-_H?0U?*GVX4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: R;B$3)M[]O\ #\:VB^5F
M35SR36M%>P<R1@F$G_OCV/MZ'\#SUV]#$Y^@84 % !0 4 % !0 4 % !0 4
M% %@W4QB%N9'\D'(CW-L!SG(7.W.23TZFE;J'D5Z8!0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % %@
M74RQ&W$CB$G)CW-L)R#DKG:3D ].H%*W4/(KTP"@ H * )[>YFM&WP.\3$8)
M1BIQP<94@XR <>PI6ON&VQ!3 * "@ H * "@ H$% !F@+B9%%@N@R*=F*Z[A
MD468<R[AN%%GV%S+N)N%/E?8.:/<-X]:.5]A<\>XF]?6CE?87M(]P\Q:?(^P
MO:1[B>:M/D?87M8]P\U:.1A[6/<3SEI^SD+VT.X><M'LY$^W@)YZT_92%[>
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MOY_Y?(^PH4E1@H1T2_IOYG35RG4% !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M_P (9%ZR_P#?4?\ \31>/<+,/^$,B]9?^^H__B:+Q[A9A_PAD7K+_P!]1_\
MQ-%X]PLP_P"$,B]9?^^H_P#XFB\>X68?\(9%ZR_]]1__ !-%X]PLP_X0R+UE
M_P"^H_\ XFB\>X68?\(9%ZR_]]1__$T7CW"S#_A#(O67_OJ/_P")HO'N%F'_
M  AD7K+_ -]1_P#Q-%X]PLP_X0R+UE_[ZC_^)HO'N%F'_"&1>LO_ 'U'_P#$
MT7CW"S#_ (0R+UE_[ZC_ /B:+Q[A9A_PAD7K+_WU'_\ $T7CW"S#_A#(O67_
M +ZC_P#B:+Q[A9A_PAD7K+_WU'_\31>/<+,/^$,B]9?^^H__ (FB\>X68?\
M"&1>LO\ WU'_ /$T7CW"S#_A#(O67_OJ/_XFB\>X68?\(9%ZR_\ ?4?_ ,31
M>/<+,/\ A#(O67_OJ/\ ^)HO'N%F'_"&1>LO_?4?_P 31>/<+,/^$,B]9?\
MOJ/_ .)HO$5F'_"%Q>LO_?4?_P 31>(<K_JP?\(7%ZR_]]1__$4[Q_JX<K_J
MP?\ "%Q>LO\ WU'_ /$4<T?ZN'*_ZL)_PA<7K+_WU'_\11S1_JXN5^?X!_PA
M<7]Z;_OJ/_XBCFC_ %<.5]W^ ?\ "%1?WIO^^X__ (BGS1_JXN1]W^ G_"%1
M?WIO^^X__B*.>/E^(N1]W^ ?\(3%_>F_[[C_ /B*?/'R^YA[-]W]Z_R >"(C
MP&F_[[C_ /B*.>/E]S%[-]W]Z_R'_P#"!IZS?]]Q?_$TO:Q\ON8>Q?>7WK_(
M/^$"3UF_[[B_^(I^UCY?<Q>Q?>7WK_(3_A D]9O^^XO_ (BCVL?+[F+V#[R^
M]?Y!_P ("GK-_P!]Q?\ Q%/VT?+[F'L'WE]Z_P A/^$!C]9O^^XO_B*/;1\O
MN8OJ[[R^]?Y!_P (!'ZS?]]Q?_$4_;+R^YB^K^<OO7^0G_" 1^L__?<7_P 1
M1[=>7W,7U;SE]Z_R#_A7\?K/_P!]Q?\ Q%/VZ\ON8OJOG+[X_P"0G_"OX_6?
M_ON+_P"(H]NO+[F+ZKYR^^/^0?\ "OH_6?\ [[B_^(I_6%V7W,/JG]Z7WQ_R
M$_X5['ZS_P#?<7_Q%'UA=H_<Q?5/[T_OC_D'_"O8O6?_ +[B_P#B*?UA=H_<
M_P#,7U-?S3^^/^0G_"O(O6?_ +^1?_$4?65VC]S_ ,Q?4U_-/[X_Y!_PKR+^
M]/\ ]_(O_B*?UE=H_<_\Q?4E_-/[X_Y"?\*[B_O3_P#?R+_XBG]:\H_<_P#,
M/J*_FG]\?_D0_P"%=1?WI_\ OY%_\11]:\H_=+_,7U%?S3^^/_R(G_"NHO[T
M_P#W\B_^(I_6O*/W2_S%]0C_ #3^^/\ \B'_  KJ+^]/_P!_(O\ XBCZWY1^
MZ7^8OJ$?YI_?'_Y$/^%<Q?WI_P#OY%_\13^M^4?NE_F+^SX_S3^^/_R(G_"N
M(?[T_P#W\B_^(H^M^4?NE_F']GQ_FJ??'_Y$/^%<0_WI_P#OY%_\13^N>4?N
ME_F+^SH_S5/OC_\ (B?\*WA_O7'_ '\B_P#B*/KGE'[I?YB_LV/\U3[X_P#R
M(?\ "MX?[UQ_W\B_^(I_7/*/W2_S%_9L/YJG_@4?_D1/^%;0_P!ZX_[^0_\
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M?^!0_P#D _X5-:_W[G_OY#_\:H_M.?\ <^Z7^8_[$H=ZG_@4/_D!/^%36O\
M?N?^_D'_ ,:H_M.?]S[I?YA_8E#O4_\  H?_ " ?\*EM/[]U_P!_(/\ XU1_
M:4_[GW2_S#^Q*'>I_P"!0_\ D _X5+:?W[K_ +^0?_&J/[2G_<^Z7^8_[$H=
MZG_@4/\ Y$3_ (5+:?W[K_OY!_\ &J7]I3_N?=+_ ##^Q:'>I_X%#_Y$/^%2
M6G]^Z_[^0?\ QJC^TI_W/NE_F/\ L6CWJ?\ @4/_ )$/^%26G]^Z_P"_D'_Q
MJC^TI_W?NE_F']BT>]3_ ,"A_P#(A_PJ2T_OW7_?R#_XU1_:4_[OW2_S#^Q:
M/>I_X%#_ .1$_P"%1VG]^Z_[^0?_ !JC^TI_W?NE_F/^QJ/>I_X%'_Y$/^%1
MVG]^Z_[^0?\ QJE_:,_[OW2_S#^QJ/>I_P"!1_\ D0_X5':?W[K_ +^0?_&J
M/[1G_=^Z7^8_[&H]ZG_@4?\ Y$3_ (5%:?W[K_OY!_\ &J/[1G_=^Z7^8?V/
M1[U/_ H__(A_PJ*T_OW7_?R#_P"-4?VC/^[]TO\ ,/['H]ZGWQ_^1#_A45I_
M?NO^_D'_ ,:H_M&?]W[I?YC_ +'H]Y_?'_Y$3_A4-I_?NO\ OY!_\:I?VC/^
M[]TO\P_L>CWG]\?_ )$/^%0V?]^Z_P"_D'_QJC^T9_W?NE_F/^R*/>?WQ_\
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M7]W[I?YA_9E/^_\ ?'_(/^%-V7]^[_[^P?\ QJCZ]+^[]TO\P_LRG_>^^/\
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M]_8/_C-'UQ^7W/\ S#ZA#^]]\?\ (/\ A2]C_P ]+O\ [^P?_&:/KC\ON?\
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M$$<*(BK]U$4(@^B@ 9]S7%*HY?UJ=D::CHO^ ;%8FH4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 U_NGZ
M&F@*%:&84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 Y/O#ZBDQE^LRPH * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * &O]T_0TT!0K0S"@!"P7J0/K3] &><
MG]Y?S%%GV8KH/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\O
MYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS
M[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H
M/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^
M\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYB
MBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,
M+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.
M3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\O
MYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS
M[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H
M/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^
M\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYB
MBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H/.3^\OYBBS[,+H<DT88?,O4=Q1
M9]F.Z+OVF+^^G_?0_P :SY7V?W%W7=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_
MWT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]
MIB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]
MP77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\
M:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_O
MI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=
M!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]
MG]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT
M/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB
M_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P7
M7=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.
M5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_
MWT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]
MIB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]
MP77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\
M:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_O
MI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=
M!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]
MG]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT
M/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB
M_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P7
M7=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.
M5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_
MWT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]
MIB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]
MP77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\
M:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_O
MI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=
M!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]
MG]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT
M/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB
M_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P7
M7=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.
M5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_
MWT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]
MIB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]
MP77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\
M:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_O
MI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=
M!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]
MG]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT
M/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB
M_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P7
M7=!]IB_OI_WT/\:.5]G]P77=!]IB_OI_WT/\:.5]G]P77="BXB/1U_[Z'^-'
M*^S^X+KNB4$'D=*D84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: H=*T,SG-6UZ+3UY)R
M>BC[Q]_8>Y_#GBME&VYFY=CA+CQ/=2G,86,?3<?Q+<?H*NY!4_M^^_YZ_P#C
MD?\ \32N ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_QR/\ ^)HN ?V_??\ /7_Q
MR/\ ^)HN H\07P_Y: _5$_HHHN!MZ=XNDA8"<8']Y/ZJ<@^^/P!H=GNAIM;'
MIFGZBEZ@*D$D9!'1AZC^H[5SRARZK8WC*^G4TJR+"@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * &O]T_0T
MT!S>KWBV<+.W11N/OZ#\3Q73!=3"3Z'C-S</=2&60Y9C^7H![#M5D$% !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M8KM&5+?* H(Y'<FLT[MKL4U9)G,5H2% !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '3>&M3:TG$!)V.?E_V7
M[?@W0CUQ[T>3#8]IAD$R!QW'_P"O]:Y&N5V.E.ZN25(PH * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * &O]T_0
MTT!YQXQD*P$#HSH#],%OYBNN.QS/<\UIB"@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % $D3F-U<=58$?4'- 'O^F',./1C_ $/]:YZF
M_P C:&QH5D:!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 -?[I^AIH#A?%-H;BW;:,D ./JO7_QW-=4=K'/+
M1GE%42% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M^;2R5AUOXG7[.EK?VR7BP\1LS;6 &  ?E;/ QD8R ,YZDY=;IV#FZ-7$MO%
MMII66WC^SW"JC0 D+A5V@@X(R1PWR8(QQD9)R^>JZAS6Z:=B5_%,0M9K."U2
M".8$#8_W21@EOD^<_BO  [9I<NJ=PYM+)$-KXF6.R6QNK=+E8\[&9L;>N#C:
MV2N2 05XX]Z?+K=.P<VEFAMIXD5;=;2^MTO$BXC+'8RCTSM;@# &,<#!S0XZ
MW3L)2Z-7,O5=0CU!U,,$=JB# 5.IR<_,<#/MP.IZ]J2MUN)N^RL954(* "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@"]IML;JYCC'0L"?91R?T_6@1[S81^7",]6Y_/I^F*YIN\CHBK(N5F6% !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 U_NGZ&F@,N:(2KMZ'M6R?*S)JYY7K>@26KF6W4E#R4 Y3Z#NOTZ?3F
MMO-&.QRU PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M)88)+AA'$I=CV S_ /J'N>* /4/#7A[[*/,DY=OO'L!UV+_[,?\  5,I<J\R
MHJ_H=]TKD.@* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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ML/\ A$K3_GFO_?<G^-',O,.5A_PB5I_SS7_ON3_&CF7F'*P_X1*T_P">:_\
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MVW]Q/^_DO^-'/'L_Z^8<C\@_X0NV_N)_W\E_QHYX]G_7S#D?D'_"%VW]Q/\
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M^1MV>AP6@PH 'HH"C\3U-2ZC^RK%*'<V54(-JC '0"L#786@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@"*=6:-U0[&*L V,[20<'!X.#S@]::W5^XGL[',_8;__ )_/_($?^-=7-#^3
M_P F9S\L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\
M^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L
M_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1
M_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E
M0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^
M3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y
M_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_
M )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_
M (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!
M]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/
M_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\
M_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\
MF_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\
MC1S0_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V
M&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\
MF8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_
M ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";
M_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-
M'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;
M_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9
MARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y_/\
MR!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_
M "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<
MT/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_
M /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'
M+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#(
M$?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\
M)4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0
M_D_\F8<L_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\
M^?S_ ,@1_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L
M_P";_P E0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1
M_P"-'-#^3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E
M0?8;_P#Y_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^
M3_R9ARS_ )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0?8;_P#Y
M_/\ R!'_ (T<T/Y/_)F'+/\ F_\ )4'V&_\ ^?S_ ,@1_P"-'-#^3_R9ARS_
M )O_ "5!]AO_ /G\_P#($?\ C1S0_D_\F8<L_P";_P E0Y;&_P C%YW_ .>$
M?^-'-#^3_P F8<L_Y_\ R5%O^S]1_P"?[_R7C_QK/FA_)_Y,R^6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_
M)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O
M_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*@_
ML_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_Y_O_ "7C_P :.:'\G_DS
M#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_ /DJ#^S]1_Y_O_)>/_&C
MFA_)_P"3,.6?\_\ Y*@_L_4?^?[_ ,EX_P#&CFA_)_Y,PY9_S_\ DJ#^S]1_
MY_O_ "7C_P :.:'\G_DS#EG_ #_^2H/[/U'_ )_O_)>/_&CFA_)_Y,PY9_S_
M /DJ#^S]1_Y_O_)>/_&CFA_)_P"3,.6?\_\ Y*C:A5D15D;>X #-@+N(')P.
M!D\X' K%[Z:+MV-5HM22D,* "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * &O\ =/T-- 4*T,PH
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@!R?>'U%)C+]9EA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M 4KZ_CT]5>4-L9@I8#(3/0MW SQD U<8N>BW[=_0B4E#5[?D7%8, RD$$9!'
M((/<5&Q8M !0 4 % !0 4 % #7^Z?H:: H5H9A0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #D^\/J*3&7
MZS+"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@!&8("S$  9)/  '4D]@* /*[[XR>'K*X-L'FG"G!EBC#1#\2ZLP[
M956'IFNI4)M7T7D]S!U8IV/1M,U2UUBW6\L9%G@D^ZZ]..""#@@@\$$ CN*Y
MVG%V:LS9--76Q?J1A0 4 % !0 4 % !0 4 % %#4]4M=&MVO+Z18((_O.QXY
MX  '))/  !)["J2<G:*U$VHJ[T1YS8_&3P]>W MB\T 8X$LL86(_B'9E';+*
MH]<"NAT)I7T]%N8*K%NVQZHK!P&4@@C((Y!!Z$'N#7*= M !0 4 % !0 4 %
M !0 4 % ' >)?B9HOA:;[+=.\UPOWHH%#LG0_.69%4D'.-V[VK>%&4U=:+NS
M&52,-'OY&SX:\7Z;XLB,NFR[RGWXV&V1,D@;E/8XX()7WS43A*GI)%QFI_"=
M-6984 % !0 4 % !0 4 % !0 C,$!9B  ,DG@ #J2>P% 'E=]\9/#UE<&V#S
M3A3@RQ1AHA^)=68=LJK#TS74J$VKZ+R>Y@ZL4['HVF:I:ZQ;K>6,BSP2?==>
MG'!!!P00>"" 1W%<[3B[-69LFFKK8OU(PH * "@ H * "@ H * "@"AJ>J6N
MC6[7E](L$$?WG8\<\  #DDG@  D]A5).3M%:B;45=Z(\YL?C)X>O;@6Q>: ,
M<"66,+$?Q#LRCMEE4>N!70Z$TKZ>BW,%5BW;8]45@X#*001D$<@@]"#W!KE.
M@6@ H * "@ H * "@ H * "@#F?$OB_3?"<0EU&787^Y&HW2/@@':H[#/))"
M^^:TA"4](K_(B4U#<Q?#7Q,T7Q1-]EM7>&X;[L4ZA&?J3L*LZD@#.-V[T%7.
MC*FKO;NB(U(RT6_F>@5@;!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0!Y5J/C_5[*ZFMXM"O+B.&62-)5,VV14<JLBXM&&UP PPS#!X8]:]
M6&%I2C&3KP3:3:=KIM;?&MMMCYRIF&(ISE".#J249-*2YK22;2DOW;T>ZU?J
M85K\8+V^E:"UT::>6/.^..9W=,':=RK:%EPW!R!@\=:Z)8"$$I2K12>S:23]
M&YG'#.*E23A3PLI26ZC)MJVFJ5.ZUT.Z\*^*K_7YI(KW3+C3%C0,KS>9ASN
MVC?!$,@<\$G';O7!7H0HI.%6-1MVLK:>>DF>QA,75Q,I1JX>=%)73ES6;OLK
MPCZG<5PGKA0 4 % !0 4 % !0!B2>)-.BOAI3SHMXQ $/S;CN7>.V.5YZUNJ
M,W#VJB^3OT['(\31C4^KN:]J_LZWU5^UMC;K ZPH * "@ H * "@ H * "@
MH * "@ H * "@ H :\:RJ4<!E88(/((/8TT[:H6^C.;5G\//L;+V#GY6ZF G
ML>YC)Z'M]?O=.E976DU_Y-_P3#^%I]C_ -)_X!TJL& 92"",@CD$'N*Y=CH%
MH * "@ H * "@!K_ '3]#30%"M#,* "@ H * "@ H * "@ H * "@ H * "@
M H * ,;Q%K"^'].GU%QN%NA8+ZL2%4?BQ JXQYFH]R9/E3?8^0KWXB:_>W!N
M?MDT1SD)$Q2-?;8/E(_W@Q/4FO45*"5K(X'.3UN?1WPT\83>+;%S=X^U6KA)
M&4!0X8$HVT< G!!Q@9&0*X*L%3>FS.NG+F6NZ/2*YS8* "@ H * "@ H * "
M@#S?XE^,)O"5BAM /M5TY2-F (0* 7;:>I&0!G(R<D5T4H*;UV1E4ER+3=GS
MC9?$37[*<7(O)I3G)25B\9]MA^4#_="GN#FN]TH-6LOD<:G):W/KWP[K"Z_I
MT&HH-@N$#%?[K E6'X,"*\N4>5N/8[XOF29LU!04 % !0 4 % !0 4 % !0
M4 ?(WB_XFZKJ=[(EC/)9VD3LL:PL49@#C<[J=Q+8R!G !QCK7J0I1BM5=^9P
MRJ-O1V1W7PK^(%]JMW_8^IN;@NC-#*V-X* LRLW&X%<D$@D;<9Q6-:FHKFCI
MW-*<VWRL]_KA.H* "@ H * "@ H * "@ H * "@ H <GWA]128R_6984 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M#OS_ /A';'[5GS?)_BSG;N;R\YY_U>VO$JVYY6VN>I3ORJ_8[2L34* "@ H
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MGK*]AU&".ZMG$D,RAT=>A4C(/^(Z@\'FO,:<79[H[D[JZ+-(84 % !0 4 %
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M6EZX.S:<Q2D<E5W?,KXY"DMG!PV>*\ZI0=-<T=5^*.V%52T>C/8*Y#H"@ H
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M@^7%0K5,4JE:-_=Y4I-)--:3=OBZK:YR^NRI9?$&&:<B.,M!\S'"X: (#D\
M;N,FNJDG+!.,=7:6G_;U_P CSZ[5/-8RF[*\-7HM86_/0^BED5R0I!*XS@@X
MR,C/ID$$>QS7SMK'W":>SV'4AA0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ->-95*. RL,$'D$'L::=M4+?1G-JS^'GV-E[!S\K=3 3V/<QD]#V^OW
MNG2LKK2:_P#)O^"8?PM/L?\ I/\ P#I58, RD$$9!'((/<5R['0+0 4 % !0
M U_NGZ&F@*%:&84 % !0 4 % !0 4 % !0 4 % !0 4 % !0!4O[Q-/MI;N3
ME+>)Y6QUVQJ6./P%-*[2[B;LKGPUX@\07?B2[>\O'+%B=J9)6->R(.@ &,X
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M*;9!+"[$EO++;60D\D*2NWG@$CH!7GUX*-I+2^YV4I-^Z^A[I7&=(4 % !0
M4 % !0 4 % !0 4 % #D^\/J*3&7ZS+"@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * .!^*-U)9^&;Z2(E6*1QY''RRS1
M1./Q1V!]C6]%7J17]:)LQJ.T';^M3X@KVCS H * /KKX'7,D^@.CDE8+R6-
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M)*2S!)$R?[L4\L:#\$10/85XM96J22\OQ29Z=+6"_KJ=_6!L% !0 4 % !0
M4 % 'RM\>;J1M6M;8D^7':"11V#232JQQZD1(/PKU,,O=;\_T7^9P5W[R7D>
M%UVG*% %BUN9+*:.XA)62%U=&'!#*0P(^A%#5U9C6FJ/T5KYX]@* "@ H *
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M?PM/L?\ I/\ P#I58, RD$$9!'((/<5R['0+0 4 % #7^Z?H:: H5H9A0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % '/>+O^0)J'_7C=?^B)*TA\4?5?F3+X
M7Z/\CX4KV#S H * /H;X#?\ ,2_[=/\ VYKAQ'V?G^AUT>OR_4^AJX3J"@ H
M * "@ H * /&_CA_R!(/^OZ/_P!$7-==#XGZ?JCGK?"O7]&?*]>B<04 % 'V
M3\*?^18LO^WC_P!*IZ\JM\;^7Y(]"G\*^?YL]#K U"@ H * "@ H * "@ H
M^%?%W_(;U#_K^NO_ $?)7LP^&/HOR/-E\3]7^9SM60% 'LOP/_Y#<_\ UXR?
M^C[:N6O\*]?T9T4?B?I^J/J>O-.T* "@ H * "@ H * "@ H * "@!R?>'U%
M)C+]9EA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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ME5@P#*001D$<@@]Q7+L= M !0 U_NGZ&F@*%:&84 % !0 4 % !0 4 % !0
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MIVEN9;*UMK:1E*EX88XV*D@E2R*I*DJ"1G&0#V%2Y-Z-M^K&DELDOD:M2,*
M"@ H * "@ H * "@ H * "@!R?>'U%)C+]9EA0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M#/>M*F"JTHN;Y6DKNSV7S2.>AFV'Q$U27/&4G9<T5JWLKQ<M_.QZ37FGO!0
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MEGH7D>9]N3?YWF;=G,@QY?EG=]SKO7KTXYV4+Q<[[=#-RM)1MN=I6)H% !0
M4 <GJWB&\T[4[;3X+":Z@N=GF72;_+@W.5._;"Z_* '.Z1.#V'-:J*<7)R2:
MZ=_Q(<FFDE==^QUE9%A0 4 % !0 4 9.O:I_8>GW&H;/-^S1-)LW;-VT=-VU
MMN?7:?I517,U'N2WRIOL5_#&M_\ "1Z;!J?E^1]H5CY>[?MVNR?>VIG.W/W1
MUQ[TY1Y)./8(OF29O5!04 <;9>+?MGB&Z\.^1M^QP+-Y_F9W[A;G;Y>P;<>?
MU\QON]/FXU<+052^[M;[_P#(S4KR<+;+_+_,[*LC0* "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * ')]X?44F,OUF6% !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M(W 9QGG!XSCKC(/-+S"_3J?/'PA_Y#>H_P"XW_H^OHL?_"I^J_\ 23XC)_\
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M)*6&J\\;.\=5IO:UWK\D2L;%5:<,?AO95+KEGH[/9-.R=NFC=NI[/7BGU04
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MY+-*T@.T $'.-H4Y)BZG)6@O-+2_^15G%.\OF^AX_>^,%T.2&ZTG6;[4I%F
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M6TC;X##(H<HJEB$<1G<&4###:% YIJ45/D44K.U^MPY9<O-S/:]NAZ3\,O\
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MI)OEA?75MF+X?NI)? 6KV[_<@N%$8SNVAWMR5!SC:&!88ZEF/>KDK5H/NO\
M,F+_ '<EV?\ D>D>!/"&F66@P:L(0U_):22&=BS./,C=<+D[5 C/EC:!\O7J
M<\]2<G-PO[M]C:$$HJ5M;;G > O">FZGX4U#4+R(37""Y$3L6S$(H%=?+P<
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MOR.=MS?)#;J_T1MVMK'91B&$;47H/YD^I/<UA*3D[O<V2459;%BI*"@ H *
M&O\ =/T-- 4*T,PH * "@ H * "@ H * "@ H * "@ H 9(6"GRP"^#M#$@$
MXX!(!(&>I ) ['I0!YIX4^'T=D+FY\01VFH7UY.TK.8Q,BJ>0$\Z,%269BV%
M QM'.T8Z)U+V4+I)>GY&,86NYV;;%\7?#NWU.WB;0XK73[ZVF26.18UA4A>H
M8Q1L3@X9<J<,O8$T0J.+]]MIKU_,)0NO=LFOD1:SX+U2348O$&D7$%KJ9A2.
MY20,T$A"!6PVPMMP H!C!(56&UA3C.*3A)-QOIW!P=^>+2?7L-U'P9K/B73+
MBSUR[@:>22*6W\A&$4+1A@5.0C.KAL'*Y4C=EN !3C"2<$[=;[L'"4DU)^EC
MGM;\ >)M?TZ*QN[JQ"VLB&**-9(XRH1U,CL(=WF#("JJ!,,Y)S@&XU(0=TGK
M_7<APE)6;6AU?BKP9?7NIPZ]H<\=M?PKY;B8-Y<B\CDJKG.UBI&PAAM(*E<G
M.$THN$U=>1<H-M2B[,RH?!&MW&N6>NZG=6\[V^1*B;T5% 8(D"^6=PRQ9F=D
M)+8QQDU[2*BX135_ZU)Y)<RDVM/ZT+U[X.U;2]2N-4\-7,$/V\[KBWNE8QF3
M).]617;)+,<8!!9OF(. E.+BHU$]-FBG!IN4'ONF7)_#NNZGH][8ZG=6\]U>
M*JQ!$:.&$#!(WA-[!L9YCR".I!^65*,9)Q327WL?+)Q:;5V0W7@V\G\)#PXK
MPBZ$<2[RS^3E+A)3\WEE\;5('[O[V <#FFII5/::VU]=K"Y'R<G7_@AXB\&W
MFK^&K;0H7A6YMX[569V<1$P1A'VD1LQ!(^7*#(ZXZ41FHS<W>SO^(2@W%16Z
MM^ S4/!=[=ZII-^CPB+2XHTF!9]S%.OE@1D$>FYD^E"FE&4===@<'>+[%>]\
M%:MIFJSZOX:N8(3?9,\%RK>66)W%@45R<MEAPI4LPR58BFIQ<5"HGILT)P:;
ME!K7=,[GP]:ZE:6Q76)X[JY:1FW1+L15(&$48&0I!.=JGG!!(R<9.+?N*R-8
MW2]YW9Q_BOP7?7^JP:]HTL$=W!'Y92Z5FB8#=AAA7(;#D8"CHI# Y)UA-*+A
M).S[;F<H-M2C:_F5=&\%ZQ;^(5U_4KBWN,PE'\L.C!BFT*B>6%\M>!DON;EB
M,G%.4X\G)%-:B4)*7,VC5\!>$[OPM]M^UO$_VN?S4\IG.%^;AMZ)@\CIN'O4
MU)J=K7T14(N-[]68^@_#J6WL-3TW4Y(BFIR[T:$LQ3!+(S!T3YE?:V!D'&,B
MKE5UC*/V>Y,:=DT^IGIX(\4/ICZ%-?6GV%8F2(JK^<X )BB=C'\D6X*'*F1P
MF5&X<4_:0YN=)W_#S%R3MRW5CT7P?HTWA[2+?3KED:6W5@QC+%#ND=QM+*IZ
M,.JCG/UK"<E*3DMF:Q7*DF>6?$FUEO?$VDP6\IMYG7]W*!DQN)"5;!Z@,!D=
MQD=ZZ:3M"3>J[&-17E%+0W?^$)UK7=2M[SQ)=6\MO8-OBAME<!V!!RX9%"Y*
MJ6Y?(&U=H)-1[2,8M4TTWU97)*33FU9=C=T_PK=6GBF\\0.\1M;NV6%$#/YH
M8+; EE*! O[EN0Y/*\<G$.:=-0UNG?RZ_P"92BU-RZ-?Y?Y$-OX.N%\2W^LS
M-$;._M/LP16?S@2ELC%AL" ?N7P0['E>.N!S7)&"W3OY=?\ ,.5\SET:M^1R
MVG_#_P 0:1:W&D65Y:)I]P)?G,;"Y;>I4(WR%5#?=9M[L@)*#.!6KJ0DU)IW
M7W&:A**<4U;\1T_PWU*3PO%H DMA<Q71G+EY/*VGS. WD[]WSC@H!UY]5[5<
M[GK:UO/\Q^S?)R:7O<](UO1YM2T6;2XBBS2VWDJS$A VT#)(4MMR.H4GVK",
MN62ETO<U:O'E78YC_A#;S_A$O^$<WP_:O+V;]S^3G[1YOWO+WXV\?ZO[WMS6
MG.O:>TUM^.UB.1\G)U_X(S5O!=[?>%H?#\;PBZB2%2[,XBS&P+881E^<<90>
M^*%-*;GK;7U!P;@H=2IKO@&]O!IMY830)?Z7;QP%9E9X'V*!G[C'ABV,QY((
M/RE13C42YE).S=]-Q.#T:M=+Y"6/@S6V\0VGB#4[FVG\B%TE6,.FPLDZ*D*^
M7AHQYBL6=E8LTGR\+EN<>1PBFKO3\-P4)<RDVOZN>LURFX4 % !0 4 % !0
M4 % !0 4 % #D^\/J*3&7ZS+"@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M * "@ H * "@ H <GWA]128R_6984 % !0 4 % !0 4 % !0 4 % !0 4 %
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MF 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M H * "@ H * ')]X?44F,OUF6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MN[J_37N4JJKTJ%#$0Q%-PC%0G2^&2:5I-==$GI=K77H5]1NH]2T SPPK#L<
MJH&%_> L5X&%);..Q..V:RJSC6P?M(04;22LME[VMO)MFV'IRPV8JE4J.=XM
MIMZOW-+ZZM)6OUM<M:G+')H6+0H7\F'S A7=M&P-N YX/WL^^>]:UI1>#_=-
M7Y(<UK7MI>_7?<Y\-&4<Q_?J2C[2IR<U[7?,XVOIJMOD17O]G?V"-GE;O*3;
MC;O\WY=W^UNSG=[9[5-3V'U-6Y;\L;;<W/I?SO>]_+R-*/UG^T7S<_+SRO>_
M+[/6WE:UK>=NIFWT+7$.CQ7.3YC%6!Z[&>$#K_L$5S58N<<'"IU=GZ.4$O\
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MWOR\NMM]+7MRV^6ESJO#O_(.M_\ KDM>KA/X%/\ PH\''_[U6_QLY'5/L_\
MPD,7VO;Y7EK][[N[:^S=GC&['7C.,\9KR*W)]>A[6W+RK?:]G:_SL?0X;VO]
MF5/J]^?F?P[VO'FM_P!NWVUMMJ2:EY/]N6GV';YG_+7R\8VY.=VWC.S=G/\
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MQ-2_O73_ !U):LS"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * ,_4K:>[C$,#B)6.)&YW;.X3L">G/;OZZ0:B[
MR5^W:_F9R3DK1=N_>WD6+6UCLHQ#"-J+T'\R?4GN:F4G)W>Y22BK+8L5)04
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M5[7DHZ[.6NW=L\RCB(/#8SVE6+G.4FKM1<]+74='KV2.VKZ$^1"@ H * "@
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * &O]T_0TT!0K0S"@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H RSI
M,1O!?L7:55VJI(V*,8^4;<YY/5CU-<?U>#K?66Y.:5DFURK2VBM?OUZL]'ZY
M46'^I145!OF;2?-)WOJ[VZ+HMD:E=AYP4 % !0 4 9EGI,5E/+<QER]P<L&(
MVCDGY<*".O<FN.GAX4:DZT7+FJ.[O:RUOI9+OU;/0K8NI7I4\/-14:2M%I.[
MT2UNVNG1(TZ[#SPH * "@ H * "@ H * "@ H * "@ H * "@ H * ')]X?4
M4F,OUF6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '!>+M;ELV2"W\Z)E8%G
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M]O(=#ZQ#!XB%/V7LE*2G?FY[M13Y;>[;:U_,T+_Q+:V$QM\2S2J,LL*!]O\
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M2(K9QL0!'-^^!C\O.YP@DPN<%CQ754II*+3BO=\]?30YX3;;33W^[UU.MO\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MYG91EE')-:./-"&R2YM7IU)3Y92WZ:+T.YT;Q3::U%/)$LT,ED2L\$R;)HR
M6 9=Q7Y@#M(8@X/(K&4'&RTUV:V-%).]NFZ.?M_B597EM]MM;74+B!5+2M%;
MJPAQU$C>:%R%P["-I"JD%L'(%^R:=FXI]-=_P)]HK72?W;'3R^)M/ATT:R\H
M%FR!U?!R=W"J%QN+EOEVXSNR#T-9\CYN2VI?,DN;H8]MX[M))H8;JWO; 73!
M()+N 1QR,?NJ&5WVLW\(<(3D5;IM7::=M[/8E36S35]KHSK3_D=;G_L%Q?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M #7^Z?H:: H5H9A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % #D^\/J*3&7ZS+"@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#Q[Q)
MJL>C>,K2ZG5V@739!*R(SF)&F<>854%BJMM#[02JL6Q@&NN$>:DTM^;3STV.
M:3Y:B;VM^I)/JT'C77M-_L?,]MI;37%Q=!&6-2R!$B1F W,Q^\!QC!!.U@!1
M=*$N?1RLDNOJ.ZG*/+LKMLT?A_\ \?NN?]A67^0J:NT/\*'3WE_B,W2]:MO
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % #7^Z?H:: H5H9A0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * &O]T_0TT!0K0S"@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * ')]X?44F,OUF6% !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 U_NGZ&F@*%:&8
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 Y/O#ZBDQE^LRPH * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * &O]T_0TT!0K0S"@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * ')]X?44F,OU
MF6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
MU_NGZ&F@*%:&84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 Y/O#ZBDQE^LRPH * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
1 % !0 4 % !0 4 % !0!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jul. 24, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NAUTILUS BIOTECHNOLOGY, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1541723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2701 Eastlake Avenue East<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Seattle<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">333-2001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NAUT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,255,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">CIK</a></td>
<td class="text">0001808805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,166<span></span>
</td>
<td class="nump">$ 12,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">70,865<span></span>
</td>
<td class="nump">91,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,595<span></span>
</td>
<td class="nump">2,557<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">87,626<span></span>
</td>
<td class="nump">105,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,999<span></span>
</td>
<td class="nump">3,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">25,619<span></span>
</td>
<td class="nump">27,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">45,155<span></span>
</td>
<td class="nump">52,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,177<span></span>
</td>
<td class="nump">1,180<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">163,576<span></span>
</td>
<td class="nump">191,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,095<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">3,553<span></span>
</td>
<td class="nump">3,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">3,991<span></span>
</td>
<td class="nump">3,832<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,639<span></span>
</td>
<td class="nump">7,952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">23,825<span></span>
</td>
<td class="nump">26,187<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">32,464<span></span>
</td>
<td class="nump">34,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 200,000,000 authorized as of June&#160;30, 2026 and December&#160;31, 2025; 0 shares issued and outstanding as of June&#160;30, 2026 and December&#160;31, 2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value, 1,000,000,000 shares authorized as of June&#160;30, 2026 and December&#160;31, 2025; 127,224,640 and 126,469,610 shares issued and outstanding as of June&#160;30, 2026 and December&#160;31, 2025, respectively</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">492,616<span></span>
</td>
<td class="nump">488,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(331)<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(361,186)<span></span>
</td>
<td class="num">(332,020)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">131,112<span></span>
</td>
<td class="nump">156,973<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 163,576<span></span>
</td>
<td class="nump">$ 191,112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478443/942-360-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">127,224,640<span></span>
</td>
<td class="nump">126,469,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">127,224,640<span></span>
</td>
<td class="nump">126,469,610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">9,613<span></span>
</td>
<td class="nump">10,394<span></span>
</td>
<td class="nump">19,320<span></span>
</td>
<td class="nump">21,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">6,325<span></span>
</td>
<td class="nump">6,703<span></span>
</td>
<td class="nump">12,742<span></span>
</td>
<td class="nump">14,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">15,938<span></span>
</td>
<td class="nump">17,097<span></span>
</td>
<td class="nump">32,062<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">2,749<span></span>
</td>
<td class="nump">4,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">1,294<span></span>
</td>
<td class="nump">2,064<span></span>
</td>
<td class="nump">2,721<span></span>
</td>
<td class="nump">4,295<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,469)<span></span>
</td>
<td class="num">$ (15,033)<span></span>
</td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="num">$ (31,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</a></td>
<td class="nump">127,135,738<span></span>
</td>
<td class="nump">126,204,632<span></span>
</td>
<td class="nump">126,886,646<span></span>
</td>
<td class="nump">126,174,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</a></td>
<td class="nump">127,135,738<span></span>
</td>
<td class="nump">126,204,632<span></span>
</td>
<td class="nump">126,886,646<span></span>
</td>
<td class="nump">126,174,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=naut_GrantRevenueMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=naut_ServiceRevenueMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenue</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=naut_GrantRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=naut_GrantRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=naut_ServiceRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=naut_ServiceRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,469)<span></span>
</td>
<td class="num">$ (15,033)<span></span>
</td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="num">$ (31,646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized gain (loss) on securities available-for-sale</a></td>
<td class="num">(240)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(240)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (14,709)<span></span>
</td>
<td class="num">$ (15,145)<span></span>
</td>
<td class="num">$ (29,740)<span></span>
</td>
<td class="num">$ (31,626)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,106,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 208,730<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 481,679<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="num">$ (273,019)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(31,646)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,646)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,305,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="nump">181,094<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">485,669<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="num">(304,665)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,148,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2025</a></td>
<td class="nump">194,435<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">483,865<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="num">(289,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(15,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,033)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,305,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="nump">$ 181,094<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">485,669<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="num">(304,665)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2025</a></td>
<td class="nump">126,469,610<span></span>
</td>
<td class="nump">126,469,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2025</a></td>
<td class="nump">$ 156,973<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">488,737<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="num">(332,020)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="nump">670,244<span></span>
</td>
<td class="nump">670,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="nump">$ 1,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,166)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2026</a></td>
<td class="nump">127,224,640<span></span>
</td>
<td class="nump">127,224,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2026</a></td>
<td class="nump">$ 131,112<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">492,616<span></span>
</td>
<td class="num">(331)<span></span>
</td>
<td class="num">(361,186)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,070,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2026</a></td>
<td class="nump">144,415<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">491,210<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">(346,717)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(240)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(240)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,469)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,469)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2026</a></td>
<td class="nump">127,224,640<span></span>
</td>
<td class="nump">127,224,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2026</a></td>
<td class="nump">$ 131,112<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 492,616<span></span>
</td>
<td class="num">$ (331)<span></span>
</td>
<td class="num">$ (361,186)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="num">$ (31,646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">2,520<span></span>
</td>
<td class="nump">3,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">2,154<span></span>
</td>
<td class="nump">2,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization (accretion) of premiums (discounts) on securities, net</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(980)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(953)<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(2,203)<span></span>
</td>
<td class="num">(2,295)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(26,826)<span></span>
</td>
<td class="num">(27,287)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities of securities</a></td>
<td class="nump">55,715<span></span>
</td>
<td class="nump">45,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of securities</a></td>
<td class="num">(28,496)<span></span>
</td>
<td class="num">(11,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(964)<span></span>
</td>
<td class="num">(615)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">26,255<span></span>
</td>
<td class="nump">33,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">1,207<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,349<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">778<span></span>
</td>
<td class="nump">6,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">13,390<span></span>
</td>
<td class="nump">28,648<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">14,168<span></span>
</td>
<td class="nump">35,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplementary cash flow information on non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisitions of property and equipment included in accounts payable</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business and Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Description of Business and Basis of Presentation</span><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) is a biotechnology company incorporated in 2016 with corporate headquarters in Seattle, Washington and research and development headquarters in San Carlos, California. Since the Company&#8217;s incorporation in 2016, the Company has devoted substantially all of its resources to research and development activities, including with respect to its proteomics platform, business planning, establishing and maintaining its intellectual property portfolio, hiring personnel, raising capital and providing selling, general and administrative support for these operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, Nautilus Biotechnology, Inc. a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp. III, a Cayman Islands exempted company and the Company&#8217;s predecessor company (&#8220;ARYA&#8221;)), consummated the  business combination (the &#8220;Business Combination&#8221;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#8220;BCA&#8221;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#8220;Mako Merger Sub&#8221;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#8220;Legacy Nautilus&#8221;). As a result of the Business Combination, ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; and Mako Merger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as the surviving company and becoming a wholly-owned subsidiary of ARYA (the &#8220;Merger&#8221; and, collectively with the other transactions described in the BCA, the &#8220;Reverse Recapitalization&#8221;).  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in conjunction with the completion of the Business Combination, certain investors (&#8220;PIPE Investors&#8221;) subscribed for the purchase of an aggregate of 20,000,000 shares of common stock of the Company (&#8220;New Nautilus Common Stock&#8221;) at a price of $10.00 per share for aggregate gross proceeds of $200.0&#160;million (&#8220;PIPE Financing&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#8217;s financial position, results of operations, and cash flows for the interim periods. The interim financial results are not necessarily indicative of the results for a full year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025 on file with the SEC. The Company&#8217;s reporting currency is the U.S. dollar. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its technology, raising capital, and recruiting personnel. The Company&#8217;s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company&#8217;s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of June&#160;30, 2026, the Company had an accumulated deficit of $361.2&#160;million.</span></div>The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock and common stock. In June 2021, the Company received gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination offset by approximately $18.2 million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. The Company had cash, cash equivalents, and short-term investments of $84.0 million as of June&#160;30, 2026. As of the date on which these condensed consolidated financial statements were issued, the Company believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its operations for at least the next twelve months following the issuance of the condensed consolidated financial statements. The Company&#8217;s actual results and its near and long-term future capital requirements will depend on many factors, including its growth rate and the timing and extent of spending to support its research and development efforts. Future liquidity and cash requirements will depend on numerous factors. The Company will be required to seek additional equity or debt financing to fund future operations, and the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt">Significant Accounting Policies</span><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed to perform as contracted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in marketable debt securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of negative global and national events and the need to obtain adequate additional financing to fund the development of its products. There can be no </span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">aker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM re</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#8217;s long-lived assets are entirely based in the United States. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service revenue is derived from the generation and analysis of proteomic data for our Iterative Mapping Early Access Program (&#8220;Early Access Program&#8221;) customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the promised services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of the service to the customer, meaning the customer has the ability to use and obtain the benefit of the service.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service revenue consists of service fees for the generation and analysis of proteomic data for our Early Access Program customers. The Company generally has one performance obligation for the generation and delivery of proteomic data to the customer. Revenue from services is recognized once the results are delivered to the customer, which is when the customer obtains benefit of the service. Customers are invoiced generally upon delivery of services, and payment is typically due within 30 days.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities related to the grant awarded from The Michael J. Fox Foundation (&#8220;MJFF&#8221;) commenced in the second quarter of 2026. The Company recognizes grant revenue as qualifying costs are incurred and the donor-imposed conditions are substantially met under Accounting Standards Codification 958-605. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amounts received in advance of satisfying the underlying conditions are recorded as grant liabilities within other current liabilities, or within other long-term liabilities if settlement is expected beyond 12 months. Cash receipts from grants are classified as operating activities in the condensed consolidated statements of cash flows. Expenses incurred in connection with this grant arrangement are recognized as research and development expense in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Grant revenue, and the related research and development costs incurred, were $0.2 million for the three and six months ended June 30, 2026. The Company received the first payment of $0.4 million from MJFF in the second quarter of 2026, which was recorded as a grant liability in accrued expenses and other liabilities in the condensed consolidated balance sheets. Of the $0.4 million received, $0.2 million was recognized as grant revenue as qualifying costs were incurred during the six months ended June 30, 2026, and $0.2 million remained recorded as a grant liability as of  June&#160;30, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Expected Credit Losses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Following the commencement of sales under the Early Access Program in the second quarter of 2026, the Company began recording accounts receivable, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consists of amounts due from customers for the sales of services, net of any allowance for expected credit losses. As of June&#160;30, 2026, the Company had accounts receivable balances of less than $0.1 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for expected credit losses on receivables is estimated based on an evaluation of historical experience (once available), current aging of receivables, the financial condition of customers, and forward-looking economic conditions. Accounts receivable balances are written off against the allowance when they are deemed uncollectible, at which point collection efforts are discontinued. Management evaluated the Company's outstanding accounts receivable as of June&#160;30, 2026, and concluded that no allowance for expected credit losses was required, as the balances were deemed fully collectible. There were no write-offs of uncollectible accounts during the three and six months ended June 30, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers investments with an original maturity greater than three months and remaining maturities less than 12 months to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its marketable debt securities as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a marketable debt security is below its amortized cost basis, the Company evaluates whether it is more likely than not that the Company will be required to sell the security before its anticipated recovery in market value and whether credit losses exist for the related securities. Credit-related losses are recognized as an allowance for credit losses on the balance sheet with a corresponding adjustment to earnings. Unrealized gains and losses that are unrelated to credit deterioration are reported in accumulated other comprehensive income (loss).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory, net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2026, in connection with the launch of our Early Access Program and other commercialization activities, we began capitalizing inventory costs. Inventory is stated at the lower of cost or net realizable value with cost determined using a standard cost system, which approximates actual costs determined on the first-in first-out basis. Standard costs are reviewed and updated periodically to ensure they remain representative of current production costs. Materials that may be utilized for either commercial or, alternatively, for research and development purposes, are classified as inventory, specifically as raw materials and supplies. Amounts in inventory used for research and development purposes are charged to research and development expense when the item enters the research and development process and can no longer be used for commercial purposes. During the six months ended June 30, 2026, $0.5 million was charged to research and development expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for slow-moving, excess or obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values. For the quarter ended June&#160;30, 2026, the Company did not have any inventory reserves. As of June&#160;30, 2026, the Company had inventory of $0.6 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within interest expense and amortization in the Company&#8217;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#8217; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2026 and 2025, net unrealized gains and losses on marketable debt securities were included as a component of comprehensive income (loss). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The ASU is effective for the Company for the fiscal year ending December 31, 2027 and for interim periods beginning after December 31, 2027. The Company does not anticipate adoption to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2026 and December&#160;31, 2025:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.282%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cash equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,530&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,287&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,031&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,256&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">88,227&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,984&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,960&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,958&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,978&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,160&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,075&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,176&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,899&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">129,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">128,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">70,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,155&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:22.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cash equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">90,066&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">90,274&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">49,489&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,785&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">49,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,321&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,321&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,379&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,942&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,838&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,872&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,918&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,954&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">155,421&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">155,664&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,739&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments have a contractual maturity date that is one year or less from the respective balance sheet date. Long-term investments have a contractual maturity date that is more than one year, but less than two years from the respective balance sheet date.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses and fair values of available-for-sale securities that have been in an unrealized loss position for a period of less than and greater than 12 months as of June&#160;30, 2026 are as follows: </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#12644;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Securities in Unrealized Loss Position Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Securities in Unrealized Loss Position Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,867&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,867&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,958&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,958&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,584&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23,076&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">107,087&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">108,579&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed its investment portfolio based on the underlying risk profile of the securities and have  no loss expectation for these investments. The Company reviewed the securities in an unrealized loss position and evaluated the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. The Company recognized no credit losses during the three and six months ended June 30, 2026 and 2025, and had no allowance for credit losses as of June&#160;30, 2026 and December&#160;31, 2025.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Composition of Certain Condensed Consolidated Financial Statement Line Items</a></td>
<td class="text">Composition of Certain Condensed Consolidated Financial Statement Line Items<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prototype equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,714)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,121)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,457&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded depreciation expense of $0.3 million and $0.6 million for the three and six months ended June 30, 2026, and $0.4 million and $0.9 million for the three and six months ended June 30, 2025, respectively, which was primarily allocated to research and development expense. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long-term assets (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets consisted of $1.0&#160;million of restricted cash and $0.2&#160;million of deposits as of June&#160;30, 2026 and December&#160;31, 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">Common Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There were 127,224,640 shares issued and outstanding as of June&#160;30, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Reserved for Future Issuance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,974,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29,341,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,270,870&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Employee Stock Purchase Plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,697,982&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,518,072&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">58,963,655&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,130,509&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 1.D.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479921/505-20-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 1.B.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480148/855-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. For the three and six months ended June 30, 2026 and 2025, no income tax expense or benefit was recognized, due to a full valuation allowance recorded against its deferred tax assets. For three and six months ended June 30, 2026 and 2025, the effective tax rate was 0%, primarily due to a valuation allowance recorded against the net deferred tax asset balance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans and Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Plans and Stock-based Compensation</a></td>
<td class="text">Equity Incentive Plans and Stock-based Compensation<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;) and the 2021 Employee Stock Purchase Plan (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;2021 ESPP&#8221;). As of </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2026, 32,974,336 and 6,697,982 shares were available for grant under the 2021 Plan and 2021 ESPP, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 ESPP, participants are permitted to purchase shares of Common Stock, up to the IRS allowable limit, through contributions (in the form of payroll deductions or otherwise to the extent permitted by the administrator of the 2021 ESPP) of up to 15% of their eligible compensation.  Participants are permitted to purchase shares of the Company&#8217;s Common Stock at 85% of the lower of the fair market value of the Company&#8217;s Common Stock on the first trading day of an offering period or on the last trading date in each purchase period. The Company offers a six month purchase period. Participants may end their participation at any time during an offering and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The number of shares of common stock available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year in an amount equal to the least of (i) 3,734,500 shares of common stock, (ii) a number of s</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">hares of common stock equal to one percent (1%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year. On January 1, 2026, the number of shares available under the 2021 ESPP increased by 1,264,696 shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 Plan, the Company can grant incentive stock options, nonstatutory stock options, stock appreciation rig</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">hts, restricted stock, restricted stock units and performance awards to employees, non-employee directors and consultants. </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Options generally expire ten years after the date of grant. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares available for issuance under the 2021 Plan will be increased on the first day of each fiscal year in an amount equal to the least of (i) 18,672,200 shares, (ii) a number of shares equal to five percent (5%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. On January 1, 2026, the number of shares available under the 2021 Plan increased by 6,323,480 shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2017 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">At the time of adoption of the 2021 Plan and the 2021 ESPP, no further awards will be granted under the 2017 Equity Incentive Plan (&#8220;2017 Plan&#8221;). Stock-based awards forfeited or cancelled from the 2017 Plan are returned to the pool of shares of Common Stock available for issuance under the 2021 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Date Fair Value of Stock Options</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In determining the compensation cost of the option awards, the fair value for each option award has been estimated using the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> Black Scholes model</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The significant assumptions used in these calculations are summarized as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.0  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75.5% - 80.7%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.5% - 103.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75.5% - 82.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.5% - 103.0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.91% - 4.29%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.90% - 4.04%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.69% - 4.29%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.90% - 4.04%</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Expected term: The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding. The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility: We became a public company in 2021 following the Business Combination, and as such, the Company lacked company&#8209;specific historical and implied volatility information to solely utilize its own data for purposes of establishing the volatility assumption for use in the Black-Scholes model. Therefore, we estimate our expected volatility of the Company&#8217;s common stock based on a mix of company-specific historical volatility and an average of historical volatilities of selected industry peers deemed to be comparable to the Company&#8217;s business corresponding to the expected term of the awards. The Company will continue to apply this process until an adequate amount of historical information regarding the volatility of its own stock price becomes available.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield: The expected dividend rate is zero as the Company has no history or expectation of declaring dividends on its common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option award activity during the six months ended June 30, 2026:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Option Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,270,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,614,000&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.37&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(670,244)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(923,289)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,701&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable at June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,308,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,986&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2026, there was $10.1 million of total unrecognized compensation expense expected to be recognized over a weighted average-period of 2.8 years. Aggregate intrinsic value represents the difference between the fair market value of the common stock and the exercise price of outstanding, in-the-money options. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the total stock-based compensation expense included in the Company&#8217;s condensed consolidated statement of operations:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense included within cost of service revenue was not material for the three and six months ended June 30, 2026.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2026 as the Company had not yet received the related goods or services. As of June&#160;30, 2026, the Company had open purchase commitments for goods and services of $3.2 million, of which $3.0 million are expected to be received through the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#8217;s results of operations, financial condition or cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, San Carlos, California, and San Diego, California. The Company's operating lease in San Diego expired during the six months ended June 30, 2026, and was replaced by a new lease that qualifies for the short-term lease exemption under ASC 842, and therefore is not recorded on the  condensed consolidated balance sheet as of June&#160;30, 2026. The letter of credit associated with the prior San Diego lease was released in the third quarter of 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2026:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Lease Obligations</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Six months ending December&#160;31, 2026</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,889&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,495&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2031 and thereafter</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,735&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,967)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2026 and 2025, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $3.5 million and $3.6 million, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $1.0 million in cash-collateralized letters of credit with one financial institution in lieu of security deposits in connection with the San Carlos and San Diego lease agreements. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Agreements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. </span></div>The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Basic and Diluted Net Loss per Share</a></td>
<td class="text">Basic and Diluted Net Loss per Share<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2026 and 2025:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,469)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(15,033)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(29,166)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(31,646)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">127,135,738&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,204,632&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,886,646&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,174,603&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three and Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,996,250</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,375</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,653</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total potentially dilutive common share equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,378,712</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,118,903</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481468/505-20-05-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM uses consolidated net loss in assessing operating decisions, allocating resources and evaluating financial performance. Consolidated net loss is used to monitor budget versus actual results. The Company included a summary of the segment net loss, including significant segment expenses for its single reportable segment: </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:41.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,573&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,946&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,256&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,969&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional services and laboratory expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,338&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,516&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,429&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Facilities expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,167&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,839&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,520&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,603&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation to net loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,749&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,469)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(15,033)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(29,166)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(31,646)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Footnotes:</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Other segment items for the Company&#8217;s single reportable segment include travel and entertainment, insurance, tax, expensed computer hardware and software, depreciation, and other miscellaneous expenses.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#8217;s financial position, results of operations, and cash flows for the interim periods. The interim financial results are not necessarily indicative of the results for a full year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025 on file with the SEC. The Company&#8217;s reporting currency is the U.S. dollar.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#8217;s financial position, results of operations, and cash flows for the interim periods. The interim financial results are not necessarily indicative of the results for a full year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025 on file with the SEC. The Company&#8217;s reporting currency is the U.S. dollar.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed to perform as contracted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in marketable debt securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of negative global and national events and the need to obtain adequate additional financing to fund the development of its products. There can be no </span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">aker (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM re</span>views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#8217;s long-lived assets are entirely based in the United States.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition and Grant Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service revenue is derived from the generation and analysis of proteomic data for our Iterative Mapping Early Access Program (&#8220;Early Access Program&#8221;) customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the promised services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of the service to the customer, meaning the customer has the ability to use and obtain the benefit of the service.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service revenue consists of service fees for the generation and analysis of proteomic data for our Early Access Program customers. The Company generally has one performance obligation for the generation and delivery of proteomic data to the customer. Revenue from services is recognized once the results are delivered to the customer, which is when the customer obtains benefit of the service. Customers are invoiced generally upon delivery of services, and payment is typically due within 30 days.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities related to the grant awarded from The Michael J. Fox Foundation (&#8220;MJFF&#8221;) commenced in the second quarter of 2026. The Company recognizes grant revenue as qualifying costs are incurred and the donor-imposed conditions are substantially met under Accounting Standards Codification 958-605. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Amounts received in advance of satisfying the underlying conditions are recorded as grant liabilities within other current liabilities, or within other long-term liabilities if settlement is expected beyond 12 months. Cash receipts from grants are classified as operating activities in the condensed consolidated statements of cash flows. Expenses incurred in connection with this grant arrangement are recognized as research and development expense in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Grant revenue, and the related research and development costs incurred, were $0.2 million for the three and six months ended June 30, 2026. The Company received the first payment of $0.4 million from MJFF in the second quarter of 2026, which was recorded as a grant liability in accrued expenses and other liabilities in the condensed consolidated balance sheets. Of the $0.4 million received, $0.2 million was recognized as grant revenue as qualifying costs were incurred during the six months ended June 30, 2026, and $0.2 million remained recorded as a grant liability as of  June&#160;30, 2026.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Expected Credit Losses</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Following the commencement of sales under the Early Access Program in the second quarter of 2026, the Company began recording accounts receivable, net.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consists of amounts due from customers for the sales of services, net of any allowance for expected credit losses. As of June&#160;30, 2026, the Company had accounts receivable balances of less than $0.1 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for expected credit losses on receivables is estimated based on an evaluation of historical experience (once available), current aging of receivables, the financial condition of customers, and forward-looking economic conditions. Accounts receivable balances are written off against the allowance when they are deemed uncollectible, at which point collection efforts are discontinued. Management evaluated the Company's outstanding accounts receivable as of June&#160;30, 2026, and concluded that no allowance for expected credit losses was required, as the balances were deemed fully collectible. There were no write-offs of uncollectible accounts during the three and six months ended June 30, 2026.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers investments with an original maturity greater than three months and remaining maturities less than 12 months to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its marketable debt securities as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a marketable debt security is below its amortized cost basis, the Company evaluates whether it is more likely than not that the Company will be required to sell the security before its anticipated recovery in market value and whether credit losses exist for the related securities. Credit-related losses are recognized as an allowance for credit losses on the balance sheet with a corresponding adjustment to earnings. Unrealized gains and losses that are unrelated to credit deterioration are reported in accumulated other comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In 2026, in connection with the launch of our Early Access Program and other commercialization activities, we began capitalizing inventory costs. Inventory is stated at the lower of cost or net realizable value with cost determined using a standard cost system, which approximates actual costs determined on the first-in first-out basis. Standard costs are reviewed and updated periodically to ensure they remain representative of current production costs. Materials that may be utilized for either commercial or, alternatively, for research and development purposes, are classified as inventory, specifically as raw materials and supplies. Amounts in inventory used for research and development purposes are charged to research and development expense when the item enters the research and development process and can no longer be used for commercial purposes. During the six months ended June 30, 2026, $0.5 million was charged to research and development expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Provisions for slow-moving, excess or obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values. For the quarter ended June&#160;30, 2026, the Company did not have any inventory reserves. As of June&#160;30, 2026, the Company had inventory of $0.6 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within interest expense and amortization in the Company&#8217;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#8217; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2026 and 2025, net unrealized gains and losses on marketable debt securities were included as a component of comprehensive income (loss).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) 2024-03, Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The ASU is effective for the Company for the fiscal year ending December 31, 2027 and for interim periods beginning after December 31, 2027. The Company does not anticipate adoption to have a material impact on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2026 and December&#160;31, 2025:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.282%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cash equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,530&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,287&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,031&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,256&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">88,227&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,984&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,031&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,256&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,960&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,958&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,978&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,160&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">25,075&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,176&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,899&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">9,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">129,026&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">128,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">70,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">45,155&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:22.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Cash equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">90,066&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">90,274&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">49,489&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,785&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,594&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">49,489&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">40,785&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,321&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,321&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,379&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,942&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,669&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,838&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">46,872&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,918&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,954&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">63,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">41,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">155,421&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">155,664&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,907&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">91,018&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,739&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses and fair values of available-for-sale securities that have been in an unrealized loss position for a period of less than and greater than 12 months as of June&#160;30, 2026 are as follows: </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#12644;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Securities in Unrealized Loss Position Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Securities in Unrealized Loss Position Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Fair Market Value</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,867&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">69,867&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,958&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,958&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,678&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">21,584&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">23,076&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">107,087&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">108,579&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Prototype equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,326&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,759&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">11,578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,714)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(8,121)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,457&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,992&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Grant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,553&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long-term assets (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long-term assets (Note 8)</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">14,168&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">13,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,974,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">29,341,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,270,870&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Employee Stock Purchase Plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,697,982&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,518,072&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">58,963,655&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">52,130,509&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Common Stock Reserved For Future Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans and Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Significant Assumptions</a></td>
<td class="text">The significant assumptions used in these calculations are summarized as follows:<div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.0  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75.5% - 80.7%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.5% - 103.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">75.5% - 82.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">97.5% - 103.0%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.91% - 4.29%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.90% - 4.04%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.69% - 4.29%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.90% - 4.04%</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule of Option Award Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option award activity during the six months ended June 30, 2026:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Option Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December&#160;31, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,270,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,614,000&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.37&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(670,244)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(923,289)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,701&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.12&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable at June&#160;30, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">12,308,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3.74&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,986&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the total stock-based compensation expense included in the Company&#8217;s condensed consolidated statement of operations:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,423&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Principal Contractual Obligations for Operating Lease Commitments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2026:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Lease Obligations</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Six months ending December&#160;31, 2026</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,889&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,495&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2031 and thereafter</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,735&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">34,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(6,967)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">27,816&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2026 and 2025:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,469)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(15,033)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(29,166)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(31,646)</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">127,135,738&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,204,632&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,886,646&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">126,174,603&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.23)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(0.25)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three and Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,291,337</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">18,996,250</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">87,375</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">122,653</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total potentially dilutive common share equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,378,712</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">19,118,903</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Significant Segment Expenses</a></td>
<td class="text">The Company included a summary of the segment net loss, including significant segment expenses for its single reportable segment: <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:41.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and related benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,573&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">7,946&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,256&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">16,969&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Professional services and laboratory expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,338&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,516&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">6,429&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Facilities expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,167&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">5,839&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,709&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,520&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">3,877&#160;</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,603&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">15,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">17,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">32,062&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">35,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation to net loss:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">2,749&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">4,311&#160;</span></td><td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(14,469)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(15,033)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(29,166)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(31,646)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Footnotes:</span></div></td></tr><tr><td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">Other segment items for the Company&#8217;s single reportable segment include travel and entertainment, insurance, tax, expensed computer hardware and software, depreciation, and other miscellaneous expenses.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 09, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 361,186<span></span>
</td>
<td class="nump">$ 332,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction', window );">Proceeds from sale of stock and reverse recapitalization transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts', window );">Payments of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, and short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued in transaction (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate gross proceeds</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments Of Reverse Recapitalization Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_PaymentsOfReverseRecapitalizationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Stock And Reverse Recapitalization Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 190,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 190,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_GrantLiabilityCurrent', window );">Grant liability, current</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for credit loss, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Accounts receivable, write-offs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory', window );">Inventory for long-term contracts or programs, research and development expense, included in inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Balance Sheet Location [Axis]: us-gaap:PrepaidExpenseAndOtherAssetsCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, after allowance for credit loss, current (less than)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent', window );">Balance Sheet Location [Axis]: naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_GrantLiabilityCurrent', window );">Grant liability, current</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=naut_GrantRevenueMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_GrantLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_GrantLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory For Long-Term Contracts Or Programs, Research And Development Expense, Included In Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationBalanceAxis=naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=naut_GrantRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=naut_GrantRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 129,026<span></span>
</td>
<td class="nump">$ 155,421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(341)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">128,695<span></span>
</td>
<td class="nump">155,664<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">70,865<span></span>
</td>
<td class="nump">91,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">45,155<span></span>
</td>
<td class="nump">52,739<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">12,675<span></span>
</td>
<td class="nump">11,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">88,227<span></span>
</td>
<td class="nump">91,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(253)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">87,984<span></span>
</td>
<td class="nump">91,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">52,031<span></span>
</td>
<td class="nump">49,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">35,256<span></span>
</td>
<td class="nump">40,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">697<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">697<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">697<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Mutual funds | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Mutual funds | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Mutual funds | Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">697<span></span>
</td>
<td class="nump">1,528<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">87,530<span></span>
</td>
<td class="nump">90,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(253)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">87,287<span></span>
</td>
<td class="nump">90,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. treasury securities | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">52,031<span></span>
</td>
<td class="nump">49,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. treasury securities | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">35,256<span></span>
</td>
<td class="nump">40,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. treasury securities | Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">40,799<span></span>
</td>
<td class="nump">63,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">40,711<span></span>
</td>
<td class="nump">63,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">18,834<span></span>
</td>
<td class="nump">41,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,899<span></span>
</td>
<td class="nump">11,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">11,978<span></span>
</td>
<td class="nump">10,379<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">13,960<span></span>
</td>
<td class="nump">15,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">13,958<span></span>
</td>
<td class="nump">15,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,980<span></span>
</td>
<td class="nump">4,942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper | Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">11,978<span></span>
</td>
<td class="nump">10,379<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">1,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">1,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities | Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">25,160<span></span>
</td>
<td class="nump">46,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">25,075<span></span>
</td>
<td class="nump">46,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Agency securities | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">15,176<span></span>
</td>
<td class="nump">34,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Agency securities | Balance Sheet Location [Axis]: us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,899<span></span>
</td>
<td class="nump">11,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Agency securities | Balance Sheet Location [Axis]: us-gaap:CashAndCashEquivalentsAtCarryingValue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (fff)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (ff)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (fff)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (ff)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 45<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480865/815-45-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionLocationBalanceAxis=us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="num">$ (340)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Market Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="nump">107,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">1,492<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">108,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="num">(253)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(253)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Market Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="nump">69,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">69,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Market Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="nump">13,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">13,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Market Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="nump">1,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">1,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Market Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Securities in Unrealized Loss Position Less than 12 months</a></td>
<td class="nump">21,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Securities in Unrealized Loss Position Greater than 12 months</a></td>
<td class="nump">1,492<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">$ 23,076<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease', window );">Credit losses on investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for credit losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant, and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 12,713<span></span>
</td>
<td class="nump">$ 11,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(8,714)<span></span>
</td>
<td class="num">(8,121)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">3,999<span></span>
</td>
<td class="nump">3,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant, and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">6,647<span></span>
</td>
<td class="nump">6,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant, and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant, and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant, and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">322<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_PrototypeEquipmentMember', window );">Prototype equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant, and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,326<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant, and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 2,759<span></span>
</td>
<td class="nump">$ 1,807<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion, and amortization of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480204/360-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478443/942-360-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482558/350-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482558/350-40-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 905<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478704/905-360-25-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482222/360-10-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-3<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482558/350-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478443/942-360-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_FurnitureFixturesAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_FurnitureFixturesAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_PrototypeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_PrototypeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 606<span></span>
</td>
<td class="nump">$ 922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation</a></td>
<td class="nump">$ 1,992<span></span>
</td>
<td class="nump">$ 2,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development</a></td>
<td class="nump">703<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and consulting fees</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_GrantLiabilitiesCurrent', window );">Grant liabilities</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 3,553<span></span>
</td>
<td class="nump">$ 3,177<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_GrantLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_GrantLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 13,166<span></span>
</td>
<td class="nump">$ 12,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash included in other long-term assets</a></td>
<td class="nump">1,002<span></span>
</td>
<td class="nump">1,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total</a></td>
<td class="nump">$ 14,168<span></span>
</td>
<td class="nump">$ 13,390<span></span>
</td>
<td class="nump">$ 35,459<span></span>
</td>
<td class="nump">$ 28,648<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481420/860-30-50-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Narrative (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">127,224,640<span></span>
</td>
<td class="nump">126,469,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">127,224,640<span></span>
</td>
<td class="nump">126,469,610<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Schedule of Common Stock Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options issued and outstanding (in shares)</a></td>
<td class="nump">19,291,337<span></span>
</td>
<td class="nump">17,270,870<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved (in shares)</a></td>
<td class="nump">58,963,655<span></span>
</td>
<td class="nump">52,130,509<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember', window );">Shares available for grant under 2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">32,974,336<span></span>
</td>
<td class="nump">29,341,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember', window );">Shares available for grant under 2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">6,697,982<span></span>
</td>
<td class="nump">5,518,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-5<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-13<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans and Stock-based Compensation - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jan. 01, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, period for recognition (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate (as percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,158,000<span></span>
</td>
<td class="nump">$ 1,709,000<span></span>
</td>
<td class="nump">$ 2,520,000<span></span>
</td>
<td class="nump">$ 3,877,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options | Income Statement Location [Axis]: us-gaap:CostOfRevenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options | Income Statement Location [Axis]: us-gaap:ResearchAndDevelopmentExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">459,000<span></span>
</td>
<td class="nump">686,000<span></span>
</td>
<td class="nump">982,000<span></span>
</td>
<td class="nump">1,454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options | Income Statement Location [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 699,000<span></span>
</td>
<td class="nump">$ 1,023,000<span></span>
</td>
<td class="nump">$ 1,538,000<span></span>
</td>
<td class="nump">$ 2,423,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember', window );">Shares available for grant under 2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">32,974,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,974,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,341,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,672,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding stock maximum (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant', window );">Increase in shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,323,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember', window );">Shares available for grant under 2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">6,697,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,697,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,518,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod', window );">Offering purchase period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,734,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding stock maximum (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant', window );">Increase in shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,264,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember', window );">Shares available for grant under 2021 Employee Stock Purchase Plan | Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Share-based compensation arrangement by share-based payment award, maximum employee subscription rate (as percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Increase In Number Of Shares Available For Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Purchase Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant to expiration date of share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans and Stock-based Compensation - Schedule of Significant Assumptions (Details) - Options<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum (as percent)</a></td>
<td class="nump">75.50%<span></span>
</td>
<td class="nump">97.50%<span></span>
</td>
<td class="nump">75.50%<span></span>
</td>
<td class="nump">97.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum (as percent)</a></td>
<td class="nump">80.70%<span></span>
</td>
<td class="nump">103.00%<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">103.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum (as percent)</a></td>
<td class="nump">3.91%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">3.69%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum (as percent)</a></td>
<td class="nump">4.29%<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
<td class="nump">4.29%<span></span>
</td>
<td class="nump">4.04%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans and Stock-based Compensation - Schedule of Option Award Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2026</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Option Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, beginning balance (in shares)</a></td>
<td class="nump">17,270,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">3,614,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(670,244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(923,289)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, ending balance (in shares)</a></td>
<td class="nump">19,291,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest (in shares)</a></td>
<td class="nump">19,291,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and exercisable (in shares)</a></td>
<td class="nump">12,308,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 3.22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">2.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">1.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">2.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">3.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest (in dollars per share)</a></td>
<td class="nump">3.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 3.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, weighted average remaining contractual life (in years)</a></td>
<td class="text">7 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and exercisable, weighted average remaining contractual life (in years)</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 4,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Vested and exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 2,986<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average contractual term remaining for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested option for which requisite service period has not been rendered but that is expected to vest based on achievement of performance condition, if forfeiture is recognized when it occurs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans and Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details) - Employee Stock Option - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,158,000<span></span>
</td>
<td class="nump">$ 1,709,000<span></span>
</td>
<td class="nump">$ 2,520,000<span></span>
</td>
<td class="nump">$ 3,877,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Income Statement Location [Axis]: us-gaap:CostOfRevenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Income Statement Location [Axis]: us-gaap:ResearchAndDevelopmentExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">459,000<span></span>
</td>
<td class="nump">686,000<span></span>
</td>
<td class="nump">982,000<span></span>
</td>
<td class="nump">1,454,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Income Statement Location [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 699,000<span></span>
</td>
<td class="nump">$ 1,023,000<span></span>
</td>
<td class="nump">$ 1,538,000<span></span>
</td>
<td class="nump">$ 2,423,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeLocationBalanceAxis=us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($) </div>
<div>institution</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Open purchase commitment</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Open purchase commitment to be received through next 12 months</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for lease liabilities included in operating activities</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Cash-collateralized letters of credit</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_NumberOfFinancialInstitution', window );">Number of financial institution | institution</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_NumberOfFinancialInstitution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Financial Institution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_NumberOfFinancialInstitution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-15<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Principal Contractual Obligations for Operating Lease Commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lease Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Six months ending December&#160;31, 2026</a></td>
<td class="nump">$ 2,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2027</a></td>
<td class="nump">6,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2028</a></td>
<td class="nump">6,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2029</a></td>
<td class="nump">6,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2030</a></td>
<td class="nump">6,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour', window );">2031 and thereafter</a></td>
<td class="nump">5,735<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">34,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(6,967)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 27,816<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.9-06)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders, basic</a></td>
<td class="num">$ (14,469)<span></span>
</td>
<td class="num">$ (15,033)<span></span>
</td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="num">$ (31,646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common stockholders, diluted</a></td>
<td class="num">$ (14,469)<span></span>
</td>
<td class="num">$ (15,033)<span></span>
</td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="num">$ (31,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</a></td>
<td class="nump">127,135,738<span></span>
</td>
<td class="nump">126,204,632<span></span>
</td>
<td class="nump">126,886,646<span></span>
</td>
<td class="nump">126,174,603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</a></td>
<td class="nump">127,135,738<span></span>
</td>
<td class="nump">126,204,632<span></span>
</td>
<td class="nump">126,886,646<span></span>
</td>
<td class="nump">126,174,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share - Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially dilutive common share equivalents (in shares)</a></td>
<td class="nump">19,378,712<span></span>
</td>
<td class="nump">19,118,903<span></span>
</td>
<td class="nump">19,378,712<span></span>
</td>
<td class="nump">19,118,903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially dilutive common share equivalents (in shares)</a></td>
<td class="nump">19,291,337<span></span>
</td>
<td class="nump">18,996,250<span></span>
</td>
<td class="nump">19,291,337<span></span>
</td>
<td class="nump">18,996,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=naut_EmployeeStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially dilutive common share equivalents (in shares)</a></td>
<td class="nump">87,375<span></span>
</td>
<td class="nump">122,653<span></span>
</td>
<td class="nump">87,375<span></span>
</td>
<td class="nump">122,653<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=naut_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=naut_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2026 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of service revenue</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">15,938<span></span>
</td>
<td class="nump">17,097<span></span>
</td>
<td class="nump">32,062<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract', window );"><strong>Reconciliation to net loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">2,749<span></span>
</td>
<td class="nump">4,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(14,469)<span></span>
</td>
<td class="num">(15,033)<span></span>
</td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="num">(31,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=naut_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of service revenue</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and related benefits</a></td>
<td class="nump">7,573<span></span>
</td>
<td class="nump">7,946<span></span>
</td>
<td class="nump">15,256<span></span>
</td>
<td class="nump">16,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_ProfessionalServicesAndLaboratoryExpenses', window );">Professional services and laboratory expenses</a></td>
<td class="nump">3,338<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
<td class="nump">6,516<span></span>
</td>
<td class="nump">6,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_naut_FacilityExpenses', window );">Facilities expenses</a></td>
<td class="nump">2,550<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
<td class="nump">5,167<span></span>
</td>
<td class="nump">5,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">1,709<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="nump">3,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,375<span></span>
</td>
<td class="nump">2,603<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">15,938<span></span>
</td>
<td class="nump">17,097<span></span>
</td>
<td class="nump">32,062<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract', window );"><strong>Reconciliation to net loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="nump">2,080<span></span>
</td>
<td class="nump">2,749<span></span>
</td>
<td class="nump">4,311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,469)<span></span>
</td>
<td class="num">$ (15,033)<span></span>
</td>
<td class="num">$ (29,166)<span></span>
</td>
<td class="num">$ (31,646)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_FacilityExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Facility Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_FacilityExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ProfessionalServicesAndLaboratoryExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Professional services and laboratory expense includes costs for support services related to contracted projects, outsourced management, technical support, and the cost of consumable lab supplies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ProfessionalServicesAndLaboratoryExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482705/350-40-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479719/606-10-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=naut_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=naut_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>186</ContextCount>
  <ElementCount>236</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>31</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Stockholders’ Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders’ Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation</Role>
      <ShortName>Description of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Equity Incentive Plans and Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensation</Role>
      <ShortName>Equity Incentive Plans and Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Basic and Diluted Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShare</Role>
      <ShortName>Basic and Diluted Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/SignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/FairValueMeasurements</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/CommonStock</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Equity Incentive Plans and Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables</Role>
      <ShortName>Equity Incentive Plans and Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/CommitmentsandContingencies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Basic and Diluted Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables</Role>
      <ShortName>Basic and Diluted Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/BasicandDilutedNetLossperShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/SegmentInformation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Description of Business and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails</Role>
      <ShortName>Description of Business and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Fair Value Measurements - Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Fair Value Measurements - Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Accrued Expenses and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Accrued Expenses and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Common Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStockNarrativeDetails</Role>
      <ShortName>Common Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Common Stock - Schedule of Common Stock Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails</Role>
      <ShortName>Common Stock - Schedule of Common Stock Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/IncomeTaxes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails</Role>
      <ShortName>Equity Incentive Plans and Stock-based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Significant Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails</Role>
      <ShortName>Equity Incentive Plans and Stock-based Compensation - Schedule of Significant Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Option Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails</Role>
      <ShortName>Equity Incentive Plans and Stock-based Compensation - Schedule of Option Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Equity Incentive Plans and Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Commitments and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Commitments and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Commitments and Contingencies - Schedule of Future Principal Contractual Obligations for Operating Lease Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Principal Contractual Obligations for Operating Lease Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Share - Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="naut-20260630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/SegmentInformationTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="naut-20260630.htm">naut-20260630.htm</File>
    <File>naut-20260630.xsd</File>
    <File>naut-20260630_cal.xml</File>
    <File>naut-20260630_def.xml</File>
    <File>naut-20260630_lab.xml</File>
    <File>naut-20260630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>naut-20260630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="693">http://fasb.org/us-gaap/2026</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>66
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "naut-20260630.htm": {
   "nsprefix": "naut",
   "nsuri": "http://www.nautilus.bio/20260630",
   "dts": {
    "inline": {
     "local": [
      "naut-20260630.htm"
     ]
    },
    "schema": {
     "local": [
      "naut-20260630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "naut-20260630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "naut-20260630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "naut-20260630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "naut-20260630_pre.xml"
     ]
    }
   },
   "keyStandard": 222,
   "keyCustom": 14,
   "axisStandard": 13,
   "axisCustom": 0,
   "memberStandard": 20,
   "memberCustom": 9,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2026": 5,
    "http://fasb.org/us-gaap/2026": 1
   },
   "contextCount": 186,
   "entityCount": 1,
   "segmentCount": 31,
   "elementCount": 447,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2026": 693,
    "http://xbrl.sec.gov/dei/2026": 29,
    "http://xbrl.sec.gov/ecd/2026": 4
   },
   "report": {
    "R1": {
     "role": "http://www.nautilus.bio/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation",
     "longName": "9952157 - Disclosure - Description of Business and Basis of Presentation",
     "shortName": "Description of Business and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.nautilus.bio/role/SignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.nautilus.bio/role/FairValueMeasurements",
     "longName": "9952159 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems",
     "longName": "9952160 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.nautilus.bio/role/CommonStock",
     "longName": "9952161 - Disclosure - Common Stock",
     "shortName": "Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.nautilus.bio/role/IncomeTaxes",
     "longName": "9952162 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensation",
     "longName": "9952163 - Disclosure - Equity Incentive Plans and Stock-based Compensation",
     "shortName": "Equity Incentive Plans and Stock-based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.nautilus.bio/role/CommitmentsandContingencies",
     "longName": "9952164 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShare",
     "longName": "9952165 - Disclosure - Basic and Diluted Net Loss per Share",
     "shortName": "Basic and Diluted Net Loss per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.nautilus.bio/role/SegmentInformation",
     "longName": "9952166 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Significant Accounting Policies (Policies)",
     "shortName": "Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.nautilus.bio/role/FairValueMeasurementsTables",
     "longName": "9955512 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables",
     "longName": "9955513 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.nautilus.bio/role/CommonStockTables",
     "longName": "9955514 - Disclosure - Common Stock (Tables)",
     "shortName": "Common Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables",
     "longName": "9955515 - Disclosure - Equity Incentive Plans and Stock-based Compensation (Tables)",
     "shortName": "Equity Incentive Plans and Stock-based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.nautilus.bio/role/CommitmentsandContingenciesTables",
     "longName": "9955516 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables",
     "longName": "9955517 - Disclosure - Basic and Diluted Net Loss per Share (Tables)",
     "shortName": "Basic and Diluted Net Loss per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.nautilus.bio/role/SegmentInformationTables",
     "longName": "9955518 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
     "longName": "9955519 - Disclosure - Description of Business and Basis of Presentation (Details)",
     "shortName": "Description of Business and Basis of Presentation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-62",
      "name": "naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails",
     "longName": "9955520 - Disclosure - Significant Accounting Policies (Details)",
     "shortName": "Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfOperatingSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
     "longName": "9955521 - Disclosure - Fair Value Measurements - Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails",
     "longName": "9955522 - Disclosure - Fair Value Measurements - Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position (Details)",
     "shortName": "Fair Value Measurements - Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.nautilus.bio/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955523 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease",
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease",
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955524 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Property and Equipment, Net (Details)",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails",
     "longName": "9955525 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Narrative (Details)",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails",
     "longName": "9955526 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Accrued Expenses and Other Liabilities (Details)",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Accrued Expenses and Other Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "longName": "9955527 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
     "longName": "9955528 - Disclosure - Common Stock - Narrative (Details)",
     "shortName": "Common Stock - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R37": {
     "role": "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails",
     "longName": "9955529 - Disclosure - Common Stock - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "shortName": "Common Stock - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.nautilus.bio/role/IncomeTaxesDetails",
     "longName": "9955530 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
     "longName": "9955531 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Narrative (Details)",
     "shortName": "Equity Incentive Plans and Stock-based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails",
     "longName": "9955532 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Significant Assumptions (Details)",
     "shortName": "Equity Incentive Plans and Stock-based Compensation - Schedule of Significant Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-161",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-161",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails",
     "longName": "9955533 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Option Award Activity (Details)",
     "shortName": "Equity Incentive Plans and Stock-based Compensation - Schedule of Option Award Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9955534 - Disclosure - Equity Incentive Plans and Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "Equity Incentive Plans and Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-161",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R43": {
     "role": "http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails",
     "longName": "9955535 - Disclosure - Commitments and Contingencies - Narrative (Details)",
     "shortName": "Commitments and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails",
     "longName": "9955536 - Disclosure - Commitments and Contingencies - Schedule of Future Principal Contractual Obligations for Operating Lease Commitments (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Future Principal Contractual Obligations for Operating Lease Commitments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
     "longName": "9955537 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Basic and Diluted Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails",
     "longName": "9955538 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "shortName": "Basic and Diluted Net Loss per Share - Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.nautilus.bio/role/SegmentInformationDetails",
     "longName": "9955539 - Disclosure - Segment Information (Details)",
     "shortName": "Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-183",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naut-20260630.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "naut_A2021EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "A2021EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant under 2021 Employee Stock Purchase Plan",
        "label": "2021 Employee Stock Purchase Plan [Member]",
        "documentation": "2021 Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "naut_A2021EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "A2021EquityIncentivePlanMember",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant under 2021 Equity Incentive Plan",
        "label": "2021 Equity Incentive Plan [Member]",
        "documentation": "2021 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r941",
      "r943"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, after allowance for credit loss, current (less than)",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Amortization (accretion) of premiums (discounts) on securities, net",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "totalLabel": "Total",
        "label": "Accrued Liabilities And Other Liabilities, Current",
        "documentation": "Accrued Liabilities And Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional and consulting fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "naut_AccruedResearchAndDevelopmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued research and development",
        "label": "Accrued Research And Development, Current",
        "documentation": "Accrued Research And Development, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Accumulated depreciation",
        "label": "Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization",
        "documentation": "Amount of accumulated depreciation, depletion, and amortization of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r278",
      "r282",
      "r607",
      "r608",
      "r621",
      "r1058"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r16",
      "r81",
      "r343",
      "r571",
      "r572",
      "r579",
      "r618",
      "r657",
      "r658",
      "r1113"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6",
      "r9",
      "r465",
      "r468",
      "r471",
      "r528",
      "r653",
      "r654",
      "r949",
      "r950",
      "r951",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1077",
      "r1079"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r343",
      "r571",
      "r572",
      "r579",
      "r814",
      "r1195"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r671",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1114",
      "r1197"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r856",
      "r866",
      "r898"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r849",
      "r859",
      "r869",
      "r901"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r894",
      "r902",
      "r906",
      "r914"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r415",
      "r416"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, allowance for credit loss, current",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r200",
      "r236"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, write-offs",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r240"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total potentially dilutive common share equivalents (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r68",
      "r110",
      "r111",
      "r112",
      "r151",
      "r162",
      "r187",
      "r191",
      "r233",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r346",
      "r443",
      "r445",
      "r510",
      "r571",
      "r572",
      "r573",
      "r586",
      "r587",
      "r613",
      "r696",
      "r767",
      "r768",
      "r782",
      "r814",
      "r822",
      "r824",
      "r837",
      "r1069",
      "r1070",
      "r1128"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r88",
      "r110",
      "r111",
      "r112",
      "r233",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r346",
      "r443",
      "r445",
      "r510",
      "r814",
      "r938",
      "r1069",
      "r1070",
      "r1128"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r251",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r612",
      "r1139"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r251",
      "r484",
      "r503",
      "r504",
      "r505",
      "r506",
      "r571",
      "r572",
      "r581",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r802",
      "r805",
      "r812",
      "r813",
      "r1029",
      "r1118",
      "r1119",
      "r1120",
      "r1130",
      "r1144"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Debt Securities, Available-for-Sale, Current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r251"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term investments",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r64",
      "r202",
      "r251"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r909"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r910"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r908"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r907"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business and Basis of Presentation",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r934",
      "r1001"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r105",
      "r107",
      "r744",
      "r1130"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, cash equivalents, and short-term investments",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "totalLabel": "Total",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r105",
      "r107"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r23"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r75",
      "r77",
      "r78",
      "r153",
      "r311",
      "r319",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r331",
      "r335",
      "r336",
      "r338",
      "r339",
      "r341",
      "r342",
      "r345",
      "r347",
      "r463",
      "r571",
      "r572",
      "r577",
      "r578",
      "r665",
      "r666",
      "r667",
      "r668",
      "r925",
      "r1002",
      "r1004",
      "r1078"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r61",
      "r70",
      "r294",
      "r571",
      "r572",
      "r574",
      "r832",
      "r833",
      "r834",
      "r835"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 8)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r571",
      "r572",
      "r575",
      "r614",
      "r683"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r289",
      "r738",
      "r1063",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "calculation": {
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shares of common stock reserved (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r342",
      "r571",
      "r572",
      "r578",
      "r828",
      "r829",
      "r830",
      "r832",
      "r833",
      "r834",
      "r835",
      "r1008",
      "r1009",
      "r1011",
      "r1114",
      "r1194",
      "r1197"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r946",
      "r1076",
      "r1133",
      "r1134",
      "r1136"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r342",
      "r571",
      "r572",
      "r578",
      "r684"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r342",
      "r571",
      "r572",
      "r578"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r342",
      "r571",
      "r572",
      "r578",
      "r684",
      "r702",
      "r1073",
      "r1197",
      "r1198"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.0001 par value, 1,000,000,000 shares authorized as of June\u00a030, 2026 and December\u00a031, 2025; 127,224,640 and 126,469,610 shares issued and outstanding as of June\u00a030, 2026 and December\u00a031, 2025, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r309",
      "r315",
      "r342",
      "r571",
      "r572",
      "r578",
      "r617",
      "r814"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r91",
      "r93",
      "r98",
      "r584",
      "r626",
      "r627"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Loss",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer hardware",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": [
      "r1061",
      "r1062"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of Credit Risk and Other Risks and Uncertainties",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r508"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r755"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate debt securities",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r785",
      "r787",
      "r789",
      "r802",
      "r816",
      "r826",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1190"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost of revenue",
        "verboseLabel": "Cost of service revenue",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r110",
      "r111",
      "r112",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r346",
      "r510",
      "r767",
      "r935",
      "r936",
      "r1046",
      "r1069"
     ]
    },
    "us-gaap_CostOfRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "CostOfRevenueAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue:",
        "label": "Cost of Revenue [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r251",
      "r258",
      "r259"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit losses on investments",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in allowance for credit loss of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities in Unrealized Loss Position Greater than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r255",
      "r774"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Securities in Unrealized Loss Position Greater than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r255"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities in Unrealized Loss Position Less than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r255",
      "r774"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Securities in Unrealized Loss Position Less than 12 months",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r255"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrealized Losses and Fair Values of Available-for-Sale Securities in an Unrealized Loss Position",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r253",
      "r774"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r254"
     ]
    },
    "naut_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Market Value",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DepositsAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deposits",
        "label": "Deposits Assets, Noncurrent",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r940",
      "r942"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r101",
      "r276",
      "r748",
      "r749",
      "r751",
      "r753"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Incentive Plans and Stock-based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r381",
      "r410",
      "r411",
      "r413",
      "r791"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)",
        "verboseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r99",
      "r118",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r133",
      "r136",
      "r143",
      "r144",
      "r145",
      "r150",
      "r274",
      "r307",
      "r363",
      "r414",
      "r437",
      "r442",
      "r480",
      "r481",
      "r585",
      "r628",
      "r759"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net loss per share attributable to common stockholders, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r99",
      "r118",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r136",
      "r143",
      "r144",
      "r145",
      "r150",
      "r274",
      "r307",
      "r363",
      "r414",
      "r437",
      "r442",
      "r480",
      "r481",
      "r585",
      "r628",
      "r759"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic and Diluted Net Loss per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r146",
      "r147",
      "r148",
      "r149",
      "r351"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.nautilus.bio/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r793"
     ]
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Employee Benefits and Share-Based Compensation",
        "documentation": "Amount of expense for employee benefit and equity-based compensation."
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense, period for recognition (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plan",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options",
        "netLabel": "Employee Stock Option",
        "verboseLabel": "Options to purchase common stock",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1084",
      "r1085",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "naut_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee stock purchase plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "documentation": "Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CIK",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r55",
      "r77",
      "r78",
      "r94",
      "r95",
      "r96",
      "r115",
      "r116",
      "r117",
      "r119",
      "r126",
      "r128",
      "r130",
      "r152",
      "r234",
      "r235",
      "r273",
      "r274",
      "r275",
      "r306",
      "r335",
      "r340",
      "r341",
      "r342",
      "r345",
      "r347",
      "r350",
      "r361",
      "r362",
      "r364",
      "r365",
      "r414",
      "r427",
      "r428",
      "r434",
      "r435",
      "r436",
      "r438",
      "r441",
      "r442",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r479",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r528",
      "r566",
      "r571",
      "r572",
      "r577",
      "r578",
      "r609",
      "r624",
      "r653",
      "r654",
      "r655",
      "r671",
      "r721",
      "r1080"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r856",
      "r866",
      "r898"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r853",
      "r863",
      "r895"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "naut_FacilityExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "FacilityExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Facilities expenses",
        "label": "Facility Expenses",
        "documentation": "Facility Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r484",
      "r485",
      "r495",
      "r802"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r484",
      "r485",
      "r495",
      "r802"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r482",
      "r483",
      "r485",
      "r486",
      "r487",
      "r488",
      "r494",
      "r495",
      "r497",
      "r504",
      "r533",
      "r534",
      "r535",
      "r540",
      "r780",
      "r781",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r805",
      "r812",
      "r813"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r490",
      "r492",
      "r493",
      "r494",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r570",
      "r802",
      "r806"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r367",
      "r372",
      "r373",
      "r485",
      "r495",
      "r504",
      "r533",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r812",
      "r813"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r367",
      "r372",
      "r373",
      "r375",
      "r485",
      "r486",
      "r495",
      "r504",
      "r534",
      "r780",
      "r781",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r812",
      "r813"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r482",
      "r483",
      "r485",
      "r486",
      "r487",
      "r488",
      "r494",
      "r495",
      "r497",
      "r504",
      "r533",
      "r534",
      "r535",
      "r540",
      "r780",
      "r781",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r802",
      "r805",
      "r812",
      "r813"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r237",
      "r238",
      "r239",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r256",
      "r257",
      "r305",
      "r334",
      "r463",
      "r502",
      "r509",
      "r512",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r537",
      "r538",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r611",
      "r625",
      "r774",
      "r802",
      "r803",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1115",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1124",
      "r1125"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r902"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r902"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r902"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r902"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r902"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "naut_FurnitureFixturesAndOfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "FurnitureFixturesAndOfficeEquipmentMember",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture, fixtures and office equipment",
        "label": "Furniture, Fixtures And Office Equipment [Member]",
        "documentation": "Furniture, Fixtures And Office Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "naut_GrantLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "GrantLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant liabilities",
        "label": "Grant Liabilities, Current",
        "documentation": "Grant Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "naut_GrantLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "GrantLiabilityCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant liability, current",
        "label": "Grant Liability, Current",
        "documentation": "Grant Liability, Current"
       }
      }
     },
     "auth_ref": []
    },
    "naut_GrantRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "GrantRevenueMember",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant revenue",
        "label": "Grant Revenue [Member]",
        "documentation": "Grant Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r113",
      "r419",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r429",
      "r431",
      "r432",
      "r433",
      "r610",
      "r660",
      "r670",
      "r793"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r44",
      "r110",
      "r129",
      "r130",
      "r151",
      "r170",
      "r191",
      "r420",
      "r421",
      "r430",
      "r630",
      "r743",
      "r750",
      "r752",
      "r754",
      "r793"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r926",
      "r998"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r894",
      "r902",
      "r906",
      "r914"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r918"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r918"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r918"
     ]
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income (Expense), Nonoperating",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r767",
      "r798",
      "r954",
      "r1016"
     ]
    },
    "naut_InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory for long-term contracts or programs, research and development expense, included in inventory",
        "label": "Inventory For Long-Term Contracts Or Programs, Research And Development Expense, Included In Inventory",
        "documentation": "Inventory For Long-Term Contracts Or Programs, Research And Development Expense, Included In Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InventoryNet",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r87",
      "r745",
      "r814"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, net",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r54",
      "r57",
      "r86",
      "r260",
      "r261",
      "r262",
      "r568",
      "r756"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investments",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r629",
      "r661",
      "r662",
      "r663",
      "r664",
      "r727",
      "r728"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salaries and related benefits",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r752",
      "r953"
     ]
    },
    "naut_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Laboratory equipment",
        "label": "Laboratory Equipment [Member]",
        "documentation": "Laboratory Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r1061",
      "r1062"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Principal Contractual Obligations for Operating Lease Commitments",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1127"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r1003",
      "r1007",
      "r1137"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r1003",
      "r1007",
      "r1137"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r1003",
      "r1007",
      "r1137"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r1003",
      "r1007",
      "r1137"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r1003",
      "r1007",
      "r1137"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Six months ending December\u00a031, 2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1127"
     ]
    },
    "naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2031 and thereafter",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four",
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LettersOfCreditOutstandingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash-collateralized letters of credit",
        "label": "Letters of Credit Outstanding, Amount",
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date."
       }
      }
     },
     "auth_ref": [
      "r823",
      "r825"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r110",
      "r111",
      "r112",
      "r233",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r346",
      "r444",
      "r445",
      "r446",
      "r510",
      "r682",
      "r761",
      "r782",
      "r837",
      "r948",
      "r1069",
      "r1128",
      "r1129"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r571",
      "r572",
      "r580",
      "r620",
      "r814",
      "r822",
      "r824",
      "r1002",
      "r1006",
      "r1046",
      "r1126"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Stockholders' Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r53",
      "r71",
      "r110",
      "r111",
      "r112",
      "r233",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r346",
      "r444",
      "r445",
      "r446",
      "r510",
      "r814",
      "r1069",
      "r1128",
      "r1129"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "LongTermPurchaseCommitmentAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Open purchase commitment",
        "label": "Long-Term Purchase Commitment, Amount",
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r157",
      "r290",
      "r291",
      "r292",
      "r293",
      "r376",
      "r405",
      "r406",
      "r407",
      "r417",
      "r488",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r542",
      "r543",
      "r544",
      "r567",
      "r649",
      "r651",
      "r659",
      "r674",
      "r675",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r773",
      "r790",
      "r794",
      "r796",
      "r797",
      "r805",
      "r806",
      "r810",
      "r811",
      "r818",
      "r1071",
      "r1072"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r157",
      "r290",
      "r291",
      "r292",
      "r293",
      "r376",
      "r405",
      "r406",
      "r407",
      "r417",
      "r488",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r542",
      "r543",
      "r544",
      "r567",
      "r649",
      "r651",
      "r659",
      "r674",
      "r675",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r773",
      "r790",
      "r794",
      "r796",
      "r797",
      "r805",
      "r806",
      "r810",
      "r818",
      "r1071",
      "r1072"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "us-gaap_MutualFundMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "MutualFundMember",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mutual funds",
        "label": "Mutual Fund [Member]",
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective."
       }
      }
     },
     "auth_ref": [
      "r1081",
      "r1082"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r25",
      "r31",
      "r46",
      "r49",
      "r50",
      "r89",
      "r92",
      "r96",
      "r110",
      "r111",
      "r112",
      "r114",
      "r118",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r129",
      "r130",
      "r141",
      "r233",
      "r274",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r307",
      "r310",
      "r312",
      "r316",
      "r346",
      "r363",
      "r414",
      "r437",
      "r442",
      "r481",
      "r510",
      "r623",
      "r703",
      "r719",
      "r720",
      "r750",
      "r752",
      "r754",
      "r836",
      "r1069"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to common stockholders, basic",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r100",
      "r122",
      "r123",
      "r124",
      "r125",
      "r133",
      "r134",
      "r142",
      "r145",
      "r310",
      "r312",
      "r316",
      "r442"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to common stockholders, diluted",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r135",
      "r137",
      "r138",
      "r139",
      "r140",
      "r142",
      "r145"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r860",
      "r870",
      "r894",
      "r902"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions of property and equipment included in accounts payable",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r935",
      "r936",
      "r1046"
     ]
    },
    "naut_NumberOfFinancialInstitution": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "NumberOfFinancialInstitution",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of financial institution",
        "label": "Number Of Financial Institution",
        "documentation": "Number Of Financial Institution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r768",
      "r1015"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails",
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r762",
      "r772",
      "r1015"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r754",
      "r935",
      "r936",
      "r1046"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "verboseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Obligations",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesScheduleofFuturePrincipalContractualObligationsforOperatingLeaseCommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r747"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, net of current portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for lease liabilities included in operating activities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r525"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r67"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on securities available-for-sale",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount, after tax and reclassification adjustment, of gain (loss) in value of unsold investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r6",
      "r30"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive income (loss)",
        "terseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r6",
      "r30",
      "r90",
      "r93",
      "r126"
     ]
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Liabilities",
        "label": "Other Current Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other current liabilities."
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense):",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expense",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r798"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "OtherSundryLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails": {
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Sundry Liabilities, Current",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r944"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r858",
      "r868",
      "r900"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r851",
      "r861",
      "r871",
      "r903"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r851",
      "r861",
      "r871",
      "r903"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "naut_PaymentsOfReverseRecapitalizationTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "PaymentsOfReverseRecapitalizationTransactionCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments of transaction costs",
        "label": "Payments Of Reverse Recapitalization Transaction Costs",
        "documentation": "Payments Of Reverse Recapitalization Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of securities",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r102",
      "r201"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1084",
      "r1085",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1084",
      "r1085",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r321",
      "r939",
      "r945",
      "r1075",
      "r1133",
      "r1134",
      "r1135"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r77",
      "r341",
      "r571",
      "r572",
      "r577",
      "r684"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r77",
      "r321",
      "r341",
      "r571",
      "r572",
      "r577"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r77",
      "r341",
      "r571",
      "r572",
      "r577",
      "r684",
      "r702",
      "r1073",
      "r1197",
      "r1198"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.0001 par value, 200,000,000 authorized as of June\u00a030, 2026 and December\u00a031, 2025; 0 shares issued and outstanding as of June\u00a030, 2026 and December\u00a031, 2025",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r77",
      "r309",
      "r314",
      "r341",
      "r571",
      "r572",
      "r577",
      "r616",
      "r814"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from maturities of securities",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r1030"
     ]
    },
    "naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of stock and reverse recapitalization transaction",
        "label": "Proceeds From Sale Of Stock And Reverse Recapitalization Transaction",
        "documentation": "Proceeds From Sale Of Stock And Reverse Recapitalization Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r7"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock under employee stock purchase plan",
        "label": "Proceeds from Stock Plans",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r195",
      "r569",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r742",
      "r749",
      "r752",
      "r754",
      "r783",
      "r784",
      "r817",
      "r818",
      "r819",
      "r821",
      "r827",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r994",
      "r995",
      "r996",
      "r997",
      "r1067",
      "r1068",
      "r1150",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1191",
      "r1192",
      "r1193"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r195",
      "r569",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r742",
      "r749",
      "r752",
      "r754",
      "r783",
      "r784",
      "r817",
      "r818",
      "r819",
      "r821",
      "r827",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r994",
      "r995",
      "r996",
      "r997",
      "r1067",
      "r1068",
      "r1150",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1191",
      "r1192",
      "r1193"
     ]
    },
    "naut_ProfessionalServicesAndLaboratoryExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "ProfessionalServicesAndLaboratoryExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional services and laboratory expenses",
        "label": "Professional Services And Laboratory Expenses",
        "documentation": "Professional services and laboratory expense includes costs for support services related to contracted projects, outsourced management, technical support, and the cost of consumable lab supplies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Asset, Class [Axis]",
        "label": "Long-Lived Asset, Class [Axis]",
        "documentation": "Information by class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r527",
      "r776",
      "r777",
      "r778",
      "r779",
      "r1058",
      "r1059",
      "r1131"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, gross",
        "label": "Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization",
        "documentation": "Amount, before accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r65",
      "r277",
      "r622",
      "r1058"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant, and Equipment [Line Items]",
        "label": "Property, Plant, and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r527",
      "r776",
      "r777",
      "r778",
      "r779",
      "r1058",
      "r1059",
      "r1131"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total",
        "label": "Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization",
        "documentation": "Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r571",
      "r572",
      "r582",
      "r607",
      "r608",
      "r622",
      "r814",
      "r1061"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant, and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection."
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Asset, Class [Domain]",
        "label": "Long-Lived Asset, Class [Domain]",
        "documentation": "Class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r527",
      "r776",
      "r777",
      "r778",
      "r779",
      "r1058",
      "r1059",
      "r1131"
     ]
    },
    "naut_PrototypeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "PrototypeEquipmentMember",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prototype equipment",
        "label": "Prototype Equipment [Member]",
        "documentation": "Prototype Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Open purchase commitment to be received through next 12 months",
        "label": "Purchase Obligation, to be Paid, Year One",
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1007",
      "r1137"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r157",
      "r290",
      "r291",
      "r292",
      "r293",
      "r366",
      "r376",
      "r405",
      "r406",
      "r407",
      "r413",
      "r417",
      "r488",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r542",
      "r543",
      "r544",
      "r550",
      "r567",
      "r649",
      "r651",
      "r659",
      "r674",
      "r675",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r773",
      "r790",
      "r794",
      "r796",
      "r797",
      "r805",
      "r806",
      "r810",
      "r811",
      "r818",
      "r830",
      "r1064",
      "r1071",
      "r1072",
      "r1119"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2026",
     "localname": "RangeMember",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r157",
      "r290",
      "r291",
      "r292",
      "r293",
      "r366",
      "r376",
      "r405",
      "r406",
      "r407",
      "r413",
      "r417",
      "r488",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r542",
      "r543",
      "r544",
      "r550",
      "r567",
      "r649",
      "r651",
      "r659",
      "r674",
      "r675",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r734",
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r773",
      "r790",
      "r794",
      "r796",
      "r797",
      "r805",
      "r806",
      "r810",
      "r811",
      "r818",
      "r830",
      "r1064",
      "r1071",
      "r1072",
      "r1119"
     ]
    },
    "us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ReconciliationFromSegmentTotalsToConsolidatedAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation to net loss:",
        "label": "Segment Reporting, Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r853",
      "r863",
      "r895"
     ]
    },
    "naut_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r741",
      "r750",
      "r751",
      "r767",
      "r1132"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r854",
      "r864",
      "r896"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r845",
      "r855",
      "r865",
      "r897"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r852",
      "r862",
      "r872",
      "r904"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash included in other long-term assets",
        "label": "Restricted Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r105",
      "r107",
      "r615",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r105",
      "r107",
      "r940",
      "r942"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets",
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedTerseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r82",
      "r343",
      "r571",
      "r572",
      "r579",
      "r619",
      "r656",
      "r658",
      "r669",
      "r685",
      "r814"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r115",
      "r116",
      "r117",
      "r119",
      "r126",
      "r128",
      "r130",
      "r234",
      "r235",
      "r273",
      "r274",
      "r275",
      "r306",
      "r340",
      "r350",
      "r361",
      "r362",
      "r364",
      "r365",
      "r414",
      "r427",
      "r428",
      "r434",
      "r435",
      "r436",
      "r438",
      "r441",
      "r442",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r470",
      "r472",
      "r479",
      "r520",
      "r566",
      "r609",
      "r653",
      "r655",
      "r671",
      "r1077",
      "r1079",
      "r1197"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition and Grant Revenue",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r704"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/SegmentInformationDetails",
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenue",
        "verboseLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r110",
      "r111",
      "r112",
      "r151",
      "r163",
      "r164",
      "r185",
      "r191",
      "r195",
      "r197",
      "r198",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r346",
      "r510",
      "r586",
      "r588",
      "r767",
      "r798",
      "r822",
      "r824",
      "r935",
      "r936",
      "r1046",
      "r1069"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r913"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate gross proceeds",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofPotentialSharesofCommonStockExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Common Stock Reserved for Future Issuance",
        "label": "Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]",
        "documentation": "Schedule Of Common Stock Reserved For Future Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant, and Equipment [Table]",
        "label": "Property, Plant, and Equipment [Table]",
        "documentation": "Disclosure of information about property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r527",
      "r776",
      "r777",
      "r778",
      "r779",
      "r1058",
      "r1059",
      "r1131"
     ]
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Cash",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r924",
      "r1149"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Table]",
        "label": "Segment Reporting [Table]",
        "documentation": "Disclosure of information about segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Significant Segment Expenses",
        "label": "Segment Reporting [Table Text Block]",
        "documentation": "Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total."
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r413"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Significant Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r55",
      "r77",
      "r78",
      "r153",
      "r318",
      "r319",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r328",
      "r331",
      "r335",
      "r336",
      "r338",
      "r339",
      "r341",
      "r342",
      "r345",
      "r347",
      "r463",
      "r571",
      "r572",
      "r577",
      "r578",
      "r665",
      "r666",
      "r667",
      "r668",
      "r925",
      "r1002",
      "r1004",
      "r1078"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Option Award Activity",
        "label": "Schedule of Stock Options Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r151",
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r198",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r279",
      "r281",
      "r285",
      "r287",
      "r439",
      "r440",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r764",
      "r767",
      "r768",
      "r775",
      "r820",
      "r1150",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting [Text Block]",
        "documentation": "The entire disclosure for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r174",
      "r176",
      "r177",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r198",
      "r762",
      "r765",
      "r766",
      "r767",
      "r769",
      "r771",
      "r772"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Line Items]",
        "label": "Segment Reporting [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193"
     ]
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/SegmentInformationDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r176",
      "r177",
      "r191",
      "r767"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r194",
      "r197",
      "r763",
      "r764",
      "r770"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r749",
      "r750",
      "r751",
      "r754",
      "r993"
     ]
    },
    "naut_ServiceRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "ServiceRevenueMember",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service revenue",
        "label": "Service Revenue [Member]",
        "documentation": "Service Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expected dividend rate (as percent)",
        "terseLabel": "Expected dividend rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, maximum (as percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, minimum (as percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate, maximum (as percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate, minimum (as percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Increase In Number Of Shares Available For Grant",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Increase In Number Of Shares Available For Grant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r378",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r413"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, maximum employee subscription rate (as percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "calculation": {
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails": {
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares available for grant (in shares)",
        "terseLabel": "Shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.nautilus.bio/20260630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering purchase period (in months)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Purchase Period",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Purchase Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r939",
      "r945",
      "r946",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r939",
      "r945",
      "r946",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "calculation": {
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails": {
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockScheduleofCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options issued and outstanding (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Stock Option Awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding, beginning balance (in dollars per share)",
        "periodEndLabel": "Outstanding, ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and expected to vest (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and expected to vest (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of outstanding stock maximum (as percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award expiration period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant to expiration date of share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofSignificantAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable, aggregate intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term",
        "documentation": "Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and exercisable, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted-Average Remaining Contractual Term",
        "documentation": "Weighted-average contractual term remaining for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested option for which requisite service period has not been rendered but that is expected to vest based on achievement of performance condition, if forfeiture is recognized when it occurs."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price of common stock (as percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.nautilus.bio/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r151",
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r192",
      "r193",
      "r198",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r279",
      "r281",
      "r285",
      "r287",
      "r439",
      "r440",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r764",
      "r767",
      "r768",
      "r775",
      "r820",
      "r1150",
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r55",
      "r77",
      "r78",
      "r94",
      "r95",
      "r96",
      "r115",
      "r116",
      "r117",
      "r119",
      "r126",
      "r128",
      "r130",
      "r152",
      "r234",
      "r235",
      "r273",
      "r274",
      "r275",
      "r306",
      "r335",
      "r340",
      "r341",
      "r342",
      "r345",
      "r347",
      "r350",
      "r361",
      "r362",
      "r364",
      "r365",
      "r414",
      "r427",
      "r428",
      "r434",
      "r435",
      "r436",
      "r438",
      "r441",
      "r442",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r479",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r528",
      "r566",
      "r571",
      "r572",
      "r577",
      "r578",
      "r609",
      "r624",
      "r653",
      "r654",
      "r655",
      "r671",
      "r721",
      "r1080"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r61",
      "r62",
      "r69",
      "r72",
      "r73",
      "r75",
      "r76",
      "r77",
      "r78",
      "r82",
      "r115",
      "r116",
      "r117",
      "r152",
      "r308",
      "r309",
      "r311",
      "r313",
      "r318",
      "r335",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r349",
      "r350",
      "r360",
      "r520",
      "r569",
      "r571",
      "r572",
      "r576",
      "r577",
      "r578",
      "r661",
      "r672",
      "r673",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r684",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r704",
      "r705",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r721",
      "r746",
      "r752",
      "r754",
      "r831",
      "r1196"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionLocationBalanceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfFinancialPositionLocationBalanceAxis",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Location, Statement of Financial Position, Balance [Axis]",
        "documentation": "Information by location in statement of financial position line item where disaggregated cumulative balance is reported."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r447",
      "r449",
      "r450",
      "r451",
      "r452",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r509",
      "r799",
      "r800",
      "r1151",
      "r1152"
     ]
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeLocationBalanceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfIncomeLocationBalanceAxis",
     "presentation": [
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Location, Statement of Income, Balance [Axis]",
        "documentation": "Information by location in statement of income line item where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r283",
      "r284",
      "r286",
      "r448",
      "r453",
      "r454",
      "r462",
      "r489",
      "r491",
      "r496",
      "r511",
      "r512",
      "r513",
      "r650",
      "r652",
      "r706",
      "r741",
      "r794",
      "r795",
      "r800",
      "r801",
      "r804",
      "r812",
      "r813",
      "r1111",
      "r1112",
      "r1153"
     ]
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StatementTable",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r55",
      "r56",
      "r61",
      "r62",
      "r69",
      "r72",
      "r73",
      "r75",
      "r76",
      "r77",
      "r78",
      "r82",
      "r115",
      "r116",
      "r117",
      "r152",
      "r199",
      "r308",
      "r309",
      "r311",
      "r313",
      "r318",
      "r335",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r349",
      "r350",
      "r360",
      "r520",
      "r569",
      "r571",
      "r572",
      "r576",
      "r577",
      "r578",
      "r609",
      "r661",
      "r672",
      "r673",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r684",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r704",
      "r705",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r721",
      "r746",
      "r752",
      "r754",
      "r831",
      "r1196"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r857",
      "r867",
      "r899"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1084",
      "r1085",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r939",
      "r945",
      "r946",
      "r1073",
      "r1075",
      "r1076",
      "r1077",
      "r1079",
      "r1133",
      "r1134",
      "r1135",
      "r1136"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.nautilus.bio/role/EquityIncentivePlansandStockbasedCompensationScheduleofOptionAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of vested stock options (in shares)",
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r939",
      "r945",
      "r946",
      "r1073",
      "r1075",
      "r1076",
      "r1077",
      "r1079",
      "r1133",
      "r1134",
      "r1135",
      "r1136"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock under employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r939",
      "r945",
      "r946",
      "r1073",
      "r1075",
      "r1076",
      "r1077",
      "r1079",
      "r1133",
      "r1134",
      "r1135",
      "r1136"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of vested stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r939",
      "r945",
      "r946",
      "r1073",
      "r1075",
      "r1076",
      "r1077",
      "r1079",
      "r1133",
      "r1134",
      "r1135",
      "r1136"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r686",
      "r702",
      "r722",
      "r723",
      "r814",
      "r837",
      "r948",
      "r1002",
      "r1005",
      "r1006",
      "r1046",
      "r1126",
      "r1197"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r77",
      "r78",
      "r83",
      "r317",
      "r320",
      "r322",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r336",
      "r341",
      "r342",
      "r345",
      "r347",
      "r348",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r463",
      "r477",
      "r478",
      "r529",
      "r724",
      "r725",
      "r733"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Composition of Certain Condensed Consolidated Financial Statement Line Items",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r937"
     ]
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "SupplementalCashFlowElementsAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplementary cash flow information on non-cash activities:",
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable and Allowance for Expected Credit Losses",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1027",
      "r1028"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.nautilus.bio/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r238",
      "r239",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r305",
      "r334",
      "r463",
      "r502",
      "r509",
      "r512",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r537",
      "r538",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r611",
      "r625",
      "r802",
      "r803",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r816",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1115",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1124",
      "r1125"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r916"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r914"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agency securities",
        "label": "US Government Agencies Debt Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r758",
      "r785",
      "r787",
      "r815",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofAssetsCarriedatFairValueandMeasuredonaRecurringBasisDetails",
      "http://www.nautilus.bio/role/FairValueMeasurementsScheduleofUnrealizedLossesandFairValuesofAvailableforSaleSecuritiesinanUnrealizedLossPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. treasury securities",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r758",
      "r785",
      "r787",
      "r789",
      "r802",
      "r815",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r154",
      "r155",
      "r156",
      "r157",
      "r586",
      "r588",
      "r760"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)",
        "terseLabel": "Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r145"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)",
        "terseLabel": "Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r145"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2026",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareScheduleofComputationofBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2026",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-10"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-7"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480868/205-20-S45-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.Z.5.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480781/205-20-S99-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-13"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-3"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-4"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-5"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-7"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-8"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-9"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-12"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-20"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3C"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-5"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482705/350-40-65-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480204/360-10-S45-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480125/505-10-S35-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-4"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-8"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-6"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-5"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 5.Q.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-7"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481468/505-20-05-5"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S25",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479982/505-20-S25-3"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479951/505-20-S50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 1.D.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479921/505-20-S99-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479719/606-10-65-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EE",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EE"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4EEE",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4EEE"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480339/815-10-65-8"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "45",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480865/815-45-50-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 1.B.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480148/855-10-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-5"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13)(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(ff)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(fff)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478443/942-360-45-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-3"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "181",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-181"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480088/860-10-S50-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-12"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-15"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-11"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-7"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480657/210-10-S50-8"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-20"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3C"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-3D"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482558/350-40-50-1"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482222/360-10-30-2"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-2"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480100/505-10-S45-3"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480070/505-10-S50-2"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "905",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478704/905-360-25-4"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477657/942-210-S45-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478478/942-210-S50-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.9-06)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479032/944-605-50-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>67
<FILENAME>0001808805-26-000034-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001808805-26-000034-xbrl.zip
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M&&W<.]6N?ZDPD<]^@U?V'_7'*3P$'11V=<JSK=#2K_^&<-]]N_@_4$L#!!0
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M  >-I7',!BF1N76H+9YSXB*O:I%P!ZZR2,X!4BDYEP8E^!&V&)7(R#T!,,7
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MT)!%#Z<^!3XQY3W,B5L>]9/(+90_P2(%%64'W/+'4 Z&= %'(74<,&,B8$O
M AB<<#U#!P]S(YIC?]"*3(RTPF-?/-O"/RPZH"AU'6*/&+O:[L"'E3""D@C<
MG3O3]C^S-VS?JHX)PQ'\ZU)T!N#G: !6#G@/?A"'X5",PB>)@]UPP',T+.@9
M:R8T\QSRRO@ ;/[(X;I* KI0:>43.Z S;S4).G,76<)ZK[ZK0]WGV+V!1?#4
M)+_%#D*\R,3^^.#SP)=@\BFOMN.P<!.[RIMFX22:=D=3DO("^O<I*FP6LD7)
M8_J1C=A@">5$3,5!( NN5SDV!@/;9$H"HTD4;#UO0BD37A9<R'*S^,%C==UQ
MQ"GP7)<Z$GV[J^\7#]5#.B8/1C1CM+%O<Y6.6$+/R,/U>N9/"?9"%4D<XIXS
MDE1F'WE^7- Q'S-P856)K2MQ42@N^AC#1G"#(<4L6BS9B7W(P")_*-]B!?,0
M.1C:GG-4F&:*?T\* 'C*(YA5WP 3/<T>QT;")0U)OWV[DN@LV&X@K.-K'-@.
M?7 % U;B(RLPLRLPWRG!+$DUI62+=6D&QS.)HZ))S3)NJN*2./>&X@S#+?[T
M&VIZ+@:]L,",I^BX^XX9P! $8,I\B"7@L^/U9VD\^(LS'[_MF;I@>Z<>:WFO
M+B@\%QZ5Y#<\6)@'6ZB52A:NK^-+?S4MIL22OB'H#,]GA4>H_N,T :P>M9'%
M*Y3 8.Z#AJ+^*$"+>XCUFG$1&?:^QH+'$!124E48_\1*,5^6OS>]R+$6OPPH
M_;ETY31+O/0#D[)+7R/U@(Q=_'I$)HM?L1#MTI=>B/L%HES\ 5P&.^-]8 ?]
M,VL=P3!KB^@'+GTW=R$X&H$-E$&8'L&LV93DD3A=<$-1$<152EY .4Y.B%:!
MHU^H\M,%QF3;CES^MV\'0![P$9PU-'?0FN$&$/?,!KR,EI,VX!LH. IX@HOP
MV*W/"V'5=,B0^8;$'"*9QJS!K#"D.=]F1;RSS,O ]T:LBFM:A[#) V,\4A8.
MQEQ"PDSO5A77E+]1>#6K]L5+82L, BCFGD'UP?+ <@= ./C-/?%#Y>9&5>*6
M?FI6A?&4R*@3T%> &>4R<UUM>4WY'4C.C5>Q@(")%RF<V)DL :XR\1HK0O#$
M1JR7W/O>=K^#W/5>J*\JKS0.D;#U$06^9(5S8QK:TQ;[/AG;%JR7^?7X+.J^
MV+[G\HIMI%$.+GB\_TPYZGBPQF/_K0&H%-@Y6[0';(912XSD1XP$8GY7@ (2
MRG,QB@!\\LHJN2A'2TJMX:4)$<;5Z=,<49P( LY#.H+G\X)11DOL%AZC\$9]
MVYUFF>*'J2EJGJ=DYKTQZDS3*]\JDPVSJG0$I#MY]W  9>\9D9\(&Q<\"6#8
MV"=/B&^!_19+[-54!#+6T%QR,;LWH6:^FO5DQY:#Z/%,$YD8WS6_?:9&,B#
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M&"%'T#')[@ CA8F1QXZ +Z3$X2W H3YB*XAO"^@[4.).@)=:-1.*S*_!]%0
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M2*F+I&2<ICDLJGB-9\:XSXI#"3L("+]5O4&5G4?<V20^;=Y8(V:GL/V&H'W
ME]P-?H#OB&#-R1Q&'7S%IMK2=A:T,B L)C&M$;2%$I,&Q-16V^VB;%QIR6Y
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M_7TAN6H]QK[6TZCTV#BRY73ITA<X5UAYP>>IRLH]L#%5P6[+9VL-+J-PZ/F
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M<F]NI;K4+[=PGF6]J#6UWC5.0.WF'/2[<I9<[Y>^CX]+QU#E@XJ?M[>>9?C
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MMMTJ!_C%0AF#";J8^@=E#!T9XVE(F=H?P6LGF !QO1#[E_OPM0LV04B??>*
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MB<V6G617U-A 9Q0[<X:YXS"M'0JFQD]"C+SX.@9T%H7RAR+' LE,EVLS0K&
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M(\.Q:JDSU;*4.K!8Z,(THQ':3!33 0,@M3"W6]M8]&I7C 5\H(AP:ET3'W,
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MV%H,7,<^=JR<,,$Z29+"\"*F%*;M=_CA@5C;P*;MZ>U>$,<C4F9&"C*H(QE
M6&'@="OSJ_'QR;%1,,TBIQ+(["B8,U%Y2M]EA>4(0Q#G%L9\D4+YV J A_]B
MF_@P#-LXB;&7B.DX$,J7_&Y !Q[X[)-1YDIQ':CF,2?(*G>2E_D\K):J%AA[
M[E3GS!81!3,U-LU4_8\W <7N)TQ5%'NTT/5;RQ\9N67L3E9MU#)2EFACX0/
M,_BN%+W>#=DY.<W'\<-D'CO?,)DUA5B%(BX68Z=CD<V9&6[-D3,K<&&TR8)\
M>)7CF4D,\8\(#TA.6'V" PAVXZ-[_*T82\073U)G^&9DL6"/.8&7BQ?"H>U;
M5137&+MS(S32@-?]66DG"X8"_S&&X.!8?=/TP(CO6=&T;BHA9K NGV>5C+":
MOF?9=&J5)_P2VT69P3"6>)D#+:O$]*-Q<FHT1ES,Q$GU2USB@X[8A)<YQ8PD
M7/7_IA5S*$"G>L9CDA*^ *GO$)^G:#P6B,ABKI4=Y0ZP!9X6 <NC:L*/*!+X
M-V"!/]/XJ%FJP*YO>^,A\4?$I!$3(%A,"SX''NB;>3X\#,X\)*""GY27W((X
MYZXBSTTDI5I,0J?JL("\7FS"TZ6,; .5>Z,AC\WR.B9F?$Z7IW*^8(58\"OJ
M3( [EFYQ/1>&>/4TMASG:6RXVV0:?EHO]>QX_?CD+L^9H;\WYV1,5^[U&1=-
MB]C296]+L7H69$@IH_AP=+)#QG-S57S+!46+5;2RP"B3H#NRP$@6&,D"HQ,K
M,%J=JLB*!-2KC=5%/RQ.D"NS=4S]G%'-O7P28X7',RL=,-%)Q6,MD^2@,M>!
MZ%\F^HLUUN!&8F(W+O<$R6J9D;QFYA@GCP:5G&BX9&$L#(<UT_W8!HT3X/'9
M*?2:627/"[R!K2)^#O^26K,')J_-L!QJRC7H; R 9.TB(\O/+(89F-38(XZ2
MD!8+F:KX0*P!FJ_R8.O@1_E".F<+^V@Y8+ET4B(6$(<NJ?X<I</E"!T^4A:
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MB<="KN)9/D2&\F0B-8O]1$,C0""12$T:MZRU_B)[US>)@2$_%9U\"TB#;T=
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M./YS\2,1U-(^V('Y_.PSX=*"?UI SF"S!-J[IV@2>DO :@-3SMH\$1T,4>!
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M7F#C ^]]YL"3+^S75WL:SN7=IIX21VTGCY@3.%@4;GYD8?K/MBN!-,X2M<4
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M6RWN[J:)[0.#>[JF[8<8',(T#GKS$/L]YBV'W>";BI< &N(_,8[$?R.[:1)
M961%?-7A32'7>LAM;>%X0!_%>]\V'2 WTPUN<S17BN2T?)P: 6=/6+_3-8?]
M]M R>SUS,.D:/=/LSXSQR)I,1I/_&2!!E INGS@1H]_2^%WD_ZR8\!!ZUI]S
MSP$6'J#,"5?H9_I@!Y;C!9%?D.O0&W$\IO9[]Z'X#%?.9D \>(L%X!B](,^S
MU[)#"CKA\44;S\Y_ #=GVBO^L9'V@[D);&HKXWG\\BFG-!  "7Y/M,#7* Q"
M($>0J>5T@G9R:>,MK*FF[3T& 6!$U9WUT8UF#'7#Z.F#7@D)H/'M:C:]CG>U
M2P"SD8_E&UZ>&:LV)B]L2+U*D1,F6S'_!4Z/?7P_13A<74/PFZ[%]LB\HB2^
M5.I3<K/R19\\G[]&OF5#(E0_QP8: .FM],MQ%W'&XA .",)^&L(S#F%;G%VC
MCLZ :;<V/N6B\@J_G)B@P.F<%0 6\BRIH&R.U%#E2%U?CM35I-:H_"*57Y3B
MEN:+:3O$JI ]/E,%.IP*0 ,@Z6A<D<0VTW!]]@O3<,+%(=67![K9+L.M5*R&
M=7H91:R=4^#QJ=_, (SL5%/(>Q_NY)EZ9O^V2G[RS5SA1_>OIC\%G0!P^>N,
M7^F]O%&0]%3E7%F/,V[NNH8^'O;T;FVEGXWW'BLD+HG$O<M XN[-G3'6N[V.
MWA_4/$I'Y<KL*7)('_>6> .;K#Z5%%/6D*^/]+[R&TDY)3@Q5J8Y[!H[UHUQ
M!P1'DT:TJV2:>O'P2"*@-CS$$,10-X9M?30\.'36Q"2<1C< +&E9R [H7"I\
MBWQK#@B1-3!4:\#->EC_,O2PP<W=0!^,A_IX5%<W\0NT&-X /@XN Q^'-W=]
MO=\9Z>UAD_#QZI5_2LJ4$9]-/OI#M/^CIG==,FENMQI2(:('<XE!+$YI&^-%
ME2EN!!0WTL>#KC[H]Z^@]\.)K0F%UWM9(<?'ZS'@M:%WNFV]WSZX3VX#\+ID
M@MZU)08-&YH8-*@K,>C1!5G+?I@_M^4"#=KY7*!!.Y\+Q!?38#4XY%[)0+1J
MXY,)TD._3<L"4@T#,F1M#H"0 ,#M6>RD0KF?Y,R4_9M7VH*%<V_:TOX0O[(#
M\9$.C&O&?!\'+)L_9=YH^F&<YPC<"GZ'F:6P.TI*P)12EUXWM6>P ,,4A@D+
M7QGC'\_B0:N!'+1*R^);\'G2O#:\+@HPZ8:Y)F5@XA.^B6-=;5<#)9=983QJ
M>L5,A(,8'9W=#M\V3JJTQ/QHDS\,"Y(S@,.OI6'U*\<+G#;]:B;/!LB"[& .
MC[_.X6 N@Z\"TU_Q:=33R&*%\(-OZ286_++2>Y@P>!!8T[\97,>GBE/(Z2=\
M=/;^D\@+TJYBNA2S6']C+IO9NUL0)R)HT*F6IMK9E0E6PY:,BELZ_HZZ%7?4
M/_Z6>C=WKK<[0:Y$"EW"CN1X6 W0>\*W1&/=?69YSRZB/K"=B!%):K/(<;27
M/ G2KWTD ?/9M-T@U#"CN(#:)!E5)B&D/,Y/,)U LAG:Z<9;<H4;N"(V?Y2O
MB6_L.[Q*#)P&9O=UR7PZ?Q#?T:V17%)_"]YLV-$NDC]P1]NRTC?LZ+@;&E;?
MT"[J.G!'8&R6R#S=_<%?=6WIPRY]T"H2LBE%,8CA+B@#>:H!&>S@,Y><;B]>
M*WXVQ,'J5'< ^W[OXU \N+HD*?&O64U/J'CMY!%S E9,%&Y^9(-RN!]$ZM(.
M<5I?Y@93?Y8W/8;MV/28^TD2W3.[G8"V\N>M.8/#O3>=5W,5H(&6A@J )'T%
MI:%W*9FIXU%KW"[^JF3F9M:4WF4OGRFB9I0R!;^846@[4:#]9GLAL^8NO/)Y
MI6-:7CX9_O2[\]!, /X(3'J*&L@4_T; QA&9VJ?8*'F21DD@!F>\>Y FYR_G
M/\>[/UPSFMIA;C-)0NB:=Z2!7H-A75Z#Q%E 901QR$8,/GWP@C#(16P*^K@.
MQ@6.A7'>L5"8:<JM5'+BW7+[]R$S+WL?]P.]NV!'1O.=$E]=KE:/2*ON<&4Z
M2-5]R;ZNL>=BN?0]K'W #S<G]&KOD!Z-]J_T$_R$_MWY]1?N/8@?WA*SU]Y)
M\*>!LM'1>0)HI<_T\>G;-WFFEG9/@"K:[PFVE2]HVN)7N.Q,8E1PMF02$W)=
M:=[#L+,M[T'&07F%T<9$F9CPB,"$#<V16<>8Z9);2LZJM5E1OXR:N(HI08><
M[YPLZ8_LM?*+7)JH:=JPQ9![0)?H\@V%ZW(IH9"$SM,%A+H6+:7G\_'[D[!+
M$9D<&Q9!$0%G?:;>WZ%O3R*>?,L;*!/&+7#)I;GR0?,'RII&%O\)X"(UL'NU
M R;? )!%EW*RP<F*^URG8)#800B6.3XVRQ[Q%_R$;[.R0V68IG:C-FK_W?QI
M+Z*%Q+BG:!)8ODWYA^AN*'(M#+'=3CY^_5=Q7-O7&%@*-H+>2FVFI6G?JEYP
M2H23HCS\-<A<NF:&U2$YV@W)R6Y(3M8A*:GT&VA@V8K3;\RWTDT.TK#LWMR-
M-L-2 QQF,1[-3( MD/F?+"0'#"L%(D]&1'QTR?@FE11/S15%0+!AP@Q(&#Z"
MN["]*6$[?\(Q,P^$C"(@IC5/;HH_T]+202):$*Y7VZYF]\;94MV]<V7%_F/P
MTY8R4NHV8-;[:>2_@B$<,#<!?N_F+G;7KNO0^4-FL'<! &1<)81+B3D7=XEA
MK GX ?!*#5Y+)=PI0*/X>K6!QTQ@;=.6:YAB7'26/X5S6&UN@G[J>J&V0M<9
MQKBBH)!F4INDG< .X28B$ @FV?#."M@/7B_%TOAO  T843\%R5[M<)[&*7ZW
MG)3PIQOREK*B.ZXJCO)L/CZZ[5H^2X?R.(8*S"0\F]E(,7&8#44_Q;2P"SA\
M+GBQPQ!1X9EW]B_5M:CQ<;6H^^F4_'LRZ^(^"N>>CT&(RHH438T9=GMZOYWW
M[&ZX&!V  E QTS=X)G6_&''BF_1<HC1DE&!!5>7IX^-(1\&YS6=@Z*EL?&*L
M0G(6<O4!2,@\4_]%\NN04@"+B I(5+,<])'G0;5FTJ:YM" :_+>]6+"I#=P:
M:'WI,XL1^TY1DHXL'K "T"*(@,ARVTB'VKE6<Y_1:EQ/0\\'TK6YYQY:&EKP
MIAMA,+LCC;^PB-,DG*6(F21,!+9:E?;[[4+:/TP>/8H=/;IU&U)#;*9J#'I@
M3!68D )<(!"0]X:<.=J!-F,F)G==>J^0$D78#3E8%;L']Z]GJ-J"[7#+UXY/
M&:3+!76@/Q>36D"J _&L?2>D\1*ISN;RW;>?F^:0FH>!GNYR)D35^B=$P-SS
M"9*!J 65"A/)C/SL3%@M'"BW\I_:U(;C WCXL]B&+G)"5-M:Y_)UB8HN[9FY
MS"<]C/U<VDF#I0U*<C_?W&I?\^0COH]^7$5#'MW<@:%+/#O(:<@4EN-I3V@=
M ,\FS"T&\CGQK5"%+:>RDL.I62IKOW,Q*BO.:!CI@Z&A&YMUUB(=E5]1#+,9
MLL&]M<,LP,ZN'8[:-W<%)G_-VF&J?]@E:XIGXM=U**C$.@Y34(U+4E!'Y.GO
M&EV]-]ILH%ZO@MH9'EM!/:<,O>?Y7.340E8TY3IGQL<=1V?6'/O !V:13TV"
MA?(F)2HI#$ <:=+9!,=4<!9^D@[.MC*1<?$*0-X9LZG[L(]JM<4<!YO?^=XB
M>1'?L8_):X"$+G>JX;=+SW.RS#?K=RZM/%PZ7A,KT#Z@@O<)_<__D(YG#@BA
MV#;MD%M1^=&-)1=*&[RN=* "_L&5,_Q"8#G'*3UQPW/_.UX^J7WIGVES,^!>
M6K!G@%<2?@?B34U3C;7?''B[]F3-/0<67'A3YIQ-YNX[V+A8T!&""OR,BRSN
M@507_+,-_3Y'1CXK9F3D\W30J CL9]>>V1:2B)FLS-WS/+(8 '*9CA4Y/%>7
MF W\$!-J_XW,*MU5<X\L'MK9=?3@-$:M[FA83[O+0:O=J[;4"7IPJDU5V=3X
M:-U*QQ?8J/,'%9C\S@M+/F8*2P[M6WJ)X'BR?Y8 1CTM;2L4&S<67B7[V^XJ
MQ]X"@UU W'_EBX!N_Q#H*D14B'@<1+SZ[LT?X^)F'#R$V7P4J]@\4[;$X??$
MA%W5,@6%;-2(XFS]138%G7*SOO8..J''@!P&*;-+WM@/N+!.810*;S QQ[HX
M&J:;"S[=[@J=]1IUBA[VL>AL-_'VP=6]N9["=<*2W(BJLV))?T]<'S3J%-CI
M,!E\%I]"4]A^;FP?-@I/AGMB^ZA1IQ@ISMY(7!\W"DO&^^'ZH#B]XTRG&+<+
M.?NF(N%K[N(9VQTO'GKVL<U5'1Z ZR#)TIDY@TQF3K'=L4^.PS9<_T=\85C@
M]+OM;LK3&7=N[H;]5E%USFWEJJ,&G'1S1M+8N+D;M5OY205_/4",5?1M*<K(
MXHMQ=GS90AE@DX^'=5'&^4^ZA3)PDD>[6S#&69'&V4BC>W:$V4(:_3J%QOE/
MNH4TP,P?&8HRFD09O;/CRQ;*&-8I-,Y_TBV4,:HB--Y.B ;.;$^Q:!H;71XR
M._.*.KHWR%SX(*YG4]^'\?CFKEV U&>:%7+R._SK(3%%-3>GB7; #I0?M-L*
MY17*7Y4ELQ/E.PKE%<I?E8FR$^4-A?('I(Q=6NCFNQW\J<TPG=K&U#T6A-L-
M$N5O*&>E%"=<U47,>&N?X-(>Q9UM]S8,VMV;NVYK7-"%Y^#@S1G.N='7,&CW
M;NYZ+2,_=DMYX9IAR#2+*OI$%06.J8,#-\VBB@%21;NGJ*(Y5-%M+E4,D2H&
M!3STX)A-LZABI&1%TZBBUURJ&-<I*\Y]SLU4T6E7D!4[C"-900W+L,U$\!9_
MM6&F:G;:T];Y3V]\T%)_#1M3?ZJ926IFDIJ9=)$SDS;/YKF *3R9VLOWU"B<
M9<HQL7]2NC^IYK,E2&2\0^JDPU=GTUL3" 98E^Q!'T_SB1]<GZ7KLX5IN^DN
M=]DF]%,/3H@=TZEU>A#-9K9E8_/ N0T+^TB;L![S+9SI0 U&O2"\?<&&/=BG
M)]4>'96!%VQ&A=W6?0\]R=BJ/:)AG8"C)F\"Q#O]R'9".3#$YW!Y>R#X-S](
MA#,EX G1VBJP%TO'GMGPI9B0+'I<X01@GXDN>]GEJ4LB!ZCIV^$<'K0M38)4
M]#%*'RUNT06  *0"4%#/>3@IM5L46TZZ'S6NA54YK$PR\]]K_\3QT!;HG)JI
M+:.)0Y46'%4 C:A9%V_#(V_P-^S8Q *:I3 1N* 3X.#VL!MBMFTO-E&BWOWQ
M((;V^%<<2X/=@=)(ARO0'6<V")O@M1>(<8 5P/^P(R(R;C@YC9[U7MT$W9:1
M#PC+^Y+%8Z+EUE/+)CV)Z#%$-C'OA-H^W6;:/A$%^0Q^R'0@S;A[%5"9GZ!<
M:O4-TR<R;2GC8=VFMK!_BJZ5^//;(NBDMXZ@=M-H7/0[F\,@8 [?'6!>%(3^
M"C@)#J&8,I 8<O UO=@G_44T>5O?^41>NN7Y.%7(X_TSXYDO:T1-%$>-P;+,
MAYK;R192-"]UN716O-LAL! <X@T&$^R?#CA%^@WEN.ZU@Z;QPF?/\*Z"6X9'
M)(9PH"]Q! DBO+=(-ZB\4#J.T\96-G.F:W(FDU.FV=5G)V?]-05S>$\0DBP[
M+WO0Z=S<X5<%$\2"##]"&>-Z I-6V &10RP>^0%'=DP:1R(A&""5(AZEZ?>R
M4 8M_]M\9(^CC%_\)>),S*00A'^TGH"<L45J!) CG-- W+_P\3<TE!DGO*2;
M8?*&[<AA\7+ 'J(A*]F%7%)T:;S* AN><MY5G='DNL+MU3 OU1KO.\B]3YZ/
MRQ=WQ!MTC/7>=TU'A!\TT2N6Y]QFE4WW@FRWQEC!$Z-Z2/G<.L3]?4FBN*#>
M>[U.RVC7U'O/:(UZ1M,ZRJE-5=E4[R#?R8$Q@LMIM_0E[@6>;H:KD?0/2N23
M7!U _BD,>NU>J.T?I8U-4_$42  DW\EU@9+F(65U?[9G3'OWWV5[5UT=F.Z?
MG]&^ 7WL$<??N0&H,[S5-)_0Z44!6(1KL#E]Z4R]KL5R,<74: E4\X';?& 6
M0\XCIB?S^03K 8(]ZFK*M@RYZ,34XED+O>/,5!$Z=NH*OP@SM-)LA4&G>W/7
M&>K&L*V/AG5EJE;H$%,UA[5ZNYHBCG9D?&U24NI?CG5YS4T[WDBA48"C=8B@
MMI)I?9-\\F0JQ;:0VE*/(36FB#Y[F"QAY ><7REEUMN(:M^53[BSVK+B)2MJ
M%_"BM./D=IPW]\]%J7_G4UKV*MDMA,,5*A!'&LHF.!/=0/ H9O?]W?>"H+(*
M0?.#@5/I[8)9;!7YU [L/@8WVN)$J 7Y+E,;*#[AY1'5%IE_X/2^H!)I597[
M@YL[H]7-=\ZZ:'JZZ.=K<PI<HJ26^+J?K+[8*M3-(T'W$M;HS'T,@HA-/U!,
MB+,&/B8Q'3J+H5U9%@]O[@9@RQN]?-IQSOUW](+3TQCK5RR$BT_86&IIH!"6
ME+2W',:62ZV"L:-GJN$^O2W;N.??M,7\20X??5LV<\UR^$"C65Q"Y"=LI;*@
M'M_<C8VN;HSR57/E!76SM'ME+2M!O;>@+J"IBJ+::*/)/%8F<W.>/UD<?6%/
MI\Y:_J!8Y!9_GTL?O!V?.'UP0\0=\_]$M%TD 38SVAX#N"F<JECN=YL=;3<Z
M8$V,=6/<T;N'^_:.&-,3U]UP _Y<2'ET [YQU+9%+^@V-')N&!@Y[]05.6\(
M+=4F19N(=V7+#?:=5+03I^(4RE0&)8XP,G:.,!H8W9N[X99Q734U?52\]!IX
MZ58>>EM?\\H\PL=)L)0#6TY_Z29(CDWA]&$[W_WN?$SU]&TE&VYCB(IP+,QF
M4RIW31>XX\?'L#T$5%/*:!? .O4B+%)Z&ZF^QS4^_D'W>>].X]EZ'GYTN$W2
MK],FJ8H&REFIG)479Y3L)L6JMLJ@'EM%N2XOVW5Y<MKZ1UI)(!REHF(S/*9C
M4I0=KPN&HZ@.C=/^&Z0Z?$QN?$_580BJ@Z%WVR.]/<XG'!WDSCP4292W4UGH
MUZ)8I BUJF(Q0L5B6!=M-H3$E!/T<"=H953;Y!O=/=Y]8(RWCW=7OE'%>0_R
MC1Y !RF$S_I&.U6=HUW,/]''HT&#F.V&[LAI(FQXQZ7[#:Y*:I/H,^W5#+2_
M[(]/_75\^KA8.MZ*L2?FOX!,+9;H7SR7NU=Y1Y8?7F@ZZ>\?O"#\XH7_S>"E
MEO?LPGFG,<8,$HS!=(!V*^]-UP"&CFBH%N+B<"(_7HD:#LI7D7/7#;)=3"=,
M2_W< _30S+@IJFQ]>"N:HL([JHF>HX&(IWU]\GSQ$?ZNA'CI&ICX-5K'; U_
M%+2TI .('7< >:$.(&M=8Z?V; 8HY5*+P_"5,=ZW;6;:O@:D\2<+Q7.B<UJF
M'Z5L?1HW?^6]$K%%:^(6TF$+M_"K6WB.K63SUO7>:^>G2%KLO0U79EO;>ZP0
MC5+IRBUO=I>^8^TCQ\U:6LN5PKI[Q_$L^MO7V3I>(<8%^29TW>YE-Z$+&* O
MD$@XYZT#B5T$J1LIY!:V:SG1E!J;;NBU*KMF6^FNV8'LE<U[#P,?(0R^QL9U
MW5:GN[W5>X7.9]U!U;9K)VC'IC95?E,'-:[;:L..#PQ5-ZK;UH\Y]D']W:,.
MEQ\S'2[K&(-X_0!\LG^6 %])?#M?S'*T4Y/84.>SN2?;!I0IG_S:V#O/!%<.
M.>HN']EUP*I? E9O"R*GP9X2N1Z7#,1^%0Y[A Z0)W;!?0?#U_2M.1FN4_;"
M'&^)BOW1VL5=4P;-FVB5EY]HT-_NBA7&-YL6V^;"&5#D.<6TTGZ^$+8Y]3"J
M^Z0BJ:.0U.!8)-6_N1O4%HI0)*5(ZF)(:G@LDAK<W(U';Z83JR(I15*2I$;U
MD%3%>#IF%^J]?LV)A4>BN+.4(9T<;9Z8XU <\YFYS!=C!\WIPG;M(/1I8O+A
M-4175"A42$WC8PFH$>A\XX/-J(86$2C$&;;/PH;'R(;;1E?AU;7B5><<>-5K
M(U[UNR.%5]>*5\99\*J#:9B]1O&KTQ>3G1@O?I3*.CI:*5!=!NC%)'K7!)FK
M2!#O#,XCOPR47YW^P?*KUBMM;-F;HF5%RV5H^3PZ T[!TX?MFD.0BI85+;]E
M6MY1NG4D6NZA_M\W:AYFJ6A9T?);IN7>66B91LN-AC6WRCT++5]^*>93Z:*B
M5SN<VR[\**!"H8"7;&D^>V%NQ&LVJWF2,I+D\<NG.M!O9O]DT]M_,]\K:)S0
M&U1U=O5.OL7AS9WKA3G2**@FA=?ZMNG@VKQ(C,HT,'87V#^U!:\W8)EZ RJR
M;:T%\V!A/+;M1B9_50IC<ZF]Y1'T'C<':&FZP6T.-TNAYN8*2O&SH0'K++V
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MS90@D4[N,B".1%3&I778[(<000A>QWP-(E0'J? 7JZ%D@5]2*RV$R#:%H(*
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MNW3JZB[DJ3)?0.VL,3N[7"VE9);;%VEFES"N#\M8O:JN&\4GO(Z\Z4XNFS&
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M@U+;'=S<=8RAWNEB&Z/1;I7B?'V-ZDR$472R[L@Z,=IM\[C7N=W:R!I=[<9
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M<D@ HX)A '6=K,A]70</P$>:F@D6P<5,A$0!S0*M8Z7R/'PQZDZ#D1<$P%>
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M:Y9N_=9E=%!B%*71M,A ;M"-)LU7S8N;BJQ=#**@7)V0*XQA;3(*JAK^P:(
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M%?^<-0)ZXRB<Z)]SV.097@Z[>N*SPXGY9.S:\:OI,$MR2@_/+ADL,%K/8$F
M9K<;!!MP'/W#Y4=;>T-;B[*8C.@$GFQ0H :I5C\G5$'CK)E8JSMO%B-TOLMH
M4F3@[4?) DYLK18!ICG"F'O5&/"P72R"S75KP/,L9, E*J9_-7#[V0$:X5),
M3!QEZ0+N+"O](M_U_7-83MP[>$Q59!0]0$.L *4*-YIF,DE6DC $ PVN^J)!
MDPQ3CR.053?!\/!1:-;)J-B-:JVI"!3[]G!W1G23TCKCV061"5QTC(VX(  -
MUDX*%@4D$OR&S]WY\<F?K4[KT-KP*G\.@S-(RV"/G1M<L^F$'$?_=.9L5(!
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MU'/+TC!Y;LH$'.6$A#,U40NM&YQX^,0L">K<[PXH9'C\,C/=\!T,<<Z/;Q&
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M-HU/'V:&ZZ-':;$)SSSNAC"/+88#/[PHX85R>K%H< ESQP<WTN6(EFQICA3
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M,,1."OO!31S2]DS2I;*HG@PJNB'FH8'V"&J4:Y4"F,6B;,F+L28QL3FK%&&
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MNG-]O.><Z9TPWS.]\A;3GNE HSP483\,5A1SSOI^N8FTUQ#(>161'][&;^V
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ME#-?D&6ITQTG'3>3JIB!V\R]^H+\^&A0OWD2](_HI3VP)_*>-<7OM(P.;H.
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MHK D*PM+KWD1R108!(7/XB?,:>J([DYI[3FL"F,XMPB>H#)GU?4'EG-YIQ5
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MP)^I^4"YT1Y45?M1_.5ON2S(H:0MD!<'\7MDRI>]%.WH1VC?GY[2AT\6O=>
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M]$2#C%1_Z&O<"(')A'FX]Y"\N4%_LR)__\#9R%MZIN7$:2;Z4\.38'>:[I'
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MZ_P,Z]%]PR=O=(*_?3,ZP82ZE-N08P)]+"Y(2?.1'J/?(UA=B*3M@Y*14V;
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M.OMC(HSH\^M9V]8K+GB%Q5_(G6 1#::MIF/V5KMRM*7Y+U^_M89F5?&\/.G
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ML3HBN/B@=(4X1W![=OB#!]_<,_B(1]-?6<?3#FM48;4*8F0X]#==N=\>66R
MIT_F[%<V1;_YVZO?O7[[6Y7DQ-9O[2G=M$*-@+D</%;<JTH\<Y3#/D9A#,6_
M<-L/J@D1G0KMV+43?U"R?=K=J $KYTO^/HI_.92^ _.*"0IL@.+HG-61W@.X
MVB9UW%(&6ARLC]W!)<4W(S!,"K+_7=O-2"^XX:GQ93*B*7W1)&W$B@-/+4SP
M_975#-3LTER(*]#F"K2)HIG:;V328MBA2M!R9;5]"GOXT>>:00#<%IY(RJQ;
M\#=HLI&0 GP[ZI!.9IO-GZA7)+\A4/)/U4Y;MZ)Q6;0DLS0T:&U-RT8F@5PK
MYD)KX)X84(_N$+*6L*5O(R%6KX/*@3(46$4@J5^,'-\H/^6%Z*@%HQ&*FOPK
ME-"&HGS.^C/LHNNP5&*N.M6%^<,H%JEZ]S(/A*UN26=0N:-4H.^89E9$_)KY
MIZ2@<-V\'[!YU?6NL42D9H#;%&,G.?5_;EN\X0\MKZ&3#CILW<4O3W"M?\0*
MISY0U$!*#@"<'EQWT2J#RQ8B/!AFS=WGEB>;V&76SI1N-4D\NZ^H&E')';"I
M_B:P-XP\-$BG8'82AZ%=E%@X?X;[-(/QB7:,]GHJ+<L'YN>>$L#>Z>WX/B/)
M[&<24&AD;KDUZ^P5%4U59+EJC.N"\8],Z$C:7)0>C8\?<15*^T\?62%/ K_8
MCCCZ8MJS]"3- 3^"<7G/%9I4QV;Z>>K7@M<C9A*CHH]E-BW?^=+=STDP( ?I
M(7@&'O,"$%&P+,EQ?CL:Y<97Q-GN-R?&B,^$CPS/&%/3TDIQG(@1'<SCMEJR
M7B_#K@II#O2J3#>L*=<%:3QB>I;"H;GDOM>V^;0UKR->*XKKJ 2O[&;<VX\F
M3[O\F<.6_K6N.I@)[G#%*@?_BY79<4\H2(FY[[13G9)9$!E7K* KX3/1MO'S
MN46T#\B[\ORQ;M>+\S_>8GICPZ".PO93U#RA/8(9 6ZXM]/HF--47?Z8K"H1
M I1\-[MEYV41E!E2;#1'4B?!_T:]:.9G:XY6/G8I"D+.$I#&_9"*SXL=B4=X
MF#]M0MY:$6<#(Z_6N THTTM*ZJC='!4;S=EUW3^=R2U0:W;5;.J!*2N$O&:!
MY(."Y2\;&R9\W;Y<D3Z/'')JX<M/^G\O_@+^1^B.GCX]SGP"O1GS@2V6_,=%
MVK?,#RQ7'=(#TB/D*)2J;V)GX9=B2*6WR3S02$1;-HD(8!(XV15SROLPYT/9
M^SQ'4],VS\A<SRIR>MZ_R5'97N,L!PQG6^W%/U46SHR0B%MRN>;[00;[G+UF
MH@WX$9%X8>%[T]&U?] 7-X"'[/<$WS'=?I^U$B^VH6;V2:FD<%S+MYTE*:M:
M.HJ=JZA5B@][];8[\>;% CUWR>!)S(&5#7A'?'6C"E5>3AT4,X7IE-&>,@XO
M^JBR$[1=8CWO.#P?76XERQ,BL_LZUI\VU*O-S !@;DPEB' XF4!F)" "FT/2
M>;CG-\:#DWIY_#?JO=7'*6W.'XA>!F>$N&7"XM@.,K8Z!H8/L1WY^+4B%U)&
M1&$R VDG/VVI!%>(6)8=Q8RV^U!2!_G*X6\N+OPZ:>^^<^*#>*]$RFK.NKP+
M8;]0O@BX ]IWVIX")VR=99KD3JEC/=B 6 S2(KJ'-=$?>6[-/86YA[C)C=PW
MY>_,VN7M62?H.6TWLU3I]+9K")GS[^R[D[; R<K,;;D1&4"Z!XOQ)H2=Y_;A
M:!,NA,A=;O14+BJ]^V,.+D951,A"R"0K+O5.$M">%J\?3O3<=.4NU<Z=U]^5
MMT  H'!6:59D&6*RY8HVFD$;_>&*-GJ"_F6BKT 1BD#P2!$EV@0^=FB7N*@9
MB\'C0YC)Y^4)<\QUA-6@#'M+=_V3594,%O[6H^_3;Z0TE;_&,^W;E&U(*(A.
MN1DQZ9#&+D[B\T0BHEA,YJ# 0H(Q"<NZO5/\"]JAE FS#X=#K5ZU3@ZEC;RT
M;ZD?%RI-)@_%6T$24DRV34@;TGOF1H>HCZR<ZE*UQG"IPCG"$7A&&$J;T3TY
MRIL) 5./K"X5TQFMPQ(<*E.E<R&LTK..>3L?*4UQ_VR>IV*=R.?-\Q<]7[RA
M.V\MJ8*2?&>W#K03&>5$QT'(C:-/ZSQ5ORH,))>M&LF'(X#B0*B&.#:I%W$"
MS3TG; A'%E49C?=J$TA0"'WI<($,(.^9$OXR<D%)EYB(?2"=NC*5IWRF"=6L
M4!>I<^G@>+)'_*)_)9S)60P=DC',J"*?YLU]HG2J7R64SH7T/'A6>IJ-J(:5
M3E6D$"_@Q/X+/H.Y @GW=%MO2:I@&[4+9&6)P/.D,A(Q=,YUB?GLB1!4F)(/
MZ@S.#2=+=Y>4X@@L5[,Y.QWWV"JY&!8J@)"A)P8[!%EN!:99@0GJF2>-+@6Y
MX@HW;<0\Q%OVQ!33UY0(4*[+):)0;HJ$.P^"KN.*?WQ 4CRKB.D01 :(ZZ,B
MGHBO,/6-RJ+F"R0=":+M$!))3 .G\B\X6#[,>'#NROX0S)KRHWA4R N[\:9V
MS'=Q=C&>+[[OY]Y#66S=>S#/4R_GFP8J13V(9$D;AL"A/PZ8\:1IPHM7[XN4
M"/L8V_YHX6T;</]_J:>F6=>"<_"+$0=L4T.>U%U0JO=^(!6TSJ1QW7ND:LO9
M0-F%<G.W((0[,5SYS!"Y>>-IXWA8A6Q<]DP<'3XN[/LP?^71S8G8T6@Y:VH#
MQ_0D!YC*&:S^$9^%?[^V=\H7^%LF0'.?^X#ATS^V5:,0CUOBX: ,HZCIL-ED
M/ +UBQ)642BGGQ-:\_VVLWJN?.D1HJ!!6&>3Z#C/)]^2FW,B$U=X/GS<Y:.\
MF+52"2>^R/H(KZE]4>I+\5M$$T=.#9(0W?/:%=9'YIL]$$TG[EKEKQ:U##Q%
M-T3Y.:-K+7$/Y8>9>"W-0F8T;%$"_53F,7XJIH4G7\52B%2NU[,I2!-5KK;?
M=ZQHQN4J1&NE;<=R.;#^E=HF](;^.51\.SK-" G.2$>+H>[B-(U>.=V!<?03
M*Y@( ,V=-SEDE)"GDW=QWM$'L/.[1!^.#JDU?1BE&AM1(L55?&*]>@2[$[D.
M)L1$>BX*?7?8DT%X$E>1T&1]S/[[VD=J#D2XW:[C5 #/5XHN;FWN US@>VN=
M7-<,BODW5RH33?'+5<2[]]]?N>>+U_&#S-'41RII8="6%A,YTV.=EICS_>J+
MERE_L*KS6BH^D0/D68,_*I('*JD4F76BD!7W?479F:X<1(AU.<R8N\*^D*)F
MRF1$*^''T(J^3U0N#+F\H17>8+Q#3UI"$2=7<!ZZ<&B_I*B98.[$I/JWJ:P5
M+PT,HI+:I#G'5#@EKUT9@B:F<"M?+-Y5JW>8-J3T4;UYMD;<G@Q1@$TX4JQ1
M1(G:[^9O$8F$*<H5X KC:$I8.5CFCK5H2?MK)7B6GO)RTCKMYPA%#%M19*)<
M/H%:*;L0Q1!P]V'*@H8H>?HX^LEIOL^>IJ*1C]OL;$@ E^P1@D?$*Q$>T?&G
M5JK.=^BX!NPA85X")1I 3>B)V\;U;;K*1@(_JK9,%S\EP)WP<JM*L"*P1FU?
MN_D7C]$/[)=5*=(>JOQ)S=JD;<@KPSN*BA[NF5.%#M+\X;H9;:VA>=>T=W2P
MAH934&OM%F?%1JT"NZYZ#'FRQ&#NQCEY(JU&M0Q%'! I@D1*.R.E+,T!R6R5
M\Y#:+@W5OMZ,"GD+/J$PA@/GH6]*_!=I#$@M'S^!4Y(BR"E_ME;&;3QZD3E=
M?VH\[=07I-^8H E]BD=[B_)@(Z6L9U?4:N+N[YV7[8@H,(M;Q!0N6=5$W]?_
MG>62-;=<]3=MQZ>N<,$;'::J9T\.<V3P=924%*Q4)UU<%2M&N63P9B"CQ@9R
M)2  .O11>>XUD0IT''Q<JVS35;8_7JML%R-RPANV6GNU:B:AA\_(%8L>"AF&
M*!>0*M?9V1LQT^,YI!.[Y5HV 4(I"\+!G<A)Q50=.$;8H*VY%[K/!Z'%TJ*^
MRT]<FE_^GC'3%Z2<8IU!3H+:LD@0[0XKSAR*<@1SEC%,0"0&8#%6U(T. 3@5
M8=7DBL. X&($*>;JY;Y%W7)IES:G)_?O-[[I53$<O?J>[-]/O3V)9E%__^0D
M\&U J814R>^6$Y+6N/]=IFEM[AC+9_K1V9+2^*CIP>77)5"1TQ7%*NBVI=Q;
M?30-CY.;(+]V]?4#<AX'A@ 39<Z:KE]#:,'A1TJAH>/J!0T:Y=V8-UGI% ZD
M5Q\X(<N7.?Y*VX5W9$\2XCR.E,*.V_JU9O%\\9^)SJ-3 J*)*J2]$>LA]KI1
MXV;H*!T-=@@+LQM2[=M5W*4F1+)$-1'# ^%%R$Z$OIY '.6W^C:3YX,%G^W(
MM5WJ&":%-EYS&II_OM\7Q<=NU3B1SKVTH_V>YO)M4@5V\C2X 2.IHZ&PU)4V
M%!@;!0HE.$"$&"]$##=AN$(?V^<5 1?)Y[DOSN?Y*--\9ITT\9\OU<4MR.F.
MA N:?F_D(OF<?A$:5\QG1_)P9N',6#:=<P\&!5ZAIQ^[%,@,7Z?DS)6%\W<)
M0R=OC-/UV_>NPR142VJ>XOC[$V+LI."%3L1"*(BZ\*S?$K^S,!$Q1'F/@2A,
M0M60)T=_ 4$)YTHQ&J+B7%AKBJ]WB9(05UWL&J4(\'9\A<*A<#+<9&^1FU3(
MFRC-P,!QOWR6W=?BT1%N#=U!](4LDIEV,8IYY=JT7D7P(<X=I3P0#7$APQ_*
MD[6WBP9GG8M"@.E)F&P>;MI6<L5,='E@2%$/=_SA+@A/B&G9XSR4B]##D+"J
M4$A9H633C^"P6*MQL7'A%??<:/*D%@_&QF8%U@1^=GE"42?M_1O*S+QQ.NYP
MA+Z)M=Q+>YD/;<I5A:\RPTOU"L^3<GR2GXZQ@C!U4]-=AQN*CQ.ECIT.N+^/
MS!>=4*F[M%D]5^M0;HPSLP/;AX#WOL^;\/9@B\L5$5\=@JIF3L-J() ]5 I8
MY_0A_4%RK22TJ@;9_B=<'USDIVPDDO[4&RQ[6BX9AD+5+Y%OC+^@=>0+QUZP
M\&!P5=RU]\%<]= PNR4#Q*D5CX'ETD[@%3F5\EEL12=->4IF)FBC,_/+$7P;
M'5RM_= M8<TD74CHBVZ'&OM>)6L<MWQA25)M=P"#ADU^:VY$I,S0NKVCF<!K
M S/5,",=)_/TCP9,/-]6W4"Q BK>M[N[TM=^XU_W[>9P1W>^_5+'<QNH]>C@
M8RM6=L;T*KGW9* *O 8I@(*_1/2.$IHAUQ.L^WX;"%/Q+EA N0F+?E5QSW82
M_UOOKW9J1$.QMF.-P^$"M[\TDV8N9U](0I;RQ&F-/9=,C4R.G[[X] ]%:J76
MTMI/7RME"LZM)X4IVL/, Z"U1OPIWD/B%S A%]VWV*:)5R(O&RN5LV(G_$(%
M?+0/YKA$BR7O3^/B=9$B 2\-N #O!.L5"7&M3(__B"X<);6H[G.<FECRREC
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M\CYDV6 \_S4TX?_\[T\^>_'Y[U^0UN=G@E-9+S[Y]$\Q0M(BNA:%JPZ&#38
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MV@!)4$(W"*@!PC3WUV_EL[+P("6W9%,V-V)CVB()U",K,RL?YV .&_&WX])
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ME=%P->[7U&[GKZF!Q(F'9Y,@IGLJMV"6&$K621<65QX7=LA^N R<,G,#FO
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MEX_I?N-V&CT;&_SB3(-HF?97-N.1A@I,B#*MC&&%BOLS\*7#1E_&1).!"8,
M6-'+"'@H(B)D 7 0+1)2)R%!#Y(GH2M."HM_@;YS /DDV-Y.6V8EA3R1^RCA
MNO^,J6)P^@M@1@)(Q8 ),F8FXZDG<B2F5TB>(38,9V[(R&+CO&WL (N")AGW
MNI&CYCAH"OYH+S&T;"-@LA5*6QDT?.J)$YFG2F^B0C8C0V9"4A]XU4L?#Q\#
MGK/K>2GY]&!D&%L >.*8BI9F@GXRR@%5+M@&HF5C97,'9WM-RN$[3Q;M;9-%
M#\E*0WP1:EJT,COPE1B\28M>0LV=57CS71T5('5 OM5-$K/H$Q7Y=:BE^Y3
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M/ST^>JVW9?:[N.T'3*I)@T("38^FZ=C&U>;>5;]9!CS)M^F3[7 C<M8&'-,
MFI(LMG_]T/G0E\1.*WR;\'BYYK]WMS9G>/9T\ (:05#<M01N"<BR!!AD5ER_
M+0@\=,OV/XZD.06%H$2VV[]'SC4JEKUG0C&'.^&6$9PF]_@QL;NYQ^V,ECOH
M&5*UW4<@H)EB=FXD3EK\B?B]Z!MN)' N=ZZC@D:.($29,#&B>82Q8XRWO1&+
ME^5BD1,&4U*"4-5##AQ=1\LO\Z&+^'-R4&ZSV9)Y:SL=K"2:9ZO?-&%]_)
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M7[8H"D*6L 5_/WUU3IN29_7V(&Z806X(:MD!S7]C>6B^S(8U![WS-?M)T+V
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M&]+(9T@:9'W@F9VF@78I.4A6$%LX3GBRE-HB24H]MC69/AD'_YH<%5@@-IE
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M#28PP65*#VI!H\P':+_7:RZEA,'F$$E8(HL@J+$\V ([%7\ 8'_#> /CR8J
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MQ5U 3HMA+@F^$^5Y7>;OK]VHNZIVH9VXT9D?E1=3$$WVS@\;P<[=>L\(Y7
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M1[&;W@^W!"4O*!!%& [.6@5Q83VRJ>>'S9"="TDRV"'#!#(G^RP@+P40N"A
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M0GD!H&;$"68I]ZECZ4>CSII<WA8R9Z4Y$C)FM,OZI'1,RRJKAT=DBY-E*&%
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MR_&<#R62:W^>&33;[G'4\&@^%0<#@10#PA8J7OC!)4M]4K4:48O8D28PFM
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M^5J'NB)^4QR'K@'?23_M+0Q'8=HS& $N!)-ARM,0ILYZ/-?"\* ^BC%0R#H
MO;&80*813AY3Z0K#5[+T,(7AZXS=EL+PY7G@\7PJULL8A4'!H3'".P)M:KJ>
M<<716@YL7'&TSA:G6+&Q3*:NXFCGBJ.U-#ETZ<:F-CY1_KJBB*/; DN$$]Q
MR>W!S[A;P]N=*X[:2-N5ILU=<;2J,,%"# 1U!6#*2A*4Y920B3EW214D:VV]
M:P7)2D,E3*JOJ^;[EZB-QW&E%#6 2 2#_\LE$!I;@ MLH.(0(KQ1\EEXZC.F
MA)^>6/+BA9?IL>VN\X39MH\@GO%O'8QMG*M-*)!^6ECO!^VA_%GS[:&YA&O
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M^.'48+#<"7F;N(P:1:3M0D!! MQPUZWZE,\C[?R49@K"]+SS^SW^:_;F?!Z
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MM;7J&R/HPC*';RAA4E)L2HM+V]C+.G-__ 6^P84!%I(O14>'+OG]9D:OQ!1
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MNYY;954!8NG-E:CPS!%*T-7<ZH3%,C-K:'T:,5Z0\1COUNH/,B=II,]]!"M
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M1%H<I1/Z-*HD/GE)PC->HK ;\Q#E+H>AY;Q^9RP_-!VHJ&6UG9I7Q<=)X+Z
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MBVG>!P.&MN63 Q64Q]=>&4_PK& !\!TII$+K65;+9=SQP0!,6(>+?$_(XS#
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MO**NZOX<,N* KYK/QZY3GECFI!>D:_W!O&J'.G*UU))E"IIJ\6[L@#UC<8[
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MV ),-34*&'<60$-\"+$V"O30_D</,>#E,/1-1,>O,2!G 3-@0)^[41U]_CG
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MM<DM-$7E\TTCS1WIU$L6H( MLIO\R)&2*:+ I/0D@D&=G;P"'QUE"[6J"*H
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ME#_^ _V;AL;EDJS!HP&_(A)&R+<#1G.!BP%B+EKMC#LOKJ&D /2/9M+K_0(
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M\1=++??Q$61?[4ZND65F"9'5\41QZT I,BD'Q=H+0;OJP.;P,:"#32#SK"C
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M.3UZ=.@>$KR-QN#T\3*/2VGO_(&ET#+LK%!OLY6M"":R[-8XHC!4&XP+#RG
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M#TBE(/<=90BW\9]\/_V*<?[18MI8A,:+K24*T+KA$:_#^RJI_P)RG:.'$$4
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M4D>/Q>EU[QC%Q6,'/K7JTJJC&XH6N!(I@"].&@^>1#/N(&:Z10]4/7]VH>S
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ME1(2!R&\B_JRYQ><L/N9D/U#(#3\9R7A(QW0&GD#&O0,Y)?GN_XS;;&+KA]
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M++F<3IPQW2U&$3]Y&E6]NRC&7EY^2[VJSN-_;#.RARB/[G[8%2A:BN(6>_3
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M6A+V'*\Z=XKMW]^BP;%"Z WG[TX\%">5Z>MG[L)<UK+B[ON/U^2,Z<_K(L_
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M&\#$G*E'@:)29F1CT/(07],]'Y#,:^3T5*K=9S(WCL37NS7L7V8L6]-7O9P
MN.^/'ZSY%%8[7WB556/3BN1DV)W\9Q8_=K;C2 !5-P TX>VL?C//NIZQO $(
M,0E<57A'J7ZR/:!8K"T;%;O2CHI<*(LQ@E&^?-U%"%.2",@.[ELT@6/!O&J,
M4SK1N=2JV0EJ5_Y"@U/N]05JIJ#ZZA4+'$=-K-;!V'76+_#L9JK'Z2^MWW.L
MJJ(?$,Y;9N+>/(J^1"_KR8A")J)Y$4/0G-&<K':&NAN 5E^4M%ZB1;JE4^8V
M9/OOV/DM5&7EO UMVPLW@$V-?A7.<X]&A9?Z3,L%VQ?EFQ>'L2_W%6AQ5&EZ
M8^9MC/2H0)YKG;H7$H7E\>$>21Q/5<SQ_3 N;4G+;$Q*F>PJ\@,YOC]OAQMN
M2[[AKIZ97FM^,KFP%V"TC H=:9YCA<GI:*2<.A/%@.E_ [U4I;NKU\REU.@9
M'\[&A&G&/%.P2K=J,@\OG LG\;03PXC%GDP$-X0LQX8?(TRU5!O*/VE7?HV<
MVRS#I@D;/S84>=R@=@-P$9B3#R$EEI(<X,-Q@WN7;@#,;2H\;^T#-.8'(4=R
M:6V9Y/O)H3@Y?R>WK*DZZZ'80<&*:-:ZLF]M_M#HQB@,@,B2/?QOFZN2IX/N
M5[-C.,8?O%XZQJ63=S\SWG\2N]U>-?<T63')])'R.-\LI7@$R(?C4F+^346"
M7&OQ%$44M#.ZK_X%]O6Q?5VAO6X!0>.R9S"LM%5,*_Y02;VB"',V,WL>L12H
M9(ZWX87A=1X=Y>O+B6]D?DMAY9PCQ+.KJ9[(MI[>3OU*/Q^SO]/H3P6"3"F:
M!UZK0I9)0RY((W!"GJYYV2V!EO:L5T7JS##3TM]P*]":</D/#RM" '%8,[7L
M\0%9QLO<(K"QD7UQTK%X!K42<:=*T@T@:\Z5DO9D(N*:O*CJ^5"OJSL?ZEL*
M,2U0-FQ2D+G 6H?:^3N*^L.3^L^9',-3;)B-^*B$:%)O1/62M>%Y<.OAQB/G
M )DE[A,:9/6CD[+$@HR_PMV,_.+4$LMVAP,;6.92#N2 @_=IXJC.N6_2;&8:
M[HQ=A3[IU'VMZG3[;">0;C]I63>MU:N[6%56(H[F&<N:1(Q^-#7V32\S49!2
M(75LFC.0DPU;.:JGNC-=/J'1<"JS<>3&[_^K8D+%3\,MXS\Q*WO0]YC2 H#_
M#RFN_0YV&!0=D^>SD[8*I_!UGO+AF*5(9'JQ>X (U(W?,TL7%/M58LUT(*-0
MRWF>26PR_^C581YW)2Y2[*R:_-I N2+K*RTE@J>E#FS@'G;TEP>F"9B)98%>
ME.+/12XXZIB,@]2QYAO##/1H8F,UJD2Z(7<$[T4>6Y,7VP%IVY5(JT%)GNDK
MC\.VQPE/7^JLOUV^]TOY+W155;[1'M0RBKP'(N&6V9T]]MJDE%6Q5WVH_;>
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MG1+RO#!U2VN78DHQ7]E]8ZYENL0V5OH"SJ>90O-1("35*VW@D8 Z9/N"&.2
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M8(1H(+&9_8Q/>,%",(WAEH3$-?UXW"M?WAZG$LL^UV0%3P5OZ8_? 32LT#C
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M_G]K>0W1+%BU;,*I/S/WKL%;H;N=/ 0F,5"1H7!-ZO?AFL2Z5@M[E".'[.U
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MU>!D)1KU*,,Z*6MINU%>TFEM:+K'D.+)BRS[L 0[,Y;-BH4)MMQP*#K1T;W
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M,_TA%?U9FY,]&Z,%EYA<$8TEZD=,O0IV+=PB=76G[3&;6^X)4R_&E/Y!K&)
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M\K=EMA[U&+UD[UGG^Y*!+ZZX(E8CY:S\>)U-IRSZY<2?$W.%<Y9Z%\?"H1N
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M2N,=RK-"/I[;X9YW2P;7F%:+Y_>MOY%*=KQ8'P#H=E?Y.XXN/:QNK11GIP^
MG,K)* \1EJ%7M86GM^$#K1@Z.F[\3+;L9 HD(*N0TJ89Y.C;BN^KBBF6W='1
MA$IU;2,+UT5QB*+E"YLQC?-Z9OIW*=#8>JNN#Q0PN!=_"W5(KW.(9&Y?(SMX
M0S!FX%6TS'RUA%<[/FNF&@"P&X_.ISC3^D7=RD7Q^)0T*YO<^=C\P/)J\FB'
M^)9?:*)Y?3^ V]<R9G;P^9@,O-K29+ \%LO0Z87CVY]ZCJKR#C^'.',]]<_@
MO\W/&6Q.E"UJK&9\Y<1],7XR9Y0$C#&R5.\SNU&,A&TAX2CD$*X%H.?-ZKM2
MA1?PH1'AYI=X;TOV"1$O+'B\[0%[%A8@="]9[\FN6.2GSAR%\R(<=#P#0G6D
MU0,E(F*)B^E>#&J'!^"O,;N$JT\4TLF.CDF>CA7B+N62##1>$YT@>DK<R-UM
M?S;4P9,W"&F^Q>S@F"@YILM$69[P8@AQJ/OH%$I+@KA;Q!=26J ?>J!N[SJ2
M72(L\+K"T9%AW$=)VHZ) D\=8Z15% EW]6)3<V9C&^2GMP+4U.$U</[?O;^.
ME9<1!MAN/:J1MYRUQV*F&\\'"ZFN1=_&6J#X>W72"X"MO]GKIP[C9@\T+[1R
MI,3+.K1,ZN!Q)01=?D@$-U8UMXXYI7@:^\-_/26TH'J^\9[836Y?B4I4+BIN
M[6G:!$D!?5Y<SCSB-B%<4=NA>A:LS3*E9N.FZ!/OZE8(\<S;\C4Y;5_PRD)7
MBJ8+**F,C\CJS/#",X'\ (#X;OHL4P\A_*6)H\X,PKL>7"0&']*#T8I[LM*8
MK>YH%2=TEJE.,R?T9(2=^5X3Y:1I%;XY0."SNBG91ZP.#6;32R%X[Q/DSMF]
M:IO4RN &8P),G]R]E!VSS"]5!%U@%WDG>U2X''&!I)+U,F\Q<?1>_%@S+*"B
MFTU.G=R><;>JS[Y,_71A>3@BGAAZRV*RO"\G">'D:F*W5 :UD<U2=L1'J\_4
M\I+$ARWQ4ME1B^6CUW=[S;9HEAF(R3(P"S985;S(=29O+3.0+-):W$E(]I1^
MWMQ<KHIEK>H4(YOGYBH8T6_,BL$6^SDH$4BY2M?56+MP_U7J^2GXE 8^2@W;
M"-W'V1B3FX)H3)Z,R-T@PW6H-W@ZNQ>4.66\^GQ=OY7XU2-&H+1F= +YS":>
M'L7"?J5Q$\D1:67;!0.^3[44ER7&S4Z!K?I<S)3U[+W @-RZ&-PH+#RJ"/&\
M7ZBBP+0>YQ?9ZGR:'4.FT):&Q7$^ NJ%B^8;BTSI+I>$V8/ K%T">W1;9NJQ
MI02-X8V(+TFX2ZM6O=H-9AN[ZJC+?#\%@#EPW)@X(]J6D(MFBG<5O]YRSSJ!
M(*_YOA69H?2J,_4)QJM3!-K+*BB<N)K)AD5&:PA&K9 WW1,?/R_-QI5:7AX[
MX/XQC&0V2W;<&\%1?SR,RCN\/"4K>&1OLW#"MR,7 RX=W#J+P !Y,^QJIYN,
M<ST7G]0&-I*6CKV&A+T\$,]P B !O=H,&3;I/?O1';JX3$[GKQ.RS>MY7!ZC
MG_4U]Y;\[)FY*P%P<P*U9Z"G.7(P'S;G";Y"W4_@9OCI9(-:<C%O?E[9IA%^
M(M! GV#%PR!4\ UC=7#5T1ZY;)\];B+KS[>AFX&*AT9@HA9-$X S$2#2\<L0
M^H)FP6\!'FC&.POQT6H"?17X5OYRBN_+F1W[W/CFC2BOWAO(YFL)&!WN0:]9
M#-&@VV*\0UO$6NU8, \/@4LN^<[P8JQX%(,'+<',O,&96?$4_:__W+?K_]<D
M:$*NKLS9]!45 N+'@JM9+[;22[T;?(R=I!@PTWTO]CRO6ZG0>7CZ7J;LKS4-
M?963*?GTJIV[Z-[X$GA)6W\?'YZS=G#)%:ZF'FV:\^.O>AO?"Z86\BWK0]IH
MRNI2N#"BN!IE;CW%<A@7QQM $0C9I_ZC):%9'_D?#0LY=#HZ^%U2D&O+)=[S
M4.'D5,JQ?O1GN]F,?8KVH^UP,K.O-L4#6FL0+4MO'AYXY?J#DK#K!X/]I':?
M4@DI,HV*D7X;3H&Z N!-),-=SA\M%$/7HFP'MQ9E:CPGQF<X7$FE\&(=CTFX
M5QI=K?EL'-1@+2"!1H>SN4;0J?/;22?,EZ^D*BRQT1-H%H(=LZD\BKM[=P^#
M $MFO+BKM"\#IQ48=%,7PYW0:ZPP(3C]C+--OW).\%4,:P/\9:\C-CB#+8OB
MYZ;GZ_P<;'"4;2"[9K;<O7$V<1KS7M%S73BB7W$-&2@#U4D!1:R "X"A!DTN
MYCSEE%(R9DK<*;#*$0BL\HN4PK3&P@YYNLX,A14MQ:JE@'.G[#G34K8K<E4X
MV)\3PV<W/*>S$4)+8GQS-\;/N$NW!@A/"*CLE#I?QSA8UJ> G70Q^KAO#CY*
M+CU')0K8-O\<?QFX2!_"[1B-[OB,[TRVU8*I[-K@<"Y2YM!V]U=S\96BW)2)
M]N$/G/=?JV7*@(JPF]P5IT_\1^"GM)-Q9G3;!/GG<S8,.M7OTXG'J"KX=1"2
M%]Q];'C],0IR. Y=I[T.KD]07SY)Y"P;\O:,BM=-F,6M/D0QGU7;=898(X_>
M];A3Q_4\ /1N9TAI;P%8+GF;-"4+&=37Z.(@M9"R)O0L2PZAP8N.H>\)WW)B
M)8# M42M'$D'16!E:FIL:K)E3E9)QMH+;(]J\P]N!G(M-9'MGN:SLUCN,DB*
MC)%;O>IQO^/?Q/8!QPO[!/*+2<(L)W^91B_+LXA'YU?X27-$0*D$8_I@-YGK
MKH;-[$B )6,[^OI^'9[\^>LG89&]B+K:L!-N_V5\K1Q"8V>L$B&,5'_A&G2$
MFL9OCDB1%UXBLU,8"K+HI<B^EUNR5#VU<QHMD]X/ )1[*9]AH5:.0GZ3S)H;
MM%B*&1=W'X6?ZWOW!W-&%,$?/"9=79O/#_3CH;\V]P71,J?[8SLL&U<$LA>!
M<$KL7GK2&$%+L34\Y2^]/XN=@6>M:R%*81-4#L\I)V</(%*<"$>'@IB638$$
MM@ 2.5R]%SL_TJ\+&BNC)"M<P(O%SPVDJZ<@R?WW;)POU.*I$^/??L8*U):A
M*BH'&I.C(X>GZJ]FH\;%IW=6;D^>ZG"G;PD/'A-B&7X3S$K7%A7#0AUF?T95
MP+?QM?JZ8>$!P%I9TV"MGB%67E^ASV"N(<<[2J65P8AGA*2*!?8J *#.-[;L
M;61P*"8)2?9#!R 8'M(!U5 ,57L30.2G1L%N=VJ[)J\B>&/\!S0,T;Q->O.%
M#-<U:CPR%7H]MZ?B]?%YGNK/J6R<P321/#8YU6#*[IG#.+Z\(K"%;Z]>])ZS
MG1A9B1461D4/(4;(#X:BR#_*D-%$04+GIBGFX1#-#F(;&*<K3WDHC=]'X$N@
M-:IC=;5-8"+P%AJ_=MPW1-_/T+?59Z^H$=80['_FK;*VH*\+&KQZ\7--C(;?
M/22RD%;L<J*2EW-\'<_X['6 ;J/$P+(0$V,>?!+ Q)QC81(B^(.C"H1#XK-.
M)"F@'"_%"B#"=>S?T9RP)BV:JQV-,VCC?SU(:R7!2.(#/[GV;&WZN+B.+]0G
MKG7B8'$#AO@.G,[I12]T0<TZBHL-+"Z#+1^#N@%@TC5L^1L@#&FF)DTYM9SQ
M"2  U;I@(![L2A(QZQV9_+^XR?9W3"^TY0?6I)#VY.^RYQ )J.Q,@O+?7VC+
M=:ZQ2#[_AF:YF,ZRXM\::W4TWI,@MYR0;KE^1_7S:/IK(4NNM]2NB@'SCH6H
M_O$^:!UH$1@IE!-1Y$N.BILW'Z?)$-GG>KBC$ECFK3LW #L*@N9+,)9PN;^M
M%*OE]-0R2>;]C0R>"<;@51FM4$)E^ZRV25"2658L=_  \%<$)H3I>(#N-H:F
M@H1'??,,DN8> $:Y[9\D%TZOCQ@%TD5[\;KG]\2Y3V3:Q^EG9+FOH"=5]7H-
M78O+K<,[W9/0O*X2[:&/=AQX@Q 23U1D8\_"Z\][HES87E"P$U-Q7H;JRY\+
M> ;H,R2J] W)VL3:9B;3<+;V,I)4OY"B'[:"_ATD%9HJ/J,+D_K8KZ(H:^]-
MA$3:)B]^0S:BW39VGHNO6 6U7YL(3FHHM7*L9QMCE;4!L?)X.7>$37BWX'('
M./[@KIT4:TAPD/-7C2"^&G?3&I@Q)1L$1XXRC[N'\2:U(?5CKZ09\GK]T M[
MUVH<VR'$VF<IV86+KP/GZ+=4KA;.0@O!/K-V38Z,1\T->IUCK!VR82,D4B,_
MK=F0+[H!N&-@!9[:T(7A^2_1>7-D90TUY_SR)(H9\GX]SHY,9\/KL]IXKV,
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M-PH[=]:?)1UY[^*A@?"RM:/FUA"FO:JU;6OR"<)$;*)/M$]=5I0)01"ASR/
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M%8]"61@AMU#Q-0-9DE"O^.#U=K]<O-37W[1JW9E^ 4#TG(L-)8T?UG,F#QX
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M&@ I/-]36YLINBBBS%MW/@G__JGOW@RGW,!4?<4L_HQ77*2N0UDSR1"65WL
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MD46>6>2=OJ^=1YXBOS90]?])$V_9O[U+>'GJFR7\FG.(FDB0&6\&2LO5X#M
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M'<+[5.6MO XW2_:@*;6+*AUEVC 6]@[E_/"HFZU4=Q'H(?EZ%>D\,MG0*\T
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M?;1B&"(ER,%20S[;I+Z^5>$NM6')K^J:ZGJ+GA7)I.1,GU;8W7C3DR"TAD3
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M,!S%40"-1O#@WF8T^:(:61)D4'023P'\Y"8_"X1<HP"4"X*GVH*_!O\W&(E
M0^36V;0,2#ZD&OE!V#Y*)E\-.PP[X?;W.3DQ"YYZ%CRK-N1( 7!1 !O4P5_^
MT/RA^4/S_R9->(!>7D8YGN/8A?&@;]>T<_5OB+_CZ#T 5F /26 *(#B+ F )
M-D2<)"IO4%.-N&*WCV+_]52X:D G>R@* -L7',WQ!_ '\ ?POP-XMRF5=#V
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M_;G],LW:@"BX[JUD21-5FKTZ6 067(GJ2PG>2%K*W/FK[&PXY2L?U(R,&E
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M1LE.MR<KY5=&X&%AE0C!IYIO)X\#^,LS,V=XPTA9,7XB?W&MF#R$)@LPE;P
M,\==?MRR:S[+R0E;,E;OKLJ71^P:'J_;;]G?*F=[P,G<45B1. QU'JDLU:D9
M\GJ^Y)G^NM?\(\DTH$C!I&6^]Z)'J.X%_@:JJ^<:J)@D>^7<<PX%>%+PJBB%
M9X&YU/QJX))3F#]\KB^ZR'?QV>]YJ7VT UM1T_UB:%FFZ@U.DE+W1[.GUPP+
M%SZQ6NR O'#5G68<H4V=4,2S'#107=-_"^Z2 M$<D2#<?#33.,VKFVM^KRG?
M*BKA%;/_AHFK=LDU>SDO/DG2_8$)D)/"<.9GE,".FYMCU&!B,2G;:,L?"9,)
M#CUR"4/85B<WC>A-I)<^F'1/O$+MGNKA<AF(&VMX:Y-F:X]EE-O2,0YOD<=-
M>&-QR<DV;9T.5G=7-"[I>GA')(NAD!#3C="]P)XFD\VDV.E#A?0G\_>2 :OG
MYESIGK2SU JK<;HRL\4(QF2P(^S\W9Q\^D0P%?Y>I54!XO,('54+E,M"5BI(
MK"=R)E#\USULN3.]^\<'V>Y55-5J-%/>/>/V40M9N2P)P9]O8T4P%BPOFW5^
M$48UU?$(/1!//+KMPW$SSC#%'V8W."-8($5Z IU=Y.(7NRB:+R/[8.HZ_'RA
MA(#6]6).WR*BUT#'_LF5@JCOJEE-@^F%\B:F%M[#XT4+.RNO8\,G[XB??K5L
MQ<I[5+Y,62:C[1-C P_V$4$%EN/C,9.%%(#7^@%3L(.5+"83%;WNE.MR0C..
ME1\EO>_ES'7-^/&_GLJL0(3V!YE6I0L>^X0#*[UQ"@"U).C;S-VK'):U3@$
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M&UT-W#+NB)%O<&R\$3RN#PO4^-8\G,<!,GRNIIPCKQ[<GFM?SL3S/@'8SI<
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MX+A%'O#O:YCXFB6XWMX5C6K59.G-\_BQK!%C$1#;T6W1?0+,?&.OEL]W;;5
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M3&F!UIYEY;-)%IED.PL/7;52'@1]3*[U[;;HD2Z;/"5UAVF'MJS1(U+,:OJ
MQCH\P6="U1_=6],QK7/^3:8BO:K]&LSWDG%E<FT+]Y@+L#YMGSZ -81)Y]K=
M[IS1R78/Z?-"1"!;Q"NZLJ^MW&<J#S-!)?(,O9%^J#9ZO82W9;[S>CI%?27/
MUF#=&>\97H+R+X3Y&Q@.F)5%YQ2!UV0OYJXMH.&1^*LOB/U\0R)YS GC&LC8
M2Y:*YZB&C*S>%MP>3HV>-9'S;YN&3TUU(HO&!MMXD<)26TG(K?OJP9/]O7WK
MN'R#0:NH&>4/]>4J%H4.[Q/&JSKO+JCBVC^W<Z/<VT?Y-JN'TY.A^J.&PZ\G
M!M>*0GPHT!YEW3"'-N5<U+>@ZB+=BL*JW)1]5^QD+QXGFF"ARNU,?]/-, EN
M]_3^.;;K]^>N^]TFT08+.N8.%RZGC>;,F+B[2&A+K0[TY5=I>SGLQD7"2-.G
M #/.GTN6D1XBC'1$T3H%N*ATJIP"WKL>[HL=5Y!6 H6BNHXS!7C&8B9-)&?E
M6WU"HW_,*KLY327-7HL%R1+6Q+K(S'H9ID?\(,A4L@CAR**=L*>L.H-%D)9U
MN^)Q#Y/#61K%U9O+Z9.IJ "O/ +H+"X8RK4F?9A+RM"T)>#V;<K&#\=/$,3P
MF$>M8,%H5^YTK:E"'#9^;G?'OI7SMX-MBR@-)\/D'L)^5TRX[$6V?)G-&FK
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M]4,REV-0<$F1O_5:Y2R+ )WKT6H;7N6H?,,,_Z3),GT4==@QY;UVP+XBTUI
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M\O!.982^EMYH[K .3_S =SV/V2G)</&"8K\"N^+:P*(1:CIXOJ.Q5C7=K38
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MGR&B:QI8.MKR%#2O_UJS')6T\_;&4AM 3MKTB"/ E<")B#6RI=)*()"BVMO
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M-^E78CK+D1^<"!<T,(9;D4> =@N$*J&'NZY/4H9*=+T8.U.C;WC 9JO[2R=
M6=2@$,,@2!E>_7/2LMFNMP-VCD=)R3^E-DC #KS ]K]M7+*?I:/)H3/@&G.0
M5KLC/ZJL7T-"'VL0&+[P,(>N-B#[X42Z3@D[NQW;QY@G,6MV-T=$#OR,0RQ9
MSD/5*6KB]<[TF(KO+QRZNV'?5?W4XB;7RM9<Z&I]=OTS_<ZW*.+9+^]HUC]1
M^FI+N9EC\\J-O2(^VN^X"'=KTDUNO]RU7;Z/W.-Y\65@G%6A9<,LSZMR=0P.
M!44\6B>'A;Z 0Z4E*[YOLIMZ_Z"Y%>=5\"H%#.B]<6UQC7/O4FC/F4_%5]:*
MJVJJ*S[/KH&A1">]MGL]G<LJ35/_T8.\_S^,W/ZWI&[_7XV"ZOI>^#/;O<ZR
M\Z=?;*I< N@'*-Y8.!,8=@08-BMJ8_KQ_@A0GKT=U!FT(7/PI\K+:M;BY0'R
M!NK0^@CP(6=,37)YGBNB4^U_8!":<P?^C;&^851#"PPMYE @QI[>@/GD)GGW
ML#UB\ @@=01HZB7S)&U3+JO/\XSJ^37,J^VF_*4?>_FCKG%?1-*8WGH$8-'$
M!EH.=RK<^!3T+RHS>VI,QQXM[ [ERDHAP9+"0]?A[J4%6=[]+Q*2ENLG3\]-
M)"T9TX6+VE8:I-SR\**?7K?2L<Z4(P  5;=_[$DGYSA!6-[:+#D"+.0<:AX!
MWF=35HX/-U.9W-Z\(M)SZ*<V&[0;+JEZS"SDG]A_8O^)_;\;>TWSE5I4S*^@
MW92_8R?W]B-<=6'GQF_QF-\/DA:58R<< 1[UAX^D[C^ZLA88=<BJ'$>F74GV
MOD(^KT;8D]O5:Y.8_.@N,760=6ZG0>-/ 2X_<?.R[;@:]M;ASN_)*4T^?.##
M3GP8]1T/Z8"3+C2;Y/Q#(<GE\.?;_<F<H!"N8V_GI%=YQJX&(;:<UW/BH VW
MYJ&-?P]VS4T;-\O541UD__!@K;?A>S30B_[V_ZK8SO]N4Y=KHV.'C:<ULP.M
MK>,4KJ/RP4'C'Y[!_Q?FO_XAX?^"N:Q;IYH=SQY8(?:??#LL<UAVQ,/'#&AR
MRP(],+ME='.$RG/@[_DS2Z1/+QP?H&8\RF42^>3N%T^'>I/2^@!F*&3%1Q4S
ML[\\?&?X@%O-@N/QJDGPN5X-S9VH@ "N^G39_1[?@UY+_H:>536EI@6CI:HO
M1P!\6%O7'BZ;)JY4\<DQ2-\]WM-U5VMFZ^(9[Q(5UB. Q-01X UF4]DXJHD
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M>3(\:[G<QJV"!V7+USV"M1<#*#OMA!_L>$_*,V_+S>\1.V]JUMX8=5CLRE1
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MEW$X-IUZG-X7L*"O4$U@.=5 #[EQ<(8N->ZTX=#4P*$Y/G(*DP.Z>:7* 74
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M\[%J/>$][(MW0SDT,ND>NQ@E6UR?3!RN[EHUKH,'S6I_L/_ Z/\5] $ZW$$
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M"YY:0;-FR'[K<4 F.D'IH9;J'T.Y@GG@Y&3A?#!Q%RP8?]_T;)%9488//^>
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M"FKA*XJ0*HNOYD9<L:X):;?*K%-\E9 8D_F-J/N!^%['R[7JV$/Y=81/J7T
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M[KFVP&NVZ-&P-=$K#P95--7Q!]7L@%HY+X/<.5RP/>P%MTBTP& 6Z! SVA]
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M!.8)S!.8)S!/8)[ /(%Y O/_3S!Q-<^H,ASPN]:"A8RV Q?1921V3J177^$
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MU=YYSB ],35K_#+>*>.XI3;^J<F4#9KX]^[,9YZP7Z9<:L9H3$<NX.(5(HM
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M,>QSH;XUF[;@L&L:&V]C$AQ]MM-H5T0V^Y$[QVQ6[R_ UICXNO6"(-I;='.
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MQ'_VK$:>M#13GOX%A/HSZQ17P@6K2W:Y-?93#53%H0+[TN"+G:@%LJ97'DM
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M1=!3\X<%Y(,-@_7+<CVOZ-RS@ 0Z;Z!<OK\O2Q=9OERXZ&G!C#Z[2F3)Y3"
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MU$5TL98M.['QV^B/'U%$NH^R4J(I,$K"Q(!Q/9N\M3*?Q@T!NP9=*3[TC[A
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M%F"AWTK&8:E,$%HA:>EZ6AQ@&R#)UL?!N.M0<+%;W&"M,[U6ESDOK6L$PA,
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M&UHX'[4MA*H%/'W+:=L5:Q];U080N^5^VQ_MH&M<A1E)Y<[*'_X$5=M37W>
M(9A4ZR!V517/2A[E29+,D0*BFKMXEI;F"=>U?;0\0414)<UN3Z1F]Q9+Y%=V
MJQ@[1?L#)0";T'B>5I;[SI &(GM12.AL".=WDD/-B[>PXRG+$(&H,P:U+) 9
MH)B:D]J,)W4*BAQ5,\ ;&SQO.W=N[G5..[!_\UB$A"/=IDR0(6?!19?@K:6)
M?*5^\;'-EMK(2C<@N#T( 0S@/9]N28#R-WSF,<#8J[U5N@%X<?[<1ONN0,=S
M(&^*]ICE,2')>UD02NK0%3D"8[PB1HJTH>\W_OFAU+V[R>FD;,'$%Z\ANU])
MF9JF"(7Y%O@@]R_-3C@,HL)*%QM"'+/0(JZ5;G'>>[\=8Q;N6Y^1,Q5)R[U[
MXD<RTAZXBP0QIDL.%_/W>N43A^-+2T<!Z&T2.434)LF\%7P@+#;6V"AGIL)S
M*:0!#X'G+B_IUP\2?/0VK@ 'RMKSCM);\YOS"2?K6+86LM>KXR^59>>L\>.$
M2RL5Q/@)FX_(1I4*Z)*O+NX$NS@!7S_/FCC)J O9V-I0WPM"$[GW9* SK2+8
M2KD.TI?#3JFAR$,.XZ I;%UC)60&%# # 2UXSK747GQKE#L)R.N&[.ZN!M=A
MMOI#%%:\CJR=SKE^GWSM),3W70'\[/%*6%BE<M",0:3T](2>MO9!X_K(XN5(
M67=KU5%K>_^#X8ZEJ" \T* LI',]I,3Q[,MRU/$\UR;</GAC&7=_<\Z^.J0C
MY$;(@PO<:=#X<D:LY1]9Q=:+R9"'8M%7@)FMRO9EIVVR5,)YA,^#T[F9,QXK
ME:-RC6..2X(3Z**3X@I@PW4%P%)MQZ72@E/>K)1O# L(7Y.]T\"ZS\R],XVZ
MIOO@@9QL$3$99S:DYJPXCGDSMZHJX2+PLC 3V*B 5WH8&J%WK %R](VIS.0@
M$?#!6/*YAR7E%<# %X^O:$FW"2?O*3GU7I2P0VS^P%OG<,3!]"L 5PCHLO^R
MW4:HAU2O(@0CG=7@FKRR8#.YG5EF>9\/.4PLL[!U 5#(C/8)&3ZSIYC%,=[2
M<G)"#MB;/F]N(@:+P#V)B\B!LI^MN]38*T"%MG4%W3']%>!' @7'Y0'HW'7!
M1Z_VW^8K1L+AB37P8@N'@VR0<L1Q;/X#SSL@7>CN@Q4XR',7?8C/KMRKWI=U
M@UQ\-5H[6EX*H3YL#D!? 6 S4&A](2(CY:(1?,C6XG2.V=V):Y0C86,W2%E7
M .KG[28P&_30X:.E,TM\T_0,"7\>]7/O"N TIXQY;U,]&+R!AEP! L?W\+$X
M'ASDK"K.I?8$C2._V.02B<L58/&(G6>%DJ,7BDKEQU*M>)2=0L#XBDLV]EQD
M$]M!-D/$ST9U'*H+O0&UWV@1,<(?MH(.I+U)]Y<Q^/IT[0#%)5.#&[35/==@
MX2\LL[.H)]F$ZN.9>[)=#--D^D:TJ-<DQ@Y-SQ2\&Y?FQ*M1H/M FC(.1T1*
M:7+J7P*HZ*1EO!+]-1+J(XIE*XK]_HD^;OD*T,A!X@A=##RX9_DLJ]H &>IG
M61-T!9B-G_%L.JA>,T92454SIT+![7"Q';V0%M/W<9G/RS7G&$#?\I_<H8GL
M&&"\P3R_Y=9Y9B77[MNM9F=8YL"NUAU<OQHL@V\^'Y2F=A-V>^"GXGR!$CG!
MI&/K<9XSO5T/TJX =^EMWA$3^$^(XE@%&SEBAT?MY:W8/8323*7&'^!490X1
M*D2>F#TA]BE= 38:+R"(\_7)O2#39BAD_[C%#/NRA:HNP@R7_-KL'>]O\QL?
MM&EO!\-/AWMGF>5KDG7V0";!4NQ04_=X=IJ4Z 5\"L1*>)_\NZ.:JLFTL-K>
M]O5?7ZN_,K-5K&>4<RB?B%_%WLE$K'1KY-] D_*=+P)ZY3QE6STG(;L04-]D
MRIG"&<"N9V8A87-KKV'PS&(FZXA(MJK\$ZRM"]H5G9JZ"-H*^=FU9W>02Q8)
M. DNN(39.*";T;U7@)2 ;,9PE05&BK-_F96'"93E. I\GW %T')*^'H%P(\=
M)%RFT%'\NJY"+GL5D%#K>BGL.I.Q_B]=>__E[$3TWW;/"UA"_26'F%5E@%NP
MS&)KTMK?@):\J-/6G<:F(,OZ^/'QPV5,TX8K1,AY/./IU&NG,P78[N'F'[EE
M-]G3"<<G1MYK9\K6(8Y;O9#=$V+>\CLV!V!D_;+Q12E6ZB0@%W*P+[??'!XD
MM9BAO\CLNP C+:7$^@S(K8[DI"V7)II36SO I2#K[_V0_QK;QY+U)A-VR$"!
MJ+6#T"1A*@9$;LEI@CFN]>+4JFS,N/9(EIBQ[2\^RY=., 8B1TQPP16@*SLR
MJGRV=MCIS4.[:_I!WZAOH(Q&+W0UUZT'1+,$9HM*VM4L7-&'27L-E!@A.P&M
M<B1?/U^9VT8O;.8)0B3Y9:%P^LI-\HTJ'X-FG-##/9\!=PKE4-0#'0TJI*Y0
M=EO=\%'%R'JC><]PCK0^FF\CS1SU:$8PVN446E\^OR\KZE1G'[ZA*OZ.,U?9
M367Z1(_IK)#U006D\Z=Z88D4Q4N^]PX*>T'[9ZU]I\+VJT852$-9%'?^W"HH
MY9(T!B%)'9O[5CH?-IF4TVJR?M>=!?(*XW3]J5X,4&O<8$]=;QOY:1B&9!;U
M<V+T@09.^C3* JO+8BM-:5(Y:F(\$ 89THBZ3)+%D;2B$^1^N?2TEC#<@5+Z
MPQVFU:3!M^^;)QS?W1D)%WV#!%M8@+39?0U,?5S,#I,]FT4WM]!G09W^41K4
ME?:;#%Q\2WS7-$D#\R,-W<K-(^V[G72JAC4)ION@@[/V#YXY]^B8K+I=TXC'
MWECK^'&%!G89RQ_&WP:D:31:=94Q6VKME9[CNYC6&XN.*,:S7Z.M>.\K )NF
M2]__X73A_S_%\P,A\.8\S?<Y'KO/+-E$A;"-NZN#L,NFE\6X;ALLY.1KMYR0
M&K$5'O!(Y/^=>\;%@8_/KU'S?WEH_R^+87@I\XX4-<<+H"-616;\];:H[W8V
M",IN/I]NCO6Y.Q8K:&"6)F=-&L]=J%L+OFWV&:7J(V 65%7&;@T;M#I'N%DC
MZ"9=CA@]"Z%@24$O_-1;T6NKB3+V?YWVT0*V+B:I;U=T[Y&U@#P%A%4;FV.[
MQ\?RDD\$DWZ-%(\UVE'X;HX?PL;-0DH&5FV@PT\S],XDDR7CV[EO/#SOH1/^
MTS%];3WGVUQSN4K]CPY_&SL!.<W=[B!Y) L64]>RC(LYK9?VWFDU#Z.W8W=6
M<MK$"O%O!0,))!_AE=^#8*2\4JU6A]$72ZAPI*,ND_V^['?%_57@K)V\N86Z
M<5:N0C-W^50P$2=U!&X<C,L6_+.BQ3"O*XC F+?8%S:65S(Z-.$)(\$]XB"M
MHV?9RN-PD0HJ9&^84(XZRZ>.0)_5>$B.Y,):VZSS: %8U(^/A\5G:&6_A7BH
MP&?ZL,#$KIK>@S'&>-38<K0)PF9:/P/=RD.6_/1Z5RI:0"_FP<([S'6S2E;H
M]_5@:H]/715-.R6OZ*OU48))'K4&8RB(MU[WAOL[)PVZT/3;2/-A1*Z$%YBW
M(H>,) &/)F.;XM>$&C!1W_RH,^TC+X%/VMC$<[XHR6][)!D9F,0YV\WJZL@2
M],\,AM!88N^$9XE6V/:!1%-:'B/S-(/R+XP>G A''XY9]R7?$?6)4U>8? =W
MADY0<L_^V=6XZ532/<_$-*!C_,2(X7/\4^]%W6RI_/1D-Q!X[4(8BWM:N/+W
MF=</P[+'&!>\I52L:<88N*9F_ AN0>=O2P %P/J*=R)3&821?E2M7)SVGG+L
MF*+K="C!38]4-X6RHHI*D<K&=+!I]IMW:7(=NI*$#.&4VCI)WT E]@5K9@QB
MFK#H$#?OZ"O(K)6R>WB3ZI*!Z;%7N&"I1RH(UEU4B=+>!"-,4(:8NT99]JEV
M?LR\&?@Q%*IOH'8()KKOBQ4<^J>6F<&27B3\!H>T>*+N@W_B=24T1(1%M!KD
M#,$=+@7)AKHR-=IH[/@@)/N@NJ[8\6%%(4IG6#_UVRC:E[2/)SOXX'.[0A7X
MF>X,9,AD?N=N+F.'9[=7QQ\/UL/'/9"W4]^CC'*=MG34+S9)Z O+<9,UWJ5:
M2NM!TPP>&05ORU*95KV1O#K7!1V8 *T,3:'"*ZAMP9WO]Z=B]]F\K"-K4CVJ
M4NU$U>Y9#_227":(.XII0-I>%U6C!$R:-0R$Y MHQ_86U&]!'LNO]N3C2YH3
MDHGO=]G%ZZBP7'(="EZ$IFJXFE8,FLT-.K>/05<T38\?R+H_EM-B2HO,25\Z
MML?@MS97D97OFWS$]X4"AO>[J8R DQMM\8936%<AK_/MYX.R%53<O&5R1F&K
M!HNUL<2Q_9K *X">E6O@E]/4'&95M)9/M>*$45%!82"I4Z]GDP#V^C:1'U#.
M^V84)[%=>I<OZ3>U3N"7AD;]$B9>(I"[8KHL7_&?%@-4-%(.PU3B0M0482>O
M1.W#'2_[X^^^4N^0-KU)\Y,G\E67XE'QSY<70,FB+!LA'2G'RO>Q(RPFP9X^
M)1CNHD*$G^[X6I.S1^*J$&HS8K<#5$3EVTNGB8ET#>=\T)EKT.[_\&<I(\KF
MOGR<$A^%D-2(D\/)D<;8X*,=18Q[0X^W[? 2RD!U)QC:5W$%$!TT4K\"_/-U
M?Q3TAOW6GG8WC+660?%&LJ;BM;0-7=\=*Y]BG=G\8J-41H74U1)IPJ0+$0[2
M^_GJTX-H%*O]XF?TXX3)XA^UT;%&0(Q],A +]C5M*3(F>(!%%NIJ$"33E\W8
M+WWN9LDH!6.OO;>WNSNU9M-N+VH9/SO@3,UX'M2/DRH#[B)GM,\3_ET7)M,(
M/D:M\BP.P01NVPIDOLM4_R'.I;<1[\$PD%""W]#']\G<"^6Z]56O-P=P8!D;
M2^.1]<DZ:][HWN?TI_2+A@P,N8(X/=V8_D"++:\.E+SL!OVS-,&..*!AT[)O
M;'K]6,L@2*&HOO:UKZ:/1_F]QF_^!@6<]K3T4,[;KE"JP'DYYAMH'1Y3_W9K
MI)RJJ.B$GAI$" ?<@GOC8RI6#'NG'Z>9&R,0>(0.CM30<;0(LD%G\A]'C[\1
MJP<F4G_[R.R_WN@9_/%[]Q4@9+JQNFZ1\KS.[Y>:6J5"V2F?0^5Q?%]]N>"[
M@.I[_PAGS9TW.C@LC9$RCH/B3X<GA?/><)U5%QMLQ:/6]/BF)D:,BHI_2,[7
M&=ILOX?G,@++RT;3P%N\Q-U6O==UUAI*<YG,%7/QVCX2DK0P?OG$8(H@&EG6
MOV=F&5\,LLU5O3.>AU4ZX*QM/,B+4JN_2PRS SS5"^6,<[I/#H?PUN%L.J(^
MZ^^$W35OU@_??MC=YA'ONR"F2C&1<USALE8AC<@"]]"AA(I[=1V@4._Z<]T^
MX>)%3+; >+B6S[>YY?O&;/OX3)+,ZJJGDA9HAN:I!;HN?=X?S/Y"-?:Z+#=5
MO%<GWX=;:@&FG>J2#,Q&1RFIA0BM"<*J%>3]I?H7YW>[C7H,PJ\%6TSS[D@N
M;#F5ZDRNPGI]!^9D?VD]#.0'! .^5Q9$&V@)V2>?)22F9BTL'4&Q:Z1!I6H<
MHM>P.9D?,>M7Y:/7HNP52N$Q2J.D%H073"GX7,G_LM]+V8'C,WR@7Q0/"\8'
M2J[_W:XJ,91$=F597C)NEA6=>H-/GFOHUC4V-S6,5G YW^@PE/U#T[EX(U$]
M4,Q=0H^5<JU %PG$>/B\G?5OZ! +3B8&9_3CI64]I(I_YVF(%1@8>R"REM ]
M&+=@;# I><)+>42]H6EH>JI 0Z+/WMA=OYY!7=G5CC.+_2M3!= ?F/;,$]DS
M+V7T54 4-,DS3EQWFB*CXY :S^)\^'LR"_,$U$IX?&<F6_J%T!N;YLU-+:/D
MVSGUR1T;#ZVF:#X(4' F4G ';LLR2Z&!:3OTZ0SZ6?8GQD@>YU4G;T(].N3G
MER%D>-N$_Z0MN.<>PB#,:GF+MWP8NI(+M:[H2E_72;]'O!G'-O^1P6+,O)AS
M5[/C=N!>=%,J#^6Q<X=(Q\-H3\VZ\@/<I)\$\G/X/]+21JEV\LFI!8S<A9MU
MFM:;1&?@&!F98E*7]G"2CN6+@&"K^-J+[^<05QVY7@95C]@L4S+O\-CFH88R
M-5KVK8?DHFQ)[VQ,LN'[M4D9OUT),<F$&FL=D?:RZ9\*C$8/@[O,DU\:<S5N
MK=Q14G,?^PD7',D&2J#O8KG_+OK7$\'%K<HMIO"<;%:G^I_#J%</696 '@;)
MQ06]W,F:*.XS[\T1D,1!2WQ&NM_#-M=Q'7[]%KMJL;I(9BI-@T0*W8MM2!&3
M@VF<N5'^2B,_LI]WJOP$HX-S06.-DHLDC,7I^<P>LJI^2LG@MDT-2(FIC=8"
M*FR-(/NB7&T_WS0"URJN/;.PUH_5V(%1&3N5=+)GF5$Y=XCKEX05KXFP&.8*
M!6]FIYW7;01Z5<IICB(3D(]U2&H=N8I&JSWS?K",B98B/"GL<[#=HNHZO5;>
M!ZIU#NXTL:[YT=S S1)UK1:69%K]:#/,0D'% )!,JNTKB/KTTTX):=XX8.A"
M5AO4MM+0J+2/)[2$G=#\7RWFP92AS#)2R?U<^WH&'W=H;\J::M7-TV2Y+<OG
M/_1+1 /:K ZA-F.\26M&?>+&MB4CI:.FGZ48'2;E>">Z4Z96ZLT\>)JK!>)%
M::@JAC:,0Y_/Y 1F(8;] TV>E@S<2U<0,<$_KKT"/'_LW[/O)%BW)B5WKJ<1
M8CQBC0#_=JC_:.?T5(?J)7<83=CSG08:3YEWGZG4S>FVOO_Z>4\]JT#VI8#Z
MH5^PV_NFS0,_A]%.6R%UXS5CSUB"IXX&$E&?H;7J7-YR^,IC-EMZL:_F!;*[
M^TFVIYZA:A4'\G65-^\)\I;?).:8-PFIV,F@)4A3>F)8TQ1;CK?//->1JO[(
M>2;8D<\*G4S(H*ADO_":4#RH0.I2LG>K>0*GZH<[[Z$-1@\WW0C6YQ/C5X")
MV3S=7M6:D:^(:<X(-<%)Q[?&!TR.[Q+>*I4]]G<Q!GG/PQR<RORLRHD:.JXP
M+IJ"QR-0M6EY=1&I\1W-F24SO7NKG_D0G%;?EY/;0[9"VU7N-Y2/WZ-&#I24
MG>*")[!_7?>$00FU/@[0^NB08UK+F<]Y/D7$:4WZ6MYE+'2(K4\ZJV2 _D.
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M-'DC6,K@Q&O>;9S)F]=8/<7/2IFM#FM#[KB'+9@T0:W^I\'7ZMA "N1'+C5
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M<WU!=Z]CAHX9+&/\0ACT0X.V=+12U1Q<W&.YYA<3[!T(09.1E:5.R(D1#OH
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MN1K/Q]8MP\PW_?D*P++,\?O)N4K*Q9LQ!F7VMP"*0[#*9V:^-4V^=8WSEBL
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MQOK;<P([NDW'+*G@;^Q_66S?G-(6J+S4M;FI0M[J,SA>W#V/]G4U^P5<HV9
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MQ6=>9A[1XEA/#4R[5^R=/"S3/5DHWX+?21_,>AW1^ULC0JQ@10CID2&*TDP
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MX1,%TS6[Q=X.T.!7A5,#0UEV^_A-F'&VSB=<;69I;\EH98C ?0^YOFI@9M[
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MG5YJ3YZD'P8M#1;QJF"5 ZN=+,GA][62KT'SPEQ\/5AP^ 1E)U/-!'F+I&/
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M;<]L-U4T]?0IS?4)CKR$=_../<OQ N)$'NBR#XC\@N<TSH<XFHD?>AP![^'
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M9S3A,.]C Y@N'A.KZUW^R.,#'S_=7HM<_+JL-Q-WE0'BSR<5M4@.L^ IH4V
MML])J ;8/CKJ<F#M<X(= +7//JRV3O.BT?HFNTQ$&0&;T=MRG2<O[?^/@[/;
M*8XRIE,KRBS;MY(TM$'@[')D#5NO8((O0[>\^+.K_H,MRY+JDUN8]2L%9M@[
M?>PYN$ M=?1']U\C6.LPP36MT))$%UVC88HX7J6!;ZM '-'JUZK</(DLGSA
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M3TOM+4)^J5"<<R_K>O/X)$K9\BRC%652*$"[P48U;:/M1<D=-VC/#MKSHX(
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M,D!,[_."?P,H)NRI1$\(Z94F.W0#'*4TP5;@V:LP6F59['23?56D_^13O95
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MNH\]N'F"BAVWJS*A-*UY0HQ'DRZ+]"-/1K#3QTUV^4SR-8]:OR\K_L=]'FT
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MX(06$$Q\LL(DBC+/":/,#6((X%H[+,C X&!J+9"A2M"UDUHRV0F6!9@:F18
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MU9\[XM!>7C/:$HL9JG0 \^BGXO=TM33R6A9061^O&5(KM_%:%OJ\BY? .V\
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MQDTLSP"P%9UZ7[/SH&31_>V=\9G^OP<ZX>1/,O& >]-);2POK%4H N98U.@
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M5WTJBT=2W23)[FFWQ4W[V.F5>I"Y*'*B$*518+,J.V):SE\%>60O/*R%@+/
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M> E*'9-D*?&S($J$(<@GB&CV$P>J1D<6@,4]I9=YJU<E+<S(SP6501^?DA@
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M$GLHQ(F/,,$DR2(K-CWA3M>SE'3G&;:=,REQXY@ZN GVO+[F35VI%F V+JT
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M['KVNRC:D:$N/RV;O+HO4QZO*?9,"X6.&2*/Q($5!TX8$% 3Q#,*FHUU" $
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MA9[.&F5F?WM&H2,FH) @(#76 &M=6<E113!ZR7HD>QKH7BADZLP?K^O[7\/
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MXKT'*/R[@EQ"YTZ[ZMXV:S\,%!R2/%F411P'WL^;**[E#5R$=-#!?-I.X/!
MH>#+4(&,-A!B(U(<"+;/W@\:Q8<@$XBV"(A\GH31@CA&]^Z#FJD56ZW[.A^V
M.8PA$!YY*;7D3)]F-7;-W@\BQ0<B$XBV"(C$:]SFO9JYZ[IY:"&<&:"A8,"Y
M8 H%06%73!&'?#%IO[2IXF.0QPNR"!Q\OU7C\;OY=#1QTY:E$T("!8T"W%JA
M#)1<D!06XL6D_7!0?+3Q>$$6@8./MZZY#EO>GYKZ]]G-^_KV3DU:< ZV#&AF
M-=!."6<A"^<CF@ /6R?OAXOBPXRG"[8(?'R_<>-Q!_6J$L$A@A1@BUDEB T
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M^<)60@K94-)8C--%71I>'HE786?U(G;G#RO&!.>)",%L$$?%9>J&"B\(R&M
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MYBEO*?@YET!1Z"A@M:1.60Z<BD FX%H;8BRDQJ6.))PC0WVPDO1S8OV<NBT
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M5V<)J%4/C_5#YK_FH\9UL_;!Z;9KA!10EDM0*<<]98JGOT<ZD,0B\T,&0^F
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M5V9K(Z ?\7"<KF71:KCA&A=MHS=#^R)O(5!(*2!)<*F,)5[JU%?W9VE?M&S
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M42+Q?:ZGP;E0S<-EL[RW_LW-;FJ[;!'D7"R"6MT>A$7:^O+CUQ8[6ZO3F2=
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M6C7H_K(JSWZGQK$STK:EXCF)]8\2D. 6>FH<\39YRN%A)&:^F!ED-SJ'M@H
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MDM?;2X6$3>.20NX%[&0?O7<FQG2>^/FF9H^O 8?]^?+.-0M=M1^_-A+("G&
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MX^$A^.>)'4U-O ES]N-/$[ZZ_5X,!>=#&U(%#X0;+BEWU*4N'CN*T+QM6<H
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M3U;T;U*ZR4]P-O[:I-C/CY^U#*-Q-%I.%G=FN/PE,'C]8;85[X&/\.,GV">
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M+7$R,C8N:'1M4$L! A0#%     @ T*#\7#/T-!PT"   OR@  !,
M     ( !:@@  &5X:&EB:70S,3(M<3(R-BYH=&U02P$"% ,4    " #0H/Q<
MAOK#<\L$  "5$P  $P              @ '/$   97AH:6)I=#,R,2UQ,C(V
M+FAT;5!+ 0(4 Q0    ( -"@_%R.I)R2R00  )(3   3              "
M <L5  !E>&AI8FET,S(R+7$R,C8N:'1M4$L! A0#%     @ T*#\7#SG6MWB
M$ ( +_$4 !$              ( !Q1H  &YA=70M,C R-C V,S N:'1M4$L!
M A0#%     @ T*#\7$+[AAMH#   UX4  !$              ( !UBL" &YA
M=70M,C R-C V,S N>'-D4$L! A0#%     @ T*#\7 %G-U.G%0  HO,  !4
M             ( !;3@" &YA=70M,C R-C V,S!?8V%L+GAM;%!+ 0(4 Q0
M   ( -"@_%Q^AMXI:"@  .F/ @ 5              "  4=. @!N875T+3(P
M,C8P-C,P7V1E9BYX;6Q02P$"% ,4    " #0H/Q<ACW#^BEM P"$\00 %
M            @ 'B=@( ;F%U="TR,#(V,#8S,%]G,2YJ<&=02P$"% ,4
M" #0H/Q<+T9E2TRR  "%G < %0              @ $]Y 4 ;F%U="TR,#(V
M,#8S,%]L86(N>&UL4$L! A0#%     @ T*#\7,LLRE<Z6P  62 % !4
M         ( !O)8& &YA=70M,C R-C V,S!?<')E+GAM;%!+!08     "P +
+ - "   I\@8    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>naut-20260630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:naut="http://www.nautilus.bio/20260630"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="naut-20260630.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2026-07-24</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:GrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">naut:ServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-09</startDate>
            <endDate>2021-06-09</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-09</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:PrepaidExpenseAndOtherAssetsCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CashAndCashEquivalentsAtCarryingValue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfFinancialPositionLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:PrototypeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:PrototypeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-01</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-01</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:ResearchAndDevelopmentExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpense</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CostOfRevenue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:CostOfRevenue</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">naut:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>naut:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="institution">
        <measure>naut:institution</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001808805</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-26">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-27">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q2</dei:DocumentFiscalPeriodFocus>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-750"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2026-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39434</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">NAUTILUS BIOTECHNOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">98-1541723</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">2701 Eastlake Avenue East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Seattle</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">98102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">206</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">333-2001</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">NAUT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-24" unitRef="shares">127255223</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">13166000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">12388000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">70865000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">91018000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">3595000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">2557000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">87626000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">105963000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">3999000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">3457000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">25619000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">27773000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">45155000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">52739000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">1177000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">1180000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">163576000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">191112000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">1095000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">943000</us-gaap:AccountsPayableCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">3553000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">3177000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">3991000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">3832000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">8639000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">7952000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-56" unitRef="usd">23825000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">26187000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-58" unitRef="usd">32464000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">34139000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-60" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-61" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-62"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-63"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-64" unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-65" unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-66" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-67" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-68" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-69" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-3" id="f-70" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-72"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-73"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-74" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-75" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-76" unitRef="shares">127224640</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-77" unitRef="shares">127224640</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-78" unitRef="shares">126469610</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-79" unitRef="shares">126469610</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-80" unitRef="usd">13000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">13000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-82" unitRef="usd">492616000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">488737000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-84" unitRef="usd">-331000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">243000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-86" unitRef="usd">-361186000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">-332020000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-88" unitRef="usd">131112000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">156973000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-90" unitRef="usd">163576000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">191112000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c-5" decimals="-3" id="f-92" unitRef="usd">180000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-6" decimals="-3" id="f-93" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-7" decimals="-3" id="f-94" unitRef="usd">180000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-8" decimals="-3" id="f-95" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-9" decimals="-3" id="f-96" unitRef="usd">10000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-10" decimals="-3" id="f-97" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-11" decimals="-3" id="f-98" unitRef="usd">10000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-12" decimals="-3" id="f-99" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-13" decimals="-3" id="f-100" unitRef="usd">190000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-14" decimals="-3" id="f-101" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-102" unitRef="usd">190000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-15" decimals="-3" id="f-103" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c-9" decimals="-3" id="f-104" unitRef="usd">15000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-10" decimals="-3" id="f-105" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-11" decimals="-3" id="f-106" unitRef="usd">15000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-12" decimals="-3" id="f-107" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-13" decimals="-3" id="f-108" unitRef="usd">15000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-14" decimals="-3" id="f-109" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="-3" id="f-110" unitRef="usd">15000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-15" decimals="-3" id="f-111" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-13" decimals="-3" id="f-112" unitRef="usd">9613000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-14" decimals="-3" id="f-113" unitRef="usd">10394000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-114" unitRef="usd">19320000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-15" decimals="-3" id="f-115" unitRef="usd">21930000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-13" decimals="-3" id="f-116" unitRef="usd">6325000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-14" decimals="-3" id="f-117" unitRef="usd">6703000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-118" unitRef="usd">12742000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-15" decimals="-3" id="f-119" unitRef="usd">14011000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-13" decimals="-3" id="f-120" unitRef="usd">15938000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-14" decimals="-3" id="f-121" unitRef="usd">17097000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-122" unitRef="usd">32062000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-15" decimals="-3" id="f-123" unitRef="usd">35941000</us-gaap:OperatingExpenses>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-13" decimals="-3" id="f-124" unitRef="usd">1307000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-14" decimals="-3" id="f-125" unitRef="usd">2080000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-3" id="f-126" unitRef="usd">2749000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-15" decimals="-3" id="f-127" unitRef="usd">4311000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-13" decimals="-3" id="f-128" unitRef="usd">-13000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-14" decimals="-3" id="f-129" unitRef="usd">-16000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-130" unitRef="usd">-28000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-15" decimals="-3" id="f-131" unitRef="usd">-16000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-13" decimals="-3" id="f-132" unitRef="usd">1294000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-14" decimals="-3" id="f-133" unitRef="usd">2064000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-134" unitRef="usd">2721000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-15" decimals="-3" id="f-135" unitRef="usd">4295000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-136" unitRef="usd">-14469000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-137" unitRef="usd">-15033000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-138" unitRef="usd">-29166000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-139" unitRef="usd">-31646000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-140"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-13"
      decimals="2"
      id="f-141"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-14"
      decimals="2"
      id="f-142"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-143"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-144"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-145"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-15"
      decimals="2"
      id="f-146"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-15"
      decimals="2"
      id="f-147"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="0" id="f-148" unitRef="shares">127135738</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="0" id="f-149" unitRef="shares">127135738</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-14" decimals="0" id="f-150" unitRef="shares">126204632</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-14" decimals="0" id="f-151" unitRef="shares">126204632</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-152" unitRef="shares">126886646</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-153" unitRef="shares">126886646</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-15" decimals="0" id="f-154" unitRef="shares">126174603</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-15" decimals="0" id="f-155" unitRef="shares">126174603</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-156" unitRef="usd">-14469000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-157" unitRef="usd">-15033000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">-29166000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-159" unitRef="usd">-31646000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-13" decimals="-3" id="f-160" unitRef="usd">-240000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-14" decimals="-3" id="f-161" unitRef="usd">-112000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-162" unitRef="usd">-574000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-15" decimals="-3" id="f-163" unitRef="usd">20000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-13" decimals="-3" id="f-164" unitRef="usd">-240000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-14" decimals="-3" id="f-165" unitRef="usd">-112000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-166" unitRef="usd">-574000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-15" decimals="-3" id="f-167" unitRef="usd">20000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-13" decimals="-3" id="f-168" unitRef="usd">-14709000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-14" decimals="-3" id="f-169" unitRef="usd">-15145000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-170" unitRef="usd">-29740000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-15" decimals="-3" id="f-171" unitRef="usd">-31626000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-16" decimals="0" id="f-172" unitRef="shares">127070480</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-3" id="f-173" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-3" id="f-174" unitRef="usd">491210000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-175" unitRef="usd">-91000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-176" unitRef="usd">-346717000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-177" unitRef="usd">144415000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-21" decimals="0" id="f-178" unitRef="shares">69374</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-22" decimals="-3" id="f-179" unitRef="usd">102000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-13" decimals="-3" id="f-180" unitRef="usd">102000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-21" decimals="0" id="f-181" unitRef="shares">84786</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-22" decimals="-3" id="f-182" unitRef="usd">142000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-13" decimals="-3" id="f-183" unitRef="usd">142000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-22" decimals="-3" id="f-184" unitRef="usd">1162000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-3" id="f-185" unitRef="usd">1162000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-23" decimals="-3" id="f-186" unitRef="usd">-240000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-13" decimals="-3" id="f-187" unitRef="usd">-240000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-24" decimals="-3" id="f-188" unitRef="usd">-14469000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-189" unitRef="usd">-14469000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-25" decimals="0" id="f-190" unitRef="shares">127224640</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-191" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-192" unitRef="usd">492616000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-193" unitRef="usd">-331000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-194" unitRef="usd">-361186000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-195" unitRef="usd">131112000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-29" decimals="0" id="f-196" unitRef="shares">126148469</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-3" id="f-197" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-30" decimals="-3" id="f-198" unitRef="usd">483865000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-3" id="f-199" unitRef="usd">189000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-3" id="f-200" unitRef="usd">-289632000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-201" unitRef="usd">194435000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-34" decimals="0" id="f-202" unitRef="shares">18140</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-35" decimals="-3" id="f-203" unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-14" decimals="-3" id="f-204" unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-34" decimals="0" id="f-205" unitRef="shares">138513</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-35" decimals="-3" id="f-206" unitRef="usd">87000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-14" decimals="-3" id="f-207" unitRef="usd">87000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-35" decimals="-3" id="f-208" unitRef="usd">1709000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-209" unitRef="usd">1709000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-36" decimals="-3" id="f-210" unitRef="usd">-112000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-14" decimals="-3" id="f-211" unitRef="usd">-112000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-37" decimals="-3" id="f-212" unitRef="usd">-15033000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-14" decimals="-3" id="f-213" unitRef="usd">-15033000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-38" decimals="0" id="f-214" unitRef="shares">126305122</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-215" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-216" unitRef="usd">485669000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-217" unitRef="usd">77000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-218" unitRef="usd">-304665000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-219" unitRef="usd">181094000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-43" decimals="0" id="f-220" unitRef="shares">126469610</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-221" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-3" id="f-222" unitRef="usd">488737000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-223" unitRef="usd">243000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-224" unitRef="usd">-332020000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-225" unitRef="usd">156973000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-47" decimals="0" id="f-226" unitRef="shares">670244</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-48" decimals="-3" id="f-227" unitRef="usd">1207000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-228" unitRef="usd">1207000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-47" decimals="0" id="f-229" unitRef="shares">84786</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-48" decimals="-3" id="f-230" unitRef="usd">142000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-1" decimals="-3" id="f-231" unitRef="usd">142000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-48" decimals="-3" id="f-232" unitRef="usd">2530000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-233" unitRef="usd">2530000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-49" decimals="-3" id="f-234" unitRef="usd">-574000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">-574000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-50" decimals="-3" id="f-236" unitRef="usd">-29166000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-237" unitRef="usd">-29166000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-25" decimals="0" id="f-238" unitRef="shares">127224640</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-239" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-240" unitRef="usd">492616000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-241" unitRef="usd">-331000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-3" id="f-242" unitRef="usd">-361186000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-243" unitRef="usd">131112000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-51" decimals="0" id="f-244" unitRef="shares">126106176</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-3" id="f-245" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-3" id="f-246" unitRef="usd">481679000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-3" id="f-247" unitRef="usd">57000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-248" unitRef="usd">-273019000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-249" unitRef="usd">208730000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-56" decimals="0" id="f-250" unitRef="shares">60433</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-57" decimals="-3" id="f-251" unitRef="usd">26000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-15" decimals="-3" id="f-252" unitRef="usd">26000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-56" decimals="0" id="f-253" unitRef="shares">138513</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-57" decimals="-3" id="f-254" unitRef="usd">87000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-15" decimals="-3" id="f-255" unitRef="usd">87000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-57" decimals="-3" id="f-256" unitRef="usd">3877000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-15" decimals="-3" id="f-257" unitRef="usd">3877000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-58" decimals="-3" id="f-258" unitRef="usd">20000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-15" decimals="-3" id="f-259" unitRef="usd">20000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-59" decimals="-3" id="f-260" unitRef="usd">-31646000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-261" unitRef="usd">-31646000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-38" decimals="0" id="f-262" unitRef="shares">126305122</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-263" unitRef="usd">13000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-264" unitRef="usd">485669000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-40" decimals="-3" id="f-265" unitRef="usd">77000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-266" unitRef="usd">-304665000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-267" unitRef="usd">181094000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-268" unitRef="usd">-29166000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-269" unitRef="usd">-31646000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-270" unitRef="usd">2520000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-15" decimals="-3" id="f-271" unitRef="usd">3877000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-272" unitRef="usd">2154000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-15" decimals="-3" id="f-273" unitRef="usd">2336000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-274" unitRef="usd">606000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-15" decimals="-3" id="f-275" unitRef="usd">922000</us-gaap:Depreciation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-1" decimals="-3" id="f-276" unitRef="usd">56000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="c-15" decimals="-3" id="f-277" unitRef="usd">980000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-278" unitRef="usd">953000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-15" decimals="-3" id="f-279" unitRef="usd">-160000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-280" unitRef="usd">-104000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-15" decimals="-3" id="f-281" unitRef="usd">-51000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-282" unitRef="usd">376000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-15" decimals="-3" id="f-283" unitRef="usd">390000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-284" unitRef="usd">-2203000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-15" decimals="-3" id="f-285" unitRef="usd">-2295000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-286" unitRef="usd">-26826000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-15" decimals="-3" id="f-287" unitRef="usd">-27287000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-3" id="f-288" unitRef="usd">55715000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-15" decimals="-3" id="f-289" unitRef="usd">45878000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-3" id="f-290" unitRef="usd">28496000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-15" decimals="-3" id="f-291" unitRef="usd">11278000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-292" unitRef="usd">964000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-15" decimals="-3" id="f-293" unitRef="usd">615000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-294" unitRef="usd">26255000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-15" decimals="-3" id="f-295" unitRef="usd">33985000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-296" unitRef="usd">1207000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-15" decimals="-3" id="f-297" unitRef="usd">26000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans contextRef="c-1" decimals="-3" id="f-298" unitRef="usd">142000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans contextRef="c-15" decimals="-3" id="f-299" unitRef="usd">87000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">1349000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-15" decimals="-3" id="f-301" unitRef="usd">113000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-302" unitRef="usd">778000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-15" decimals="-3" id="f-303" unitRef="usd">6811000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-304" unitRef="usd">13390000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-55" decimals="-3" id="f-305" unitRef="usd">28648000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-306" unitRef="usd">14168000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-42" decimals="-3" id="f-307" unitRef="usd">35459000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-1" decimals="-3" id="f-308" unitRef="usd">355000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-15" decimals="-3" id="f-309" unitRef="usd">112000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c-1" id="f-310">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Description of Business and Basis of Presentation&lt;/span&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nautilus Biotechnology, Inc. (the &#x201c;Company&#x201d;) is a biotechnology company incorporated in 2016 with corporate headquarters in Seattle, Washington and research and development headquarters in San Carlos, California. Since the Company&#x2019;s incorporation in 2016, the Company has devoted substantially all of its resources to research and development activities, including with respect to its proteomics platform, business planning, establishing and maintaining its intellectual property portfolio, hiring personnel, raising capital and providing selling, general and administrative support for these operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 9, 2021, Nautilus Biotechnology, Inc. a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp. III, a Cayman Islands exempted company and the Company&#x2019;s predecessor company (&#x201c;ARYA&#x201d;)), consummated the  business combination (the &#x201c;Business Combination&#x201d;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#x201c;BCA&#x201d;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#x201c;Mako Merger Sub&#x201d;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#x201c;Legacy Nautilus&#x201d;). As a result of the Business Combination, ARYA changed its name to &#x201c;Nautilus Biotechnology, Inc.&#x201d; and Mako Merger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as the surviving company and becoming a wholly-owned subsidiary of ARYA (the &#x201c;Merger&#x201d; and, collectively with the other transactions described in the BCA, the &#x201c;Reverse Recapitalization&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, in conjunction with the completion of the Business Combination, certain investors (&#x201c;PIPE Investors&#x201d;) subscribed for the purchase of an aggregate of 20,000,000 shares of common stock of the Company (&#x201c;New Nautilus Common Stock&#x201d;) at a price of $10.00 per share for aggregate gross proceeds of $200.0&#160;million (&#x201c;PIPE Financing&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#x2019;s financial position, results of operations, and cash flows for the interim periods. The interim financial results are not necessarily indicative of the results for a full year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025 on file with the SEC. The Company&#x2019;s reporting currency is the U.S. dollar. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its technology, raising capital, and recruiting personnel. The Company&#x2019;s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company&#x2019;s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since inception and expects this to continue for the foreseeable future. As of June&#160;30, 2026, the Company had an accumulated deficit of $361.2&#160;million.&lt;/span&gt;&lt;/div&gt;The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock and common stock. In June 2021, the Company received gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination offset by approximately $18.2 million of transaction costs and underwriters&#x2019; fees relating to the closing of the Business Combination. The Company had cash, cash equivalents, and short-term investments of $84.0 million as of June&#160;30, 2026. As of the date on which these condensed consolidated financial statements were issued, the Company believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its operations for at least the next twelve months following the issuance of the condensed consolidated financial statements. The Company&#x2019;s actual results and its near and long-term future capital requirements will depend on many factors, including its growth rate and the timing and extent of spending to support its research and development efforts. Future liquidity and cash requirements will depend on numerous factors. The Company will be required to seek additional equity or debt financing to fund future operations, and the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c-60"
      decimals="INF"
      id="f-311"
      unitRef="shares">20000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-61"
      decimals="2"
      id="f-312"
      unitRef="usdPerShare">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-60" decimals="-5" id="f-313" unitRef="usd">200000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-315">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#x2019;s financial position, results of operations, and cash flows for the interim periods. The interim financial results are not necessarily indicative of the results for a full year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025 on file with the SEC. The Company&#x2019;s reporting currency is the U.S. dollar.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-314">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#x2019;s financial position, results of operations, and cash flows for the interim periods. The interim financial results are not necessarily indicative of the results for a full year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2025 on file with the SEC. The Company&#x2019;s reporting currency is the U.S. dollar.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-316" unitRef="usd">-361200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction contextRef="c-62" decimals="-5" id="f-317" unitRef="usd">345500000</naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction>
    <naut:PaymentsOfReverseRecapitalizationTransactionCosts contextRef="c-62" decimals="-5" id="f-318" unitRef="usd">18200000</naut:PaymentsOfReverseRecapitalizationTransactionCosts>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c-3" decimals="-5" id="f-319" unitRef="usd">84000000.0</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-320">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"&gt;Significant Accounting Policies&lt;/span&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#x2019;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed to perform as contracted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in marketable debt securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks similar to those of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of negative global and national events and the need to obtain adequate additional financing to fund the development of its products. There can be no &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;aker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s Chief Executive Officer is its CODM. The Company&#x2019;s CODM re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#x2019;s long-lived assets are entirely based in the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s service revenue is derived from the generation and analysis of proteomic data for our Iterative Mapping Early Access Program (&#x201c;Early Access Program&#x201d;) customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the promised services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of the service to the customer, meaning the customer has the ability to use and obtain the benefit of the service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s service revenue consists of service fees for the generation and analysis of proteomic data for our Early Access Program customers. The Company generally has one performance obligation for the generation and delivery of proteomic data to the customer. Revenue from services is recognized once the results are delivered to the customer, which is when the customer obtains benefit of the service. Customers are invoiced generally upon delivery of services, and payment is typically due within 30 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Grant Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s activities related to the grant awarded from The Michael J. Fox Foundation (&#x201c;MJFF&#x201d;) commenced in the second quarter of 2026. The Company recognizes grant revenue as qualifying costs are incurred and the donor-imposed conditions are substantially met under Accounting Standards Codification 958-605. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts received in advance of satisfying the underlying conditions are recorded as grant liabilities within other current liabilities, or within other long-term liabilities if settlement is expected beyond 12 months. Cash receipts from grants are classified as operating activities in the condensed consolidated statements of cash flows. Expenses incurred in connection with this grant arrangement are recognized as research and development expense in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Grant revenue, and the related research and development costs incurred, were $0.2 million for the three and six months ended June 30, 2026. The Company received the first payment of $0.4 million from MJFF in the second quarter of 2026, which was recorded as a grant liability in accrued expenses and other liabilities in the condensed consolidated balance sheets. Of the $0.4 million received, $0.2 million was recognized as grant revenue as qualifying costs were incurred during the six months ended June 30, 2026, and $0.2 million remained recorded as a grant liability as of  June&#160;30, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Expected Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the commencement of sales under the Early Access Program in the second quarter of 2026, the Company began recording accounts receivable, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of amounts due from customers for the sales of services, net of any allowance for expected credit losses. As of June&#160;30, 2026, the Company had accounts receivable balances of less than $0.1 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for expected credit losses on receivables is estimated based on an evaluation of historical experience (once available), current aging of receivables, the financial condition of customers, and forward-looking economic conditions. Accounts receivable balances are written off against the allowance when they are deemed uncollectible, at which point collection efforts are discontinued. Management evaluated the Company's outstanding accounts receivable as of June&#160;30, 2026, and concluded that no allowance for expected credit losses was required, as the balances were deemed fully collectible. There were no write-offs of uncollectible accounts during the three and six months ended June 30, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers investments with an original maturity greater than three months and remaining maturities less than 12 months to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its marketable debt securities as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the estimated fair value of a marketable debt security is below its amortized cost basis, the Company evaluates whether it is more likely than not that the Company will be required to sell the security before its anticipated recovery in market value and whether credit losses exist for the related securities. Credit-related losses are recognized as an allowance for credit losses on the balance sheet with a corresponding adjustment to earnings. Unrealized gains and losses that are unrelated to credit deterioration are reported in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2026, in connection with the launch of our Early Access Program and other commercialization activities, we began capitalizing inventory costs. Inventory is stated at the lower of cost or net realizable value with cost determined using a standard cost system, which approximates actual costs determined on the first-in first-out basis. Standard costs are reviewed and updated periodically to ensure they remain representative of current production costs. Materials that may be utilized for either commercial or, alternatively, for research and development purposes, are classified as inventory, specifically as raw materials and supplies. Amounts in inventory used for research and development purposes are charged to research and development expense when the item enters the research and development process and can no longer be used for commercial purposes. During the six months ended June 30, 2026, $0.5 million was charged to research and development expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions for slow-moving, excess or obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values. For the quarter ended June&#160;30, 2026, the Company did not have any inventory reserves. As of June&#160;30, 2026, the Company had inventory of $0.6 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within interest expense and amortization in the Company&#x2019;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#x2019; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2026 and 2025, net unrealized gains and losses on marketable debt securities were included as a component of comprehensive income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The ASU is effective for the Company for the fiscal year ending December 31, 2027 and for interim periods beginning after December 31, 2027. The Company does not anticipate adoption to have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-321">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#x2019;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-322">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed to perform as contracted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in marketable debt securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks similar to those of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of negative global and national events and the need to obtain adequate additional financing to fund the development of its products. There can be no &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-323">&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;aker (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s Chief Executive Officer is its CODM. The Company&#x2019;s CODM re&lt;/span&gt;views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#x2019;s long-lived assets are entirely based in the United States.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-324"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-325"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-326">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s service revenue is derived from the generation and analysis of proteomic data for our Iterative Mapping Early Access Program (&#x201c;Early Access Program&#x201d;) customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the promised services is transferred to its customers, in an amount that reflects the consideration expected to be received in exchange for those services. This process involves identifying the contract with a customer, determining the performance obligations in the contract, determining the contract price, allocating the contract price to the distinct performance obligations in the contract, and recognizing revenue when the performance obligations have been satisfied. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. Performance obligations are considered satisfied once the Company has transferred control of the service to the customer, meaning the customer has the ability to use and obtain the benefit of the service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s service revenue consists of service fees for the generation and analysis of proteomic data for our Early Access Program customers. The Company generally has one performance obligation for the generation and delivery of proteomic data to the customer. Revenue from services is recognized once the results are delivered to the customer, which is when the customer obtains benefit of the service. Customers are invoiced generally upon delivery of services, and payment is typically due within 30 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s activities related to the grant awarded from The Michael J. Fox Foundation (&#x201c;MJFF&#x201d;) commenced in the second quarter of 2026. The Company recognizes grant revenue as qualifying costs are incurred and the donor-imposed conditions are substantially met under Accounting Standards Codification 958-605. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts received in advance of satisfying the underlying conditions are recorded as grant liabilities within other current liabilities, or within other long-term liabilities if settlement is expected beyond 12 months. Cash receipts from grants are classified as operating activities in the condensed consolidated statements of cash flows. Expenses incurred in connection with this grant arrangement are recognized as research and development expense in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Grant revenue, and the related research and development costs incurred, were $0.2 million for the three and six months ended June 30, 2026. The Company received the first payment of $0.4 million from MJFF in the second quarter of 2026, which was recorded as a grant liability in accrued expenses and other liabilities in the condensed consolidated balance sheets. Of the $0.4 million received, $0.2 million was recognized as grant revenue as qualifying costs were incurred during the six months ended June 30, 2026, and $0.2 million remained recorded as a grant liability as of  June&#160;30, 2026.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:Revenues contextRef="c-7" decimals="-5" id="f-327" unitRef="usd">200000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-5" decimals="-5" id="f-328" unitRef="usd">200000</us-gaap:Revenues>
    <naut:GrantLiabilityCurrent contextRef="c-63" decimals="-5" id="f-329" unitRef="usd">400000</naut:GrantLiabilityCurrent>
    <naut:GrantLiabilityCurrent contextRef="c-63" decimals="-5" id="f-330" unitRef="usd">400000</naut:GrantLiabilityCurrent>
    <us-gaap:Revenues contextRef="c-7" decimals="-5" id="f-331" unitRef="usd">200000</us-gaap:Revenues>
    <naut:GrantLiabilityCurrent contextRef="c-3" decimals="-5" id="f-332" unitRef="usd">200000</naut:GrantLiabilityCurrent>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-333">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-334">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the commencement of sales under the Early Access Program in the second quarter of 2026, the Company began recording accounts receivable, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of amounts due from customers for the sales of services, net of any allowance for expected credit losses. As of June&#160;30, 2026, the Company had accounts receivable balances of less than $0.1 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for expected credit losses on receivables is estimated based on an evaluation of historical experience (once available), current aging of receivables, the financial condition of customers, and forward-looking economic conditions. Accounts receivable balances are written off against the allowance when they are deemed uncollectible, at which point collection efforts are discontinued. Management evaluated the Company's outstanding accounts receivable as of June&#160;30, 2026, and concluded that no allowance for expected credit losses was required, as the balances were deemed fully collectible. There were no write-offs of uncollectible accounts during the three and six months ended June 30, 2026.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-64" decimals="-5" id="f-335" unitRef="usd">100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-3" decimals="INF" id="f-336" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-13" decimals="INF" id="f-337" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-1" decimals="INF" id="f-338" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-339">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers investments with an original maturity greater than three months and remaining maturities less than 12 months to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its marketable debt securities as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the estimated fair value of a marketable debt security is below its amortized cost basis, the Company evaluates whether it is more likely than not that the Company will be required to sell the security before its anticipated recovery in market value and whether credit losses exist for the related securities. Credit-related losses are recognized as an allowance for credit losses on the balance sheet with a corresponding adjustment to earnings. Unrealized gains and losses that are unrelated to credit deterioration are reported in accumulated other comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-340">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-341">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2026, in connection with the launch of our Early Access Program and other commercialization activities, we began capitalizing inventory costs. Inventory is stated at the lower of cost or net realizable value with cost determined using a standard cost system, which approximates actual costs determined on the first-in first-out basis. Standard costs are reviewed and updated periodically to ensure they remain representative of current production costs. Materials that may be utilized for either commercial or, alternatively, for research and development purposes, are classified as inventory, specifically as raw materials and supplies. Amounts in inventory used for research and development purposes are charged to research and development expense when the item enters the research and development process and can no longer be used for commercial purposes. During the six months ended June 30, 2026, $0.5 million was charged to research and development expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions for slow-moving, excess or obsolete inventories are recorded when required to reduce inventory values to their estimated net realizable values. For the quarter ended June&#160;30, 2026, the Company did not have any inventory reserves. As of June&#160;30, 2026, the Company had inventory of $0.6 million recorded in prepaid expenses and other current assets in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <naut:InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory contextRef="c-1" decimals="-5" id="f-342" unitRef="usd">500000</naut:InventoryForLongTermContractsOrProgramsResearchAndDevelopmentExpenseIncludedInInventory>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-5" id="f-343" unitRef="usd">600000</us-gaap:InventoryNet>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-344">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within interest expense and amortization in the Company&#x2019;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-345">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#x2019; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2026 and 2025, net unrealized gains and losses on marketable debt securities were included as a component of comprehensive income (loss).</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-346">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2024-03, Income Statement&#x2014;Reporting Comprehensive Income&#x2014;Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The ASU is effective for the Company for the fiscal year ending December 31, 2027 and for interim periods beginning after December 31, 2027. The Company does not anticipate adoption to have a material impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-347">Fair Value Measurements&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2026 and December&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.457%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments have a contractual maturity date that is one year or less from the respective balance sheet date. Long-term investments have a contractual maturity date that is more than one year, but less than two years from the respective balance sheet date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unrealized losses and fair values of available-for-sale securities that have been in an unrealized loss position for a period of less than and greater than 12 months as of June&#160;30, 2026 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x3164;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities in Unrealized Loss Position Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities in Unrealized Loss Position Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Market Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Market Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Market Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed its investment portfolio based on the underlying risk profile of the securities and have  no loss expectation for these investments. The Company reviewed the securities in an unrealized loss position and evaluated the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. The Company recognized no credit losses during the three and six months ended June 30, 2026 and 2025, and had no allowance for credit losses as of June&#160;30, 2026 and December&#160;31, 2025.&lt;/span&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-348">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2026 and December&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.457%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.393%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.814%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.141%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-65" decimals="-3" id="f-349" unitRef="usd">697000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-65" decimals="-3" id="f-350" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-65" decimals="-3" id="f-351" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-65" decimals="-3" id="f-352" unitRef="usd">697000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-66" decimals="-3" id="f-353" unitRef="usd">697000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-67" decimals="-3" id="f-354" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-68" decimals="-3" id="f-355" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-69" decimals="-3" id="f-356" unitRef="usd">87530000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-69" decimals="-3" id="f-357" unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-69" decimals="-3" id="f-358" unitRef="usd">253000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-69" decimals="-3" id="f-359" unitRef="usd">87287000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-70" decimals="-3" id="f-360" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-71" decimals="-3" id="f-361" unitRef="usd">52031000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-72" decimals="-3" id="f-362" unitRef="usd">35256000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-73" decimals="-3" id="f-363" unitRef="usd">88227000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-73" decimals="-3" id="f-364" unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-73" decimals="-3" id="f-365" unitRef="usd">253000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-73" decimals="-3" id="f-366" unitRef="usd">87984000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-74" decimals="-3" id="f-367" unitRef="usd">697000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-75" decimals="-3" id="f-368" unitRef="usd">52031000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-76" decimals="-3" id="f-369" unitRef="usd">35256000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-77" decimals="-3" id="f-370" unitRef="usd">13960000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-77" decimals="-3" id="f-371" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-77" decimals="-3" id="f-372" unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-77" decimals="-3" id="f-373" unitRef="usd">13958000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-78" decimals="-3" id="f-374" unitRef="usd">11978000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-79" decimals="-3" id="f-375" unitRef="usd">1980000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-80" decimals="-3" id="f-376" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-81" decimals="-3" id="f-377" unitRef="usd">1679000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-81" decimals="-3" id="f-378" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-81" decimals="-3" id="f-379" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-81" decimals="-3" id="f-380" unitRef="usd">1678000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-82" decimals="-3" id="f-381" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-83" decimals="-3" id="f-382" unitRef="usd">1678000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-84" decimals="-3" id="f-383" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-85" decimals="-3" id="f-384" unitRef="usd">25160000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-85" decimals="-3" id="f-385" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-85" decimals="-3" id="f-386" unitRef="usd">85000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-85" decimals="-3" id="f-387" unitRef="usd">25075000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-86" decimals="-3" id="f-388" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-87" decimals="-3" id="f-389" unitRef="usd">15176000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-88" decimals="-3" id="f-390" unitRef="usd">9899000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-89" decimals="-3" id="f-391" unitRef="usd">40799000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-89" decimals="-3" id="f-392" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-89" decimals="-3" id="f-393" unitRef="usd">88000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-89" decimals="-3" id="f-394" unitRef="usd">40711000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-90" decimals="-3" id="f-395" unitRef="usd">11978000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-91" decimals="-3" id="f-396" unitRef="usd">18834000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-92" decimals="-3" id="f-397" unitRef="usd">9899000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="-3" id="f-398" unitRef="usd">129026000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="-3" id="f-399" unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="-3" id="f-400" unitRef="usd">341000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="-3" id="f-401" unitRef="usd">128695000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-93" decimals="-3" id="f-402" unitRef="usd">12675000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-94" decimals="-3" id="f-403" unitRef="usd">70865000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-95" decimals="-3" id="f-404" unitRef="usd">45155000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-96" decimals="-3" id="f-405" unitRef="usd">1528000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-96" decimals="-3" id="f-406" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-96" decimals="-3" id="f-407" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-96" decimals="-3" id="f-408" unitRef="usd">1528000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-97" decimals="-3" id="f-409" unitRef="usd">1528000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-3" id="f-410" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-99" decimals="-3" id="f-411" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-100" decimals="-3" id="f-412" unitRef="usd">90066000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-100" decimals="-3" id="f-413" unitRef="usd">208000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-100" decimals="-3" id="f-414" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-3" id="f-415" unitRef="usd">90274000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-3" id="f-416" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-3" id="f-417" unitRef="usd">49489000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-3" id="f-418" unitRef="usd">40785000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-104" decimals="-3" id="f-419" unitRef="usd">91594000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-104" decimals="-3" id="f-420" unitRef="usd">208000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-104" decimals="-3" id="f-421" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" decimals="-3" id="f-422" unitRef="usd">91802000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-3" id="f-423" unitRef="usd">1528000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-3" id="f-424" unitRef="usd">49489000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-107" decimals="-3" id="f-425" unitRef="usd">40785000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-108" decimals="-3" id="f-426" unitRef="usd">15321000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-108" decimals="-3" id="f-427" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-108" decimals="-3" id="f-428" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-108" decimals="-3" id="f-429" unitRef="usd">15321000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-109" decimals="-3" id="f-430" unitRef="usd">10379000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-110" decimals="-3" id="f-431" unitRef="usd">4942000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-3" id="f-432" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-112" decimals="-3" id="f-433" unitRef="usd">1668000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-112" decimals="-3" id="f-434" unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-112" decimals="-3" id="f-435" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" decimals="-3" id="f-436" unitRef="usd">1669000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-3" id="f-437" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-3" id="f-438" unitRef="usd">1669000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-3" id="f-439" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-116" decimals="-3" id="f-440" unitRef="usd">46838000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-116" decimals="-3" id="f-441" unitRef="usd">46000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-116" decimals="-3" id="f-442" unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-3" id="f-443" unitRef="usd">46872000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-3" id="f-444" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-3" id="f-445" unitRef="usd">34918000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-3" id="f-446" unitRef="usd">11954000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-120" decimals="-3" id="f-447" unitRef="usd">63827000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-120" decimals="-3" id="f-448" unitRef="usd">48000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-120" decimals="-3" id="f-449" unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-120" decimals="-3" id="f-450" unitRef="usd">63862000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-121" decimals="-3" id="f-451" unitRef="usd">10379000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-122" decimals="-3" id="f-452" unitRef="usd">41529000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-123" decimals="-3" id="f-453" unitRef="usd">11954000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-4" decimals="-3" id="f-454" unitRef="usd">155421000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-4" decimals="-3" id="f-455" unitRef="usd">256000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-4" decimals="-3" id="f-456" unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-3" id="f-457" unitRef="usd">155664000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-124" decimals="-3" id="f-458" unitRef="usd">11907000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-125" decimals="-3" id="f-459" unitRef="usd">91018000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-126" decimals="-3" id="f-460" unitRef="usd">52739000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-461">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unrealized losses and fair values of available-for-sale securities that have been in an unrealized loss position for a period of less than and greater than 12 months as of June&#160;30, 2026 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x3164;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.515%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities in Unrealized Loss Position Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities in Unrealized Loss Position Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Market Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Market Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Market Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-127" decimals="-3" id="f-462" unitRef="usd">253000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-127" decimals="-3" id="f-463" unitRef="usd">69867000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-127" decimals="-3" id="f-464" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-127" decimals="-3" id="f-465" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-127" decimals="-3" id="f-466" unitRef="usd">253000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-127" decimals="-3" id="f-467" unitRef="usd">69867000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-128" decimals="-3" id="f-468" unitRef="usd">2000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-128" decimals="-3" id="f-469" unitRef="usd">13958000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-128" decimals="-3" id="f-470" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-128" decimals="-3" id="f-471" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-128" decimals="-3" id="f-472" unitRef="usd">2000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-128" decimals="-3" id="f-473" unitRef="usd">13958000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-129" decimals="-3" id="f-474" unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-129" decimals="-3" id="f-475" unitRef="usd">1678000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-129" decimals="-3" id="f-476" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-129" decimals="-3" id="f-477" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-129" decimals="-3" id="f-478" unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-129" decimals="-3" id="f-479" unitRef="usd">1678000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-130" decimals="-3" id="f-480" unitRef="usd">84000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-130" decimals="-3" id="f-481" unitRef="usd">21584000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-130" decimals="-3" id="f-482" unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-130" decimals="-3" id="f-483" unitRef="usd">1492000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-130" decimals="-3" id="f-484" unitRef="usd">85000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-130" decimals="-3" id="f-485" unitRef="usd">23076000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss contextRef="c-3" decimals="-3" id="f-486" unitRef="usd">340000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months contextRef="c-3" decimals="-3" id="f-487" unitRef="usd">107087000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss contextRef="c-3" decimals="-3" id="f-488" unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger contextRef="c-3" decimals="-3" id="f-489" unitRef="usd">1492000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c-3" decimals="-3" id="f-490" unitRef="usd">341000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition contextRef="c-3" decimals="-3" id="f-491" unitRef="usd">108579000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease contextRef="c-14" decimals="INF" id="f-492" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease contextRef="c-13" decimals="INF" id="f-493" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease contextRef="c-1" decimals="INF" id="f-494" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease contextRef="c-15" decimals="INF" id="f-495" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-4" decimals="INF" id="f-496" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss contextRef="c-3" decimals="INF" id="f-497" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-498">Composition of Certain Condensed Consolidated Financial Statement Line Items&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prototype equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded depreciation expense of $0.3 million and $0.6 million for the three and six months ended June 30, 2026, and $0.4 million and $0.9 million for the three and six months ended June 30, 2025, respectively, which was primarily allocated to research and development expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other long-term assets (Note 8)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term assets consisted of $1.0&#160;million of restricted cash and $0.2&#160;million of deposits as of June&#160;30, 2026 and December&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-499">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prototype equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,714)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-131" decimals="-3" id="f-500" unitRef="usd">6647000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-132" decimals="-3" id="f-501" unitRef="usd">6531000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-133" decimals="-3" id="f-502" unitRef="usd">117000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-134" decimals="-3" id="f-503" unitRef="usd">118000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-135" decimals="-3" id="f-504" unitRef="usd">542000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-136" decimals="-3" id="f-505" unitRef="usd">542000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-137" decimals="-3" id="f-506" unitRef="usd">322000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-138" decimals="-3" id="f-507" unitRef="usd">322000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-139" decimals="-3" id="f-508" unitRef="usd">2326000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-140" decimals="-3" id="f-509" unitRef="usd">2258000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-141" decimals="-3" id="f-510" unitRef="usd">2759000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-142" decimals="-3" id="f-511" unitRef="usd">1807000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-512" unitRef="usd">12713000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-513" unitRef="usd">11578000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-514" unitRef="usd">8714000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-515" unitRef="usd">8121000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-516" unitRef="usd">3999000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-517" unitRef="usd">3457000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-13" decimals="-5" id="f-518" unitRef="usd">300000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-519" unitRef="usd">600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-14" decimals="-5" id="f-520" unitRef="usd">400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-15" decimals="-5" id="f-521" unitRef="usd">900000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-523">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-522">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-524" unitRef="usd">1992000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-525" unitRef="usd">2514000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <naut:AccruedResearchAndDevelopmentCurrent contextRef="c-3" decimals="-3" id="f-526" unitRef="usd">703000</naut:AccruedResearchAndDevelopmentCurrent>
    <naut:AccruedResearchAndDevelopmentCurrent contextRef="c-4" decimals="-3" id="f-527" unitRef="usd">221000</naut:AccruedResearchAndDevelopmentCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-3" id="f-528" unitRef="usd">398000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-529" unitRef="usd">259000</us-gaap:AccruedProfessionalFeesCurrent>
    <naut:GrantLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-530" unitRef="usd">224000</naut:GrantLiabilitiesCurrent>
    <naut:GrantLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-531" unitRef="usd">0</naut:GrantLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-532" unitRef="usd">236000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-533" unitRef="usd">183000</us-gaap:OtherSundryLiabilitiesCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-534" unitRef="usd">3553000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-535" unitRef="usd">3177000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock contextRef="c-1" id="f-537">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other long-term assets (Note 8)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-536">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other long-term assets (Note 8)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-538" unitRef="usd">13166000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-539" unitRef="usd">12388000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-3" decimals="-3" id="f-540" unitRef="usd">1002000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-4" decimals="-3" id="f-541" unitRef="usd">1002000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-542" unitRef="usd">14168000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-543" unitRef="usd">13390000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-5" id="f-544" unitRef="usd">1000000.0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-3" decimals="-5" id="f-545" unitRef="usd">1000000.0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c-3" decimals="-5" id="f-546" unitRef="usd">200000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="c-4" decimals="-5" id="f-547" unitRef="usd">200000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-548">Common Stock&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were 127,224,640 shares issued and outstanding as of June&#160;30, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Reserved for Future Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,974,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,341,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,270,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,697,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of common stock reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,963,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,130,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-549" unitRef="shares">127224640</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-550" unitRef="shares">127224640</us-gaap:CommonStockSharesIssued>
    <naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock contextRef="c-1" id="f-551">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,974,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,341,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,270,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,697,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of common stock reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,963,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,130,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-143" decimals="0" id="f-552" unitRef="shares">32974336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-144" decimals="0" id="f-553" unitRef="shares">29341567</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-3" decimals="0" id="f-554" unitRef="shares">19291337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="0" id="f-555" unitRef="shares">17270870</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-145" decimals="0" id="f-556" unitRef="shares">6697982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-146" decimals="0" id="f-557" unitRef="shares">5518072</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-3" decimals="0" id="f-558" unitRef="shares">58963655</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-4" decimals="0" id="f-559" unitRef="shares">52130509</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-560">Income Taxes &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. For the three and six months ended June 30, 2026 and 2025, no income tax expense or benefit was recognized, due to a full valuation allowance recorded against its deferred tax assets. For three and six months ended June 30, 2026 and 2025, the effective tax rate was 0%, primarily due to a valuation allowance recorded against the net deferred tax asset balance.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-14" decimals="INF" id="f-561" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="INF" id="f-562" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="INF" id="f-563" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-15" decimals="INF" id="f-564" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-13"
      decimals="INF"
      id="f-565"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-14"
      decimals="INF"
      id="f-566"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="INF" id="f-567" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-15"
      decimals="INF"
      id="f-568"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-569">Equity Incentive Plans and Stock-based Compensation&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 8, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (&#x201c;2021 Plan&#x201d;) and the 2021 Employee Stock Purchase Plan (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;2021 ESPP&#x201d;). As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2026, 32,974,336 and 6,697,982 shares were available for grant under the 2021 Plan and 2021 ESPP, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2021 ESPP, participants are permitted to purchase shares of Common Stock, up to the IRS allowable limit, through contributions (in the form of payroll deductions or otherwise to the extent permitted by the administrator of the 2021 ESPP) of up to 15% of their eligible compensation.  Participants are permitted to purchase shares of the Company&#x2019;s Common Stock at 85% of the lower of the fair market value of the Company&#x2019;s Common Stock on the first trading day of an offering period or on the last trading date in each purchase period. The Company offers a six month purchase period. Participants may end their participation at any time during an offering and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The number of shares of common stock available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year in an amount equal to the least of (i) 3,734,500 shares of common stock, (ii) a number of s&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hares of common stock equal to one percent (1%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year. On January 1, 2026, the number of shares available under the 2021 ESPP increased by 1,264,696 shares pursuant to this feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2021 Plan, the Company can grant incentive stock options, nonstatutory stock options, stock appreciation rig&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hts, restricted stock, restricted stock units and performance awards to employees, non-employee directors and consultants. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options generally expire ten years after the date of grant. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of shares available for issuance under the 2021 Plan will be increased on the first day of each fiscal year in an amount equal to the least of (i) 18,672,200 shares, (ii) a number of shares equal to five percent (5%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On January 1, 2026, the number of shares available under the 2021 Plan increased by 6,323,480 shares pursuant to this feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2017 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the time of adoption of the 2021 Plan and the 2021 ESPP, no further awards will be granted under the 2017 Equity Incentive Plan (&#x201c;2017 Plan&#x201d;). Stock-based awards forfeited or cancelled from the 2017 Plan are returned to the pool of shares of Common Stock available for issuance under the 2021 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Grant Date Fair Value of Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the compensation cost of the option awards, the fair value for each option award has been estimated using the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Black Scholes model&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The significant assumptions used in these calculations are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.0  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.5% - 80.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5% - 103.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.5% - 82.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5% - 103.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.91% - 4.29%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.90% - 4.04%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.69% - 4.29%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.90% - 4.04%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term: The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding. The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#x201c;simplified method,&#x201d; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility: We became a public company in 2021 following the Business Combination, and as such, the Company lacked company&#x2011;specific historical and implied volatility information to solely utilize its own data for purposes of establishing the volatility assumption for use in the Black-Scholes model. Therefore, we estimate our expected volatility of the Company&#x2019;s common stock based on a mix of company-specific historical volatility and an average of historical volatilities of selected industry peers deemed to be comparable to the Company&#x2019;s business corresponding to the expected term of the awards. The Company will continue to apply this process until an adequate amount of historical information regarding the volatility of its own stock price becomes available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividend yield: The expected dividend rate is zero as the Company has no history or expectation of declaring dividends on its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes option award activity during the six months ended June 30, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Stock Option Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,270,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,614,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(670,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(923,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June&#160;30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of June&#160;30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at June&#160;30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,308,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2026, there was $10.1 million of total unrecognized compensation expense expected to be recognized over a weighted average-period of 2.8 years. Aggregate intrinsic value represents the difference between the fair market value of the common stock and the exercise price of outstanding, in-the-money options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the total stock-based compensation expense included in the Company&#x2019;s condensed consolidated statement of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.130%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.364%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense included within cost of service revenue was not material for the three and six months ended June 30, 2026.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-143" decimals="0" id="f-570" unitRef="shares">32974336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-145" decimals="0" id="f-571" unitRef="shares">6697982</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate contextRef="c-147" decimals="2" id="f-572" unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="c-148" decimals="2" id="f-573" unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod contextRef="c-149" id="f-574">P6M</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPurchasePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="c-149" decimals="0" id="f-575" unitRef="shares">3734500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum contextRef="c-149" decimals="2" id="f-576" unitRef="number">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant contextRef="c-150" decimals="0" id="f-577" unitRef="shares">1264696</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-151" id="f-578">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="c-151" decimals="0" id="f-579" unitRef="shares">18672200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum contextRef="c-151" decimals="2" id="f-580" unitRef="number">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant contextRef="c-152" decimals="0" id="f-581" unitRef="shares">6323480</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-582">The significant assumptions used in these calculations are summarized as follows:&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:28.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.047%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.049%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.0  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.5% - 80.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5% - 103.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.5% - 82.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5% - 103.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.91% - 4.29%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.90% - 4.04%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.69% - 4.29%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.90% - 4.04%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-153" id="f-583">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-154" id="f-584">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-155" id="f-585">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-156" id="f-586">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-157" id="f-587">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-158" id="f-588">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-159" id="f-589">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-160" id="f-590">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-161" decimals="3" id="f-591" unitRef="number">0.755</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-161" decimals="3" id="f-592" unitRef="number">0.807</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-162" decimals="3" id="f-593" unitRef="number">0.975</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-162" decimals="3" id="f-594" unitRef="number">1.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-163" decimals="3" id="f-595" unitRef="number">0.755</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-163" decimals="3" id="f-596" unitRef="number">0.820</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-164" decimals="3" id="f-597" unitRef="number">0.975</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-164" decimals="3" id="f-598" unitRef="number">1.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-161" decimals="3" id="f-599" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-162" decimals="3" id="f-600" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-163" decimals="3" id="f-601" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-164" decimals="3" id="f-602" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-161" decimals="4" id="f-603" unitRef="number">0.0391</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-161" decimals="4" id="f-604" unitRef="number">0.0429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-162" decimals="4" id="f-605" unitRef="number">0.0390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-162" decimals="4" id="f-606" unitRef="number">0.0404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-163" decimals="4" id="f-607" unitRef="number">0.0369</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-163" decimals="4" id="f-608" unitRef="number">0.0429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-164" decimals="4" id="f-609" unitRef="number">0.0390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-164" decimals="4" id="f-610" unitRef="number">0.0404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-163"
      decimals="INF"
      id="f-611"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="c-1" id="f-612">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes option award activity during the six months ended June 30, 2026:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Stock Option Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,270,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,614,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(670,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(923,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June&#160;30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of June&#160;30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at June&#160;30, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,308,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="0" id="f-613" unitRef="shares">17270870</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-614"
      unitRef="usdPerShare">3.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="0" id="f-615" unitRef="shares">3614000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-616"
      unitRef="usdPerShare">2.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="0" id="f-617" unitRef="shares">670244</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-618"
      unitRef="usdPerShare">1.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="0" id="f-619" unitRef="shares">923289</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-620"
      unitRef="usdPerShare">2.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-3" decimals="0" id="f-621" unitRef="shares">19291337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-622"
      unitRef="usdPerShare">3.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-623">P7Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-3" decimals="-3" id="f-624" unitRef="usd">4701000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c-3" decimals="0" id="f-625" unitRef="shares">19291337</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-626"
      unitRef="usdPerShare">3.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c-3" decimals="0" id="f-627" unitRef="shares">12308094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-628"
      unitRef="usdPerShare">3.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-629">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-3" decimals="-3" id="f-630" unitRef="usd">2986000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-3" decimals="-5" id="f-631" unitRef="usd">10100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-632">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-633">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the total stock-based compensation expense included in the Company&#x2019;s condensed consolidated statement of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.130%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.364%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-165" decimals="-3" id="f-634" unitRef="usd">459000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-166" decimals="-3" id="f-635" unitRef="usd">686000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-167" decimals="-3" id="f-636" unitRef="usd">982000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-168" decimals="-3" id="f-637" unitRef="usd">1454000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-169" decimals="-3" id="f-638" unitRef="usd">699000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-170" decimals="-3" id="f-639" unitRef="usd">1023000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-171" decimals="-3" id="f-640" unitRef="usd">1538000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-172" decimals="-3" id="f-641" unitRef="usd">2423000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-161" decimals="-3" id="f-642" unitRef="usd">1158000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-162" decimals="-3" id="f-643" unitRef="usd">1709000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-163" decimals="-3" id="f-644" unitRef="usd">2520000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-164" decimals="-3" id="f-645" unitRef="usd">3877000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-173" decimals="INF" id="f-646" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-174" decimals="INF" id="f-647" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-648">Commitments and Contingencies &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2026 as the Company had not yet received the related goods or services. As of June&#160;30, 2026, the Company had open purchase commitments for goods and services of $3.2 million, of which $3.0 million are expected to be received through the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#x2019;s results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, San Carlos, California, and San Diego, California. The Company's operating lease in San Diego expired during the six months ended June 30, 2026, and was replaced by a new lease that qualifies for the short-term lease exemption under ASC 842, and therefore is not recorded on the  condensed consolidated balance sheet as of June&#160;30, 2026. The letter of credit associated with the prior San Diego lease was released in the third quarter of 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2026:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ending December&#160;31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June 30, 2026 and 2025, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $3.5 million and $3.6 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has $1.0 million in cash-collateralized letters of credit with one financial institution in lieu of security deposits in connection with the San Carlos and San Diego lease agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. &lt;/span&gt;&lt;/div&gt;The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LongTermPurchaseCommitmentAmount contextRef="c-1" decimals="-5" id="f-649" unitRef="usd">3200000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths contextRef="c-3" decimals="-5" id="f-650" unitRef="usd">3000000.0</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-651">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2026:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ending December&#160;31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2031 and thereafter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-652" unitRef="usd">2814000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-653" unitRef="usd">6889000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-654" unitRef="usd">6540000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-655" unitRef="usd">6310000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-656" unitRef="usd">6495000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <naut:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour contextRef="c-3" decimals="-3" id="f-657" unitRef="usd">5735000</naut:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-658" unitRef="usd">34783000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-659" unitRef="usd">6967000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-660" unitRef="usd">27816000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-661" unitRef="usd">3500000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-15" decimals="-5" id="f-662" unitRef="usd">3600000</us-gaap:OperatingLeasePayments>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-3" decimals="-5" id="f-663" unitRef="usd">1000000.0</us-gaap:LettersOfCreditOutstandingAmount>
    <naut:NumberOfFinancialInstitution
      contextRef="c-3"
      decimals="INF"
      id="f-664"
      unitRef="institution">1</naut:NumberOfFinancialInstitution>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-665">Basic and Diluted Net Loss per Share&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of the Company&#x2019;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2026 and 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.970%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,135,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,204,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,886,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,174,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three and Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,996,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total potentially dilutive common share equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,378,712&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,118,903&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-666">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of the Company&#x2019;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2026 and 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.970%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.361%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,135,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,204,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,886,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,174,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-13" decimals="-3" id="f-667" unitRef="usd">-14469000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-13" decimals="-3" id="f-668" unitRef="usd">-14469000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-14" decimals="-3" id="f-669" unitRef="usd">-15033000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-14" decimals="-3" id="f-670" unitRef="usd">-15033000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-671" unitRef="usd">-29166000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-3" id="f-672" unitRef="usd">-29166000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-15" decimals="-3" id="f-673" unitRef="usd">-31646000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-15" decimals="-3" id="f-674" unitRef="usd">-31646000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="0" id="f-675" unitRef="shares">127135738</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="0" id="f-676" unitRef="shares">127135738</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-14" decimals="0" id="f-677" unitRef="shares">126204632</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-14" decimals="0" id="f-678" unitRef="shares">126204632</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-679" unitRef="shares">126886646</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-680" unitRef="shares">126886646</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-15" decimals="0" id="f-681" unitRef="shares">126174603</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-15" decimals="0" id="f-682" unitRef="shares">126174603</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-683"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-13"
      decimals="2"
      id="f-684"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-685"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-14"
      decimals="2"
      id="f-686"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-687"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-688"
      unitRef="usdPerShare">-0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-15"
      decimals="2"
      id="f-689"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-15"
      decimals="2"
      id="f-690"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-691">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three and Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,291,337&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,996,250&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,653&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total potentially dilutive common share equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,378,712&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,118,903&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-175" decimals="0" id="f-692" unitRef="shares">19291337</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-176" decimals="0" id="f-693" unitRef="shares">19291337</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-177" decimals="0" id="f-694" unitRef="shares">18996250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-178" decimals="0" id="f-695" unitRef="shares">18996250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-179" decimals="0" id="f-696" unitRef="shares">87375</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-180" decimals="0" id="f-697" unitRef="shares">87375</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-181" decimals="0" id="f-698" unitRef="shares">122653</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-182" decimals="0" id="f-699" unitRef="shares">122653</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-13" decimals="0" id="f-700" unitRef="shares">19378712</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-701" unitRef="shares">19378712</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-14" decimals="0" id="f-702" unitRef="shares">19118903</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-15" decimals="0" id="f-703" unitRef="shares">19118903</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-704">Segment Information&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Chief Executive Officer is its CODM. The Company&#x2019;s CODM uses consolidated net loss in assessing operating decisions, allocating resources and evaluating financial performance. Consolidated net loss is used to monitor budget versus actual results. The Company included a summary of the segment net loss, including significant segment expenses for its single reportable segment: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.000%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and related benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional services and laboratory expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facilities expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation to net loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Footnotes:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other segment items for the Company&#x2019;s single reportable segment include travel and entertainment, insurance, tax, expensed computer hardware and software, depreciation, and other miscellaneous expenses.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-705">The Company included a summary of the segment net loss, including significant segment expenses for its single reportable segment: &lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.000%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.448%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:1.5pt 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and related benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional services and laboratory expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facilities expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reconciliation to net loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:1.5pt 0 1.5pt 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0 1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:1.5pt 1pt 1.5pt 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:94.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:1.5pt 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Footnotes:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:1.5pt 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other segment items for the Company&#x2019;s single reportable segment include travel and entertainment, insurance, tax, expensed computer hardware and software, depreciation, and other miscellaneous expenses.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues contextRef="c-183" decimals="-3" id="f-706" unitRef="usd">190000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-184" decimals="-3" id="f-707" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-185" decimals="-3" id="f-708" unitRef="usd">190000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-186" decimals="-3" id="f-709" unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c-183" decimals="-3" id="f-710" unitRef="usd">15000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-184" decimals="-3" id="f-711" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-185" decimals="-3" id="f-712" unitRef="usd">15000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-186" decimals="-3" id="f-713" unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:LaborAndRelatedExpense contextRef="c-183" decimals="-3" id="f-714" unitRef="usd">7573000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-184" decimals="-3" id="f-715" unitRef="usd">7946000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-185" decimals="-3" id="f-716" unitRef="usd">15256000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c-186" decimals="-3" id="f-717" unitRef="usd">16969000</us-gaap:LaborAndRelatedExpense>
    <naut:ProfessionalServicesAndLaboratoryExpenses contextRef="c-183" decimals="-3" id="f-718" unitRef="usd">3338000</naut:ProfessionalServicesAndLaboratoryExpenses>
    <naut:ProfessionalServicesAndLaboratoryExpenses contextRef="c-184" decimals="-3" id="f-719" unitRef="usd">3240000</naut:ProfessionalServicesAndLaboratoryExpenses>
    <naut:ProfessionalServicesAndLaboratoryExpenses contextRef="c-185" decimals="-3" id="f-720" unitRef="usd">6516000</naut:ProfessionalServicesAndLaboratoryExpenses>
    <naut:ProfessionalServicesAndLaboratoryExpenses contextRef="c-186" decimals="-3" id="f-721" unitRef="usd">6429000</naut:ProfessionalServicesAndLaboratoryExpenses>
    <naut:FacilityExpenses contextRef="c-183" decimals="-3" id="f-722" unitRef="usd">2550000</naut:FacilityExpenses>
    <naut:FacilityExpenses contextRef="c-184" decimals="-3" id="f-723" unitRef="usd">2827000</naut:FacilityExpenses>
    <naut:FacilityExpenses contextRef="c-185" decimals="-3" id="f-724" unitRef="usd">5167000</naut:FacilityExpenses>
    <naut:FacilityExpenses contextRef="c-186" decimals="-3" id="f-725" unitRef="usd">5839000</naut:FacilityExpenses>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-183" decimals="-3" id="f-726" unitRef="usd">1158000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-184" decimals="-3" id="f-727" unitRef="usd">1709000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-185" decimals="-3" id="f-728" unitRef="usd">2520000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-186" decimals="-3" id="f-729" unitRef="usd">3877000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-183" decimals="-3" id="f-730" unitRef="usd">1319000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-184" decimals="-3" id="f-731" unitRef="usd">1375000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-185" decimals="-3" id="f-732" unitRef="usd">2603000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-186" decimals="-3" id="f-733" unitRef="usd">2827000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingExpenses contextRef="c-183" decimals="-3" id="f-734" unitRef="usd">15938000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-184" decimals="-3" id="f-735" unitRef="usd">17097000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-185" decimals="-3" id="f-736" unitRef="usd">32062000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-186" decimals="-3" id="f-737" unitRef="usd">35941000</us-gaap:OperatingExpenses>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-183" decimals="-3" id="f-738" unitRef="usd">1307000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-184" decimals="-3" id="f-739" unitRef="usd">2080000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-185" decimals="-3" id="f-740" unitRef="usd">2749000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-186" decimals="-3" id="f-741" unitRef="usd">4311000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-183" decimals="-3" id="f-742" unitRef="usd">-13000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-184" decimals="-3" id="f-743" unitRef="usd">-16000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-185" decimals="-3" id="f-744" unitRef="usd">-28000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-186" decimals="-3" id="f-745" unitRef="usd">-16000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-183" decimals="-3" id="f-746" unitRef="usd">-14469000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-184" decimals="-3" id="f-747" unitRef="usd">-15033000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-185" decimals="-3" id="f-748" unitRef="usd">-29166000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-186" decimals="-3" id="f-749" unitRef="usd">-31646000</us-gaap:NetIncomeLoss>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-13" id="f-751">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-13" id="f-752">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-13" id="f-753">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-13" id="f-754">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
